A M EDICAL D ICTIONARY , B IBLIOGRAPHY , AND A NNOTATED R ESEARCH G UIDE TO I NTERNET R EFERENCES
J AMES N. P ARKER , M.D. AND P HILIP M. P ARKER , P H .D., E DITORS
ii
ICON Health Publications ICON Group International, Inc. 4370 La Jolla Village Drive, 4th Floor San Diego, CA 92122 USA Copyright Ó2003 by ICON Group International, Inc. Copyright Ó2003 by ICON Group International, Inc. All rights reserved. This book is protected by copyright. No part of it may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise, without written permission from the publisher. Printed in the United States of America. Last digit indicates print number: 10 9 8 7 6 4 5 3 2 1
Publisher, Health Care: Philip Parker, Ph.D. Editor(s): James Parker, M.D., Philip Parker, Ph.D. Publisher's note: The ideas, procedures, and suggestions contained in this book are not intended for the diagnosis or treatment of a health problem. As new medical or scientific information becomes available from academic and clinical research, recommended treatments and drug therapies may undergo changes. The authors, editors, and publisher have attempted to make the information in this book up to date and accurate in accord with accepted standards at the time of publication. The authors, editors, and publisher are not responsible for errors or omissions or for consequences from application of the book, and make no warranty, expressed or implied, in regard to the contents of this book. Any practice described in this book should be applied by the reader in accordance with professional standards of care used in regard to the unique circumstances that may apply in each situation. The reader is advised to always check product information (package inserts) for changes and new information regarding dosage and contraindications before prescribing any drug or pharmacological product. Caution is especially urged when using new or infrequently ordered drugs, herbal remedies, vitamins and supplements, alternative therapies, complementary therapies and medicines, and integrative medical treatments. Cataloging-in-Publication Data Parker, James N., 1961Parker, Philip M., 1960Autism: A Medical Dictionary, Bibliography, and Annotated Research Guide to Internet References / James N. Parker and Philip M. Parker, editors p. cm. Includes bibliographical references, glossary, and index. ISBN: 0-597-83701-5 1. Autism-Popular works. I. Title.
iii
Disclaimer This publication is not intended to be used for the diagnosis or treatment of a health problem. It is sold with the understanding that the publisher, editors, and authors are not engaging in the rendering of medical, psychological, financial, legal, or other professional services. References to any entity, product, service, or source of information that may be contained in this publication should not be considered an endorsement, either direct or implied, by the publisher, editors, or authors. ICON Group International, Inc., the editors, and the authors are not responsible for the content of any Web pages or publications referenced in this publication.
Copyright Notice If a physician wishes to copy limited passages from this book for patient use, this right is automatically granted without written permission from ICON Group International, Inc. (ICON Group). However, all of ICON Group publications have copyrights. With exception to the above, copying our publications in whole or in part, for whatever reason, is a violation of copyright laws and can lead to penalties and fines. Should you want to copy tables, graphs, or other materials, please contact us to request permission (E-mail:
[email protected]). ICON Group often grants permission for very limited reproduction of our publications for internal use, press releases, and academic research. Such reproduction requires confirmed permission from ICON Group International Inc. The disclaimer above must accompany all reproductions, in whole or in part, of this book.
iv
Acknowledgements The collective knowledge generated from academic and applied research summarized in various references has been critical in the creation of this book which is best viewed as a comprehensive compilation and collection of information prepared by various official agencies which produce publications on autism. Books in this series draw from various agencies and institutions associated with the United States Department of Health and Human Services, and in particular, the Office of the Secretary of Health and Human Services (OS), the Administration for Children and Families (ACF), the Administration on Aging (AOA), the Agency for Healthcare Research and Quality (AHRQ), the Agency for Toxic Substances and Disease Registry (ATSDR), the Centers for Disease Control and Prevention (CDC), the Food and Drug Administration (FDA), the Healthcare Financing Administration (HCFA), the Health Resources and Services Administration (HRSA), the Indian Health Service (IHS), the institutions of the National Institutes of Health (NIH), the Program Support Center (PSC), and the Substance Abuse and Mental Health Services Administration (SAMHSA). In addition to these sources, information gathered from the National Library of Medicine, the United States Patent Office, the European Union, and their related organizations has been invaluable in the creation of this book. Some of the work represented was financially supported by the Research and Development Committee at INSEAD. This support is gratefully acknowledged. Finally, special thanks are owed to Tiffany Freeman for her excellent editorial support.
v
About the Editors James N. Parker, M.D. Dr. James N. Parker received his Bachelor of Science degree in Psychobiology from the University of California, Riverside and his M.D. from the University of California, San Diego. In addition to authoring numerous research publications, he has lectured at various academic institutions. Dr. Parker is the medical editor for health books by ICON Health Publications.
Philip M. Parker, Ph.D. Philip M. Parker is the Eli Lilly Chair Professor of Innovation, Business and Society at INSEAD (Fontainebleau, France and Singapore). Dr. Parker has also been Professor at the University of California, San Diego and has taught courses at Harvard University, the Hong Kong University of Science and Technology, the Massachusetts Institute of Technology, Stanford University, and UCLA. Dr. Parker is the associate editor for ICON Health Publications.
vi
About ICON Health Publications To discover more about ICON Health Publications, simply check with your preferred online booksellers, including Barnes & Noble.com and Amazon.com which currently carry all of our titles. Or, feel free to contact us directly for bulk purchases or institutional discounts: ICON Group International, Inc. 4370 La Jolla Village Drive, Fourth Floor San Diego, CA 92122 USA Fax: 858-546-4341 Web site: www.icongrouponline.com/health
vii
Table of Contents FORWARD .......................................................................................................................................... 1 CHAPTER 1. STUDIES ON AUTISM ..................................................................................................... 3 Overview........................................................................................................................................ 3 The Combined Health Information Database................................................................................. 3 Federally Funded Research on Autism ........................................................................................ 16 E-Journals: PubMed Central ....................................................................................................... 70 The National Library of Medicine: PubMed ................................................................................ 71 CHAPTER 2. NUTRITION AND AUTISM ......................................................................................... 157 Overview.................................................................................................................................... 157 Finding Nutrition Studies on Autism ....................................................................................... 157 Federal Resources on Nutrition ................................................................................................. 166 Additional Web Resources ......................................................................................................... 166 CHAPTER 3. ALTERNATIVE MEDICINE AND AUTISM ................................................................... 169 Overview.................................................................................................................................... 169 National Center for Complementary and Alternative Medicine................................................ 169 Additional Web Resources ......................................................................................................... 180 General References ..................................................................................................................... 182 CHAPTER 4. DISSERTATIONS ON AUTISM ..................................................................................... 183 Overview.................................................................................................................................... 183 Dissertations on Autism ............................................................................................................ 183 Keeping Current ........................................................................................................................ 207 CHAPTER 5. CLINICAL TRIALS AND AUTISM ................................................................................ 209 Overview.................................................................................................................................... 209 Recent Trials on Autism ............................................................................................................ 209 Keeping Current on Clinical Trials ........................................................................................... 214 CHAPTER 6. PATENTS ON AUTISM ................................................................................................ 217 Overview.................................................................................................................................... 217 Patents on Autism ..................................................................................................................... 217 Patent Applications on Autism ................................................................................................. 228 Keeping Current ........................................................................................................................ 234 CHAPTER 7. BOOKS ON AUTISM.................................................................................................... 235 Overview.................................................................................................................................... 235 Book Summaries: Federal Agencies............................................................................................ 235 Book Summaries: Online Booksellers......................................................................................... 241 The National Library of Medicine Book Index ........................................................................... 268 Chapters on Autism ................................................................................................................... 270 Directories.................................................................................................................................. 281 CHAPTER 8. MULTIMEDIA ON AUTISM ......................................................................................... 283 Overview.................................................................................................................................... 283 Video Recordings ....................................................................................................................... 283 Audio Recordings....................................................................................................................... 286 Bibliography: Multimedia on Autism ........................................................................................ 286 CHAPTER 9. PERIODICALS AND NEWS ON AUTISM ...................................................................... 289 Overview.................................................................................................................................... 289 News Services and Press Releases.............................................................................................. 289 Newsletter Articles .................................................................................................................... 294 Academic Periodicals covering Autism...................................................................................... 294 CHAPTER 10. RESEARCHING MEDICATIONS................................................................................. 297 Overview.................................................................................................................................... 297 U.S. Pharmacopeia..................................................................................................................... 297 Commercial Databases ............................................................................................................... 298
viii Contents
Researching Orphan Drugs ....................................................................................................... 299 APPENDIX A. PHYSICIAN RESOURCES .......................................................................................... 303 Overview.................................................................................................................................... 303 NIH Guidelines.......................................................................................................................... 303 NIH Databases........................................................................................................................... 305 Other Commercial Databases..................................................................................................... 308 The Genome Project and Autism ............................................................................................... 309 APPENDIX B. PATIENT RESOURCES ............................................................................................... 313 Overview.................................................................................................................................... 313 Patient Guideline Sources.......................................................................................................... 313 Associations and Autism ........................................................................................................... 327 Finding Associations.................................................................................................................. 330 APPENDIX C. FINDING MEDICAL LIBRARIES ................................................................................ 333 Overview.................................................................................................................................... 333 Preparation................................................................................................................................. 333 Finding a Local Medical Library................................................................................................ 333 Medical Libraries in the U.S. and Canada ................................................................................. 333 ONLINE GLOSSARIES ................................................................................................................ 339 Online Dictionary Directories ................................................................................................... 340 AUTISM DICTIONARY............................................................................................................... 341 INDEX .............................................................................................................................................. 407
1
FORWARD In March 2001, the National Institutes of Health issued the following warning: "The number of Web sites offering health-related resources grows every day. Many sites provide valuable information, while others may have information that is unreliable or misleading."1 Furthermore, because of the rapid increase in Internet-based information, many hours can be wasted searching, selecting, and printing. Since only the smallest fraction of information dealing with autism is indexed in search engines, such as www.google.com or others, a nonsystematic approach to Internet research can be not only time consuming, but also incomplete. This book was created for medical professionals, students, and members of the general public who want to know as much as possible about autism, using the most advanced research tools available and spending the least amount of time doing so. In addition to offering a structured and comprehensive bibliography, the pages that follow will tell you where and how to find reliable information covering virtually all topics related to autism, from the essentials to the most advanced areas of research. Public, academic, government, and peer-reviewed research studies are emphasized. Various abstracts are reproduced to give you some of the latest official information available to date on autism. Abundant guidance is given on how to obtain free-of-charge primary research results via the Internet. While this book focuses on the field of medicine, when some sources provide access to non-medical information relating to autism, these are noted in the text. E-book and electronic versions of this book are fully interactive with each of the Internet sites mentioned (clicking on a hyperlink automatically opens your browser to the site indicated). If you are using the hard copy version of this book, you can access a cited Web site by typing the provided Web address directly into your Internet browser. You may find it useful to refer to synonyms or related terms when accessing these Internet databases. NOTE: At the time of publication, the Web addresses were functional. However, some links may fail due to URL address changes, which is a common occurrence on the Internet. For readers unfamiliar with the Internet, detailed instructions are offered on how to access electronic resources. For readers unfamiliar with medical terminology, a comprehensive glossary is provided. For readers without access to Internet resources, a directory of medical libraries, that have or can locate references cited here, is given. We hope these resources will prove useful to the widest possible audience seeking information on autism. The Editors
1
From the NIH, National Cancer Institute (NCI): http://www.cancer.gov/cancerinfo/ten-things-to-know.
3
CHAPTER 1. STUDIES ON AUTISM Overview In this chapter, we will show you how to locate peer-reviewed references and studies on autism.
The Combined Health Information Database The Combined Health Information Database summarizes studies across numerous federal agencies. To limit your investigation to research studies and autism, you will need to use the advanced search options. First, go to http://chid.nih.gov/index.html. From there, select the “Detailed Search” option (or go directly to that page with the following hyperlink: http://chid.nih.gov/detail/detail.html). The trick in extracting studies is found in the drop boxes at the bottom of the search page where “You may refine your search by.” Select the dates and language you prefer, and the format option “Journal Article.” At the top of the search form, select the number of records you would like to see (we recommend 100) and check the box to display “whole records.” We recommend that you type “autism” (or synonyms) into the “For these words:” box. Consider using the option “anywhere in record” to make your search as broad as possible. If you want to limit the search to only a particular field, such as the title of the journal, then select this option in the “Search in these fields” drop box. The following is what you can expect from this type of search: ·
Management of the Autistic Patient by the Dental Hygienist Source: Journal of Practical Hygiene. 8(1): 19-23. January-February 1999. Contact: Available from Montage Media Corporation. 1000 Wyckoff Avenue, Mahwah, NJ 07430-3164. (201) 891-3200. Summary: As the methods of treatment for autism have shifted toward mainstreaming rather than isolation, increasing numbers of autistic patients are being treated in dental practices. In order to provide the autistic patient with the highest quality of dental health care, the hygienist should be aware of and familiar with autism. This article describes the characteristics of autism, as well as treatments, dental considerations, and management interventions useful to the practitioner. The authors briefly outline the three defined stages of autism: social impairment, rigid thought and behavior patterns,
4
Autism
and language impairment. Treatment options are then summarized, including psychodynamically oriented therapies, biological interventions (drug therapy), and behavioral interventions. The authors then note that dental appointments may be frightening for patients with autism, since many of them have had little social interaction. While most autistic patients can be treated in the dental office under standard conditions, some may require the use of sedation and the use of soft physical restraints. Although there are no known autism-related oral manifestations, oral problems may arise due to personal neglect and resistance to receiving dental care. The authors conclude with a brief discussion of the importance of educating the caregivers of people with autism. 5 figures. 2 tables. 16 references. ·
Two-Year Outcome of Preschool Children with Autism or Asperger's Syndrome Source: American Journal of Psychiatry. 157(12): 1980-1987. December 2000. Contact: Available from American Psychiatric Publishing Group. 1400 K Street NW, Washington, DC 20005. (800) 368-5777 or (202) 682-6240. E-mail:
[email protected]. Summary: Asperger's disorder is a type of pervasive developmental disorder without clinically significant cognitive or language delay. There are no data, however, on the outcome of children with Asperger's disorder or on whether their outcome differs from that of children with autism. This article reports on a study undertaken to compare the outcome of groups of children with these disorders over a period of 2 years on variables independent of the defining criteria and to identify variables that might account for these differences. Children who received a diagnosis of autism (n = 46) or Asperger's syndrome (n = 20) on the basis of a diagnostic interview and who had an IQ in the nonretarded range were given a battery of cognitive, language, and behavioral tests. Families were contacted roughly 2 years after the date of their enrollment in the study, and many of the tests were readministered. Children with Asperger's syndrome had better social skills and fewer autistic symptoms 2 years after study enrollment than the children with autism. The differences in outcome could not be explained by initial differences in IQ and language abilities. Children with autism who had developed verbal fluency at follow up were very similar to the children with Asperger's syndrome at study enrollment. The authors conclude that it appears that Asperger's disorder and autism represent parallel but potentially overlapping developmental trajectories. 3 tables. 33 references.
·
Pediatrician's Role in the Diagnosis and Management of Autistic Spectrum Disorder in Children. Technical Report Source: Pediatrics. 107(5): [18 p.]. May 2001. Contact: Available from American Academy of Pediatrics. 141 Northwest Point Boulevard, Elk Grove Village, IL 60007-1098. (888) 227-1773. Fax (847) 434-8000. E-mail:
[email protected]. Website: www.pediatrics.org. Full text of this article is available at www.pediatrics.org/cgi/content/full/107/5/e85. Summary: Autism and its milder variants are not rare. Most pediatricians will have the opportunity to care for a child with autism. This technical report serves to complement and expand on the information in the accompanying policy statement which aims to increase the pediatrician's knowledge and comfort level in caring for children with autism. In so doing, the authors anticipate that earlier diagnosis and referral for appropriate intervention will be possible. This, in turn, will have a positive effect on long term outcomes for children with autism and their families. Early management
Studies
5
strategies include parental education and support, early intervention (children younger than 3 years), school based special education (children older than 3 years), behavior management, medical treatment, community services, and alternative therapies. The authors emphasize that early diagnosis has become increasingly important, as recent studies have shown improved outcomes with implementation of early, consistent, and appropriate intervention strategies that have been individually tailored to the needs of the child and parents. The pediatrician can play a significant role by acting immediately on parental concerns, monitoring behavior and development, referring promptly for a comprehensive evaluation, searching for etiology and comorbid (coexisting illness) conditions, expediting enrollment and implementation of appropriate interventions, managing medical issues, and coordinating care among various service delivery systems. This approach could minimize the disabling aspects of ASD. 201 references. ·
Practice Parameter: Screening and Diagnosis of Autism. Report of the Quality Standards Subcommittee of the American Academy of Neurology and the Child Neurology Society Source: Neurology. 55(4): 468-479. August 22, 2000. Contact: Available from Lippincott Williams and Wilkins. 12107 Insurance Way, Hagerstown, MD 21740. (800) 638-3030 or (301) 714-2300. Fax (301) 824-7390. Summary: Autism is a common disorder of childhood, affecting 1 in 500 children. Yet, it often remains unrecognized and undiagnosed until or after late preschool age because appropriate tools for routine developmental screening and screening specifically for autism have not been available. Early identification of children with autism and intensive, early intervention during the toddler and preschool years improves outcome for most young children with autism. This article reviews the available empirical evidence in this field and offers specific recommendations for the identification of children with autism. This approach requires a dual process. Routine developmental surveillance and screening specifically for autism should be performed on all children to first identify those at risk for any type of atypical development, and then to identify those specifically at risk for autism. Second, strategies must be used to diagnose and evaluate autism, and to differentiate autism from other developmental disorders. A diagnostic algorithm is provided, as is a chart of the diagnostic criteria for autistic disorder (299.00). The article concludes with a list of consensus based general principles of management, in the areas of surveillance and screening, diagnosis, medical and neurologic evaluation, evaluation and monitoring of autism, speech, language and communication evaluation, cognitive and adaptive behavior evaluations, sensorimotor and occupational therapy evaluations, and neuropsychological, behavioral, and academic assessments. 1 figure. 1 table. 101 references.
·
Pervasive Developmental Delay in Children Presenting as Possible Hearing Loss Source: Laryngoscope. 109(1): 129-135. January 1999. Contact: Available from Lippincott Williams and Wilkins. 12107 Insurance Way, Hagerstown, MD 21740. (800) 638-3030 or (301) 714-2300. Fax (301) 824-7390. Summary: Children who fail to develop adequate language skills and or appropriate social skills by age 2 years are often referred to the department of otolaryngology for otolaryngologic examination and evaluation of possible hearing deficits. Discovering a gross disparity between hearing function and language ability often uncovers an underlying developmental disorder satisfying criteria for diagnosis on the spectrum of autism and pervasive developmental delay (PDD). This article reports on a study that
6
Autism
reviewed 4 years of charts of children presenting for possible hearing loss; the review identified 15 children who were later diagnosed with PDD. Males outnumbered females 4 to 1, with the average age of referral being 2 years. One third of the patients displayed middle ear disease that improved with PE tube placement. One third of the patients showed brainstem conduction dysfunction on auditory brainstem evoked response (ABR) testing. The authors conclude that children with developmental delays, especially higher functioning ones, may present with a myriad of language and communication deficits that are often mistakenly attributed to hearing loss. The authors stress that the otolaryngologist has a unique opportunity to identify these autistic children and initiate their evaluation and management. 5 tables. 17 references. ·
Diagnostic Assessment of Communicative and Interactive Behaviours in Children with Autism and Receptive Language Disorder Source: European Child and Adolescent Psychiatry. 9(4): 295-300. December 2000. Contact: Available from Springer-Verlag New York, Inc. Journal Fulfillment Department, P.O. Box 2485, Secaucus, NJ 07096-2485. E-mail:
[email protected]. Website: www.springer.ny.com. Summary: Children with autism and children with a severe specific receptive language disorder both show clear deficits in communicative language skills and in social relationships. This article reports on a study in which the usefulness of the Autism Diagnostic Observation Schedule (ADOS) in the differential diagnosis between these two groups of developmentally impaired children is assessed. The study included 11 children with early infantile autism and 20 children with a specific receptive language disorder; an additional 18 children with an expressive language disorder were used as a control group. The ADOS was individually administered to all children by the same examiner. The results showed that on most of the ADOS measures, the autistic children were clearly more deviant than the language impaired children. There were no significant differences between the two groups of language impaired children. Eight out of 11 autistic children reached the defined cut off values on the measures 'language and communication' and 'social interaction' of the ADOS algorithm, whereas only three autistic children did so on the measure 'stereotyped behavior.' None of the language impaired children reached the cut off values on more than one measure. The ADOS allowed for good assessment of certain types of behavior. The ADOS can be a useful tool in the discrimination of children with high functioning autism and children with a receptive or expressive language disorder. However, to confirm the diagnosis of infantile autism, additional information from the parents is required. 4 tables. 17 references.
·
Autistic Disorder: A Review for the Pediatric Dentist Source: Pediatric Dentistry. 20(5): 312-317. September-October 1998. Contact: Available from American Academy of Pediatric Dentistry. Publications Department, 211 East Chicago Avenue, Suite 700, Chicago, IL 60611-2616. Summary: Dental publications on autism have been sparse since the first comprehensive article geared for the dental profession. New findings on the etiology of autistic disorder (AD) have been discovered, suggesting that it is an organic disorder characterized by abnormalities in the brain, especially the cerebellum and limbic system. This article summarizes the latest medical findings on the etiology, diagnosis, and treatment approaches of AD, and reviews the dental literature since 1969. The main dental topics reviewed are oral health status and dental needs of patients with AD, characteristics of
Studies
7
patients with AD, and self-injurious behavior (SIB) in the context of AD. Clinical behavior management issues such as pharmacological and communicative techniques and physical restraint and desensitization are described. The authors also present the affect of the dental office's environment and appointment structure on a patient with AD. 47 references. (AA). ·
Delayed Language Onset as a Predictor of Clinical Symptoms in Pervasive Developmental Disorders Source: Journal of Autism and Developmental Disorders. 28(6): 527-533. December 1998. Contact: Available from Plenum Publishing Corporation. Subscription Department, 233 Spring Street, New York, NY 10013. (212) 620-8468. Fax (212) 807-1047. Summary: Diagnostic guidelines state that Asperger disorder may be distinguished from Autistic disorder by a lack of a delay in early language development. This article reports on a study that was undertaken to establish whether the presence or absence of early language delay would predict autistic symptomatology in children diagnosed with a pervasive developmental disorder (PDD) or autism spectrum disorder. In the study, 46 language delayed and 62 normal language onset children (mean age 11 years) were compared on research and diagnostic criteria, receptive language, and developmental history variables. Retrospective data were also obtained to determine whether language onset predicted autism symptomatology when young (less than 6 years of age). The authors found that early language delay predicts more autistic symptomatology when young, but not at an older age. Early language delay is also associated with developmental motor milestone delays and lower receptive language abilities. The results question the use of early language delay as a valid discriminating variable between PDD subgroups. 2 tables. 21 references.
·
Autism Spectrum Disorders: Interdisciplinary Teaming in Schools Source: The ASHA Leader. 2003;8;7:4. Contact: Available from American Speech-Language-Hearing Association. 10801 Rockville Pike, Rockville, MD 20852. Web site: www.professional.asha.org. Summary: In this article the author discusses the benefits of professional team work in schools for creating the best systems and treatment interventions to facilitate improved social and cognitive deficiencies for children on the autism spectrum in the regular school system. Such teams regularly include parents, teacher, SLP, occupational therapist (OT), speech therapist, and others.
·
Effect of Auditory Integration Training on Autism Source: American Journal of Speech-Language Pathology. 3(2): 16-24. May 1994. Summary: In this article, the authors present a description of the auditory integration training (AIT) procedure, currently considered controversial as a treatment for autism. They give an overview of the background of AIT and of research on auditory problems in autistic individuals, a summary of the findings of a pilot study undertaken in 1991, and the preliminary findings of their large-scale study of AIT on 445 autistic subjects. The authors conclude from the data obtained in their study that there does appear to be a reasonable basis for expecting worthwhile improvement in various aspects of comprehension and behavior of autistic persons exposed to only 10 hours of AIT. 8 figures. 1 table. 27 references.
8
Autism
·
Pervasive Developmental Disorders in Preschool Children Source: JAMA. Journal of the American Medical Association. 285(24): 3093-3099. June 27, 2001. Contact: Available from American Medical Association. P.O. Box 10946, Chicago, IL 60610-0946. (800) 262-2350 or (312) 670-7827. Fax (312) 464-5831. Website: jama.amaassn.org. Summary: Prevalence rates of autism spectrum disorders are uncertain, and speculation that their incidence is increasing continues to cause concern. This article reports on a study undertaken to estimate the prevalence of pervasive developmental disorders (PDDs) in a geographically defined population of preschool children. The survey was conducted between July 1998 and July 1999 in 15,500 children aged 2.5 to 6.5 years in Staffordshire, England. The children were screened for developmental problems. Children with symptoms suggestive of a PDD were intensively assessed by a multidisciplinary team, which conducted standardized diagnostic interviews and administered psychometric tests. A total of 97 children (79.4 percent male) were confirmed to have a PDD. The prevalence of PDDs was estimated to be 62.6 per 10,000 children. Prevalences were 16.8 per 10,000 children for autistic disorder and 45.8 per 10,000 for other PDDs. The mean age at diagnosis was 41 months, and 81 percent were originally referred by health visitors (nurse specialists). Of the 97 children with a PDD, 25.8 percent had some degree of mental retardation and 9.3 percent had an associated medical condition. The authors note that these results suggest that rates of PDD are higher than previously reported. 1 figure. 3 tables. 36 references.
·
Pediatrician's Role in the Diagnosis and Management of Autistic Spectrum Disorder in Children Source: Pediatrics. 107(5): 1221-1226. May 2001. Contact: Available from American Academy of Pediatrics. 141 Northwest Point Boulevard, Elk Grove Village, IL 60007-1098. (888) 227-1773. Website: www.pediatrics.org. Summary: Primary care physicians have the opportunity to be the first point of contact when parents have concerns about their child's development or behavior. This article offers a policy statement from the American Academy of Pediatrics, Committee on Children With Disabilities, with the goal of helping the pediatrician recognize the early symptoms of autism and participate in its diagnosis and management. This statement and the accompanying technical report (published in the same issue) are designed to familiarize the pediatrician with currently accepted criteria defining the spectrum of autism, strategies used in making a diagnosis, and conventional and alternative interventions. Early management strategies include parental education and support, early intervention (children younger than 3 years), school based special education (children older than 3 years), behavior management, medical treatment, community services, and alternative therapies. The authors emphasize that early diagnosis has become increasingly important, as recent studies have shown improved outcomes with implementation of early, consistent, and appropriate intervention strategies that have been individually tailored to the needs of the child and parents. 70 references.
·
Screening and Diagnosis of Autistic Spectrum Disorders Source: Journal of Autism and Developmental Disorders. 29(6): 439-484. December 1999.
Studies
9
Contact: Available from Plenum Publishing Corporation. Subscription Department, 233 Spring Street, New York, NY 10013. (212) 620-8468. Fax (212) 807-1047. Summary: The Child Neurology Society and American Academy of Neurology recently proposed to formulate Practice Parameters for the Diagnosis and Evaluation of Autism for their memberships. This endeavor was expanded to include representatives from nine professional organizations and four parent organizations, with liaisons from the National Institutes of Health. This document is the result of this multidisciplinary Consensus Panel's systematic analysis of over 2,500 relevant scientific articles in the literature. The Panel concluded that appropriate diagnosis of autism requires a dual level approach: routine developmental surveillance; and diagnosis and evaluation of autism. Specific detailed recommendations for each level are established and reported in this document. These recommendations are intended to improve the rate of early suspicion and diagnosis of, and therefore early intervention for, autism. Autism includes (but is not limited to) three core defining features: impairments in socialization, impairments in verbal and nonverbal communication, and restricted and repetitive patterns of behavior. 1 figure. 6 tables. 406 references. ·
Developing an Information Pack for the Asian Carers of People with Autism Spectrum Disorders Source: International Journal of Language and Communication Disorders. 36(Supplement): 216-221. 2001. Contact: Available from Taylor and Francis Inc. 1900 Frost Road, Suite 101, Bristol, PA 19007. Summary: The complexity and interaction of the cognitive, social and communicative impairments within autism spectrum disorder (ASD) are difficult to explain. At present, the information needs for people of Asian descent about ASD are not being met to an equal standard with their white majority counterparts. This article describes an investigation that forms the basis for the development of an information package for the Asian caregivers of people with ASD and learning disabilities. The authors present the results of semi structured interviews and planning for questionnaires with three different linguistic Asian groups (Urdu, Gujarati, and Bengali). The views, attitudes, and awareness of autism, knowledge of support services, and perceived priority of needs are analyzed for the three different communities. The authors conclude with recommendations as to whether separate information is needed by each culture or whether a single information pack can be used and presented in each language format. They determine that one audiovisual presentation about ASD and adults with learning disabilities can meet the needs of direct caregivers from these different Asian communities in Bradford, England. Each community would require a spoken dialog in its own tongue. The authors also discuss the possible presentation format in which the information can be produced. They note that contact with religious leaders, women's support groups, and community leaders is also important. 1 table. 8 references.
·
Issues Raised by Facilitated Communication for Theorizing and Research on Autism Source: Journal of Speech and Hearing Research. Volume 36: 1108-1119. December 1993. Summary: There is considerable disagreement in the literature and among clinicians about the success of facilitated communication (FC), a new method of augmentative communication being used with people diagnosed as autistic. Some claim almost everyone exposed to FC achieves success; others claim minimal or no success. In this article, the author argues that both claims can be valid and that FC users with autism are
10 Autism
sometimes competent and other times incompetent, depending on the conditions under which they are evaluated. The author supports her argument by offering a collaborative view of communication in place of the commonly held view that communication involves passing messages over an invisible conduit. Other topics covered include various unusual phenomena being revealed by facilitation and FC users, some theoretical approaches for explaining these phenomena, some research ideas for studying FC, and suggestions for ways to develop the understanding of when and how FC works for people with autism. 71 references. (AA-M). ·
Through the Lifespan: Managing Communication and Social Issues in Autism Source: Advance for Speech-Language Pathologists and Audiologists. 5(9): 13,17. March 6, 1995. Summary: This article brings readers up-to-date on the communication and related social deficits associated with autism, focusing on interventional strategies for this population. Topics covered include the symptoms of autism; the wide variability among individuals with autism, especially in the areas of communication and communication related social skills; language comprehension; establishing learning readiness; home programming and behavior modification; developing functional verbal skills; sign language; the use of augmentative and alternative communication; and the pragmatic use of social skills, including greetings and conversations. The authors present three brief case histories to highlight the changing communicative needs of individuals with autism across years and environments. 6 references.
·
Preventing Factitious Gingival Injury in an Autistic Patient: A Case Report Source: JADA. Journal of American Dental Association. 127(2): 244-247. February 1996. Summary: This article describes a case of a patient with autism who developed factitious stomatitis. A 34-year-old man with a history of autism developed a deep gingival cleft. During clinical evaluation, the patient repeatedly scraped the affected area with his fingernail. The lesion's clinical features were consistent with focal inflammatory hyperplasia, periodontal disease, and factitious stomatitis. The authors discuss diagnostic and behavioral issues important in treating patients with cognitive disabilities. 1 figure. 10 references. (AA-M).
·
Child'sTalk for Children with Autism and Pervasive Developmental Disorder Source: International Journal of Language and Communication Disorders. 36(Supplement): 469-473. 2001. Contact: Available from Taylor and Francis Inc. 1900 Frost Road, Suite 101, Bristol, PA 19007. Summary: This article describes a research assessment protocol and early intervention approach (Child'sTalk) designed for use by multidisciplinary professionals with children who have the severe social communication deficits of early autism and pervasive developmental disorder (PDD). The assessment analyses the specific pattern of social communication impairment in each child and defines the characteristics of the dyad communication between parent and child. The intervention aims to identify facilitative (coping) strategies, using video feedback, which lead to close interpersonal interaction between the child and their parents. Parents can reflect on their own interaction and identify which strategies successfully engage their child. The six stages of Child'sTalk are: establishing joint attention, synchrony, sameness, variation,
Studies
11
communicative teasers, and modeling. Child'sTalk aims to facilitate adaptations to the child's level of communication by sensitively and finely tuning the interaction and mutual sharing of intentions as a support for the emergence of communication. 8 references. ·
Facilitated Communication and Autism: Separating Fact from Fiction Source: Journal of Vocational Rehabilitation. 4(1): 66-74. January 1994. Summary: This article examines facilitated communication in light of what is known about autism. First, the authors examine claims made about facilitated communication and empirical issues involved in its validation. Then, claims of why it works and why it might appear to work are discussed in relation to the psychology of autism. Finally, ethical concerns are addressed. The authors include a review of the literature and a discussion of their own work with people with autism over a 16-year period. They conclude that facilitated communication should be considered experimental and its use limited to scientific inquiry. 33 references. (AA-M).
·
Autism and the Pervasive Developmental Disorders: Part 2 Source: Pediatrics in Review. 16(5): 168-177. May 1995. Summary: This article is the second in a two-part series that presents evolving concepts about autism and describes a clinical approach for the diagnosis and management of children with the condition. The author discusses the differential diagnosis of autism, the assessment of children who are autistic, diagnostic instruments, the physical and neurological examination, laboratory and other medical evaluations, the evaluation of functional level, prognosis, and management considerations including educational management, pharmacologic management, and other therapies. The article concludes with a section on the role of family support and advocacy. The section on other therapies briefly reviews two controversial methods of treatment: facilitated communication and auditory integration training. Facilitated communication is an alternative communication modality for autistic children in which a trained 'facilitator' provides physical support under the arm of the autistic child to allow him or her to type messages on a keyboard communicator. Auditory integration training is based on the unproven theory that symptoms in autism and other developmental disabilities may be caused by a disturbance of the auditory system. These children are said to have hyperacute sensitivity to some frequencies of sound, a phenomenon said to be demonstrable on a carefully performed audiogram. 1 table. 24 references. (AA-M).
·
Procedures for Teaching Appropriate Gestural Communication Skills to Children with Autism Source: Journal of Autism and Developmental Disorders. 28(6): 535-545. December 1998. Contact: Available from Plenum Publishing Corporation. Subscription Department, 233 Spring Street, New York, NY 10013. (212) 620-8468. Fax (212) 807-1047. Summary: This article reports on a study of four children with autism who were taught to use gestures in combination with oral communication. Using a multiple baseline across response design, intervention was introduced successively across three response categories containing gestures representative of attention directing, attention getting, affective, and descriptive behavior. Although none of the participants displayed appropriate gestural and verbal responses during baseline, all participants acquired this skill with the systematic implementation of modeling, prompting, and reinforcement.
12 Autism
Generalization measures indicated that the children learned to respond in the presence of novel stimuli and a novel setting. Social validity measures revealed that the participants' behavior appeared more socially appropriate at the completion of the study than at the start of the study, and that the participants' behavior was indistinguishable from that of their typically developing peers. 4 figures. 2 tables. 33 references. ·
Naltrexone and Communication Skills in Young Children with Autism Source: Journal of the American Academy of Child and Adolescent Psychiatry. 38(5): 587-593. May 1999. Contact: Available from Lippincott Williams and Wilkins. Subscription Department, P.O. Box 350, Hagerstown, MD 21740-0350. (800) 638-3030. Website: www.aacap.org/journal/journal.htm. Summary: This article reports on a study that examined the impact of naltrexone, a potent oral opiate antagonist, on the communication skills of young children with autism. Autism is characterized by 3 core deficits: qualitative impairments in reciprocal social interactions; qualitative and quantitative impairments in communication; and restricted, repetitive, or stereotyped behaviors, interests, and activities. In the study, 24 children with autism (3.0 to 8.3 years old) who were living at home and attending appropriate school programs, participated in a randomized, double blind, placebo controlled, crossover trial. Naltrexone, 1.0 mg per kg, or placebo was administered daily for 2 weeks. Communication was evaluated from videotaped samples of seminaturalistic parent child interaction. Child and parent language were assessed using similar measures. In this heterogeneous sample, the median number of words the child produced on placebo was 9.5 (range 0 to 124). The median proportion of utterances with echolalia was 0.16. No differences were found between the naltrexone and placebo conditions in any of the measures of children or parents' communication. Significant correlations were found between the child's number of words and developmental quotient and between the child's and parent's number of words. Previous studies showed that naltrexone was associated with modest reductions in hyperactivity and restlessness in this group of children with autism. In this short term study, the medication did not lead to improvement in communication, a core deficit of autism. 2 tables. 46 references.
·
Prenatal, Perinatal, and Neonatal Factors in Autism, Pervasive Developmental Disorder-Not Otherwise Specified, and the General Population Source: Pediatrics. 107(4): [6 p.]. April 2001. Contact: Available from American Academy of Pediatrics. 141 Northwest Point Boulevard, Elk Grove Village, IL 60007-1098. (888) 227-1773. Fax (847) 434-8000. E-mail:
[email protected]. Website: www.pediatrics.org. Full text of this article is available at www.pediatrics.org/cgi/content/full/107/4/e63. Summary: This article reports on a study undertaken to examine various prenatal, perinatal, and neonatal factors in children with autism and in children with pervasive developmental disorder not otherwise specified (PPD NOS); the study compared the incidence of each factor to that of the normal population. The 74 participants (66 males, 8 females) were diagnosed with autism between age 2.5 and 4 years. At age 5, all participants were reevaluated, resulting in 61 autistic and 13 PDD NOS diagnoses. The study examined 28 factors in these 2 groups, using medical records and parental interviews. Incidences were compared with those of the United States population as reported in the Report of Final Natality Statistics (1995). Factors included maternal age,
Studies
13
parity (number of pregnancies), number of previous abortions or miscarriages, gestational age, bleeding in pregnancy, vaginal infections, fever, preeclampsia, gestational diabetes, rhesus (blood factor) incompatibility, smoking during pregnancy, use of contraception at conception, induced labor, Cesarean section, nonvertex presentation, forcep extraction, vacuum extraction, prolonged labor (longer than 20 hours), precipitous labor (less than 3 hours), multiple gestation, cord complication (prolapse, around the neck, knotted), trauma on delivery, low birth weight, low Apgar score, respiratory distress syndrome, oxygen treatment, hyperbilirubinemia, seizures, and birth defect. Although most of the factors showed comparable incidences between the index and control groups, several factors showed statistically significant differences. The autism group was found to have a significantly higher incidence of uterine bleeding, a lower incidence of maternal vaginal infection, and less maternal use of contraceptives during conception when compared with the general population. Similarly, the PDD NOS group showed a higher incidence of hyperbilirubinemia when compared with the general population. The results of this study support previous findings. However, the authors caution that interpretation of these results is difficult. Additional studies are needed to corroborate and strengthen these associations, as well as to determine the possibility of an underlying unifying pathological process. 5 tables. 25 references. ·
Visual Pedagogy in Dentistry for Children with Autism Source: Journal of Dentistry for Children. 66(5): 325-331. September-October 1999. Contact: Available from American Society of Dentistry for Children. John Hancock Center, 875 North Michigan Avenue, Suite 4040, Chicago, IL 60611-1901. (312) 943-1244. Summary: This article reviews the condition of autism in children and outlines strategies for the effective dental care of these children. The authors emphasize that dental care is a large problem for people with autism, as well as for their families. The authors report on a study undertaken to present and evaluate a model based on visual pedagogies for the introduction of dentistry to preschool children with autism. Visual pedagogy (the use of communicating via pictures rather than words) is described. The authors detail a book the study has produced. The book includes distinct color prints that show every step when visiting the dentist, i.e., the front door, the waiting room, the dentist, the operating room, and the instruments that will be used. The pictures are distinct and simple without irrelevant details and are to be read from the left to the right. Before actual treatment begins, the parents and the dentist meet without the child for information about the method and for sharing relevant information about the child. A common choice of words is agreed upon for the different situations and persons involved, to assure that the same vocabulary is used at home and at the clinic. After 1.5 years in the project using this visual pedagogy, the cooperation of the 11 children with autism was compared with that of sixteen children with autism of the same age, who had not been treated according to visual pedagogy. Compared to the control children, the children using visual pedagogy demonstrate a superior capacity to cooperate, a capacity far beyond the expectations of their parents. The parents have positive comments for the program and all families want to continue in the project. 1 figure. 2 tables. 19 references.
·
Autism: Current Concepts Source: New England Journal of Medicine. 337(2): 97-104. July 1997. Summary: This article reviews the current thinking on autism, a group of developmental disorders of brain function known as pervasive developmental disorder. The author
14 Autism
begins with a discussion of the symptoms of autism, as they are expressed in behavior, communication, play, attention and activities, cognition, and sensorimotor symptoms. The author continues with a discussion of epilepsy and autistic regression, the prevalence of autism, the causes of the condition, the neurologic basis of autism, its course and prognosis, the diagnostic considerations, and intervention. Comprehension and the communicative use of speech and gesture are always deficient, at least in young children with autism. There is a compromised ability to decode the rapid acoustic stimuli that characterize speech results in the most devastating language disorder in autism: verbal auditory agnosia or word deafness. Children with verbal auditory agnosia understand little or no language; they therefore fail to acquire speech and may remain nonverbal. The author stresses that the most important intervention in autism is early and intensive remedial education that addresses both behavioral and communication disorders. The effective approaches use a highly structured environment with intensive individual instruction and a high teacher-to-student ratio. Parents need specific instruction in how to deal with tantrums and destructive behavior and in useful techniques for keeping their children organized and occupied to minimize detrimental effects on the family. 5 tables. 62 references. (AA-M). ·
Pervasive Developmental Disorders: A 10-Year Review Source: Journal of the American Academy of Child and Adolescent Psychiatry. 39(9): 1079-1095. September 2000. Contact: Available from Lippincott Williams and Wilkins. Subscription Department, P.O. Box 350, Hagerstown, MD 21740-0350. (800) 638-3030. Website: www.aacap.org/journal/journal.htm. Summary: This article summarizes recent advances about the nature, diagnosis, and treatment of pervasive developmental disorders (PDDs). The author conducted a review of MEDLINE databases, books, and book chapters published between July 1989 and November 1999. Clinical and genetic studies support expansion of the concept of autism to include a broader spectrum of social communication handicaps. The prevalence of autism is approximately 1 per 2,000; the prevalence of autism and Asperger's disorder together is 1 per 1,000. The Checklist for Autism in Toddlers is a useful screening instrument for 18 month old children; the Autism Diagnostic Interview Revised and the Autism Diagnostic Observation Schedule are instruments of choice for research. Although twin and family studies clearly support genetic factors as important in autism, linkage analysis studies indicate that many genes may be involved. There is no one treatment of choice. Social pragmatic approaches, augmented by individualized strategies and social coaching, may be best for teaching social communication skills. Pharmacological interventions have a limited role in improving social communication, but selective serotonin reuptake inhibitors and atypical neuroleptic medications may help lessen aggression, hyperactivity, and other secondary problems. The authors concludes by calling for continued private and government support of basic and applied research on PDDs. 209 references.
·
Brain Wiring in Autism Source: ADVANCE for Speech-Language Pathologists and Audiologists. 9(1): 6-9. January 4, 1999. Contact: Available from Merion Publications, Inc. 650 Park Avenue, Box 61556, King of Prussia, PA 19406-0956. (800) 355-5627, ext. 279. E-mail:
[email protected]. Website: www.advanceweb.com.
Studies
15
Summary: This article, from a newsletter for speech language pathologists and audiologists, describes research on the deficits in cognitive processes in people with autism, the brain location of these deficits, and the behavioral basis of autism. The author describes the work of Dr. Nancy Minshew and her collaborators from the University of Pittsburgh, the Center for Cognitive Brain Imaging at Carnegie Mellon University (CMU) in Pittsburgh, and the Division of Neurology at Case Western Reserve University Medical School in Cleveland. Their studies will compare people with high functioning autism to control subjects in order to pinpoint the critical differences in language, spatial, and executive processes. The article describes the research being undertaken, the results so far, the neurophysiology of the brain that may be involved, the part of the research that measures the reflexive and voluntary control of eye movements, the use of brain imaging studies, and the impact of information processing on coping in real life settings. The researcher emphasizes that discovering the cognitive basis of behavior and where the problems with the wiring of the brain lie in autism will lead to more effective intervention and, possibly, treatment. The article concludes with the addresses and contact information of the researchers interviewed. 3 figures. ·
Autism and the Pervasive Developmental Disorders: Part 1 Source: Pediatrics in Review. 16(4): 130-136. April 1995. Summary: This article, the first in a two-part series, presents evolving concepts about autism and describes a clinical approach for the diagnosis. The author notes that there are three general categories of behavioral impairment common to all persons who have autism: a qualitative impairment of reciprocal social interaction, a qualitative impairment in the development of language and communication, and a restricted range of activities and interests. The author discusses these aspects in more detail, then considers classification issues, epidemiology, associated medical conditions, biologic aspects, psychological aspects, and clinical presentation (in the three categories noted above). Regarding communication, most autistic children have an early delay in the onset of expressive language, often the symptom that prompts referral for evaluation. The language defect in autism is described as a pragmatic defect, meaning that the use of language for social communication is particularly impaired compared with other aspects of language. Lack of nonverbal types of communication can provide some of the earliest diagnostic evidence for the presence of autism. Even in older, higher functioning children, subtle deficits in nonverbal communication, such as in the use of hand or facial gestures, frequently remain. 3 tables. 14 references.
·
Some Infantile Autism May be Inherited, Studies Find Source: Advance for Speech-Language Pathologists and Audiologists. 4(18): 3. September 5, 1994. Contact: Available from Merion Publications, Inc. 650 Park Avenue West, King of Prussia, PA 19406. (610) 265-7812. Summary: This brief news article reports on recent findings that some types of infantile autism may be inherited. Two studies conducted at Duke University Medical Center in Durham, NC indicate that autistic children who have no apparent neurological basis for their disorders may actually be suffering from an inherited, early-onset form of manicdepression. When manic-depression strikes in early infancy, it appears to blunt the child's cognitive, social and emotional development irreversibly, so that the child's brain never develops the framework in which to build communication or social skills. The article discusses the research conducted, family history of depression or manic-
16 Autism
depressive illness, the area of the brain most likely to be affected, and the patterns of affective and cognitive symptoms. ·
Identifying Autism Susceptibility Genes Source: Neuron. 28(1): 19-24. October 2000. Contact: Available from Cell Press. Neuron, 1100 Massachusetts Avenue, Cambridge, MA 02138. (617) 661-7057. Fax (617) 661-7061. E-mail:
[email protected]. Website: www.neuron.org. Summary: This review article focuses on the identification of susceptibility loci for autism. The genetic mechanisms predisposing to autism and related milder phenotypes are unknown. Neither the level of familial risk nor the very different concordance rates in monozygotic and dizygotic twin pairs is compatible with a simple monogenic model. Most cases seem likely to arise on the basis of multiple susceptibility genes. Models using family and twin data for autism and related phenotypes suggest that between two and 10 loci may be implicated. Although various chromosomal abnormalities have been reported in people who have autism, one potentially specific association is with abnormalities of an unstable region of chromosome 15 (15q11-q13). The most common abnormalities are interstitial duplications or a supernumerary pseudodicentric chromosome 15 in patients who have autism spectrum disorders. When the parental origin has been investigated, all of the 15q duplications associated with autism were derived from the mother. Sex chromosome abnormalities have rarely been reported in association with autism. Genetic mapping relies on tracking the cosegregation of polymorphic deoxyribonucleic markers with a disorder. If a statistically significant association between the disorder and markers is found at an identified location, it implies a nearby susceptibility locus. The article discusses the use of linkage and association in genetic mapping and reports on association and genome wide linkage studies on autism. Linkage studies suggest that there is a high probability that a region on chromosome 7q contains a susceptibility locus for autism. Although the 15q region shows weaker evidence for linkage, the relatively high incidence of chromosomal abnormalities supports a role for this region in autism etiology. 1 figure. 2 tables. 22 references.
Federally Funded Research on Autism The U.S. Government supports a variety of research studies relating to autism. These studies are tracked by the Office of Extramural Research at the National Institutes of Health.2 CRISP (Computerized Retrieval of Information on Scientific Projects) is a searchable database of federally funded biomedical research projects conducted at universities, hospitals, and other institutions. Search the CRISP Web site at http://crisp.cit.nih.gov/crisp/crisp_query.generate_screen. You will have the option to perform targeted searches by various criteria, including geography, date, and topics related to autism.
2
Healthcare projects are funded by the National Institutes of Health (NIH), Substance Abuse and Mental Health Services (SAMHSA), Health Resources and Services Administration (HRSA), Food and Drug Administration (FDA), Centers for Disease Control and Prevention (CDCP), Agency for Healthcare Research and Quality (AHRQ), and Office of Assistant Secretary of Health (OASH).
Studies
17
For most of the studies, the agencies reporting into CRISP provide summaries or abstracts. As opposed to clinical trial research using patients, many federally funded studies use animals or simulated models to explore autism. The following is typical of the type of information found when searching the CRISP database for autism: ·
Project Title: 1999 WORLD CONGRESS ON PSYCHIATRIC GENETICS Principal Investigator & Institution: Delisi, Lynn E.; Professor; Internatnl Society Psychiatric Genetics Psychiatric Genetics New York, Ny 10016 Timing: Fiscal Year 2001; Project Start 10-DEC-1999; Project End 30-NOV-2003 Summary: The International Society of Psychiatric Genetics (ISPG, a non- profit professional research society) is the sponsor of annual World Congresses of Psychiatric Genetics which are held alternating years between North America and Europe. It is a four day meeting with invited plenary speakers, freely submitted oral and poster presentations, as well as various workshops. These meetings have as their goal the education of researchers, students and the public about the latest research findings in the neurogenetics of all major psychiatric conditions. The work reported at these sessions ranges from epidemiological to molecular topics. An international program committee is assembled from senior researchers in the field to invite approximately 12 plenary speakers to present timely reviews of new and exciting advances in genetic technology or other topics relevant to a wide range of research in psychiatric genetics. However, the major portion of the program is devoted to the free submissions from investigators interested in attending. Graduate students and post-doctoral fellows are particularly encouraged to participate and present new data. Travel fellowships are provided for as many young investigators as possible, usually 15- 20. The meeting is generally held in the Fall and a public call for abstracts to be submitted in the May prior to the meeting is solicited by the internet, journal advertising and a mailing list of over 8000 professionals. It is hoped that this annual meeting will facilitate the acquisition of new knowledge pertinent for rapid advancement and progress toward finding genes for major psychiatric disorders, such as schizophrenia, bipolar affective disorder, unipolar depressions, and autism. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
·
Project Title: A DEVICE FOR STEREOTYPE QUANTIFICATION Principal Investigator & Institution: Greeley, Harold P.; Creare, Inc. Box 71, Etna Rd Hanover, Nh 03755 Timing: Fiscal Year 2003; Project Start 01-JUN-2003; Project End 30-NOV-2003 Summary: (provided by applicant): Stereotypy, describing motor behavior that is repetitive, rhythmical, and non-goal directed, is commonly observed in persons with autism and other developmental disabilities. For some children with autism or other developmental disabilities, stereotypy may be a target for intervention. On the other hand, stereotypy may serve as a proxy for other behaviors or conditions, for example, anxiety or mood disorders that are targeted for treatment. Taken together, stereotypy is a long-recognized and important behavior for persons with developmental disabilities. Measurement difficulties present an obstacle to the study of stereotypy, and ultimately, to its treatment. The objective of this program is to provide a tool that quantifies the level of stereotypy in autistic children. This will be achieved through an innovative integration of triaxial accelerometer and radio frequency telemetry technologies. The resulting long-term, free-living measurements performed in the clinic and at the subject's home, will provide objective measures of clinical change in autism treatment.
18 Autism
Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen ·
Project Title: A MULTI-FACETED SEARCH FOR AUTISM DISEASE GENES Principal Investigator & Institution: Wassink, Thomas H.; Psychiatry; University of Iowa Iowa City, Ia 52242 Timing: Fiscal Year 2001; Project Start 05-AUG-2000; Project End 31-JUL-2005 Summary: In this application for a RCDA (K08), the candidate proposes to obtain expertise in molecular genetics, applying this expertise to the investigation of autism. The candidate is a psychiatrist who recently completed a research fellowship at a Mental Health Clinical Research Center, where he initially performed research in the phenomenology and neurobiology of schizophrenia. Midway through his fellowship, however, driven by his underlying interest in the molecular genetics of neurodevelopmental psychiatric disorders, he began genetic investigations of both schizophrenia and autism. He has now joined the research faculty at his institution and is in a position, with the support of this award, to move towards leading and conducting independent investigations into the molecular genetic basis of these disorders. Autism is characterized by the childhood onset of stereotyped, repetitive behaviors and severe deficits in social interaction and communication. No effective treatment currently exists. Autism is largely heritable, and increasing effort is being expended to identify autism disease genes, though none have yet been discovered. The candidate's Research Plan uses two approaches to attempt to identify such genes: 1) Creating somatic cell hybrids from autistic subjects with chromosome 15 anomalies in order to isolate the abnormal chromosomes, characterize them molecularly, and more narrowly define a potential disease gene harboring region; and 2) Using the genome wide shared segment analysis approach, as well as traditional linkage analysis, to test for linkage in a number of extended pedigrees highly penetrant for autism. Linked or narrowed regions identified through these approaches will be screened for candidate genes, which, once identified, will be evaluated using appropriate molecular techniques. There is also opportunity for the candidate to analyze and compare genetic data from other types of family structures and to examine the effect of novel definitions of the autism phenotype. The candidate's molecular mentoring will be provided by a Howard Hughes geneticist at the University of Iowa, and will be supplemented by mentoring from recognized experts in statistical genetics, genetic computational bioinformatics, the genetics and phenotype of autism, and cytogenetics, and by a rigorous, well- organized series of didactic coursework. Taken together, the training plan and research proposal provide for a breadth of training, the potential for meaningful discovery, and support for the establishment of an independent research career. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
·
Project Title: A QUANTITATIVE GENETIC MEASURE OF AUTISTIC TRAITS Principal Investigator & Institution: Constantino, John N.; Psychiatry; Washington University Lindell and Skinker Blvd St. Louis, Mo 63130 Timing: Fiscal Year 2001; Project Start 01-MAR-2001; Project End 30-NOV-2002 Summary: This proposal represents the third step of a quantitative approach to identifying genetic loci that contribute to the susceptibility for autistic spectrum disorders. It seeks to provider further validation of a new measure of autistic spectrum deficits, the Social Reciprocity Scale (Constantino et al., 2000), which, in studies involving over 900 children, has proven feasible for use in large-scale epidemiologic samples. The Social Reciprocity Scale (SRS) is unique in that it is designed to quantify
Studies
19
autistic traits across the entire spectrum from unaffected to severely affected (referred to as the "broader autism phenotype). It therefore is useful for identifying extreme discordant sib pairs in the population, which is potentially important for gene mapping studies in autism since such pairs provide the highest degree of statistical power for identification of quantitative trait loci. Although SRS scores are highly genetically influenced (Constantino and Todd, submitted) and correlate well with clinical diagnoses of autistic spectrum disorders (Constantino et a., 2000), the instrument has never yet been directly compared with established diagnostic instruments for autism. This is a proposal to validate the Social Reciprocity Scale with the Autism Diagnostic InterviewRevised (ADI-R) among clinical and research subjects with and without pervasive developmental disorders at the Washington University School of Medicine. If the SRS compares favorably with the ADI-R, the SRS could feasibly be used to study the genetics of autism by examining the genetic structure of autistic traits in whole populations. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen ·
Project Title: A TRANSLATIONAL AUTISM PROGRAM AT THE M.I.N.D. INSTITUTE Principal Investigator & Institution: Amaral, David G.; Professor; Psychiatry; University of California Davis Sponsored Programs, 118 Everson Hall Davis, CA 95616 Timing: Fiscal Year 2001; Project Start 25-SEP-2001; Project End 31-AUG-2003 Summary: (Provided by applicant): The UC Davis M.I.N.D. (Medical Investigation of Neurodevelopmental Disorders) Institute was founded in 1998 as an interdisciplinary organization to study autism and other neurodevelopmental disorders. This unique collaboration among parents, community leaders, and researchers and clinicians at UC Davis takes a three-pronged approach to solving neurodevelopmental disorders; it brings together resources at UC Davis, from the Sacramento community and from the broader UC system to focus on basic and clinical research, patient treatment, and the education of patients, families and providers. Current activities include: an aggressive recruitment campaign to develop a critical mass of researchers, clinicians and educators; the construction of a campus of five buildings comprising approximately 142,000 sq. ft. of space that will include a comprehensive pediatric clinic, two research buildings, a community center and a laboratory school; and the expansion of an active intramural and extramural research program. The vision of the M.I.N.D. Institute is entirely consistent with the establishment of a translational Center of Excellence in Autism Research as outlined in the Children's Health Act of 2000. However, with the intense activity currently underway at the Institute and our need to incorporate many new Institute faculty into the preparation of a Center grant, we believe that it is premature to submit an application for the December deadline. The Developmental Grants for Autism Centers of Excellence provide a useful mechanism for enabling comprehensive discussion, consultation and decision-making in preparation for submission of such an application in 2002. During the planning year we will focus on defining those areas of translational research and community outreach that the M.I.N.D. Institute is best suited to pursue as an Autism Center of Excellence. A broad-based, twenty member, leadership team will participate in weekly brainstorming sessions to shape the aims of our expected application. Intensive two-day Focus Group sessions, during which consultants will not only present their latest data, but also advise the Institute on such promising areas as Biomarkers Research, Clinical Drug Trials, and Innovative Treatments for Autism, will inform the deliberations of this group. We will pursue collaborative relationships with California State University, Sacramento, and several Sacramento County school districts to establish pilot educational programs for children
20 Autism
with autism. Evaluation, selection and implementation of a comprehensive database management system will be a priority for ensuring the seamless flow of information between the Institute's clinical and research efforts. Finally, we will explore the feasibility of using telemedicine technology for clinical care and education in autism. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen ·
Project Title: ANALYSIS OF CHROMOSOME 15 DUPLICATIONS IN AUTISM Principal Investigator & Institution: Schanen, Carolyn N.; Head of Human Genetics Research; University of California Los Angeles 10920 Wilshire Blvd., Suite 1200 Los Angeles, Ca 90024 Timing: Fiscal Year 2002; Project Start 23-SEP-2002; Project End 31-MAY-2007 Summary: Duplication of the maternally-derived copy of the imprinted region on chromosome 15q is associated with a major risk for autism or autism spectrum disorders. The duplications arise by homologous but unequal recombination through series of transcribed repeats in the region and variation in the alignment at crossing over lead to difference in the content and origin of the chromatin involved. The investigator?s goals are directed toward understanding the role that duplication of chromosome 15q plays in autism by examining the phenotypic sequelae in probands with known duplications. She also proposes to define the autism critical region by detailed examination of rearrangements in probands with unusual breakpoints or imprinting errors. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
·
Project Title: AP3 IN NEUROLOGICAL DISORDERS Principal Investigator & Institution: Burmeister, Margit M.; Associate Professor of Genetics in Psych; Psychiatry; University of Michigan at Ann Arbor 3003 South State, Room 1040 Ann Arbor, Mi 481091274 Timing: Fiscal Year 2001; Project Start 01-APR-1994; Project End 31-MAY-2003 Summary: (Adapted from investigator's abstract) The P.I. has recently identified the mutant gene in mocha mice as the delta subunit of the adapter-related complex AP-3. They have also found that the ZnT-3 transporter is not transported correctly to synaptic vesicles, resulting in a lack of zinc in cortex and hippocampus. In this application, the P.I. proposes to genetically map all subunits of the AP-3 complex to determine if other mutants with a similar phenotype are caused by mutations in these AP-3 subunit genes, and test for interaction between mocha locus and pale-ear, the mouse homologue of HPS, the gene most commonly mutated in human Hermansky-Pudlak syndrome (HPS). They will focus on the neurological phenotype of mocha, and determine if mocha may be a mouse model for epilepsy, ADHD, autism or other neurological disorders. Mocha mutant mice have an HPS-like phenotype as well as neurological deficits (seizures, hyperactivity, spike-wave discharges, a hypersynchronized electrocortigram, increased auditory gating). In contrast, pearl mice have HPS but none of these neurological phenotypes, which they postulate is because pearl mice miss the non-neuronal form of the beta subunit, Ap3b1, but not the neuronal form of AP-3 beta, Ap3b2, whereas the delta subunit mutated in mocha is ubiquitously expressed. Dr. Burmeister postulates that inactivation of the neuronal form of AP-3 beta will result in a mouse with the neurological defects of mocha without the HPS-like phenotypes and higher fertility and viability than mocha mice. They will prepare a LoxP construct to knock out Ap3b2 in such a way that they can not only generate a complete knockout in ES cells, but also, by mating to mice in which Cre is under region-specific promoters, mice in which the AP-3
Studies
21
complex is missing only in specific brain regions. The P.I. will characterize the behavior of mocha, mh-2J, ZnT-3 deficient mice as well as the proposed knockout mice for the nature of hyperactivity (is it generally more active, has increased startle, or stereotypic behavior), seizure propensity, anxiety, learning and memory and electrophysiological parameters. To determine if AP3B2 plays a role in human neurological disorders, Dr. Burmeister will isolate and characterize the human AP3B2 gene and search for mutations or polymorphisms that may be present in the normal population or in patients. Given the mocha phenotype, it is anticipated that this gene may be involved in human neurological disorders characterized by increased seizure frequency and hyperactivity (e.g. autism, OCD, ADHD and epilepsy). Such polymorphisms will be made available for the scientific community to test as a candidate gene for other neurological or psychiatric disorders if justified by the results of the behavior tests. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen ·
Project Title: AUTISM AND AMPS LYASE MUTATIONS: CELL AND MOUSE MODELS Principal Investigator & Institution: Patterson, David; President and Senior Fellow; Eleanor Roosevelt Inst for Cancer Res 1899 Gaylord St Denver, Co 80206 Timing: Fiscal Year 2003; Project Start 11-FEB-2003; Project End 31-JAN-2008 Summary: (provided by applicant): Adenylosuccinate lyase (ADSL) catalyzes two steps of de novo purine biosynthesis. In 1984, a genetic syndrome was described in which a deficiency in ADSL leads to profound developmental delay and, in up to 30% of cases, autistic features (5). Currently, over 30 mutations in ADSL are known to cause ADSL deficiency. The clinical picture in these individuals can vary widely. Interestingly, in 2000 an ADSL deficiency patient was reported with minimal developmental delay and autistic features. (6) In 1987, we mapped the gene for ADSL to human chromosome 22 (29). The precise location of the ADSL gene is now known to be in the 22q13 region. Chromosomal anomalies in this region are also associated with autism. This data suggests that ADSL deficiency is a contributing factor to autism as well as to psychomotor delay and mental retardation. Autism affects approximately 1 in 2000 individuals. Defining features are impaired sociability, language and communication, and range of interests and activities. Mental deficiency may or may not be present, and the cognitive profile is narrow, occasionally with superior but narrow talent. Perseveration, concreteness, affective blunting, and lack of insight into other persons' thinking may be present. We have isolated and extensively characterized a Chinese hamster ovary cell (CHO-K1) cell mutant, Adel, completely lacking in ADSL activity. We now propose to create and characterize a mouse model of ADSL deficiency. For this purpose, we will inactivate the mouse ADSL gene by targeted mutagenesis. We will then introduce the wild type and selected mutant human ADSL genes into different lines of transgenic mice and by appropriate breeding create mice carrying only the wild type or mutant forms of human ADSL. We will produce mice with the R426H mutation that leads to severe developmental delay, often with autistic features, and the R303C mutation that leads to mild disease. These mice will then be analyzed neuroanatomically, biochemically, physiologically, and behaviorally to understand the consequences of ADSL mutations. We will then attempt to intervene with appropriate pharmacological agents to reverse the effects of ADSL deficiency, and, we hope, to other forms of autism. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
22 Autism
·
Project Title: AUTISM CLASSROOM CONNECTIONS Principal Investigator & Institution: Rao, Patricia A.; Danya International, Inc. 8737 Colesville Rd, Ste 1200 Silver Spring, Md 20910 Timing: Fiscal Year 2003; Project Start 15-JAN-2003; Project End 31-JAN-2004 Summary: (provided by applicant): Danya International proposes to develop a multimedia intervention package designed to help facilitate the inclusion of children with autism in the general education classroom, based on a peer-based model used successfully in our previous corporate experience developing classroom materials for children with other development disabilities. The intervention package will consist of an educational video, a Facilitator's Guide for use with the video, and an online learning center about autism for teachers, parents, advocates and peers of children with autism. During Phase 1, Danya will develop the content for the video script, the Facilitator's Guide, and the online learning center, film the video, and conduct a feasibility study of the video. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
·
Project Title: AGONISTS
AUTISM
THERAPEUTICS:
NOVEL
SECRETIN
RECEPTOR
Principal Investigator & Institution: Evans, David M.; Psychiatric Genomics, Inc. 19 Firstfield Rd Gaithersburg, Md 20878 Timing: Fiscal Year 2002; Project Start 01-MAY-2002; Project End 31-OCT-2002 Summary: (provided by applicant): Using a high-throughput robotic system we plan to screen a library of 70,000 small molecules (each <700 daltons) for agonists at the secretin receptor transfected into cells. Small molecule non-peptide agonists at this receptor may overcome some of the anticipated issues with administration of the peptide hormone in the treatment of patients with Autistic disorders, such as its short in vivo half life, its need to be administered by injection and its pharmacokinetic parameters. We propose to: Clone and express the human secretin receptor in a Chinese Hamster Ovary cell line. Confirm transfection by showing secretin stimulated accumulation of cAMP only in the transfected cells. Demonstrate that we can obtain cells which respond to secretin (by increasing cAMP) in a dose-dependent manner and that show a maximal response to secretin at least 2 fold that of the un-transfected cells. Develop and validate an assay that detects an increase in cAMP levels in these cells by compounds acting as agonists at the secretin receptor. Using High Throughput Screening (HTS) robotics, screen for nonpeptide small organic compounds from Psychiatric Genomics' (PGI) collection that can act as agonists at the secretin receptor and stimulate cAMP accumulation. PROPOSED COMMERCIAL APPLICATION: Patients with autism, or those within the broader category of autism spectrum disorder, are those who might benefit from secretin agonist drug therapy. A novel and innovative drug for autism would qualify under orphan drug status since there are less than 200,000 patients with autism in the U.S. This would increase the commercial viability and attractiveness of such a drug to small biotechnology or pharmaceutical businesses, and enhance the interest by the FDA. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen ·
Project Title: AUTISM: SOCIAL AND COMMUNICATION PREDICTORS IN SIBLINGS Principal Investigator & Institution: Landa, Rebecca; Director; Kennedy Krieger Research Institute, Inc. Baltimore, Md 21205
Studies
23
Timing: Fiscal Year 2001; Project Start 25-SEP-2001; Project End 31-AUG-2006 Summary: (provided by applicant): Autism spectrum disorders (ASD, including Autism, Pervasive Developmental Disorder-Not Otherwise Specified, Asperger syndrome) are characterized by significant impairment in communication and emotional understanding and expression, as well as a limited behavioral repertoire with restricted interest and activities. Although early diagnosis and intervention are critical, ASD is rarely diagnosed before three years of age. This is problematic given evidence: 1) of prenatal brain abnormality in autism (Rodier et al, 1996; Bauman & Kemper, 1994; Bailey et al., 1998); 2) that symptoms of autism manifest before 24 months of age; and 3) of the importance of early intervention to capitalize on the neuroplasticity of the young brain. Particular attention should be paid to a very high-risk group: the young siblings of autistic children (hereafter, autism sibs). Family history studies indicate that autism sibs are at increased risk for ASD and communicator disorder, implying a need for screening during infancy. Young autism sibs provide researchers with an important opportunity to learn about the early manifestation and developmental trajectory of ASD, the relationship between social and language domains in the development of typical and atypical populations, the genetics of autism, and neuropsychological bases brain development in ASD and the broader autism phenotype. The proposed prospective study will enroll 340 autism sibs, tested at 14, 24, and 36 months of age, to address these specific aims: 1) To identify behavioral profiles that enhance diagnosis of ASD in the first two years of life of infant siblings of children with autism. 2) to test hypotheses about the relationship between joint attention, shared positive affect, and communication in infant siblings later diagnosed with ADS (at 3 years of age) and in those siblings without ASD. In addition, a sample of infants at no known risk for autism (having no developmental disorder) will be included as a basis of comparison of joint attention, communication, and affect development in non-ADS autism sibs. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen ·
Project Title: AUTISM--A MODEL OF ANOMALOUS NEURAL SYSTEMS DEVELOPMENT Principal Investigator & Institution: Filipek, Pauline A.; Associate Professor; Pediatrics; University of California Irvine Campus Dr Irvine, Ca 92697 Timing: Fiscal Year 2001; Project Start 01-JUL-1997; Project End 31-MAY-2004 Summary: By school age, the rate of normal human brain growth declines sharply, but these final phases are especially critical to the maturation of motor, linguistic, cognitive and social aptitudes in the acquisition of adaptive behaviors. These growth rates reflect a delicate balance of normal progressive and regressive histogenic mechanisms. The developmental disorders can be a model for study of anomalous brain development, in particular autistic disorder (AD), which is characterized by deficits in socialization, attention, concept formation, verbal and non-verbal communication, and ritualistic, perseverative behaviors. The investigator's prior MRI-based morphometric analysis in children with AD, developmental language disorders (DLD), non-autistic low IQ (NILIQ), and normal children have shown that both AD and DLD brains are unexpectantly larger in volume and controls which is due to excessive white matter disproportionately localized to the temporal and posterior parietal region, including the angular gyrus, superior parietal lobule, and visual/association regions. These results point to maldevelopment of neocortical systems and are consistent with some of the classic neocortical localization theories. The investigators propose: 1) To recruit three new cohorts of children in early adolescence, aged 10.0 through 15.11, N=30 in each: a) autistic disorder, divided into high IQ (nonverbal IQ70) and low (nonverbal IQ<70) AD
24 Autism
cohort; b) nonautistic low IQ (nonverbal IQ<70); c) normal control volunteers are children with headaches, with normal birth, development, and medical histories, and normal, cognitive, linguistic and behavioral function (nonverbal IQ<70); 2) To replicate the investigator's previous morphometric findings of localized anomalous white matter volumes in the AD cohorts by performing the first of two sequential high-resolution three dimensional (3D) gradient echo T(1) - weighted MRI scans. Complete morphometric analysis will include computation of volume for whole brain, individual substructures, and hemisphere gradients. A new method of cortical localization and parcellation will then be applied to these MRI scans, reference to the Brodnann architectonic map and compatible with the Mesulem scheme of neurosystems hierarchy; 3) To test the hypothesis that the anomalous dysfunctional neurosystems are related to linguistic and neurobehavioral deficits in AD, independent of nonverbal IQ; and 4) To further investigate the effects of puberty on brain development in AD by performing a second of two sequential MRI scans three years later with repeated morphometric and cortical parcellation analysis on these AD and control cohorts. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen ·
Project Title: TREATMENT
AUTISM--DEVELOPMENT,
GENETIC
EPIDEMIOLOGY
AND
Principal Investigator & Institution: Todd, Richard D.; Professor of Psychiatry; Psychiatry; Washington University Lindell and Skinker Blvd St. Louis, Mo 63130 Timing: Fiscal Year 2001; Project Start 30-SEP-2001; Project End 31-AUG-2004 Summary: (Provided by applicant): This is an application for a developmental grant for an Autism Center of Excellence. The long-term goal of this proposed Autism Center of Excellence is the delineation of the genetic and neurobiological mechanisms underlying specific autistic traits and the application of this information to treatment and outcome studies. The basic assumption of this goal is that there are multiple and heterogeneous genetic and neurobiological mechanisms that contribute to the observed clinical heterogeneity of autistic children and determine the social and language differences observed in the relatives of these children. The short-term goal of this developmental grant application is the establishment of an interactive structure and environment for interested investigators to realize these aims. The proposed list of investigators include child psychiatry, child neurology, psychology, and occupational therapy experts with a broad range of interests spanning basic neuronal mechanisms, genetic epidemiology, clinical syndromes and treatment response. The central theme of the proposed center, using developmental and genetic epidemiological methods to determine the underlying mechanisms for specific autistic deficits, is based on our recent success applying these approaches to the genetics of the core autistic feature of reciprocal social behavior. The long range goal of the proposed center is to extend these approaches to include tests of basic neurobiological mechanisms which might be associated with these characteristics, to investigate if similar mechanisms act in the broader autistic spectrum of disorders and to investigate the contribution of these proposed mechanisms to the prediction of treatment response. During the initial phase of this center we will concentrate on the establishment of an organizational structure to facilitate the development of junior and established investigators as autism researchers and on the creation of an enhanced integration of clinical and educational programs in autism and related disorders. Pilot studies for this developmental period will include extension of instruments developed for children to adult versions to test for extended familial transmission of autistic traits and the piloting of the use of established instruments in a quantitative trait locus (QTL)
Studies
25
analysis of the possible involvement of the X chromosome in deficits in reciprocal social behaviors. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen ·
Project Title: AUTISM--MR NEUROANATOMIC ABNORMALITIES Principal Investigator & Institution: Courchesne, Eric; Professor of Neuroscience; Children's Hospital Research Center 3020 Children's Way, Mc 5074 San Diego, Ca 92123 Timing: Fiscal Year 2001; Project Start 10-SEP-1983; Project End 31-JAN-2002 Summary: Infantile autism is a neurological disorder that severely disrupts social, cognitive, and language development. The neurophysiological/neuroanatomical defects responsible for autism have, until recently, resisted discovery. The advent of a powerful, yet non- invasive in vivo imaging method -- magnetic resonance (MR) - combined with disciplined quantitative data analysis has yielded important new insight into the disorder. Our prior NIH-funded MR research has disclosed that specific sites of cerebral and cerebellar anatomical abnormality are present in diagnostically confirmed autistic patients as young as 5 years of age. Quantitative analysis of our MR imaging data indicate that specific loci of abnormality undergo distinct age-related changes in these affected patients. For example, initially small posterior callosal subregions undergo agerelated growth to near normal size, yet cerebellar vermian lobules VI and VII are reduced in size in autistic subjects at all ages, and show no growth over time. Results in even younger patients with a provisional diagnosis of autism indicate that a rapid decrease in size of posterior callosal subregions and cerebellar vermian lobules may occur between the ages of 2 and 6 years. These findings are intriguing, but require confirmation in the larger, carefully designed study herein proposed. To most efficiently explore the incidence and age-related size changes in specific sites of CNS abnormality in autism, we propose a cross- sequential experimental paradigm which will obtain MR imaging data in both autistic and normal control subjects longitudinally over 5 years. Analysis of the prospective longitudinal data acquired will reveal the developmental time course of anatomical deviations in autistic patients, particularly during the age range of 2 to 6 years, an important period of rapid growth in the normal brain. The completion of this study will further our long-term objective of elucidating the neuroanatomical substrate of infantile autism. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
·
Project Title: BEHAVIOR ALTERATIONS IN AUTISM AND RODENT MODELS Principal Investigator & Institution: Bryson, Susan; University of Rochester Orpa - Rc Box 270140 Rochester, Ny 14627 Timing: Fiscal Year 2003; Project Start 01-SEP-2003; Project End 31-MAY-2008 Summary: NO ABSTRACT PROVIDED Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
·
Project Title: BEHAVIORAL AND BIOCHEMICAL MECHANISMS OF SELF INJURY Principal Investigator & Institution: Symons, Frank J.; Assistant Professor; Educational Psychology; University of Minnesota Twin Cities 200 Oak Street Se Minneapolis, Mn 554552070 Timing: Fiscal Year 2001; Project Start 01-JUL-1997; Project End 31-AUG-2004
26 Autism
Summary: Why some people with mental retardation and/or autism repeatedly and persistently injure themselves, some so severely to the point of tissue damage and often times permanent scarring, has remained a mystery eluding a single solution. Unraveling this mystery poses paradoxial biomedical and behavioral science questions and creates deeply troubling problems for practitioners and family members of affected individuals. Over the past decade, many cases of self-injurious behavior (SIB) have been treated successfully using behavioral interventions that teach communication and other functional skills. Practical problems of implementation, costs associated with long-term treatment, and cases with no clear social profile appearing about 1/3 of the time suggest, however, that there is still much to be learned about why people self-injure. Our overall goals are to improve treatment, refine diagnosis, and to clarify mechanisms underlying different forms of self-injury. Given the severity of self-injury, it is surprising that few of the models have examined in more detail the relation between variables common to SIB and the neurophysiology of pain regulation. The main objective of this project is to evaluate the validity of several of these variables as possible predictors of response to self-injury. Treatments will be based on the hypothesis that some forms of self-injury involve intense stimulation of body sites sufficient to elicit the release and receptor binding of endogenous opioid peptides. Accordingly, treatments will include transcutaneous electric nerve stimulation (TENS)(an opioid agonist treatment) or naltrexone (an opioid antagonist treatment). Predictors will include observationallybased measures of the environmental functions of self-injury, body site location and intensity of self-injury, and salivary baseline levels of three bioactive substances (substance P, metenkephalin, & cortisol). Following initial identification of subjects (age range 4-25) with mold to profound mental retardation and/or autism, our first aim is to observe and describe in detail how frequently self- injury occurs, what its duration and intensity is, and where on the body it is directed. Following this characterization, substance P, met-enkephalin, and cortisol will be noninvasively examined through saliva as markers for altered pain transmission and predictors of response to treatment. After screening and SIB subtyping (i.e., social, nonsocial, or mixed) 37 subjects whose self-injury is primarily nonsocial or mixed will be evaluated over a 16-week period with TENS and the opiate antagonist naltrexone for self-injury. Subjects whose self-injury is primarily socially motivated will be evaluated with TENS and the opiate antagonist naltrexone for self-injury. Subjects whose self-injury is primarily socially motivated will be evaluated with TENS and receive behavioral interventions through a technical assistance service delivery model. Three- and six-month follow-ups will be conducted for each subject. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen ·
Project Title: BEHAVIORAL TECHNOLOGY FOR TEACHING MATCHING SKILLS Principal Investigator & Institution: Mahon, Karen L.; Praxis, Inc. 13 West St Belmont, Ma 02478 Timing: Fiscal Year 2001; Project Start 01-JUN-2001; Project End 31-MAY-2003 Summary: This application seeks support for an SBIR Phase II project to complete development and evaluation of a computer-based product, StartMatching!, which is intended primarily for teaching children with mental retardation, autism, and other intellectual disabilities. The product addresses a pivotal skill --generalized identity matching to sample -- which is a target of many current programs for teaching this population (and also for teaching young typically developing children). In identity matching, students are presented with an array of two- or three-dimensional stimuli and
Studies
27
required to select the item that physically matches (i.e., is identical to) a sample; hence the name "matching to sample." The project has two major objectives. First, based on a successful prototype developed in Phase I, we will develop a full-feature version of the StartMatching! product, in anticipation of commercialization. Second, we will verify that the product (1) can be implemented effectively by its intended users and (2) teaches matching skills reliably in settings in which it will be routinely used. PROPOSED COMMERCIAL APPLICATION: The product being developed and evaluated may have a significant impact on special education practice for a variety of student populations. As such, the product is potentially marketable to educators, psychologists, other professionals, and parents. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen ·
Project Title: BIOLOGY OF AUTISM Principal Investigator & Institution: Dunn, Michelle A.; Associate Professor; Neurology; Yeshiva University 500 W 185Th St New York, Ny 10033 Timing: Fiscal Year 2001; Project Start 01-JUN-1997; Project End 31-MAY-2003 Summary: Essential to understanding the symptomatology of autism is the need to unravel its neurophysiology, neurochemistry, and neuropathology. Progress in understanding its pathophysiology has been stymied by a dearth of post-mortem tissue. This Program Project focuses on sensorimotor deficits, their pharmacologic treatment, and their neural basis. The Core will provide a group of well-characterized DSM IV autistic children and a common data base for statistical analysis. In Project l, we will investigate the physiologic basis of aberrant auditory processing by systematically assessing cochlear, brainstem, and cortical auditory function (automatic and attentional discrimination of auditory stimuli). Abnormalities in timing, amplitude and topographic patterns of cortical event related potentials will be identified. In Project II, we will test the hypothesis that excessive endogenous brain opiods contribute to autistic behaviors by assessing the effectiveness of naltrexone, an opioid antagonist, in conventional and ultra-low doses on sociability, hyperactivity, attention, stereotypies, and self- injurious behavior. In animal studies we will localize changes in neural activity associated with naltrexone treatment. Project III will create an international registry of autistic brain specimens and a brain bank to provide the essential material for the scientific community's and our own studies of morphology, opioid and other neurotransmitters and receptors, growth factors, and apoptosis. We will canvas new neuropathologists nationally, and proselytize parent support groups and chronic disease facilities with the pressing need for brain donations. The applicants bring to this project many years of scientific collaboration and experience in brain banking, and management and participation in multidisiplinary research on autism and other cognitive disorders under the aegis of the Rose F. Kennedy Center for Research in Mental Retardation and Human Development. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
·
Project Title: BIRTH RISK AND SEVERE MENTAL DISORDERS IN DENMARK Principal Investigator & Institution: Eaton, William W.; Professor; Mental Hygiene; Johns Hopkins University 3400 N Charles St Baltimore, Md 21218 Timing: Fiscal Year 2001; Project Start 30-SEP-1996; Project End 31-JAN-2005 Summary: (Applicant's Abstract): It is now accepted that pregnancy and birth complications (PBC's) are associated with increased risk for schizophrenia. It is not known whether PBC's are associated with increased risk for bipolar disorder and other
28 Autism
affective psychoses; whether the increase in risk is explained by life style factors of the mother associated with lower socioeconomic status; whether the increased risk is an expression of genetic predisposition to disorder; whether PBC'S, and/or family history of disorder, are associated with early age of onset; the degree to which intergenerational transmission of socioeconomic status is explained by PBC's, in the general population; and in general, how the major risk factors for severe mental disorders combine in raising risk. Continuation of research on the relationship of PBC's to severe mental disorder (especially schizophrenia, bipolar disorder, autism, and their associated disorders) is proposed. Prior analyses, based on linkage of the medical birth register and psychiatric case register of Denmark for births 1973-1993, showed that PBC's were related prospectively to the entire range of hospitalized mental disorders, in both adults and children, with the possible exception of affective psychosis. This continuation expands: 1) the data collection years through 1999; 2) the case-finding beyond hospitals to include specialty outpatient clinics; and 3) the linkage to include the Central Population Register and the National Bureau of Statistics. A reference sample of 5 percent sample of the population of Denmark, including over 60,000 births after 1973 will be linked as well. The expansion will: 1) generate an expected 1200 cases of schizophrenia, 350 cases of affective psychosis, and 1150 cases of autism; 2) permit linkage of first degree relatives, including siblings, mothers and fathers; and 3) permit linkage to socioeocomic variables, obtained on yearly basis, when taxes are paid, such as occupation, income, education, employment, and wealth. Analytic procedures are mostly in the form of logistic regression, and its extensions to time-to-event models (Proportional Hazards); dependent variables with more than two categories (Polytomous Logistic); and to dependent observations (Generalized Estimating Equations). Denmark's system of social medicine provides free care for all, minimizing leakage of cases; and the system of registers is as highly developed and reliable as anywhere in the world. Results will clarify the etiologies of the severe mental disorders; improve understanding of nosologic relationships between the several disorders; provide quantitative information relevant to planning of longitudinal observational and preventive intervention research; and suggest subsets of cases to improve power for genetic analyses. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen ·
Project Title: BRAIN ACTIVATION & FUNCTIONAL CONNECTIVITY IN COGNITION Principal Investigator & Institution: Just, Marcel; University of Pittsburgh at Pittsburgh 350 Thackeray Hall Pittsburgh, Pa 15260 Timing: Fiscal Year 2002; Project Start 26-SEP-2002; Project End 31-MAY-2007 Summary: Project IV will focus on the aspects of brain activation and cognition that appear to be unusual in autism, namely on inter-cortical region integration or coordination. The main approach will be the use of fMRI studies, many of them eventrelated, to examine the location and relative time course of the activation in key cortical areas, particularly in tasks that require varying amounts of interprocess coordination. The main types of cognitive tasks to be studied include language comprehension, problem-solving and planning. Another component of this project examines the development of cognitive abilities in the age range of 9 to 14, again focusing on processes that integrate various streams of information. Finally, the project will develop a computational model of the cognition and brain activation in autism, using as a point of departure a new computational neuroarchitecture, 4CAPS. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
Studies
·
Project Title: BRAIN MEASUREMENT
IMAGE
SEGMENTATION,
COMPARISON,
29
AND
Principal Investigator & Institution: Staib, Lawrence H.; Associate Professor; Diagnostic Radiology; Yale University 47 College Street, Suite 203 New Haven, Ct 065208047 Timing: Fiscal Year 2001; Project Start 30-SEP-2000; Project End 31-AUG-2004 Summary: (Adapted from applicant's abstract): Technologies for high resolution structural imaging of the brain provide neuroscientists with tremendous opportunities for measuring the brain quantitatively and accurately. There is a need, however, for reliable true inter-subject comparison and accurate automated region-of-interest definition. Limitations in these areas have impeded progress in neuroscience in the understanding of normal and abnormal brain structure and in the characterization and treatment of an array of brain disorders, including posttraumatic stress disorder (PYSD) and autism, two conditions having subtle yet distinctive structural abnormalities. The objective of this work is the development of an automated computer system for the analysis of the brain from structural images from magnetic resonance (MR). The aim is to develop and validate methods and provide a tool to allow for accurate, detailed, inter-subject comparison of structure in the brain. Such methods would also be directly applicable to associated functional image. This work requires the refinement and development of segmentation and non-rigid registration methodologies. The limitations of current approaches to registration in terms of lack of detail and inaccuracy can be overcome by incorporating prior statistical information of shape for boundary finding and integrating this image-derived information using physical models for deformation. Characterizing neuroanatomic variation in a detailed probabilistic manner is crucial for constraining the necessary transformation and making it consistent and reliable. The resulting representation allows detailed morphologic description in terms of geometry and deformation. This methodology would also be applicable to comparison within an individual where there is structural change over time. This system will be validated with synthetic, phantom and real images from separately funded studies of PTSD and autism. The results are ideally suited for statistical analysis of structure. This system will allow the accurate and routine analysis and comparison of brain imaging studies to compute regional structural measures for improved understanding of the normal and abnormal brain and in the treatment of patients with brain disorders. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen ·
Project Title: BRAIN SEROTONIN SYNTHESIS IN AUTISM Principal Investigator & Institution: Chugani, Diane C.; Associate Professor; Pediatrics; Wayne State University 656 W. Kirby Detroit, Mi 48202 Timing: Fiscal Year 2001; Project Start 15-DEC-1998; Project End 30-NOV-2002 Summary: Autism is a devastating neurodevelopmental disorder characterized by a spectrum of abnormal behaviors including profound impairment in social interaction and communication, restrictive repetitive and stereotyped patterns of behavior, interests, and activities, as well as stereotypic motor abnormalities. Studies investigating alterations of neuro- transmitters in blood of autistic patients have consistently found increased platelet serotonin in approximately one-third to one-half of autistic patients. Studies of the serotonin metabolite 5-HIAA in cerebrospinal fluid, however, have failed to demonstrate consistent abnormalities of central serotonergic tone. Previously, no method for direct in vivo measurement of serotonin synthesis in humans was available, and only indirect and relatively insensitive measures could be made. Alpha[C-11]Methyl-L-tryptophan has been developed as a tracer for serotonin synthesis with
30 Autism
positron emission tomography (PET) and now allows a direct in vivo measurement of serotonin synthesis in humans. Using this technique, we have preliminary data demonstrating alteration in the whole brain serotonin synthesis in autistic children, as compared to their siblings aged 8-14 years or children with epilepsy aged 2-12 years. Furthermore, we have found focal differences between autistic boys and their siblings. Asymmetries of serotonin synthesis in frontal cortex, thalamus and cerebellum were found in autistic boys, but not in autistic girls nor in the majority of siblings studied. We propose that abnormal serotonin synthesis plays a role in the pathophysiology of autism. In order to further characterize whole brain and focal abnormalities of serotonin synthesis in autistic children, we propose to use alpha[C-11]-Methyl-L-tryptophan imaged with PET to: 1. Determine whether autistic children differ from their siblings with expanded phenotype of autistic disorder, their normal siblings and epileptic children with regard to changes in values for whole brain serotonin synthesis capacity with age. 2. Determine whether there are abnormalities of serotonin synthesis in specific brain regions in autistic children. An understanding of the neurochemical disturbances in autism is important for the development of new treatment approaches. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen ·
Project Title: COGNITIVE EFFECTS OF CEREBELLAR DYSFUNCTION IN AUTISM Principal Investigator & Institution: Townsend, Jeanne; Associate Professor of Neurosciences; Neurosciences; University of California San Diego 9500 Gilman Dr, Dept. 0934 La Jolla, Ca 92093 Timing: Fiscal Year 2003; Project Start 16-JUN-2003; Project End 31-MAY-2008 Summary: (provided by applicant): Cerebellar abnormality may underlie many of the cognitive and clinical symptoms in autism. While brain abnormalities in autism are diverse and involve cortical and subcortical regions, the cerebellum is the most consistently reported site of damage. Developmental abnormality of the cerebellum has been found in 95% of postmortem autism cases and in several hundred individuals with autism on quantitative MRI studies performed by six independent research groups. More than 60 studies have found molecular, metabolic, functional or structural abnormalities of the cerebellum in autism. A rapidly growing body of literature suggests that the cerebellum controls or modifies diverse cognitive processes, thus altering the traditional neurologic view of the cerebellum as a brain structure that supports only motor function. Work in our laboratory has linked the cerebellum to both cognitive function and neural response not only in autism, but also in normal function. We have proposed that some deficits in autism may reflect fundamental cerebellar dysfunction--failure to track sensory information, predict future events and prepare a response. We now propose to test this emerging model of cerebellar dysfunction in autism using functional and structural imaging. We will assess the specificity of cerebellar involvement in these cognitive operations (track, predict, prepare) by comparison of subjects with autism: 1) to patients with cerebellar damage acquired in early childhood; and 2) to those with Asperger syndrome in which the cerebellum may be less affected. We will ground our results from these comparisons by performing fMRI (functional magnetic resonance imaging) studies in normal control subjects to establish that the cerebellum is normally active during these same operations. The fMRI studies of clinical groups will allow us to investigate whether patterns of activation suggest abnormal interaction of the cerebellum and cerebral cortical systems during these important processing operations. Our studies will link both behavioral and neural response (ERP, fMRI) to the underlying neuroanatomy (MRI). These results will help us understand the specific functional deficits associated with developmental or acquired
Studies
31
damage to the cerebellum and thereby will contribute to understanding the brain substrates of behavioral dysfunction in autism. Such knowledge may enable more effective treatment and aid the search for the origins of this debilitating disorder. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen ·
Project Title: CORE--NEUROTOXICOLOGY Principal Investigator & Institution: Cory-Slechta, Deborah; Professor; University of Rochester Orpa - Rc Box 270140 Rochester, Ny 14627 Timing: Fiscal Year 2002; Project Start 01-APR-2002; Project End 31-MAR-2003 Summary: The basic research goal of the Neurotoxicology Core is to understand the nature of the effects of environmental chemicals on nervous system function, their consequences over the life span, the mechanisms by which these effects are produced, and the risks they pose to human health. A key element in this goal is to understand the contribution of combined effects of genetic predisposition and environmental chemical exposures on neurological dysfunctions, particularly as it relates to neurodegenerative diseases. The research within this Core involves both basic neuroscience research and neurotoxicology and explores the age spectrum from development to aging. The general theme of the Core is that both early and late stages of life represent periods of potentially enhanced vulnerability to neurotoxic effects. Embedded within this theme is the emerging concept that neurological effects of toxic exposures may not manifest themselves until years after exposure, and that toxicants interact in complex ways with the genetic composition of the human to influence the nature and severity of functional outcomes. The Core consists of seven members of which five are continuing members and two are new members, drawn from the Departments of Neurology, Environmental Medicine, and Obstetrics-Gynecology. The members have been chosen on the basis of their productivity, commitment to multidisciplinary neuroscience research, and experience in areas of thematic interest to the Center. In the past funding period, the Core was called the Neurobehavioral Toxicology Research Core to reflect its focus on behavioral toxicology. The present Core, now named the Neurotoxicology Core, has expanded its focus to include a broader spectrum of issues, ranging from mechanisms, genetic predispositions and contributions to human diseases, and human risk assessment, while maintaining strengths in behavioral toxicology. Of particular note are the inclusions of sophisticated molecular biology and neurochemistry into the battery of Core skills. The present proposal continues to advance the traditional strengths in metal neurotoxicology, while venturing into several new initiatives as well. A major change is the plan to recruit a new faculty to replace Dr. Cory-Slechta as Core Director. The individual will be selected to further integrate the neurotoxicology and basic neuroscience. Another change is the new initiative into molecular neuroscience and genetic-toxicant interactions, which has been developed through the addition of Drs. Federoff and Gelbard to the Core. This group will focus particularly on toxicant contributions to the development of neurodegenerative disorders. The major thematic areas of the Neurotoxicology Core are the following: 1) Neurochemical mechanism of lead-induced behavioral toxicology (Cory-Slechta). This project examines the neurochemical and neuroanatomical sites through which lead alters neural functions. Work had identified neurotransmitter alterations, neural pathways and behavioral deficits in animal models of lead exposure. 2) Environmental neurotoxicant genetic interaction: murine model (Federoff). This work would test the hypothesis that neurotoxicants interact with yet uncharacterized genetic determinants to produce selective vulnerability. Focusing on the dopamine transporter (DAT), the principal investigator will engineer a population of dopaminergic neurons overexpressing DAT
32 Autism
by means of a somatic mosaic approach and directed gene expression to compare the responses of expressing and non-expressing neurons in the same animal. 3) A murine model of genetic and environmental neurotoxicant action (Richfield). This project would look at the role of the alpha-synuclein gene and gene product in Parkinson?s disease using the somatic mosaic approach. Studies will determine whether mice overexpressing alpha-synuclein show an enhanced dopaminerigic vulnerability when exposed to low does of paraquat. 4) Genotype and phenotype of autism spectrum disorders (Rodier). This project will continue the investigator?s work linking injury during early development (as early as neural tube fusion) and specific genes with the development of the autism disorders. Work will continue to examine the valproic acid model of brain injury (which phenocopies some aspects of autism spectrum disorders), and the toxicant involves the HOX family of genes. 5) The role of inflammation and oxidative stress in human immunodeficiency virus type 1- associated neurologic disease (Gelbard). This project has been investigating how HIV type 1 results in neurotoxicity. In the proposed research, the principal investigator would examine the role of tumor necrosis factor alpha (TNF-a) and platelet activating factor (PAF) in the pathogenesis of neurotoxicity. Future plans include the development of TNF-overexpressing mice by somatic mosaic methods, and subsequent examination of neuronal death under various challenges. 6) Neurobehavioral and developmental effects of methylmercury exposure (Clarkson). This represents a continuation of the large human study of methylmercury exposure via fish and its consequences on development. This is one of two definitive epidemiological studies of human methylmercury exposure, which will continue and expand during the next funding period. In addition, the project director will continue his involvement in a prospective study of mercury exposure via dental amalgams. 7) Persisting functional consequences of neurotoxicant exposure during early development (Weiss). This work will continue studies of developmental exposure to several classes of toxicants. These will include solvents in addition to ongoing work in metals, endocrine disruptors (e.g., TCDD), and drugs (e.g., cocaine). Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen ·
Project Title: CPEA DATA COORDINATING CENTER Principal Investigator & Institution: Dukes, Kimberly A.; Dm-Stat, Inc. 407 Rear Mystic Ave, Unit 11A Medford, Ma 02155 Timing: Fiscal Year 2003; Project Start 26-SEP-2003; Project End 31-MAY-2008 Summary: (provided by applicant): Since 1997, the National Institute of Child Health and Human Development (NICHD) and the National Institute on Deafness and Other Communication Disorders (NIDCD) has provided funding for a Network on the Neurobiology and Genetics of Autism: Collaborative Programs of Excellence in Autism (CPEA). The CPEA network of 10 multidisciplinary projects is being extended for an additional five years to continue studies of genes, brain structure, brain function and behavior and the clinical course of autism. Three separate entities (DMSTAT, Inc., the Boston University Statistics and Consulting Unit at the College of Arts and Sciences and the Department of Biostatistics at the Boston University School of Public Health) have formed a group, DMSTAT/BU, proposing to collaborate with the CPEA network and to serve as its centralized data coordinating center (DCC). Our multi-disciplinary team of biostatisticians, epidemiologists, statistical geneticists, project managers, programmers and data managers can effectively and efficiently serve the ongoing and changing needs of the CPEA network. The primary goal of DMSTAT/BU is to provide integrated support to all CPEA project staff on two fronts: 1) consistent, efficient, cost-effective and high quality data management, and 2) biostatistical expertise in study design,
Studies
33
randomization schemes, matching procedures, statistical genetics and multivariable analysis. DMSTAT/BU will assist project staff in the following areas: study design and protocol development, innovative processes to streamline data collection and increase data quality, administrative management, staff training, study monitoring, regulatory compliance, statistical design, analysis and reporting, and study documentation, in addition to applying our proven data management and statistical analysis procedures, DMSTAT/BU will develop a website for the network which will serve as the backbone of the study infrastructure. The website will have administrative (e.g., e-mail links, meeting information, personnel contact information, project documentation, expense tracking) and data collection (distributed tracking and data entry systems) components. A reporting module in the website will make all of the administrative and data management information accessible to authorized members of the CPEA network. The team we have assembled has the requisite experience to effectively serve the needs of the CPEA network. The qualities that set us apart from our competitors are: innovation in streamlining and organizing processes, our abilities to educate and communicate with study staff at all levels, the breadth and depth of our analytic and statistical knowledge, our commitment to integrity in all aspects of data management, and our outstanding track record on studies of similar size and scope. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen ·
Project Title: DEFINITION AND DEVELOPMENT OF THE PHENOTYPE IN AUTISM Principal Investigator & Institution: Rogers, Sally J.; Professor of Psychiatry; Psychiatry; University of Colorado Hlth Sciences Ctr P.O. Box 6508, Grants and Contracts Aurora, Co 800450508 Timing: Fiscal Year 2001; Project Start 01-JUN-1997; Project End 31-MAY-2002 Summary: The overall goal of this Program Project is to define more clearly what is both familial and specific in the autism phenotype at three levels of analysis "brain, neuropsychology, and behavior" through a series of converging tests. The Program Project is designed to provide a rigorous set of converging tests of five competing neuropsychological explanations of autism: 1) a basic sensory deficit measured by means of magnetoencephalograph (MEG), 2) a praxis deficit, 3) an affective deficit, 4) an inter-subjectivity deficit, and 5) a deficit in executive functions. The converging tests of the latter four, higher level deficit/s are 1) Does the candidate deficits/appear early in the development of children with autism? (0003) 2) Is the deficit/s specific to autism? (Projects 0002 and 003) 3) Are sib pairs concordant for autism also concordant for the deficit/s? (Project 0002) 4) Is the deficit/s pervasive in the sense that it is part of the familial phenotype? (Project 0002) and 5) Is the deficit/s correlated with the brain phenotype, either at a structural (measured by MRI scans) or functional (measured by MEG) level? To permit this set of converging tests, we are studying the same behaviors and neuropsychological constructs in all the samples across Projects. The samples to be studied are 1) 25 multiplex families with idiopathic autism and 25 Down syndrome control families (Project 0002) 2) 40 adults with idiopathic autism, 40 adults with FXS, 40 adults with developmental disabilities (DD) but neither autism nor FXS, and 40 CA and 30 MA controls (Project 0001); and 3) 25 very young children with idiopathic autism, 25 MA and CA controls with DDs but neither autism nor FXS and 25 typically developing MA controls (Project 0003). In collaboration with Jeanette Holden, we will also test the hypothesis that lowered maternal serum dopamine betahydroxylase (DBH), secondary to allelic differences at the DBH locus, provides a uterine environment which is part of the etiology of autism and autistic features in both idiopathic autism and Fragile X
34 Autism
syndrome (FXS). GRNT P01HD354680001 Autism is a devastating developmental disorder with an incidence of approximately 1 in 1,000 live birth. While strongly genetically determined, specific abnormalities remain to be determined, and the clinical picture is sufficiently diffuse to implicate pathology in multiple neural systems. Central to the syndrome is impaired social interaction, a severely restricted range of interests, and abnormalities of attention (a hyper-attentiveness), sensation (usually hyperreactivity). We propose to utilize magnetoencephalographic (MEG) sensory evoked field (EF) data, EEG evoked potential (EP) data, and MRI anatomical data to specifically address early cortical processing of sensory information. We will study 1) 40 high functioning (IQ>50) autistic adults, 2) 40 IQ and age matched FraX patients, 3) 40 age matched MR subjects, and 4) 40 age matched normal adults. We will specifically: 1) Using MEG and EEG, we will quantify reactivity of primary auditory and somatosensory cortex to stimuli of varying intensity; 2) By localizing and quantifying very high frequency (VHF) MEG activity (600 Hz) from primary somato-sensory cortex we will directly measure cortical GABA-ergic inhibitory interneurone activity, which we hypothesize will be deficient in autistic subjects (and correlated with cortical hyperreactivity); 3) Using an MEG auditory EF based goodness of fit metric, we will quantify the ability of autistic subjects to shirt attention from one hemisphere to the other during a binaural auditory oddball task; 4) Using the amplitude of the 100 msec latency auditory EF (termed M100) as a function of auditory interstimulus interval (ISI) we will calculate tau (t), the time constant of the decay of the echoic memory trace, generated in Heschl's gyri. We hypothesize this will be prolonged in autistic subjects, relative to normals, Fra-X or MR groups; 5) Using the EEG EP based metric termed mis-match negativity (MMN) we hypothesize that autistic subjects will demonstrate evidence of an accentuated pre-attentive, automatic cortical feature detection processes; 6) Using and MEG EF metric of auditory cortex MEG alpha suppression during a tonal memory task, we hypothesize that autistic subjects will demonstrate evidence of greater alpha suppression than normals, supporting enhanced should term auditory memory storage, scanning and retrieval; 7) using high resolution MR images of the brain we will quantify volume and relate MEG EF sources to specific cortical areas to determined is MEG and EEG based functional abnormalities are related to observed anatomical deficits in the cortex generating those signals. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen ·
Project Title: DETERMINANTS OF SOCIAL COMMUNICATION SKILLS IN AUTISM Principal Investigator & Institution: Sigman, Marian D.; Professor; Mental Retardation Res Center; University of California Los Angeles 10920 Wilshire Blvd., Suite 1200 Los Angeles, Ca 90024 Timing: Fiscal Year 2002; Project Start 01-JUN-1997; Project End 31-MAY-2007 Summary: (provided by applicant): This program project aims to discover the biological bases of and environmental influences on the social communication deficits in autism. The first two projects propose experimental interventions and longitudinal follow-ups to test the extent to which joint attention, symbolic play, and language can be modified. Based on results showing that particular caregiver behaviors lead to gains in language skills over a 15-year period of development, Project I will test an experimental approach to modifying caregiver behaviors and measuring the consequences. Project II will follow a group of children whose nonverbal communication and play skills were improved through intervention, and will also attempt to generalize the intervention from skilled clinicians to paraprofessionals with a new sample of children. In order to understand
Studies
35
the basis for the deficits associated with autism, Project III aims to explicate the role that duplication of chromosome 15q plays in autism by assessing the phenotypic sequelae in probands with known duplications. The proposed project also plans to define the autism critical region by detailed examination of rearrangements in probands with unusual breakpoints or imprinting errors. Lastly, the extent of cryptic duplication in the population of idiopathic autism will be investigated with newly developed mapping techniques. Project IV focuses on the neuroanatomical bases of social communication deficits in autism. The proposed project will use fMRI to investigate fundamental aspects of information processing: imitation, joint attention, and referencing. These studies will test the hypothesis that deficits in the response properties of specific neural populations, such as mirror neurons, and deficits in the brain's reward systems underlie impairments in perception of referencing and joint attention, which give rise to the social communication deficits in autism. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen ·
Project Title: DEVELOPING A CENTER FOR AUTISM RESEARCH Principal Investigator & Institution: Warren, Stephen T.; William Patterson Timmie Professor and c; Psychiatry and Behavioral Scis; Emory University 1784 North Decatur Road Atlanta, Ga 30322 Timing: Fiscal Year 2001; Project Start 30-SEP-2001; Project End 31-AUG-2003 Summary: (Provided by applicant): This application will develop the Autism Research Center at Emory University. The application will integrate basic science and clinical research programs, establish cores in genetics and phenotyping, and create the organization for a center. The ultimate goal is to use the resources from this application to apply for a Center for Excellence in Autism Research. The program is built on a strong clinical base that has been developed over the past 10 years at Emory University. Both mouse and non-human primate models will be developed to study the neurobiology and genetics of deficits in social behavior. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
·
Project Title: DEVELOPMENT OF THE FLORIDA AUTISM CENTER OF EXCELLENCE Principal Investigator & Institution: Lewis, Mark H.; Professor of Psychiatry; Psychiatry; University of Florida Gainesville, Fl 32611 Timing: Fiscal Year 2001; Project Start 30-SEP-2001; Project End 31-AUG-2003 Summary: (Provided by applicant): We are in the early development stage of building an interdisciplinary team of investigators focused on both basic and clinical issues related to autism. Our goal is to establish a Center for Excellence in Autism Research made up of a highly interactive set of investigators who have a strong record of research in developmental disorders and an increasing focus on and commitment to autism. Thus, consistent with NIH goal, this developmental grant will serve to attract both young and experienced investigators to the field of autism. We have significant resources to be developed including ready access to clinical populations for study and an excellent research environment in which to plan and develop a research Center. Our multidisciplinary research team has a history of collaborative efforts. Among this group are leaders in the field of abnormal repetitive behaviors, behavior analysis/functional analysis, and clinical and basic psychopharmacology. Our focus will be on a core and defining but understudied feature of autism: restricted and repetitive behaviors. We will employ approaches with which we have considerable experience including behavior
36 Autism
analysis, psychopharmacology, movement analysis, and animal models. The period of support of the developmental grant will allow completion of several key developmental activities. First, the organizational structure for the successful development of an autism research program will be designed and implemented. A second activity will be to attract outstanding investigators into the field. A third activity will be the development of pilot projects. This will involve development and review of clinical protocols for assessment and treatment of repetitive behaviors disorders as well as research protocols for basic animal studies. Fourth, core services that will be cost effective and support the largest number of proposed or planned projects will be designed and implemented. Fifth, the planning and development of training activities will also be a major undertaking. We will identify current resources (relevant coursework, grand rounds, journal clubs, etc.) and supplement those where necessary. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen ·
Project Title: DIFFUSION TENSOR IMAGING IN AUTISM Principal Investigator & Institution: Haznedar, M M.; Psychiatry; Mount Sinai School of Medicine of Nyu of New York University New York, Ny 10029 Timing: Fiscal Year 2002; Project Start 01-AUG-2002; Project End 31-JUL-2005 Summary: (provided by applicant): Autism may be due to an abnormal development of a neural network involving-several regions of the brain. The proposed project will be the first to directly examine white matter connectivity in autism. It has been suggested that the dysfunction in the frontal lobe may relate to the characteristic speech problems and that dysfunction in the limbic system, may be one of the mechanisms responsible for the emotional and executive function symptoms of the illness. Compared to control subjects, in the patients with autism the anterior cingulate gyrus, which is a part of the limbic system, showed decreased metabolic rate and structural changes. The anterior cingulate gyrus communicates with many other areas of the brain to coordinate complex behaviors. Communications from this area travel through the axons or white matter of the brain. The axons from the cingulate cortex form the cingulum and this sheaf of communication sweeps up and out of the cingulate. Failure of this communication bundle to systematically find its targets and instead to develop as a tangled and misrouted jumble may explain the disordered executive function and impaired emotional processing in autism. Diffusion tensor imaging makes it possible for the first time to image the direction and alignment of axons in the brain's white matter. This new technique provides a unique opportunity to directly examine quality of white matter connectivity between key brain regions. We propose to collect diffusion tensor MRI scans, anatomical MRI's and PET scans in 30 adult patients with autism spectrum illnesses and 30 healthy control subjects. In the current project along with the cingulum, we will examine the white matter organization in the cerebellar peduncles, striatum, corpus callosum and frontal white matter and will correlate our findings with the clinically distinct presentations of autism spectrum illnesses. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
·
Project Title: DISORDERED VISUAL PROCESSING IN AUTISM Principal Investigator & Institution: Hbehrmqnn, Marlene; University of Pittsburgh at Pittsburgh 350 Thackeray Hall Pittsburgh, Pa 15260 Timing: Fiscal Year 2002; Project Start 26-SEP-2002; Project End 31-MAY-2007 Summary: The overarching goal of this application is to investigate the face recognition deficits of individuals with autism. Initially, this will entail documenting the behavioral
Studies
37
as well as functional and structural cortical signatures associated with this impairment and, in doing so, contrasting face processing with that of other stimulus classes, such as objects or words. To understand the nature of the face impairment further, two additional lines of investigation will be pursued. In the first, the investigators will characterize the topography and function of striate and extrastriate visual areas in these individuals using functional magnetic resonance imaging of visual eccentricity and meridian maps. In addition, they will undertake analyses of the structural morphometry of regions such as fusiform and lingual gyrus to explore the neural substrate further. In the second, the investigators will explore the intermediate level vision of these individuals, with specific emphasis on their ability to derive configurations from local elements using sensitive behavioral assays. The investigators will also explore the developmental aspects of these perceptual processes by comparing the performance of young and older high-functioning autistic individuals, along with matched controls. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen ·
Project Title: DIVALPROEX SODIUM/PLACEBO IN CHILD/ADOLESENT AUTISM Principal Investigator & Institution: Hollander, Eric; Associate Professor; Psychiatry; Mount Sinai School of Medicine of Nyu of New York University New York, Ny 10029 Timing: Fiscal Year 2001; Project Start 30-SEP-2001; Project End 31-AUG-2004 Summary: (provided by applicant): Autism is a pervasive developmental disorder affecting social, communicative, and repetitive behavior domains and cognitive function, and has dramatic impact on quality of life. It is also frequently accompanied by aggression, self-injury, impulsivity, and mood instability, as well as EEG abnormalities and seizure disorders. While large scale studies of childhood autism are currently underway with SSRI's and atypical neuroleptics, little controlled data is available with other agents that might target these core and associated symptoms of autism. This application aims to determine whether there is scientific evidence to support the practice of prescribing divalproex sodium (DS)(valproate) to child/adolescent autistic patients. When a medication is used extensively prior to scientific substantiation in controlled clinical trials, the consequences can sometimes be problematic. Neither the side effects nor efficacy of valproate in treating child/adolescent autistic disorders has been definitively established. Of theoretical interest, valproate has possible neuroprotective effects mediated by signal transduction pathways (i.e., protein kinase-c inhibition and bcl-2 activation) which may potentially be beneficial for a neurodevelopmental disorder such as autism. This study is the first double-blind placebo-controlled medication trial of valproate for children and adolescents with autism, and utilizes a 12-week doubleblind placebo-controlled parallel design. The study is unique in examining the treatment effects of valproate (DS) versus placebo on global autism severity; aggression, self-injury and impulsivity; affective instability; repetitive behaviors and social deficits; and functional ability. While our pilot open data evaluating the use of DS for autistic subjects has been encouraging so far (71 percent of autistic subjects were global treatment responders on open DS), a double blind placebo controlled trial with larger sample size and more precise methodology is needed to provide a scientifically sound conclusion about the efficacy, side effects, and effects on functional living skills of this medication in children with autism. This will definitively either support or contradict its widespread use in this understudied and neglected population, and provide a benchmark by which new treatments could be compared. It will also assess the relationship between dose and blood levels and response, potentially identify subgroups particularly responsive to this treatment, and identify which components and associated symptoms are most responsive to change.
38 Autism
Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen ·
Project Title: DIVERGENCE AND VARIABILITY OF LANGUAGE MAPS IN AUTISM Principal Investigator & Institution: Mueller, Ralph-Axel; Psychology; San Diego State University 5250 Campanile Dr San Diego, Ca 92182 Timing: Fiscal Year 2002; Project Start 01-SEP-2002; Project End 31-AUG-2007 Summary: (provided by applicant): Despite a general consensus that autism has biological causes, the specific links between brain loci of abnormality and cognitivebehavioral impairments remain unknown. Functional neuroimaging studies do not provide a clear picture, possibly due to etiological heterogeneity of autism samples. We will explore potential abnormalities of functional brain organization in autism with specific focus on individual variability, using functional MRI (fMRI) -- an imaging technique with sufficient power for individual analyses. Thirty verbal individuals with autism, 24 subjects with Asperger syndrome (AS), and age, gender, and handednessmatched controls will be studied. Our project will focus on language -- a domain which not only differentiates autism and AS in terms of delay and deficit, but is also characterized by a wide spectrum of abilities within the adult autistic population. FMRI will be performed during auditory and phonological discrimination, and lexical semantic association. Several complementary data analysis paths (groupwise and intraindividually; in normalized and native space) will enable us: (i) to identify consistent abnormalities of functional maps for autism and AS groups; (ii) to quantify activation foci in each subject in terms of spatial divergence from normal and individual variability within patient groups; (iii) to relate varying patterns of abnormal functional maps with measures of language skill; and (iv) to distinguish effects of pathological disturbance of functional maps from those of compensatory plasticity. We will test hypotheses, according to which in autism (and to a lesser extent in AS) pathological disturbance of neural differentiation and impoverished interactive language experience during critical developmental periods result in aberrant neurofunctional maps and abnormally pronounced individual variability. Language delay in autism is further hypothesized to be associated with atypical hemispheric dominance for language. Finally, we expect that individually variable patterns of abnormal functional maps will be correlated with level of language outcome. Identifying such links between brain maps and level of functioning achieved in adults will elucidate the significance of individual variation in autism in terms of different pathways of etiology and abnormal development. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
·
Project Title: DONEPEZIL HCL: TREATING COGNITIVE DEFICIT IN AUTISM Principal Investigator & Institution: Handen, Benjamin L.; Associate Professor and Program Director; Psychiatry; University of Pittsburgh at Pittsburgh 350 Thackeray Hall Pittsburgh, Pa 15260 Timing: Fiscal Year 2001; Project Start 25-SEP-2001; Project End 31-AUG-2004 Summary: (provided by applicant): Children with autism spectrum disorders (ASD) are characterized by deficits in social interaction, impaired communication, and repetitive and stereotyped patterns of behavior, interests, and activities (APA, 1994). Interest in the amelioration of some of the core and secondary features of ASD has led the use of a wide range of pharmacological interventions, with inattention and overactivity, ritualistic behavior, self-injury and agitation/aggression among the most frequently
Studies
39
targeted symptoms. Recent survey data indicates that up to 34 percent of individuals with ASD are prescribed medication and/or vitamins for control of a wide range of behaviors (Aman et al., 1995). While most pharmacological research to date has attempted to treat many of the behavioral deficits commonly associated with ASD, few pharmacological studies have attempted to ameliorate the core features of this disorder (an area of particular interest for this RFA). Donepezil HC1, a cholinesterase inhibitor which increases brain levels of acetylcholine, is purported to enhance cognitive functioning in a range of disorders, including multiple sclerosis, Alzheimer's disorder, and ADHD. A recent open-label study of the safety and efficacy of donepezil HC1 in 25boys with ASD found significantly increased speech production and a statistical trend toward improvement in core symptoms of ASD (Chez et al., 2000). The present application will provide an opportunity to conduct further pilot testing of the tolerability, safety and effect of donepezil HCl on the cognitive deficits presumed to underlie the core features of ASD. Forty children and adolescents with ASD will be recruited to participate in a 10-week, double blind, placebo-controlled parallel groups study of donepezil HC1. This feasibility study is designed to provide documentation of medication-enhanced cognitive functioning in ASD using a 5mg and 10 mg/day donepezil HC1 dose. This study will also examine the side effects profile of donepezil HC1 in children with ASD, explore possible correlates of treatment response, and provide an opportunity to obtain initial pilot data to determine the sample size needed to conduct a full-scale intervention trial. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen ·
Project Title: EARLY LANGUAGE CHARACTERISTICS IN AUTISM Principal Investigator & Institution: Kuhl, Patricia K.; Professor; University of Washington Seattle, Wa 98195 Timing: Fiscal Year 2003; Project Start 01-JUN-2003; Project End 31-MAY-2008 Summary: Language and communication impairments are key components of autism. Our laboratory has been conducting studies on preschool age children with autism examining early aspects of language processing. These studies have revealed critical differences in phonetic discrimination, social communication, and crossmodal processing between preschool age children with autism and mental-age and chronological-age matched groups of developmentally delayed (DD) and typically developing children. As these measures reflect abilities that emerge during infancy, these results signal the potential of early speech measures for identifying children with autism at a very young age. Furthermore, it is possible that these early measures of language and communication ability may prove to be very sensitive predictors of language outcome for children with autism. In the current proposal, we plan to examine these early speech measures - namely, (1) event-related brain potential measures of phonetic perception, (2) listening preference for speech versus mechanical-sounding auditory signals, and (3) vocal imitation abilities - in 18-24 month children with autism, and comparison groups of children with DD and typical development to determine whether such measures discriminate children with autism at an early age. Furthermore, we will assess their value in explaining individual differences and predicting language outcome at age 4 for children with autism. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
40 Autism
·
Project Title: ELECTROPHYSIOLOGICAL AND FMRI STUDIES OF SOCIAL COGNITION IN AUTISM Principal Investigator & Institution: Aylward, Elizabeth H.; Professor; University of Washington Seattle, Wa 98195 Timing: Fiscal Year 2003; Project Start 01-JUN-2003; Project End 31-MAY-2008 Summary: We propose to study the brain bases of one of the most basic aspects of social cognition, face processing. Parallel studies utilizing event-related potentials (ERPs) and functional magnetic resonance imaging (fMRI) will provide information about abnormalities in the timing and regional distribution of brain response to faces in autism. Twenty-five adults with idiopathic autism and 25 IQ- and age-matched typical individuals will participate in each study. These studies will examine ERP and flVIRI in response to face vs. nonface visual stimuli, to specific face parts (eyes vs. mouths), to moving vs. static face parts, and to familiar vs. unfamiliar faces. Separate eye-tracking studies on the same individuals will examine eye movements during viewing of different types of face stimuli. We will test a novel hypothesis that abnormalities in face processing in autism are related to atypical attentional strategies when viewing faces. Results of the ERP, fMRI, and eye-tracking studies will also be correlated with performance on neuropsychological tests of face perception and memory, and behavioral measures of social impairment. These studies will shed light on the nature and neural bases of face processing impairments in autism. Such information is clinically important for early identification, development of targeted interventions, and investigation of the genetic basis of autism. There is strong evidence of a genetic component in autism, and we expect that this research will lead to more refined measures of quantitative traits that can be used in genetic studies. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
·
Project Title: ENHANCING MENTAL HEALTH SERVICES TO CHILDREN WITH AUTISM Principal Investigator & Institution: Nesbitt, Thomas S.; Human Physiology; University of California Davis Sponsored Programs, 118 Everson Hall Davis, Ca 95616 Timing: Fiscal Year 2002; Project Start 18-SEP-2002; Project End 31-AUG-2005 Summary: (provided by applicant): This project represents the first step in a formal collaborative, interdisciplinary research program at the University of California, Davis Health System (UCDHS) between the Medical Investigation of Neurodevelopmental Disorders (M.I.N.D.) Institute and the Center for Health and Technology (CHT). The project will review obstacles and develop strategies and guidelines for optimizing the effectiveness of telehealth technologies (clinical telemedicine, distance learning, internet communication and information distribution) in the delivery of high quality, empirically supported, well coordinated mental health services for children with autism and their families in rural communities. The project will develop an interdisciplinary network or "M.I.N.D. Bank" of faculty scholars from such areas as anthropology, medical sociology, special education and adult learning, public relations and marketing, political science, medical ethics and law, child psychiatry, child psychology, communication sciences and technology, and autism treatment. A Community Advisory Board (CAB) of stakeholders, including representatives from community and state mental health departments, developmental services organizations, special education, and parent organizations, will advise the M.I.N.D. Bank throughout the guideline development process. The aims of the proposed project are to: 1. Form an interdisciplinary faculty M.I.N.D. Bank of academic scholars and a Community Advisory Board (CAB) of
Studies
41
stakeholders, who will engage in an interactive, iterative process to identify the potential advantages and barriers to the use of telehealth technologies in supporting best practices for children with autism; 2. Review and integrate disciplinary perspectives to produce a set of interdisciplinary guidelines regarding best practices for using telehealth to enhance empirically supported interventions to rural children with autism that will take into account cultural and ethical challenges; 3. Design and write research proposals to investigate the efficacy of the newly developed interdisciplinary telehealth guidelines to enhance delivery of mental health practices for children with autism in rural communities. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen ·
Project Title: EPHB SIGNALING IN DENDRITIC SPINE DEVELOPMENT Principal Investigator & Institution: Ethell, Iryna M.; None; University of California Riverside 900 University Ave Riverside, Ca 92521 Timing: Fiscal Year 2003; Project Start 01-JAN-2003; Project End 31-DEC-2007 Summary: (provided by applicant): This research project will investigate the role of EphB receptor signaling in dendritic spine development. Understanding the molecular basis of dendritic spine morphogenesis is fundamentally important to a variety of inherited developmental disorders associated with mental retardation and autism, including Rett Syndrome and FragileX Syndrome. Patients with these disorders exhibit malformation of dendritic spines. These abnormalities result in synaptic dysfunctions, mental retardation and autism. The molecular mechanisms of dendritic spine abnormalities are not well described and require further investigation. Recently I made an important discovery that spine morphogenesis is controlled by the EphB-type receptor tyrosine kinases (Ethell et al., Neuron, 2001). I showed that expression of kinase-inactive EphB2, which prevents activation of EphB-type receptors in a dominantnegative fashion, blocked spine formation in cultured hippocampal neurons, the dendritic protrusions remained long, thin filopodia, as seen in patients with mental retardation and autism. I hypothesize that EphrinB (ligand)-induced activation of EphB receptors control dendritic spine formation. Preliminary results support this hypothesis and shows that clustered EphrinB2-Fc promotes dendritic spine morphogenesis. In Specific Aim 1, I will conduct experiments with knock out mice in which expression of one or multiple EphB receptors is disrupted to find which of the EphB receptors is responsible for the EphrinB2-induced spine formation. I propose to investigate two possible mechanisms through which EphB receptors may trigger dendritic spine mophogenesis: 1) recruitment of signaling molecules to synaptic membranes; 2) tyrosine phosphorylation of key molecules at postsynaptic sites. In Specific Aim 2, I will identify signaling molecules that may link the signaling of the EphB receptors to its effect on spine formation, by conducting mass-spectrometry analysis of the proteins recruited by EphB2 to dendritic spines upon its activation with EphrinB2-Fc. Preliminary results suggest that RhoGTPases may be responsible for the EphrinB/EphB receptor-mediated dendritic spine formation. In Specific Aim 3, I propose to investigate the molecular mechanism of EphB-mediated regulation of RhoGTPases in dendritic spines and its correlation with EphrinB-induced spine formation. In Specific Aim 4, I will also investigate role of cell adhesion molecules in EphrinB-mediated formation and stabilization of dendritic spines. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
42 Autism
·
Project Title: EXAMINING PRACTICE PATTERNS FOR CHILDREN WITH AUTISM Principal Investigator & Institution: Stahmer, Aubyn C.; Children's Hospital Research Center 3020 Children's Way, Mc 5074 San Diego, Ca 92123 Timing: Fiscal Year 2002; Project Start 10-APR-2002; Project End 31-MAR-2007 Summary: (provided by applicant): My goal in applying for this career development award is to obtain the advanced training I need to successfully develop independent R01 applications that assess the effectiveness of research-based treatments for children with autism in community settings. My research, academic and clinical training to date have prepared me to pursue this goal by providing substantive background in behavioral interventions, individualization of treatment strategies and autism specific issues. My objective is to build on this training to develop an independent translational research program designed to bridge the gap between behavioral intervention research in autism and implementation of efficacious treatments in the service delivery system. A rigorous training program is proposed which includes (1) training in methods moving efficacious interventions into effectiveness trials; (2) training in statistical methods appropriate to translation research including meta-analysis, clinical trials and sampling methods; (3) advanced training in working with culturally and economically diverse populations; and (4) continued training in the ethical conduct of research. Training will be put into practice through the conduct of a pilot research project which addresses all of the training areas. The specific aims of the proposed research project include: (1) assessing the extent to which research-based treatment developed and testing in research settings have been disseminated and translated into service systems and possible barriers to translation; (2) examining the fidelity of implementation of researchbased programming in an early intervention system and adaptations to these programs made in service systems; and (3) a small scale study examining the effect of the use of research-based treatments in the service system and family factors on child outcomes. This project will provide me with experience working with culturally and economically diverse families, assessing interventions and outcomes within a public service system and conducting statistical analyses on large data bases. This combination of training and research will provide me the necessary background to conduct independent translational research for young children with autism. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
·
Project Title: EYE-TRACKING STUDIES OF SOCIAL VISUAL PURSUIT IN AUTISM Principal Investigator & Institution: Klin, Ami J.; Harris Associate Professor of Psychology; Child Study Center; Yale University 47 College Street, Suite 203 New Haven, Ct 065208047 Timing: Fiscal Year 2002; Project Start 27-SEP-2002; Project End 31-AUG-2007 Summary: (provided by applicant): This R01 focuses on the hypothesis that spontaneous visual fixation and visual scanning patterns are predictors of level of social competence in individuals with Autism Spectrum Disorders (ASD). This hypothesis originated from research using eye-tracking technology to measure visual fixation time while cognitively-able adolescents and adults with autism watched naturalistic social scenes. Time spent looking at mouth, body, and object regions was 2+ times greater in individuals with autism relative to age-, sex-, and verbal IQ-matched controls. Time spent looking at the eyes, however, was 2+ times less in individuals with autism. Fixation time on mouths and objects was a strong predictor of level of daily social
Studies
43
adjustment and level of autistic social symptomatology, while fixation time on eyes showed little relation to these outcome measures of social competence. Increased fixation on mouths predicted more social competence, whereas increased fixation on objects predicted less. Work on visual scanning patterns seems to yield even greater differences between the individuals with autism and controls. We request 5 years of support to examine this hypothesis in the context of a wider spectrum of autism manifestations, age, and cognitive levels. We propose to complete eye-tracking procedures for 96 participants with ASD and 96 age- and verbal IQ-matched controls aged 5 to 12 years. In specific aim #1 we will study the relationship between visual fixation patterns and age, verbal IQ, and outcome measures of social competence, which include standardized measures of social impairment, social adjustment, and social cognition. In specific aim #2 we will examine the relationship between visual scanning patterns and the same outcome measures of social competence, as well as age and verbal IQ. Apart from providing a unique window into the ways in which individuals with autism search for meaning when confronted with social situations, our overarching goal is to develop the eye-tracking paradigm into a laboratory-based quantifier of social disability, which is an important need in current genetic research of the varying manifestations of autism. The proposed R01 works synergistically with other ongoing eye-tracking research including studies of toddlers at risk of having autism and studies of monkeys with mesiofrontal-limbic ablations. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen ·
Project Title: FACES AND THEIR COMMUNICATIVE SIGNALS IN AUTISM Principal Investigator & Institution: Joseph, Robert M.; Boston University Medical Campus 715 Albany St, 560 Boston, Ma 02118 Timing: Fiscal Year 2002; Project Start 01-SEP-2002; Project End 31-JUL-2007 Summary: The goal of the proposed research is to investigate the social-communicative abilities of children with autism as revealed through their capacity to process information from people?s faces. In recent research, we found that children with autism engage in atypical face recognition strategies that involve an unusual reliance on the mouth, and deficient processing of the eyes. We plan to extend this work by investigating the entire range of face perception abilities in autism, including perception of face identity, facial expressions of emotion, eye gaze direction, and facial speech. A series of experiments will be conducted with autistic children aged 10-1 6 and with NVIQ>70; an age- and NVIQ-matched, language-impaired control group, and an agematched normal control group. The main predictions are that: (1) In face identification, children with autism will exhibit impaired eye recognition even when they are cued to attend to the eye region, and will exhibit impaired processing of eyes but intact processing of mouths across measures of holistic face recognition. (2) They will show a similar pattern of deficiency in the perception of facial emotions, with intact recognition of emotions expressed via the mouth, but impaired recognition of emotions expressed primarily through the eyes. (3) They will be impaired in following eye gaze and in judging eye gaze direction. (4) They will be less proficient at reading visual speech cues from the eyes than from the mouth. Across experiments, our goal is to assess how impairments in different aspects of face perception may be related in autism. In addition, we will assess the relationship of all experimental face perception variables to visual scanning patterns; lower-level visual perception abilities; and concurrent socialcommunicative functioning. In its broad focus on all aspects of face processing, this research will provide a systematic delineation of autistic impairments in a vital channel of communication, and will thus contribute to a better understanding of autism?s core
44 Autism
symptomatology. Further, in investigating a range of face processing skills that have been intensively studied on the neuroanatomical level, this research can contribute to the elucidation of the brain bases of autism and its genetic etiology. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen ·
Project Title: FUNCTIONAL MR IMAGING OF SOCIAL COGNITION IN AUTISM Principal Investigator & Institution: Isenberg, Nancy B.; Jfk Medical Center 65 James St Edison, Nj 08820 Timing: Fiscal Year 2003; Project Start 01-APR-2003; Project End 31-MAR-2008 Summary: (provided by applicant): This Mentored Patient-Oriented Research Career Development Award, a program of research and career development, is proposed to establish a foundation for future independent research in functional neuroimaging, with a focus on social cognition in autism. The research component of the proposal is based on the hypothesis that autism will be associated with an abnormal pattern of brain activity while performing the social cognitive tasks with relative decreases in the amygdala and associated areas that are both necessary for social cognition and disordered behaviorally and neuropathologically in autism. The Specific Aims of the study are: 1) To identify the functional neuroanatomy that underlies social cognitive dysfunction in autism by the use of an implicit interpersonal threat (IIT) task that has been validated to activate an amygdala network in normal subjects. 2) To develop additional behavioral tasks that may be used in conjunction with functional imaging to further characterize social cognition in autism and other neuropsychiatric disorders. Investigators will characterize the limitations in social cognition in relation to performance on a moral judgment task, designed to differentiate between personal/high-emotion moral judgment and impersonal/low-emotion moral judgment. This task activates medial prefrontal and posterior cingulated cortex, areas of the brain that are also engaged during theory of mind tasks in normal subjects, and not in autistic subjects, despite similar performance. The extensive training portion of this proposal consists of clinical neuroscience and neuropsychology coursework and seminars, as well as hands-on instruction in behavioral analysis and fMRI imaging techniques. The multimodal studies that are outlined in the current proposal, and which contain psychophysiological, behavioral, and functional neuroimaging information, will permit the investigator to expand her area of expertise in clinical neuropsychiatry, affective processing and positron emission tomography to functional magnetic resonance imaging with specific focus on social disabilities in neurodevelopmental disorders such as autism. The proposed research will utilize combined bottom-up (social emotional evaluation) and top-down (higher order social cognition) approaches, with the IIT task and moral judgment task, respectively, to further our understanding of social cognitive dysfunction in autism. By combining these approaches and data, it is anticipated that we will begin to examine, in greater depth, social cognitive dysfunction in autism as it relates to affective processing and theory of mind, and as reflected in neural, psychological, and behavioral responses. This line of investigation is likely to improve our understanding and treatment of autism, a prevalent and chronic public health problem. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
·
Project Title: GENE EXPRESSION ANALYSIS IN TUBEROUS SCLEROSIS Principal Investigator & Institution: Crino, Peter B.; Professor; Neurology; University of Pennsylvania 3451 Walnut Street Philadelphia, Pa 19104
Studies
45
Timing: Fiscal Year 2003; Project Start 01-JAN-2003; Project End 31-DEC-2006 Summary: (provided by applicant): The tuberous sclerosis complex (TSC) is an autosomal dominant, multisystem disorder that affects the brain and results from mutations in one of two genes, TSC1, encoding hamartin, and TSC2, encoding tuberin. Neurological complications of TSC are the most disabling and include epilepsy in over 70-80% of TSC patients, as well as autism and mental retardation in half of TSC patients. These neuropsychiatric abnormalities in TSC result from the effects of cortical tubers, the characteristic brain lesions of TSC, on brain function. Tubers are developmental abnormalities of cerebral cortical cytoarchitecture (a form of cortical dysplasia) characterized histologically by disorganized cortical lamination and cells with aberrant morphologies. The prominent abnormal cell types in tubers are dysplastic neurons (DN), giant cells (GC), and abnormal astrocytes. Tubers are epileptogenic and seizures in TSC patients are often refractory to medical management despite anticonvulsant polytherapy. Surgical resection of tubers may be necessary to achieve adequate seizure control. The number of tubers present in TSC patients seems to correlate with the onset and severity of mental retardation and autism in TSC patients. The broad goal of this grant proposal is to investigate how hamartin and tuberin mutations contribute to tuber formation using 3 experimental paradigms. We will determine whether tubers form as a result of a "second hit" somatic mutation or haploinsufficency using a high resolution analysis of TSC1 and TSC2 genes in single microdissected GCs, DNs, and astrocytes. Second, we define the expression of five candidate gene and protein families that are pivotal in normal corticogenesis including cell adhesion molecules, transcription factors, growth factors, and cytoskeletal elements in single DNs, GCs, and astrocytes and then relate these changes in expression to the mutational state of these cell types. Third, the expression of the five candidate gene and protein families will be determined during distinct epochs of cortical developmental in 3 transgenic mouse strains in which tuberin or hamartin have been completely or conditionally knocked out. These experiments provide a strategy to define the molecular mechanism of tuber formation as a direct consequence of TSC gene mutations and the downstream effects on gene expression within distinct populations of cells at defined developmental timepoints. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen ·
Project Title: GENETICS Principal Investigator & Institution: Coon, Hilary H.; Associate Professor; University of Utah 200 S University St Salt Lake City, Ut 84112 Timing: Fiscal Year 2002; Project Start 20-SEP-2002; Project End 31-MAY-2007 Summary: The Genetics Component will search for susceptibility genes for autism using extended pedigrees identified through the Utah Population Database (UPDB). We have already identified hive pedigrees with 3-7 affected members and large sibships, and have DNA on one pedigree with seven affected cases. UPDB searches for two pedigrees will be performed using 800 new cases of autism ascertained from four sources. DNA from the 800 cases and their parents will be banked for future family-based association studies. Serum and whole blood will also be banked for future serotonin and immune assays. These cases will also provide approximately 40 new sib pairs for network-wide studies and a pol of subjects for network-wide regression studies. Within members of identified extended pedigrees, we will collect phenotypic data on traits that have shown promise in preliminary data as intermediate phenotypes for autism. An intermediate phenotype occurs in unaffected and affected family members, and may serve as a marker for carrier status of susceptibility genes for autism. These traits may help us to identify specific susceptibility genes associated with particular intermediate phenotypes.
46 Autism
Preliminary studies suggest several promising intermediate phenotypes, including the Broader Autism Phenotypes (BAP; mild clinical symptoms in communication, social, and behavioral domains), serotonin levels from blood, and head circumference. Immune phenotypes will be identified by the Immune Component; serum for immune assays will be stored on all subjects. A 5 cM genotype scan will be done using the Marshfield Mammalian Genotyping Service. Pedigrees will be analyzed using the clinical phenotype and intermediate phenotypes to map susceptibility loci. Four candidate genes under linkage peaks will be genotyped using SNPs. Budget resources will also be reserved to SNP type the best candidate gene identified through microarray studies in the Immune Component, for a total of five candidate genes. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen ·
Project Title: GENOTYPE AND PHENOTYPE OF BRAINSTEM INJURY IN AUTISM Principal Investigator & Institution: Rodier, Patricia M.; Professor; Obstetrics and Gynecology; University of Rochester Orpa - Rc Box 270140 Rochester, Ny 14627 Timing: Fiscal Year 2001; Project Start 01-AUG-1998; Project End 31-MAY-2003 Summary: Autism is a neuro-developmental disorder. This program will make use of new discoveries to bring research on autism into the context of modern developmental biology, neurobiology, and molecular genetics. Identification of the embryonic stage when injury can cause autism has led to the insight that the disorder is initiated by changes in the developing brain stem. The shortening of the hindbrain and loss of cranial nerve neurons in an animal model of the insult and a human case of autism resemble features of the Hoxa-1 transgenic knockout mouse. This suggests a unifying hypothesis regarding the multiple etiologies of autism: We propose that teratogens and genetic defects lead to similar developmental changes in the brain stem because mutations of early developmental genes are the cause of familial cases and the teratogens which cause the disease act by interfering with functional of the same genes. The new finding that one of the candidate genes is abnormal in some cases of autism supports this hypothesis. In Project I. Animal Models of Autism and Mechanisms of Injury, we shall compare the effects of valproic acid, hexanoic acid and retinoic acid on the Hox gene cascade, using mice transgenic for lacZ markers of Hoxa-1 expression, in situ hybridization for markers of the rhombomeres, and staining for neurofibrils. We shall develop animal models transgenic for human mutations involved in autism. Finally, we shall test for interactions between early developmental gene mutations and teratologic exposure. The goal is to understand how teratologic agents and genetic anomalies produce similar effects on the hindbrain. Project II. Behaviors Discriminating Autism in Humans and Animals, is an investigation of two behavioral tasks with promise to discriminate autism from other developmental disabilities. Both the conditioned eye-blink response and an attention task have already been shown to be affected in autism. The long- term goal is to develop animal tasks that can serve as markers of the injury that causes autism so that animal models can be tested for parallelism to the human disorder. Project III. Genotype and Phenotype in Autism and Behaviorally-Related Disorders, will assess behavioral symptomatology, minor physical anomalies, and neurological/ophthalmological deficits, and mutations of early developmental genes in four developmentally disabled groups (autism, Asperger syndrome, Moebius syndrome, and semantic-pragmatic language disorder) and normal controls. The goal is to determine whether the phenotypic or genotypic features of these disorders indicate a common etiology. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
Studies
·
47
Project Title: IDENTIFYING THE ETIOLOGY AND TREATMENTS FOR AUTISM Principal Investigator & Institution: Miles, Judith H.; Professor of Pediatrics; Child Health; University of Missouri Columbia 310 Jesse Hall Columbia, Mo 65211 Timing: Fiscal Year 2001; Project Start 30-SEP-2001; Project End 31-AUG-2003 Summary: (Provided by applicant): The University of Missouri-Columbia campus (MU) hosts several active autism research programs spread among the Colleges of Medicine, Arts and Sciences, and Education. These research programs range from basic science to clinical investigations. We plan to combine these research efforts and identify our primary areas of emphasis as we develop a design for a Missouri Center of Excellence for autism research. This initiative is established in response to the NIH RFA: MH-02001 and to the April 2001 Missouri State Senate Resolution #616. An organizational core, consisting of seven core investigators, has been assembled with expertise in the areas of Medical Genetics, Clinical Neurophysiology, Neuropharmacology, Molecular Neurogenetics, Developmental Psychology, and Educational Psychology. The active involvement of public health specialists from the Missouri Departments of Mental Health, Health, Education, and Social Services will provide valuable resources to insure the success of this initiative. The goals for the developmental year will be to: (1) Develop an overall plan to establish the Missouri Center of Excellence for Autism Research. The scientific direction of the project will be fully developed through the intensive work of the core investigators meeting weekly, gathering an autism research Advisory Committee, and preparing the NIH Autism Research Centers of Excellence submission. (2) Educate the Missouri research community about autism and the research opportunities. This will be achieved through a biweekly journal club, an autism visiting professor series, and continued support for the current autism educational program. (3) Encourage and facilitate autism research at MU and throughout the state. This will be achieved by expanding the research expertise within each core area, strengthening offcampus collaborations, and fostering active mentorship for young investigators. We also listed tentative 5-year research goals for each of the six Research Center Areas that represent existing strengths on the MU campus. The intensive interactions among these Center Areas during the developmental process will modify and enrich these goals as the center investigators participate in an intensive one year planning process leading to a cohesive, scientifically meritorious research application for the NIH Autism Center. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
·
Project Title: IERI: SCALING UP READING TUTORS Principal Investigator & Institution: Cole, Ronald A.; Institute of Cognitive Science; University of Colorado at Boulder Boulder, Co 80309 Timing: Fiscal Year 2002; Project Start 27-SEP-2002; Project End 31-AUG-2004 Summary: (Provided by Applicant): The proposed work aims to scale up powerful, computer-based learning programs with cutting-edge speech and animation technology. These programs help children with special needs to acquire the foundational speech, language, and reading skills necessary for academic achievement, social interaction and self-esteem. The investigators target four populations of students with special needs, representing between 20-25% of all K-12 students in the country, students whose needs are currently not met adequately by the public school system: students with 1) hearing impairments, 2) autism spectrum disorders, 3) English as a second language, and 4) reading disabilities. The impact of the reduced potential of all these students is devastating both to them and to society. Computer-based programs can help these students overcome significant barriers to learning so they can realize their potential. The
48 Autism
proposed project would provide students and their teachers with computer-based learning tool that enable significant learning gains whole reducing teacher load. The investigators propose to identify barriers to the widespread deployment and acceptance of these tools and to develop strategies that will enable them to successfully scale up programs using these tools to effect systemic change. The proposed work builds on a strong foundation of theoretical and empirical research by the investigators on learning in areas of speech and language, reading skills, and comprehension, and research and development of human language technologies. Their work has led to the development and successful deployment of computerized language training tutors that use intelligent animated agents to teach speech, reading, and classroom subjects to profoundly deaf children at Tucker Maxon Oral School in Portland, OR, and to students with dyslexia and ASD at schools in Boulder, CO. While educational technology is now poised to advance student achievement in many academic areas, the technology will be useless unless teachers feel invested, competent, and interested in including the technology in their own teaching. The goal of this research is to identify factors which hinder and help in the acceptance and deployment of the software, and to develop a model which will be useful for other researchers and developers in scaling up potentially valuable new technologies in education. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen ·
Project Title: IMMUNOLOGY Principal Investigator & Institution: Fujinami, Robert S.; Professor; University of Utah 200 S University St Salt Lake City, Ut 84112 Timing: Fiscal Year 2002; Project Start 20-SEP-2002; Project End 31-MAY-2007 Summary: The etiology and pathogenesis of autism is still unknown. This developmental disease is acknowledged as a syndrome having a broad range of symptoms. It appears that genetics play a major role in the development of this disease. Two lines of evidence support this. First, twin studies have shown concordance rates between 36% to 91% for monozygote twins and 0% to 30% for dizygotic twins, depending on the criteria used to define autism. Second, there is evidence for an association with autism and a region on human chromosomes 6 encompassing the major histocompatibility complex (MHC) that includes HLA class I and class II, and some of the complement components, including C4B. Since concordance rates in monozygotic twins are not 100%, this implies that other factors play a role in the development of autism or are responsible for different subtypes of this disease. Elevated serotonin levels are a consistent finding in autism. Similarly, it appears that the immune response and/or immune regulation in autistic subjects is altered versus control subjects. These immune aberrations often present as a decreased lymphoproliferative response to mitogens and immune reactivity to central nervous system (CNS) proteins. Genetic predisposition (elevated serotonin levels) and/or environmental agents such as viral injections or exposure to toxins in utero or early in life could be responsible for the immune dysregulation. Immune responses against CNS proteins during development could lead to CNS changes that affect behavior and social development later in life. First, we propose to investigate the role of serotonin in inducing dysregulation of the immune response. Second, we examine the specificity and autoreactivity of T cells and antibodies present in children with autism. Third, we plan to determine whether immune effector cells and antibodies induce or mimic CNS features often observed in autistic subjects such as hippocampal and mammillary body changes. Fourth, we propose to perform microarray analyses on RNA isolated from peripheral blood mononuclear cells (PBMC) of autistic children versus control subjects. Determining
Studies
49
what genes are altered and identifying their chromosomal positions may lead to additional loci that contribute to this disease. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen ·
Project Title: IMPACTS OF PARENTING ADOLESCENTS & ADULTS WITH AUTISM Principal Investigator & Institution: Seltzer, Marsha M.; Waisman Ctr/Mr & Human Devlmt; University of Wisconsin Madison 750 University Ave Madison, Wi 53706 Timing: Fiscal Year 2001; Project Start 01-FEB-1990; Project End 31-AUG-2005 Summary: This application seeks five years of support to continue the investigators' dual site research involving the impacts of life long parenting for adolescent and adult sons or daughters with mental retardation (MR). The focus of the work shifts in this application to a new population, as a sample of 400 families of adolescents and adults with autism will be studied. The proposed investigation will address four central issues: (1) the manifestation of symptoms of autism among adolescents and adults (both crosssectionally and longitudinally, (2) the effects of the behavioral, communicative, and social functioning of persons with autism on parental well-being (again cross-sectionally and longitudinally), (3) the antecedents and consequences of placement of the person with autism, and (4) the impact of differential diagnostic groups on family well-being. The fourth aim, families of persons with autism will be compared with two previously collected samples of families: one with a son or daughter with Down syndrome, and one with a son or daughter with schizophrenia. These samples, and the data relating to them, are available from previous or ongoing funded work by the current investigative group. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
·
Project Title: IMPROVED SECRETIN ANALOGS FOR THE TREATMENT OF AUTISM Principal Investigator & Institution: Boismenu, Richard; Assistant Professor; Repligen Corporation 41 Seyon St, Ste 100 Waltham, Ma 02453 Timing: Fiscal Year 2002; Project Start 17-SEP-2002; Project End 30-NOV-2003 Summary: (provided by applicant): Secretin is a naturally occurring, short-lived 27 amino acid neuropeptide hormone. Report of significant improvements in an autistic child treated with secretin has generated widespread clinical interest in its therapeutic potential since there is no FDA-approved treatment for autism. Studies in rodent have established that secretin transfers from blood into brain and can activate discrete brain regions. Synthetic human secretin analogs will be designed, using recently described strategies, to increase its stability and brain activity compared to the parent peptide. The secretin analogs generated in this Phase I will be tested in vitro for receptor binding and activation as well as in vivo for their ability to activate specific brain regions. Completion of these aims would validate the Phase II goal of developing a more active second generation secretin for the treatment of autism. In principle, the technologies developed to generate a more stable and active secretin could be applied to other therapeutic peptides. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
·
Project Title: INFRASTRUCTURE FOR RESEARCH ON MENTAL DISABILITIES Principal Investigator & Institution: Stevenson, Roger E.; Director; Greenwood Genetic Center 1 Gregor Mendel Circle Greenwood, Sc 29646
50 Autism
Timing: Fiscal Year 2001; Project Start 15-FEB-1999; Project End 31-JAN-2004 Summary: Autism and mental retardation are common and enigmatic disturbances of brain function which generally manifest in early childhood and persist throughout life. Systematic study of unselected series of patients identifies a specific cause in approximately 10% of cases of autism and 50% of cases with mental retardation. Recognized causes are heterogeneous, including genetic defects (e.g., chromosome aberrations, single gene mutations, uniparental disomy), environmental insults (e.g., infection, injury, chemical), or some combination of the two influences (multi-factorial causation). The lack of understanding of causation of many other aspects of autism and mental retardation, including identification of the many responsible genes, the pathogenetic mechanisms through which brain development is adversely affected, and the delineation of the clinical (including behavioral) phenotypes of autism and mental retardation syndromes, underscores the need for clinical research on these mental disabilities. The Greenwood Genetic Center operates a small but productive clinical research program related to autism and mental retardation. Strengths of the program include expertise in dysmorphology, clinical genetics, childhood development, pathology, cytogenetics, biochemical genetics, and molecular genetics. Gaps in expertise include neurology and neuropsychology, epidemiology and biostatistics. The overall goal of the proposed infrastructure support project is to enhance the capacity for the Greenwood Genetic Center, in collaboration with the SC Department of Disabilities and Special Needs, and to conduct clinical research on autism and mental retardation. This will be accomplished of a Section of Neurology/Behavioral Science, 2) developing the capacity to acquires and analyze data through establishment of a Section on Epidemiology and Biostatistic, 3) expansion of the range of molecular technologies and trained manpower available for research purposes, and 4) strengthening the administrative structure in support of the research program through development of an Office of Grants/Research Management and a Scientific Advisory Board. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen ·
Project Title: INTERGRATED METHODS FOR MEASURING NEUROANATOMY IN AUTISM Principal Investigator & Institution: Duncan, James S.; Professor; Diagnostic Radiology; Yale University 47 College Street, Suite 203 New Haven, Ct 065208047 Timing: Fiscal Year 2001; Project Start 01-JUN-1996; Project End 31-AUG-2003 Summary: Autism is a complex disorder of early onset, involving odd and repetitive movements, severe social disability, deficits in social cognition, and disruption of language. While the multiple signs and symptoms in autism suggest several different brain systems are likely involved in its pathobiology, it remains the fact that most efforts aimed at the analysis of neuroanatomical structure related to autism from (primarily Magnetic Resonance (MR) images have been limited to the measurement of rather gross features, such as overall brain size and cross sectional area, or measurements of the corpus callosum and cerebellar vermis, using fairly small samples. These limitations are in large part because, to date, manual and computer-assisted, semi-automated segmentation/measurement of neuroanatomy is a tedious, labor-intensive, and costly process, subject to human variability. The research proposed here is aimed at the further development of an image analysis strategy that will accurately, reproducibly, robustly and efficiently analyze neuroanatomical structure relevant to autism from 3D high resolution MR images. At the core of this effort are unique mathematical approaches to: i.) segment cortical structure using coupled differential equations to simultaneously locate the gray/white and gray/CSF surfaces; ii.) segment subcortical structure by
Studies
51
adding shape and inter-structure spatial relationship priors to an approach that integrates boundary finding and region growing; and iii.) nonlinearly register regional neuroanatomical structure to create atlases and match them to segmented information for the purpose of labeling cortical gyri and guiding the subcortical segmentation process. A key feature of the approach is that the final labeling and measurement that is performed is done by carefully focusing on individual regions of the brain, one at a time. The accuracy and robustness of the individual algorithm components to imaging parameters, field inhomogeneities and noise will be demonstrated by validating segmentation, registration, labeling and measurement algorithm results from synthetic data created using an MR image simulator against gold standard source images. The utility of the image analysis strategy for deriving robust, accurate measures in a variety of cortical and subcortical brain regions relevant to autism will be evaluated by running the algorithm on a cohort of 30 normal control and 30 subjects having autism and/or related conditions, sampled from a large, well characterized and separately NIH-funded subject database. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen ·
Project Title: LANGUAGE IN AUTISM: CLINICAL AND BASIC STUDIES Principal Investigator & Institution: Tager-Flusberg, Helen B.; Professor of Anatomy and Neurobiology; Anatomy and Neurobiology; Boston University Medical Campus 715 Albany St, 560 Boston, Ma 02118 Timing: Fiscal Year 2002; Project Start 01-AUG-1997; Project End 31-JUL-2007 Summary: (provided by applicant) This application has been submitted as a request for continuing support for a program of projects that has been designed to better understand the neurobiology and genetics of autism. The central organizing theme of the project is on studies of processes associated with language and social deficits in this syndrome. In its initial funding cycle the program included 3 funded projects designed to: a) provide a longitudinal study of the relations between language and theory of mind; b) develop a battery of computer based tasks that would differentiate nonverbal children with autism from children with severe autism, and c) explore the neurobiological underpinnings of language and communication abnormalities in autism with MRI. Three new projects are described in this continuation proposal. Project I proposes a detailed comparison of face processing in children with autism and controls. Project II proposes to examine the similarities and differences in language impairments in children with autism versus those with and without specific language development. Project III has been designed to provide a morphometric and functional MRI exploration of the neural substrates of social and language impairments in autism. These projects are to be carried out as a collaborative effort across Boston University Medical School; Tufts / New England Medical Center, and Harvard Medical School / Massachusetts General Hospital. These projects will be coordinated by a clinical and administrative core. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
·
Project Title: LYMPHOCYTIC TARGETS AND BEHAVIOR IN FRAGILE X Principal Investigator & Institution: Kaufmann, Walter E.; Associate Professor; Kennedy Krieger Research Institute, Inc. Baltimore, Md 21205 Timing: Fiscal Year 2003; Project Start 20-FEB-2003; Project End 31-JAN-2005 Summary: (provided by applicant): Fragile X syndrome (FraX), the most prevalent form of inherited mental retardation, is associated with the absence of FMRP, a protein
52 Autism
involved in regulation of protein synthesis. Recent microarray studies have identified transcripts that are abnormally regulated in both brains from FMRP knockout mice and lymphoblasts from males with FraX. These FMRP targets include structural and functional proteins that participate in synaptic development and plasticity. In addition, using proteomics techniques, we have demonstrated in FraX lymphocytes abnormal acetylation of several proteins that include the microglial regulatory protein annexin-1 (Anx-1) and the neuronal cytoskeletal protein a-tubulin. Abnormal Anx-1 expression is also predictive of autistic features in FraX. We hypothesize that specific aspects (e.g, autism, megalencephaly), and variability, of the FraX neurobehavioral phenotype are the consequence of abnormal expression of one or more neural proteins, and that these contributions can be identified by characterizing patterns of abnormal neural protein expression in lymphocytes and their neurobehavioral correlates in males with FraX. We propose to study the patterns of expression of 12 selected FMRP targets in lymphocytes from a well-characterized sample of males with FraX, representing the spectrum of neurobehavioral phenotypic manifestations. In Aim l, we will use a combination of immunochemical techniques to characterize patterns and levels of lymphocytic protein expression in 100 males with FraX and 20 controls. In Aim 2, we will examine the relationships between these molecular variables and selective aspects of the neurobehavioral phenotype (e.g., a-tubulin and IQ) of the FraX subjects. Since blood samples and behavioral data are available on 50 FraX and 10 control subjects, only half of the sample will be recruited over two years. Preliminary data also show the feasibility of studying 4 of the proposed proteins. Because of their innovative approach to examining genotype-phenotype relationships, we believe that the proposed studies are in accordance with the purposes of the Exploratory/Developmental Grant (R21) Program. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen ·
Project Title: MAGNETIC RESONANCE IMAGING IN AUTISM DISCORDANT SIBLINGS Principal Investigator & Institution: Lotspeich, Linda J.; Psychiatry; Stanford University Stanford, Ca 94305 Timing: Fiscal Year 2001; Project Start 10-DEC-1999; Project End 30-NOV-2004 Summary: The overall aim of this grant proposal is to enhance the applicant s skill in patient-oriented clinical research in the area of child mental health. This will be accomplished through a program of combined education, training and the completion of a research project on structural neuroimaging of autism. The candidate s major goal is to develop her research capacities in clinical studies of child mental health with a focus on the neurobiology of childhood neurogenetic disorders. At the end of the award period, the candidate expects: 1) to possess the skills necessary to be an independent investigator in clinical research; 2) to have received funding as an independent investigator; and 3) to become a leader in the scientific study of patients with childhood neuropsychiatic disorders. The objectives of the proposed research project are to a) assess the relation between brain morphology and autism through structural neuroimaging of siblings discordant for autism and b) to assess the relations among cognition, behavior and specific brain morphologies in autistic subjects. In addition to the proposed research activity, the candidate will participate in graduate course work in the School of Medicine s Departments of Genetics, Psychiatry, Neuroscience and Health Care Policy and Research. The course work will encompass genetics, behavioral research, neuroscience, biostatistics, and epidemiology. She also will participate in
Studies
53
seminars and tutorials with identified educational consultants in areas related to her planned research. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen ·
Project Title: MHCRC NEUROBIOLOGY AND PHENOMENOLOGY OF MAJOR PSYCHOSES Principal Investigator & Institution: Andreasen, Nancy C.; Professor; Psychiatry; University of Iowa Iowa City, Ia 52242 Timing: Fiscal Year 2001; Project Start 30-SEP-1987; Project End 31-AUG-2003 Summary: The focus of The University of Iowa Mental Health Clinical Research Center is on understanding the neurobiology of mental phenomena and disease processes, with the long-term goals of translating our findings "back" to the basic level of mechanisms and causes, and "forward" to the clinical level of treatment. Our primary emphasis is on schizophrenia spectrum disorders. Because the boundaries between schizophrenia and many other major mental illnesses are not clear, however, we also seek to gain insights about the neural mechanisms of normal and abnormal mental phenomena by studying other conditions with known mechanisms that can serve as "model syndromes" such as Huntington's disease or conditions with shared phenomenology and neurodevelopmental origins such as autism. The CRC consists of four core units and six research units. The Administrative Core is responsible for maintaining centralized records of all protocols, managing a five bed inpatient research unit, and coordinating the efforts of investigators between themselves and with the institution as a whole. The Assessment and Training Core maintains a core assessment battery, provides a training and calibration program for the various instruments used in CRC protocols, conducts studies of reliability, and develops new assessment techniques. The Biostatistics Core provides biostatistical consulting and collaboration to investigators at all stages of the research effort, maintains a centralized core data base, and provides quality assurance at all levels of core data processing. The Image Analysis Core provides a centralized resource for the analysis of imaging data, including the development of new software and image analysis techniques, training on the use of workstations, and a quality assurance program. The Diagnosis and Phenomenology Unit examines approaches to improving the definition of the phenotype. The Structural Imaging Unit examines anatomical aspects of schizophrenia and related disorders, with an emphasis on identifying neural circuits and linking MR findings to basic neurobiology through neuropathology studies. The Functional Imaging Unit emphasizes the use of 150 water technique in order to explore cognitive systems in normal individuals (i.e., attention, memory, language, and mood) and in various disease processes, including schizophrenia, autism, and substance abuse. The Cognitive Neuroscience Unit uses the techniques of experimental cognitive psychology and neuropsychology to focus on the relationship between cognitive systems and disease processes. The Basic and Clinical NeuroPharmacology Unit studies genetic regulation of drug metabolism, pharmacokinetics, and the effects of medications on cognition and blood flow through the use of PET and fMR. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
·
Project Title: MOUSE MODEL OF AUTISTIC REPETITIVE BEHAVIOR Principal Investigator & Institution: Garner, Joseph P.; Animal Science; University of California Davis Sponsored Programs, 118 Everson Hall Davis, Ca 95616 Timing: Fiscal Year 2002; Project Start 10-JUN-2002; Project End 31-MAY-2004
54 Autism
Summary: (provided by applicant): The presence of abnormal repetitive behaviors is necessary for a diagnosis of autism. These behaviors can be distressing, self-injurious, and difficult to treat. Despite their importance however, abnormal repetitive behaviors have received far less attention from researchers than other symptoms of autism. The specific goal of this project is therefore to develop an animal model of abnormal repetitive symptoms in autism. Abnormal repetitive behaviors in autistic patients are associated with disruption of 'executive' systems which are responsible for selecting and sequencing behavior. The performance of different executive systems can be measured using distinct neuropsychological tasks. Abnormal repetitive behavior in autism can be divided into 'high-level' behaviors which correlate with impairments in 'high-level' executive systems, measured using the IDED task; and 'low-level' behaviors which correlate with impairments in 'low-level' executive systems, measured using the gambling task. Abnormal repetitive behaviors commonly develop in captive animals. C57BL6/J laboratory mice perform two kinds - barbering (hair-pulling), and stereotypy - that closely resemble 'high-level' and 'low-level' behaviors respectively in autistic patients. If these behaviors are indeed equivalent to autistic symptoms they should correlate with the same measures of executive dysfunction. We will use a number of cognitive tasks, including the IDED and gambling tasks, to measure executive dysfunction in the mice. Our specific aims are therefore to: 1) develop standardized methods for recording these behaviors and performing these tasks in mice; 2) test the prediction that barbering will correlate with impairments on the IDED tasks; and 3) test the prediction that stereotypy will correlate with impairment on the gambling task. Developing a model of these symptoms in mice opens up several exciting new avenues for future research into environmental factors, genetic factors, and possible therapies. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen ·
Project Title: NEURAL BASIS OF SOCIAL ATTENTION Principal Investigator & Institution: Deaner, Robert O.; Neurobiology; Duke University Durham, Nc 27706 Timing: Fiscal Year 2003; Project Start 01-AUG-2003; Project End 31-JUL-2006 Summary: (provided by applicant): Humans are highly motivated to attend to socially relevant information, such as the proximity and attentional states of others. The neural basis of socially-motivated attention, however, remains poorly understood, despite the fact that the disruption of these mechanisms is a primary characteristic of several debilitating emotional disorders, including autism. The proposed research therefore aims to develop an animal model of the neurophysiology of socially-motivated attention. Two studies will investigate neuronal activation in the parietal cortex, an area that is known to be crucial in mediating visuo-spatial attention and is suggested, by neuroimaging data, to be crucial for socially-motivated attention. In one study, the activation of parietal neurons will be investigated while monkeys choose to attend to social or non-social stimuli. In the second study, parietal activity will examined when monkeys utilize the perceived gaze direction of a conspecific to orient their own attention. Together these studies will provide an improved understanding of the neural basis of social attention in healthy individuals and thus will contribute to the development of new treatments for autism and other debilitating disorders. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
Studies
·
55
Project Title: NEURAL SUBSTRATES /SOCIOEMOTIONAL DISTURBANCES /DEVELOP. Principal Investigator & Institution: Malkova, Ludise; Pharmacology; Georgetown University Washington, Dc 20057
Assistant
Professor;
Timing: Fiscal Year 2001; Project Start 03-AUG-2001; Project End 31-MAY-2004 Summary: (provided by applicant): The goal of this proposal is to understand how early brain insults influence the short-term and long-term development of cognitive and socioemotional functions. This understanding is vital for the approach to neurodevelopmental disorders such as autism, and at the same time is relevant to an entire spectrum of behavioral disorders that emerge as a result of a host of neurological disturbances in children (epilepsy, cerebral palsy, cortical dysgenesis, etc.). The analysis of human cases and experiments in animals suggest the hypothesis that dysfunction in medial temporal lobes, and the amygdala in particular, is an etiological factor in autism. Therefore the goal of our proposal is to investigate the role of the amygdala and its specific subdivisions for socioemotional behavior and to identify the critical developmental periods and neural triggers for developmental abnormalities in an animal model of autism. The first Specific Aim concentrates on the effects of pharmacologically-induced imbalances in neurotransmission in the amygdala on social interactions in infant animals. Drugs known to either block or enhance GABA-ergic or glutamatergic transmission will be focally infused into specific subdivisions of the amygdala and social interactions in the experimental animals will be observed. The second Specific Aim is to compare the effects of drugs (as obtained in Aim I) with the effects of discrete lesions of subregions of the amygdala, when damaged by axonsparing excitotoxic lesions, in infant monkeys. The third aim will evaluate the effects of early prolonged seizures, known to disrupt the function of the amygdala and its projection network, on the observed behavioral categories. This aim is directed to the understanding why certain seizure disorders in infants (e.g., infantile spasms) give rise to autism. An important facet of these studies will be the analysis of the extent to which socioemotional disturbances produced by various anatomically site-specific insults are accompanied by impairment in cognitive functions. Well standardized procedures will be used to evaluate various components of socioemotional interactions of infant and juvenile animals in dyads and to assess their emotional reactions to positive and negative stimuli. Cognitive tasks will include concurrent visual objects discrimination and auditory-visual crossmodal associations and memory. The results of the proposed studies will identify specific amygdaloid nuclei critical for regulation of social and emotional interactions and determine the critical stage(s) in development during which amygdala dysfunction (by lesions, drugs or seizures) can lead to long-term socioemotional abnormalities. This information will provide a rationale basis for the design of therapeutic interventions directed at correcting the underlying biological dysfunctions that give rise to autism and related socioemotional disorders. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen ·
Project Title: NEUROBIOLOGIC STUDIES OF THE LIMBIC SYSTEM IN AUTISM Principal Investigator & Institution: Bauman, Margaret L.; Anatomy and Neurobiology; Boston University Medical Campus 715 Albany St, 560 Boston, Ma 02118 Timing: Fiscal Year 2001; Project Start 10-JUN-2000; Project End 31-MAR-2005 Summary: (adapted from applicant's abstract): Relatively few pathological studies of the brain in autism have been reported and a variety of findings in cortical, subcortical and posterior fossa regions have been described. Over the past several years, quantitative
56 Autism
and semi-quantitative analyses have been conducted in a small series of autistic brains, studies in comparison with age and sex-matched controls that were processed in whole brain serial section. Abnormalities have been consistently observed in the limbic system, cerebellum and related inferior olive. In the limbic system, the hippocampus, amygdala and entorhinal cortex have shown a small nerve cell size and increased cell-packing density at all ages, consistent with a pattern of developmental curtailment. A different pattern of change had been noted in the vertical limb of the Diagonal Band of Broca, cerebellar nuclei and inferior olive with plentiful and abnormally enlarged neurons in the brains of young autistic subjects, and in adult autistic brains small, pale neurons that are often reduced in number. These findings, combined with reported age-related changes in brain weight, have raised the possibility of a progressive process. However, technological restraints have precluded the determination of total number of neurons in these structures and the use of qualitative and quantitative immunocytochemical techniques. This project will utilize modern immunohistochemical and stereological cell counting techniques to quantitatively analyze selected regions of the limbic system in a series of autistic brains studied in comparison with age and sex-matched controls. Findings will be compared with volumetric magnetic resonance imaging (MRI) analysis in these same brains, and patterns of microscopic abnormality will be correlated with clinical characteristic of each subject based on information derived from medical records and formal interviews with families. Further, studies for evidence of a progressive process, and involvement of selected neurotransmitter systems in the limbic system that have been implicated in the clinical features of autism will be conducted. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen ·
Project Title: NEUROIMAGING AND SYMPTOM DOMAINS IN AUTISM Principal Investigator & Institution: Levitt, Jennifer; None; University of California Los Angeles 10920 Wilshire Blvd., Suite 1200 Los Angeles, Ca 90024 Timing: Fiscal Year 2003; Project Start 02-APR-2003; Project End 31-MAR-2008 Summary: (provided by applicant): Autism represents one of the most severe disorders of development, yet its biological underpinnings remain unknown. Although the prevalence of autism in the general population is estimated at 0.05 -- 0.1 percent, a variety of studies indicate that deficits in social functioning and communication affect 15 percent of first-degree relatives of autistic individuals. The poor long-term outcomes seen in such children underscores the need for a better understanding of the biological mechanisms involved in autism. Three intersecting domains of behavior: communication, social reciprocity and restricted/repetitive behaviors, taken together are diagnostic of the illness, but appear partially independent. This fact, in concert with evidence from genome-wide linkage investigations and candidate gene studies, provides evidence that a single etiology of autism is unlikely. Given the heterogeneous nature of autism, identification of homogeneous subgroups is essential to furthering our understanding of the biology underlying the behaviors associated with this disorder. The availability of noninvasive, non-radioactive neuroimaging techniques and sophisticated data analytic approaches used in combination with family genetic data holds the promise of greatly improving our ability to identify these subgroups. The principal goal of the work proposed in this project is to use these tools to identify neuromorphometric and neurochemical measures that define meaningful endophenotypes in autism. In addition, the extent to which these measures are shared among siblings and therefore are familial will be explored as a means of identifying these endophenotypes. Using these tools, Affected Sibling Pairs selected from the Autism Genetic Resource Exchange multiplex families, and a sample of non-autistic
Studies
57
control children selected from an ongoing study of normal children at UCLA will be examined. The CAN/AGRE study population is a large group of multiplex families with phenotypic and genotype data available for access by research scientists. We propose that key behavioral phenotypic dimensions of autism including: delay of language onset, repetitive/stereotyped behaviors and social reciprocity, are associated with specific brain neuromorphometric and neurochemical measures. Furthermore, we will examine the extent to which the neurobiologic findings underlying these phenotypic variations will be correlated among siblings, suggesting that they may be useful phenotypes for future investigations. Taken together, these studies will provide the basis for genetic studies to delineate specific gene > brain> behavioral pathways and lay the foundation for early detection and better intervention in autism. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen ·
Project Title: NEUROIMAGING OF LANGUAGE AND COMMUNICATION IN AUTISM Principal Investigator & Institution: Harris, Gordon; Boston University Medical Campus 715 Albany St, 560 Boston, Ma 02118 Timing: Fiscal Year 2002; Project Start 01-SEP-2002; Project End 31-JUL-2007 Summary: Deficits in language and social-communication functioning represent one of the primary manifestations of 'autism. However, to date there has been little research into the underlying neural mechanisms responsible for language and socialcommunication dysfunction in autism. Project Ill of the program project, 'Language in autism: Clinical and Basic Studies,' will use structural magnetic resonance imaging (MRI) and functional MRI (fMRI) techniques to evaluate the anatomy and physiology of brain regions and tasks related to language and Social-communication in autism. Subjects will include adolescent (age 10-1 6) autistic, specific language impaired (SLI), and matched control groups. fMRl is ideally suited for the functional studies in this project because it is non-invasive, and does not use ionizing radiation, allowing multiple experimental conditions to be evaluated within individual subjects. The structural imaging studies will examine gray matter volumes in language and socialcommunication-related regions within the cerebral cortex using segmentation, parcellation, and voxel-based morphometry (VBM) methods. White matter and cerebellum have also been implicated in autism, and so structural analyses will also include cerebellar and white matter parcellation and diffusion-tensor imaging (DTI) of white matter organization. Measures of brain structure will be evaluated for correlation with language performance determined through the Core evaluations. The fMRl experiments will evaluate high-functioning autistic subjects and matched control groups under five experimental conditions: lexical-semantic encoding, past tense processing, phonological processing, processing facial expressions linked to eyes vs. mouths, and activation related to direct vs. averted eye gaze. The three language fMRl tasks relate to experiments and findings from Project II (language), while the two socialcommunication tasks relate directly to Project I experiments and findings (socialcommunication). There is evidence that each of these domains demonstrates abnormality in autism, and we will evaluate the neural activation responses to these activation paradigms through a series of five experimental conditions. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
58 Autism
·
Project Title: AUTISM
NEUROIMAGING/DEVELOPMENTAL
NEUROBIOLOGY
OF
Principal Investigator & Institution: Hardan, Antonio Y.; Psychiatry; University of Pittsburgh at Pittsburgh 350 Thackeray Hall Pittsburgh, Pa 15260 Timing: Fiscal Year 2001; Project Start 21-AUG-2001; Project End 31-JUL-2006 Summary: (provided by applicant): The career development and research plans outlined in this Mentored Patient-Oriented Research Career Development Award application are designed to enable the candidate to independently design and conduct neuroimaging studies investigating the neurobiology of autism by examining increased brain size and the involvement of the cerebelo-thalamo-frontal circuit in the pathophysiology of this neurodevelopment disorder. Autism is a severe disorder characterized by marked social and communication deficits, restricted and stereotyped patterns of behaviors and interests. A wide range of abnormalities has been reported and studies of brain structure have implicated several aspects of brain development involved in neuronal organization including the elaboration of dendritic and axonal ramifications, the establishments of synaptic connection, and cell death. Recent neuropathologic and neuroimaging studies have reported increased brain size in autism, and evidence supporting the underdevelopment of the circuitry of neural networks that involve cerebral cortex, limbic system and cerebellum. The proposed longitudinal study will use the combination of volumetric measurements obtained from magnetic resonance imaging scans and chemical shift imaging proton spectroscopy obtained at 30 months intervals from a group of children with autism (8-12 years of age) and individually-matched controls to characterize the developmental changes of brain enlargement, and the involvement of the cerebello-thalamo-frontal circuit in autism. It will also provide the candidate with the experience necessary to apply advanced neuroimaging techniques and a solid foundation from which to conduct longitudinal studies investigating the developmental neurobiology of autism and possibly identifying clinical, prognostic and therapeutic correlates. The candidate is certified in psychiatry, and child and adolescent psychiatry with four years of post-graduate clinical experience. Drs. Nancy Minshew, and Matchery Keshavan will serve as preceptors. Course work and directed reading in biostatistcs, data management, research ethics, neuroanatorny, neuroimaging and developmental neuroscience will complement the research training. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen ·
Project Title: NEUROMAGNETIC INVESTIGATION OF ADULTS WITH AUTISM Principal Investigator & Institution: Reite, Martin L.; Professor; University of Colorado Hlth Sciences Ctr P.O. Box 6508, Grants and Contracts Aurora, Co 800450508 Timing: Fiscal Year 2001; Project Start 04-MAY-2001; Project End 31-MAY-2001 Summary: Autism is a devastating developmental disorder with an incidence of approximately I in 1,000 live births. While strongly genetically determined, specific abnormalities remain to be determined, and the clinical picture is sufficiently diffuse to implicate pathology in multiple neural systems. Central to the syndrome is impaired social interaction, a severely restricted range of interests, and abnormalities of attention (hyper-attentiveness) and sensation (usually hyper- reactivity). We propose to utilize magnetoencephalographic (MEG) sensory evoked field (EF) data, EEG evoked potential (EP) data, and MRI anatomical data to specifically address early cortical processing of sensory information. We will study 1) 30 high functioning (IQ>50) autistic adults, 2) 30 IQ and age matched FraX patients, 3) 30 age matched MR subjects, and 4) 30 age matched normal adults. We will specifically: 1)Using MEG and EEG, we will quantify
Studies
59
reactivity of primary auditory and somatosensory cortex to stimuli of varying intensity; 2) By localizing and quantifying very high frequency (VHF) MEG activity (600 Hz) from primary somato- sensory cortex we will directly measure cortical GABA-ergic inhibitory interneurone activity, which we hypothesize will be deficient in autistic subjects (and correlated with cortical hyper- reactivity); 3)Using an MEG auditory EF based goodness of fit metric, we will quantify the ability or autistic subjects to shift attention from one hemisphere to the other during a binaural auditory oddball task; 4) Using the amplitude of the 100 msec latency auditory EF (termed M100) as a function of auditory interstimulus interval (151) we will calculate tau, the time constant of the decay of the echoic memory trace, generated in Heschl's gyri. We hypothesize this will be prolonged in autistic subjects, relative to normals, Fra-X or MR groups; 5) Using the EEG EP based metric termed mismatch negativity (MMN) we hypothesize that autistic subjects will demonstrate evidence of an accentuated pre-attentive, automatic cortical feature detection processes; 6) Using an MEG EF metric of auditory cortex MEG alpha suppression during a tonal memory task, we hypothesize that autistic subjects will demonstrate evidence of greater alpha suppression than normals, supporting enhanced short term auditory memory storage, scanning and retrieval; 7) Using high resolution MR images of the brain we will relate MEG EF sources to specific cortical areas to determined if MEG and EEG based functional abnormalities are related to observed anatomical deficits in the cortex generating those signals. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen ·
Project Title: PRIMATES
OXYTOCIN
RECEPTORS
IN HUMAN
AND
NON-HUMAN
Principal Investigator & Institution: Boccia, Maria L.; Research Associate Professor; F.P. Graham Child Devel Ctr; University of North Carolina Chapel Hill Office of Sponsored Research Chapel Hill, Nc 27599 Timing: Fiscal Year 2002; Project Start 25-SEP-2002; Project End 31-AUG-2007 Summary: (provided by applicant): This K01 proposal is designed to provide training and establish the applicant as an independent researcher in the neurobiological mechanisms of social and emotional behavior development. Her previous research has focused on social and emotional development in a non-human primate model. This training program will provide her with the skills necessary to focus on the neurobiological mechanisms underlying these phenomena. This program of research includes an animal model of developmental disorders with social deficits, such as autism, or psychopathological syndromes with social and affective components, such as antisocial personality disorder or schizophrenia. To achieve these goals, the applicant has designed a program with career development activities and research studies under the mentorship of Cort Pedersen, exploring the role of oxytocin in social and emotional behavior and development. The research component of this program includes two goals, both of which utilize archival materials from human and non-human primate brain banks. Specific Aim 1 will test the hypothesis that the distribution and quantity of oxytocin receptors in limbic structures linked to social behavior will be altered and reduced, respectively, in brains derived from individuals with autism, compared to control tissue. Specific Aim 2, will test the hypothesis that the distribution and quantity of oxytocin receptors will differ in different primate taxa based on the social behavior and organizational features of the species. This second aim will provide critical data for the establishment of an animal model of these developmental disorders and psychopathological syndromes. The proposed training program is designed to develop the applicant's expertise in (1) primate neuroanatomy and neurophysiology, (2)
60 Autism
neurotransmitter receptor biology, and (3) neurobiological techniques, including immunohistochemistry and autoradiography, and will give her the necessary skills to establish an independent behavioral neurobiology research career. The research outlined here will provide a basis for important new research directions for understanding the role of oxytocin in human social behavior and associated disorders. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen ·
Project Title: PATHOPHYSIOLOGY OF RETT SYNDROME /MECP2 MUTATIONS Principal Investigator & Institution: Zoghbi, Huda Y.; Professor and Investigator; Pediatrics; Baylor College of Medicine 1 Baylor Plaza Houston, Tx 77030 Timing: Fiscal Year 2001; Project Start 23-JUL-2001; Project End 31-MAY-2006 Summary: The X-linked neurodevelopmental disorder Rett syndrome (RTT) is one of the leading causes of mental retardation (MR) and autism in females. 80% of girls with RTT have mutations in the gene encoding methyl-CpG- binding protein 2 (MeCP2), a transcriptional repressor that binds methylated cytosines. The phenotypic consequences of MECP2 mutations range from classic RTT in those with random X chromosome inactivation (XCI) to mild or even no MR in girls with favorable XCI. We hypothesize that impaired MeCP2 function leads to misexpression of genes crucial for neuronal development, which mediates RTT pathogenesis and some forms of autism and MR. Project 1 (Dr. Zoghbi) will create mouse models for RTT for pathogenesis and therapeutic studies, use microarray technology to evaluate alterations in gene expression in the RTT mice, and genotypic sporadic females and female relatives of RTT girls with MR, autism, or learning disabilities. Project 2 (Drs. Glaze and Percy) will clinically characterize the girls studied in Project 1 and test whether methyl donors (folate and betaine) can ameliorate neurologic dysfunction in RTT by enhancing cytosine methylation. Project 3 (Dr. Van den Veyver) will characterize expression of MECP2 variants in developing brain and in RTT tissue; correlate effects of MECP2 mutations on gene expression in human cell lines, mouse embryonic stem cells and Xenopus with expression data from mouse models (Project 1) and study changes in DNA methylation by methyl donors administered to mice in Projects 1 and 2. The MorphologyNeuropathology portion of the Core (Dr. Armstrong) will do systematic morphological analyses on mouse models (Project 1) and conduct immunohistochemical studies on mouse and human tissues (Project 3). Through these multi-disciplinary studies we hope to identify the cause of MR/LD or autism in a subset of patients, to gain insight into the pathogenesis of RTT, and to develop therapeutic strategies for this and related late-onset neurodevelopmental diseases. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
·
Project Title: PILOT--GLUTEN FREE AND CASEIN FREE DIETARY TREATMENT IN AUTISM Principal Investigator & Institution: Elder, Jennifer H.; Associate Professor; University of Florida Gainesville, Fl 32611 Timing: Fiscal Year 2001; Project Start 01-AUG-2001; Project End 31-JUL-2004 Summary: (from applicant's Abstract) Recent exploration into the role of the immune system, genetic susceptibility, and environmental factors such as infections, vaccines, and diet has led to the emergence of numerous theoretical models to explain the biological basis for autism. In turn, a growing number of parents are implementing a variety of still unproven treatment modalities with their autistic children. Particularly relevant to our proposed research is recent work by Cade and colleagues on diet and
Studies
61
autism. Testimonials throughout the world support the efficacy of a diet free of wheat (which contains gluten) and milk (which has casein). Most noteworthy are reports of autistic children who, after being placed on the restricted diet, are "cured" of their autism. However, there are no published reports of controlled clinical trials using the most widely accepted autism diagnostic instruments and direct behavioral observation to test dietary effects. In this proposed research, we will use a randomized, double-blind repeated measures crossover design to evaluate the recommended gluten-free and casein-free (GCF) diet in a controlled inpatient setting. The specific aims are: (a) to evaluate the effects of the GCF diet on severity of autistic symptoms as measured by the Childhood Autism Rating Scale (CARS), Ecological Communication Orientation Scale (ECOS), and direct behavioral observation frequencies, (b) to evaluate the effects of the GCF diet on urinary peptide levels and (c) to evaluate the role of parent behavior in therapeutic and placebo effects of the GCF diet in autistic children. We hypothesize that: (a) using the placebo dietary condition for comparison, scores on the CARS, ECOS, and direct in-home observation ratings (frequency counts) of child social and language behaviors and aberrant behaviors will show an improvement following completion of 5 weeks on the GCF diet, (b) adherence to the GCF diet will result in decreased urinary peptide levels, and (c) "expectant waiting" behavioral frequencies, a measure of positive expectancy and subjectivity on the part of the parent, will not increase at any point during the study. Results of this study should provide important preliminary, empirically sound data regarding current claims of positive social and language behaviors in autistic children. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen ·
Project Title: PLANNING THE UTAH CENTER OF EXCELLENCE FOR AUTISM Principal Investigator & Institution: Mcmahon, William M.; Associate Professor; Psychiatry; University of Utah 200 S University St Salt Lake City, Ut 84112 Timing: Fiscal Year 2001; Project Start 30-SEP-2001; Project End 31-AUG-2003 Summary: (Provided by applicant): Autism can be considered a prototype for neuropsychiatric developmental disorders. Diagnosis of autism has improved over the past 5 decades but still is based on developmental history and behavioral assessment, not on the underlying brain abnormality. The best current treatments for children with autism are directed at improving language, adaptive and social skills but do not address the biological basis of this disorder. Major advances in understanding the developmental neurobiology and genetics of autism may allow effective psychopharmacology and other biological treatments. Future recognition of the genetic and environmental factors contributing to the causation will allow for programs of prevention of autism and related developmental disorders. In parallel, programs to increase and improve training and to refine case identification and community awareness must be implemented to satisfy an immediate and growing need for diagnosis and treatment. Such progress will require a focused and synergistic effort by basic and clinical scientists in Centers of Excellence. The University of Utah proposes to develop such a Center over the next year. This application builds on a history of outstanding research in autism in Utah. Unique resources include a genealogical database, head circumference and structural neuroimaging findings for autism and a record of successful human gene discovery and genomics. The developmental plan for this Center includes three specific aims. First, we will develop working relationships, procedures and projects that integrate investigators at the University of Utah and Brigham Young University in basic and clinical disciplines relevant to autism research. Second, we will organize University and Department of Health and Mental Health
62 Autism
resources into a Center of Excellence for autism research, diagnosis, referral and training. Finally, we will carry out pilot studies that develop promising research components in genetics, structural neuroimaging. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen ·
Project Title: RESEARCH IN AUTISM: PARENT INTERVENTION Principal Investigator & Institution: Schreibman, Laura E.; Professor; Psychology; University of California San Diego 9500 Gilman Dr, Dept. 0934 La Jolla, Ca 92093 Timing: Fiscal Year 2003; Project Start 01-SEP-1984; Project End 31-DEC-2007 Summary: (provided by applicant): There is very little known about methods of designing interventions for very young nonverbal children. For example, the literature and our preliminary studies suggest that many nonverbal children may acquire functional communication with an intervention program that is focused entirely on verbal communication. Other children seem to require augmentative communication systems. These augmentative systems may be effective in further producing verbal communication for some nonverbal children, and may remain as the sole effective means of communication for other children who do not acquire expressive verbal communication. The purpose of the proposed research project is to systematically compare two widely used types of intervention programs (see Koegel, 2000, NIH Autism Conference; Lord & McGee, 2001, National Research Council report; Stiebel, 1999). Both approaches are consistent with our general theoretical model in that both target the key pivotal area of motivation to communicate. The primary difference in the approaches is one accomplishes this through a primarily verbal only approach, whereas the other accomplishes this through a primarily visual approach. This difference has been of major interest to the field of autism, but has not been systematically compared in scientific research. While it does not make any difference with respect to our theoretical position as to which condition turns out to be better, it may make a large difference with respect to translation from research to practice, and with respect to understanding autism, which are major NIMH priority areas. In one condition, randomly assigned children will be provided with an intervention using a welldocumented manualized intervention focused on verbal expressive communication only (Pivotal Response Training, PRT). In the other condition, randomly assigned children will receive an intervention for the same social communication functions using a welldocumented manualized augmentative system of intervention (Picture Exchange Communication System, PECS). Children in the two conditions will be compared for development of verbal and nonverbal communication, changes in disruptive behavior, changes in symptoms of autism, and general adaptive behavior gains. In addition, parent satisfaction and stress measures will be gathered in order to assess the effects of each intervention on family functioning. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
·
Project Title: RESEARCH IN AUTISM--PARENT INTERVENTION Principal Investigator & Institution: Koegel, Robert L.; None; University of California Santa Barbara 3227 Cheadle Hall Santa Barbara, Ca 93106 Timing: Fiscal Year 2001; Project Start 01-SEP-1977; Project End 31-DEC-2002 Summary: This proposal addresses the NIH priority of individualizing the treatment of autism (Bristol, et al., 1996), with particular attention devoted to the empirical measures of child and family characteristics related to prognosis. The literature and the results of our previous funding periods have supported the position that parent training is an
Studies
63
extremely effective approach to the treatment of autism. It is fast, economical, and produces relatively broad treatment changes. During our research program our work has been concerned with identifying specific variables related to the best-practice parent training and developing an improved program designed to address these variables. Accordingly, our research has assured a progressive direction in the development of a parent training treatment delivery package that is optimal for the child and for the family. In our previous research we have typically compared one type of treatment to another type of treatment. Looking back at our efforts in this area we now feel we have a substantial corpus of data both comprehensive in scope and rich in detail; and based on our pilot studies and preliminary investigations we believe that careful analyses of these data now allow us to specify several variables important for the purpose of developing "individualized" treatments for children with autism and their parents. Our data indicate that although we have consistently found one standard type of treatment to be more beneficial overall than another standard type of treatment, each individual treatment contains aspects that are very powerful for specific purposes. In fact, our data suggest that a combination of these treatment procedures, individualized based on child, family and target behavior characteristics will be far superior than implementing one type of treatment for all children as if they were all the same. Because of the large amount of heterogeneity in child and parent characteristics seen in the area of autism it is becoming abundantly clear that individualized treatment will be greatly superior to a standard package. We hypothesize that this type of treatment will significantly improve the treatment of autism, with respect to both direct measures of child behavior and with respect to measures of overall family functioning. We thus propose to carefully compare two treatment conditions. Our control condition will be our current best practice parent training package (the Self-Management condition, now called the Standard Package or SP condition). Our experimental condition will be one in which treatment will be "individualized" for each family in that the specifics of the treatment plan will be dictated by the characteristics of the child and of the family (the Individualized Package or IP condition). Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen ·
Project Title: RUPP-PI Principal Investigator & Institution: Mcdougle, Christopher J.; Albert E. Sterne Professor and Chair; Psychiatry; Indiana Univ-Purdue Univ at Indianapolis 620 Union Drive, Room 618 Indianapolis, in 462025167 Timing: Fiscal Year 2002; Project Start 15-SEP-2002; Project End 31-JUL-2007 Summary: (provided by applicant): The RUPP-PI at Indiana University School of Medicine will capitalize on the site's expertise and experience in pediatric psychopharmacology. In addition, the site will provide training opportunities for young investigators in the neuropsychopharmacology of serious childhood-onset disorders. The proposed treatment protocol will be a 16-week, randomized study of risperidone alone (n=40) vs. risperidone plus a structured behavior therapy program (n=80) in 120 children and adolescents with autistic disorder (autism) and other pervasive developmental disorders (PDDs) who have significant tantrums, aggression, and/or self- injury. Change in these maladaptive behaviors, as well as improvement in adaptive functioning will be determined. Following an additional 8 weeks of stabilization, subjects who show a positive response to combined risperidone plus behavior therapy (estimated sample size of 60) will be randomized to continued treatment with risperidone or gradual discontinuation. The goal of the discontinuation phase is to determine whether the addition of behavior therapy allows for the discontinuation of
64 Autism
risperidone. In a previous RUPP Autism Network study, we showed that risperidone was safe and more efficacious than placebo for treating tantrums, aggression, and/or self-injury in children and adolescents with autism. We also demonstrated that these symptoms returned rapidly in the majority of subjects when the risperidone was withdrawn in a placebo-controlled discontinuation phase. The present study will extend these findings and determine if the combination of risperidone and behavior therapy will enhance adaptive functioning in these children and protect against relapse. Side effects and therapeutic response will be carefully monitored. Subjects will be genotyped to explore the relationship between specific serotonin receptor genotypes and treatment response. The proposed study will be conducted by a multisite network that has already shown the capacity to collaborate on the design and conduct of clinical trials in children and adolescents with autism and other PDDs. Furthermore, this five-site network has established reliability on several measures that are relevant to the conduct of clinical trials in this patient population. The RUPP-PI at Indiana University is also prepared to participate in treatment studies involving children and adolescents with other psychiatric disorders. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen ·
Project Title: RUPP-PI PROJECT Principal Investigator & Institution: Aman, Michael G.; Professor; Psychiatry; Ohio State University 1800 Cannon Dr, Rm 1210 Columbus, Oh 43210 Timing: Fiscal Year 2002; Project Start 01-SEP-2002; Project End 31-JUL-2007 Summary: (provided by applicant): Pervasive Developmental Disorders (PDDs) are serious developmental conditions affecting 6 per 1000 school-age children. We propose a multisite study in which 120 children with PDDs accompanied by highly irritable behavior will be randomly assigned to risperidone only (N=40) or risperidone plus a structured behavior therapy program (N=80) and compared on adaptive and behavioral outcomes after 16 weeks. After an additional eight weeks of stabilization (6 months total), children who show a positive response to the combination of risperidone and behavior therapy (estimated samples size of 60) will be randomized to continued treatment with risperidone or gradual discontinuation. The goal of the discontinuation phase is to examine whether the addition of behavior therapy permits discontinuation of risperidone without relapse. PDD can be a profound disability across social, emotional, and academic domains. Thus, there is a pressing need for new treatments in PDD that are safe and effective. In a previous RUPP Autism Network study, we showed that risperidone was safe and effective for children and adolescents with autism accompanied by tantrums, aggression, and/or self-injury. We also showed that the behavioral symptoms rapidly returned in a high percentage of these pediatric patients when the medication was withdrawn in a placebo-controlled discontinuation study. The present study will extend these findings and will test whether risperidone plus behavior therapy will enhance adaptive functioning in children with PDDs and protect against relapse. Side effects and therapeutic response will be carefully monitored. Subjects will be genotyped in order to evaluate the relationship of specific serotonin receptor genotypes and treatment response. The proposed study will be conducted by a multisite network that has already shown the capacity to collaborate in the design and conduct of clinical trials in the PDD population. Furthermore, this five-site network has established reliability on several measures relevant to the multi-site clinical trials in children with PDD. O.S.U. also plans two pilot studies: (a) a randomized clinical trial in 60 children with PDDs and severe ADHD behavior and (b) a study of ziprasidone in 30 children and adolescents with PDDs and highly irritable behaviors.
Studies
65
Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen ·
Project Title: SEMANTIC NETWORK FLEXIBILITY MODULATION/AUTISM SPECTRUM Principal Investigator & Institution: Beversdorf, David Q.; Neurology; Ohio State University 1800 Cannon Dr, Rm 1210 Columbus, Oh 43210 Timing: Fiscal Year 2003; Project Start 15-DEC-2002; Project End 30-NOV-2007 Summary: (provided by applicant): I am a new faculty member in Neurology with fellowship training in Cognitive Neurology. I have put forth great effort to do research during my clinical training, but am seeking funding to release me from my current heavy burden of clinical responsibilities in order to develop as an independent investigator. My career development plan includes courses in neuroscience, cognitive neuroscience, behavioral pharmacology, statistics, and ethics, and regular guidance meetings with my mentor (Dr. Robert Bornstein, a neuropsychologist experienced in frontal lobe research) and collaborators. My previous research has shown that individuals with high-functioning adults with autism spectrum disorder (ASD) have impaired flexibility of the semantic network. This may relate to other problems with context utilization, problem solving, and social functioning in ASD. My previous research has also demonstrated a noradrenergic modulation of cognitive flexibility in normal individuals. I wish to further explore the modulation of cognitive flexibility. My hypothesis is that noradrenergic modulation of cognitive flexibility is specific to the noradrenergic system among catecholamines, that noradrenergic modulation of cognitive flexibility can occur with long-term treatment, and that noradrenergie antagonism can influence cognitive flexibility in ASD. My first Specific Aim is to further study the influence of catecholamines on cognitive flexibility. I will first test modulation of cognitive flexibility with varying doses of noradrenergic agents, and will test whether long-term propranolol can have the same effect as single-dose propranolol. I will then test whether dopaminergic agents can yield the same finding with cognitive flexibility. My second Aim is to study the effects of stress and propranolol on cognitive flexibility. I will test whether propranolol can reverse the impairment in cognitive flexibility that results from situational stressors. My third Aim is to learn the effects of noradrenergic antagonism on cognitive flexibility in individuals with ASD. I will test whether propranolol has a greater effect on cognitive flexibility in individuals with ASD than in matched controls. With better understanding of modulation of cognitive flexibility, future studies can further test noradrenergic modulation of cognitive flexibility in ASD. My long-term goal is to study neuropharmacology and cognitive neuroscience and look for benefits in cognitively impaired patients, with a particular focus on high-functioning adults with ASD. OSU and my outside consultants are well equipped for my current and future research goals, with ongoing autism research, possible potential for future high-field fMRI, and strong neuroscience training. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
·
Project Title: SEQUENCE TEACHER: BEHAVIORAL TEACHING TECHNOLOGY Principal Investigator & Institution: Mackay, Harry A.; Praxis, Inc. 13 West St Belmont, Ma 02478 Timing: Fiscal Year 2002; Project Start 01-JUN-2002; Project End 30-NOV-2002 Summary: The SBIR application seeks support to develop and study a computer- based product attended primary for teaching children with mental retardation, autism, and other intellectual disabilities. The product addresses a critical skill repertoire involving
66 Autism
the production of stimulus sequences. Sequence production is a pre-academic skill relevant to the development of reading, spelling, numeric skills, and concepts, as well as everyday tasks like making a telephone call or operating a vending machine. Research supported by NIH has resulted in the development of techniques that can establish sequencing skills in our target population. These techniques, however, are not readily accessible to parents, professionals and the children who might benefit. This proposal aims to fill that gap by the development of a user-friendly software product for computer-assisted instruction. The basic task involves a form of constructed matching to sample: A sample stimulus is presented to the student, who then must select two or more individual stimuli (e.g., letters, numbers) from a pool to construct a multi-element stimulus complex (e.g., letter-by-letter, number-by-number) that is related to computer screen, and the student would then select the individual letters (S, H, etc.) from an array of letters displayed at the bottom of the screen. As each letter is selected, it moves by computer animation to a position below the picture, so that the student "constructs" the world "SHIRT." The project has two major objectives First, we will adapt well-developed methods from laboratory and applied research for use by teachers, other child care professionals, and parents. Second, we will evaluate the product to determine that it can be used effectively in typical educational situations. PROPOSED COMMERCIAL APPLICATIONS: The product being developed and evaluated may have a significant impact on special education practice. As such, the product is potentially marketable to speech/language pathologists, special educators, psychologists, other professionals, and parents. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen ·
Project Title: SLEEP RETARDATION
ARCHITECTURE:
INDIVIDUALS
WITH
MENTAL
Principal Investigator & Institution: Kennedy, Craig H.; Special Education; Vanderbilt University 3319 West End Ave. Nashville, Tn 372036917 Timing: Fiscal Year 2003; Project Start 01-APR-2003; Project End 31-MAR-2005 Summary: (provided by applicant): Sleep dysfunction produces a range of negative health and psychological effects. The incidence of sleep problems for individuals with mental retardation (MR) has been reported to be three-fold greater than people without MR. However, previous research estimating the prevalence of sleep problems for people with MR have relied primarily on behavioral observation data. Such analyses can only identify gross behavioral changes in sleep states and are unable to identify subtler alterations in brain activity and sleep architecture that, nonetheless, have serious effects on a person's health and life quality. Hence, current estimates of sleep problems in this population may be underestimated. A more precise analysis of sleep and individual sleep stages is needed. The investigators propose to use polysomnography (i.e., EEG, EOG, and EMG) to investigate the sleep architecture of people with MR. Three groups of adults with MR (mild, moderate, and severe/profound) will be studied to assess the presence of altered sleep architectures as a function of level of MR. These groups will be compared to a contrast group of typical adults. In addition, the investigators propose to assess whether the presence of a co-morbid syndrome (i.e., autism) interacts with level of MR in determining the structure of a person's sleep architecture (i.e., autism plus mild MR, autism plus moderate MR, and autism plus severe MR). Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
Studies
·
67
Project Title: THE DEVELOPMENT OF JOINT ATTENTION AFTER INFANCY Principal Investigator & Institution: Adamson, Lauren B.; Professor; Psychology; Georgia State University University Plaza Atlanta, Ga 30303 Timing: Fiscal Year 2001; Project Start 05-APR-1998; Project End 31-MAR-2002 Summary: The objective is to characterize the developmental course of shared attention between children and their social partners. This proposal focuses on the year-long period just after infancy when children typically become increasingly competent symbol users. The basic contention is that the coordination of attention to people and objects, an organization often call joint attention, is transformed as symbols draw distant events into on-going interactions. Three specific aims are pursued: to describe normative changes in shared attention; to characterize how symbols increase the scope and coherence of social interactions; and to investigate how variations in the timing of language onset and the integrity of joint attention skills influence the development of shared attention after infancy. Seventy-two children, 48 who are developing typically and 24 who have been diagnosed with autism (a disorder characterized by deficiencies in joint attention skills), will each be videotaped five times over a year as they interact with their mothers in a series of scenes that probe requesting, social interacting, shared referring, and discussing past and future. The rate of language acquisition will also be assessed. Videotapes will be coded to document the child's attention to people, objects, and symbols; the child's symbolic actions; and the mother's attention-directing actions toward symbols. Growth curves will be examined both to chart the course of symbolinfused attention as a function of language onset and to discern how autism may disturb the infusion of symbols into shared attention. This systematic study of a period of rapid developmental change will provide a fuller view of how children are introduced to symbols as they communicate with their caregivers. This view should further the formulation of models of representational development as well as inform understanding of pervasive developmental disorders such as autism. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
·
Project Title: THERAPY FOR SELF INJURIOUS BEHAVIOR IN AUTISM Principal Investigator & Institution: Wagner, George C.; Psychology; Rutgers the St Univ of Nj New Brunswick Asb Iii New Brunswick, Nj 08901 Timing: Fiscal Year 2001; Project Start 30-SEP-2001; Project End 31-AUG-2004 Summary: (provided by applicant): A subset of motoric symptoms associated with autism includes mild, stereotypic to intense, self-injurious behaviors. In the past, these behaviors have been linked to dysfunction of brain dopamine but, unfortunately, clinical trials with dopamine antagonists have met with poor results. The accepted rodent model of self-injurious behavior relies on neonatal dopamine lesions followed by L-dopa administration to the adult. This model works well in rats but not in mice. In a series of studies using in situ hybridization as well as knockout and transgenic mice to explore the development of the topographic projections of brain dopaminergic neurons, it was observed that brain serotinergic systems are activated following neonatal damage to dopaminergic neurons. That is, it appeared that early dopamine lesions activated brain serotinergic systems. This observation was then linked to the induction of stereotypic and self-injurious behaviors in adult mice treated with high doses of amphetamine, doses which induced the release of both dopamine and serotonin. On the basis of these and other observations, a new animal model of self-injurious behaviors centering on the dual activation of brain dopamine and serotonin is proposed. In
68 Autism
addition, based on this new model, the possible beneficial effects of risperidone, an antagonist of these transmitter systems, will be explored. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen ·
Project Title: UNUSUAL SENSORY EXPERIENCES IN YOUNG CHILDREN W/AUTISM Principal Investigator & Institution: Baranek, Grace T.; Associate Professor; Allied Health Sciences; University of North Carolina Chapel Hill Office of Sponsored Research Chapel Hill, NC 27599 Timing: Fiscal Year 2003; Project Start 15-FEB-2003; Project End 31-JAN-2007 Summary: (provided by applicant): A variety of unusual responses (hypo- and hyperresponses) to sensory stimuli are documented in children with autism and appear to be exacerbated in social situations. The developmental nature of these phenomena and their relationship to the core features of autism are not well understood. Our model explaining unusual sensory experiences in autism involves a basic deficit in information processing (sensory orienting), moderated by social context and development. The specific aims of this project are to: (1) measure developmentally-related changes in responses to sensory experiences in young children with autism, children with other developmental disabilities (DD), and typically-developing children; (2) identify sensory processing patterns that are unique to autism; and (3) determine the extent to which sensory processing patterns covary with phenotypic expressions of autism. A crosssectional methodology will be used to study unusual sensory experiences in 180 children (60 with autism, 60 with DD, and 60 with typical development). The autism and DD groups will range from 2-7 years of age. All three groups will be matched according to nonverbal mental age and gender. Children will be assessed using a battery of measures (diagnostic, developmental, sensory, and phenotypic features). A crosssectional methodology will test the degree to which frequencies of sensory symptoms vary as a function of maturational variables and group membership. Composite scores reflecting four sensory processing patterns (hypo/hyper-responsiveness to social/nonsocial stimuli) will be analyzed to specifically discriminate autism from other groups. Finally, these sensory patterns will be correlated with measures of socialrelatedness, communication, and restricted/repetitive behaviors. Our conceptual model predicts that a) all three groups will demonstrate a decrease in unusual responses to sensory stimuli as age, cognitive abilities, and language increase, b) the autism group will have the highest frequency of symptoms, c) a hypo-responsive pattern (orienting deficit) will be specific to autism, magnified for social versus nonsocial stimuli, and d) the four patterns of sensory processing will differentially correlate with socialrelatedness subtypes and levels of severity in the phenotypic characteristics of autism. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
·
Project Title: VALPROATE ADOLESCENTS
RESPONSE
IN
AGGRESSIVE
AUTISTIC
Principal Investigator & Institution: Hellings, Jessica A.; Associate Professor; Psychiatry; University of Kansas Medical Center Msn 1039 Kansas City, Ks 66160 Timing: Fiscal Year 2001; Project Start 15-APR-1998; Project End 31-MAR-2003 Summary: (Adapted from Applicant's Abstract): This career (K08) award applies specified funding, 75 percent research time and a 5-year plan to develop the candidate's experience and expertise, in the understudied area of psychopharmacologic research in persons with autism and mental retardation (MR). A primary goal is for the candidate
Studies
69
to learn from Dr. Schroeder how behavioral observation and Applied Behavior Analysis can be used in research in this population. By performing a double-blind drug study, with Dr. Schroeder's weekly supervision, regular internal and expert-consultation and attending research didactic courses, the candidate will develop into an independent psychopharmacology researcher with expertise in behavioral observation and intervention techniques. The proposed study aims to test the hypothesis that aggressive autistic adolescents will show a significantly greater response to valproate maintained at blood levels of 75-100 mcg/ml than to placebo (PRO), in a double-blind casecontrolled design. The study will also critically assess the safety of valproate in autistic adolescents. The study will be performed over 5 years, on 30 outpatient autistic adolescents aged 10 to 19 years, referred to the University outpatient MR/Autism Clinic for aggression. Study candidates will undergo DSM-IV evaluation, the ADI-R and ADOS, and baseline blood tests. Exclusion criteria will include degenerative CNS disorders, unstable medical illness, seizures in the past 6 months, a history of valproate sensitivity or previous liver disease, a history of ovarian cysts in girls, a low platelet count or raised liver transaminases. No other psychoactive maintenance medication will be allowed. Any level of MR (IQ<70) will be permissible. After baseline screening, and a 1-week placebo lead-in, subjects will be randomized to PBO or valproate for 8 weeks. Dosage adjustment according to blood levels drawn at the end of weeks 2 and 4 will be arranged with parents by a child psychiatrist without breaking the blind. The Aberrant Behavior Checklist-Community (ABC-C) irritability subscale will be the primary measure; the Overt Aggression Scale (OAS), ABC-C hyperactivity subscale, Clinical Global Impressions (CGI) problem severity, Self-Injurious Behavior Questionnaire (SIBQ), and a valproate side effects checklist will be secondary measures. Primary measure scores obtained will be analyzed using a multivariate analysis of variance comparing drug placebo groups pre- and post-treatment. The secondary measures will be analyzed using a multivariate analysis of variance. Study results will be prepared and submitted as manuscripts for publications and presentations. Achievement of goals of the grant will be monitored by Dr. Schroeder weekly, quarterly and annually. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen ·
Project Title: VIDEO ENHANCED VIRTUAL REALITY PROGRAMS FOR AUTISM Principal Investigator & Institution: Strickland, Dorothy C.; President; Virtual Reality Aids, Inc. 421 Orchis Rd Saint Augustine, Fl 32086 Timing: Fiscal Year 2001; Project Start 30-SEP-2001; Project End 31-MAR-2003 Summary: The broad, long-term objectives of this project are to design, build, and evaluate the efficacy of video enhanced virtual reality restaurant social skill instruction for children with autism. Specific aims are: 1) Design a virtual reality (VR) scenario for children with autism that will teach appropriate behavior in a restaurant; 2) Incorporate this design into an interactive computer program using animated characters and videos demonstrating similar real world social situations; 3) Demonstrate the efficacy of the instructional software through use of applied behavior analysis and single subjects design. The learning environment afforded by video enhanced VR may help individuals with autism master difficult social skills by providing individualized practice in controllable, non-threatening worlds. The research design and methods for achieving these goals are: 1) Choose children who have been diagnosed with autism; 2) Design, program, and debug a PC based VR restaurant environment and appropriate video scenarios; 3) Conduct trials to evaluate the results using n, multiple baselines across subjects design. PROPOSED COMMERCIAL APPLICATIONS: Virtual reality learning environments would have a broad market appeal for children, parents, teachers. and
70 Autism
health practitioners for teaching social behavior to children with autism and related learning disabilities. A present company web site provides products for autism language and safety skills, allowing an in-place cost effective delivery and support system for this new product. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
E-Journals: PubMed Central3 PubMed Central (PMC) is a digital archive of life sciences journal literature developed and managed by the National Center for Biotechnology Information (NCBI) at the U.S. National Library of Medicine (NLM).4 Access to this growing archive of e-journals is free and unrestricted.5 To search, go to http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=Pmc, and type “autism” (or synonyms) into the search box. This search gives you access to fulltext articles. The following is a sample of items found for autism in the PubMed Central database: ·
A case-control study of autism and mumps-measles-rubella vaccination using the general practice research database: design and methodology. by Smeeth L, Hall AJ, Fombonne E, Rodrigues LC, Huang X, Smith PG.; 2001; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=29106
·
A necdin/MAGE-like gene in the chromosome 15 autism susceptibility region: expression, imprinting, and mapping of the human and mouse orthologues. by Chibuk TK, Bischof JM, Wevrick R.; 2001; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=64493
·
Aminoglycoside antibiotics and autism: a speculative hypothesis. by Manev R, Manev H.; 2001; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=59656
·
Autism funding dispute reaches Supreme Court. by [No authors listed]; 2003 Jan 21; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&rendertype=exter nal&artid=140451
·
BC court wades into medical-necessity debate over autism treatment. by Kent H.; 2002 Nov 26; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&rendertype=exter nal&artid=134149
·
BC families win suit over government payment for expensive autism therapy. by Kent H.; 2000 Oct 31; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&rendertype=exter nal&artid=80260
·
BC lawsuits try to link thimerosal to autism. by Kent H.; 2003 Apr 29; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&rendertype=exter nal&artid=153704
3 4
Adapted from the National Library of Medicine: http://www.pubmedcentral.nih.gov/about/intro.html.
With PubMed Central, NCBI is taking the lead in preservation and maintenance of open access to electronic literature, just as NLM has done for decades with printed biomedical literature. PubMed Central aims to become a world-class library of the digital age. 5 The value of PubMed Central, in addition to its role as an archive, lies in the availability of data from diverse sources stored in a common format in a single repository. Many journals already have online publishing operations, and there is a growing tendency to publish material online only, to the exclusion of print.
Studies
71
·
Dispute over autism treatment heads to top court. by Kent H.; 2003 Aug 5; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&rendertype=exter nal&artid=167134
·
Imaging autism. by [No authors listed]; 2002 Apr 30; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&rendertype=exter nal&artid=102367
·
Increased discrimination of "false memories" in autism spectrum disorder. by Beversdorf DQ, Smith BW, Crucian GP, Anderson JM, Keillor JM, Barrett AM, Hughes JD, Felopulos GJ, Bauman ML, Nadeau SE, Heilman KM.; 2000 Jul 18; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=27017
·
Is fever suppression involved in the etiology of autism and neurodevelopmental disorders? by Torres AR.; 2003; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=194752
·
Long-term treatment with clozapine in an adult with autistic disorder accompanied by aggressive behaviour. by Gobbi G, Pulvirenti L.; 2001 Sep; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&rendertype=exter nal&artid=167190
·
Measles, mumps, and rubella vaccination and bowel problems or developmental regression in children with autism: population study. by Taylor B, Miller E, Lingam R, Andrews N, Simmons A, Stowe J.; 2002 Feb 16; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=65532
·
Movement analysis in infancy may be useful for early diagnosis of autism. by Teitelbaum P, Teitelbaum O, Nye J, Fryman J, Maurer RG.; 1998 Nov 10; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=25000
·
Mumps, measles, and rubella vaccine and the incidence of autism recorded by general practitioners: a time trend analysis. by Kaye JA, del Mar Melero-Montes M, Jick H.; 2001 Feb 24; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=26561
·
Relation of childhood gastrointestinal disorders to autism: nested case-control study using data from the UK General Practice Research Database. by Black C, Kaye JA, Jick H.; 2002 Aug 24; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=119436
The National Library of Medicine: PubMed One of the quickest and most comprehensive ways to find academic studies in both English and other languages is to use PubMed, maintained by the National Library of Medicine.6 The advantage of PubMed over previously mentioned sources is that it covers a greater number of domestic and foreign references. It is also free to use. If the publisher has a Web site that offers full text of its journals, PubMed will provide links to that site, as well as to sites offering other related data. User registration, a subscription fee, or some other type of fee may be required to access the full text of articles in some journals. 6
PubMed was developed by the National Center for Biotechnology Information (NCBI) at the National Library of Medicine (NLM) at the National Institutes of Health (NIH). The PubMed database was developed in conjunction with publishers of biomedical literature as a search tool for accessing literature citations and linking to full-text journal articles at Web sites of participating publishers. Publishers that participate in PubMed supply NLM with their citations electronically prior to or at the time of publication.
72 Autism
To generate your own bibliography of studies dealing with autism, simply go to the PubMed Web site at http://www.ncbi.nlm.nih.gov/pubmed. Type “autism” (or synonyms) into the search box, and click “Go.” The following is the type of output you can expect from PubMed for autism (hyperlinks lead to article summaries): ·
A brief overview of special education law with focus on autism. Author(s): Turnbull HR 3rd, Wilcox BL, Stowe MJ. Source: Journal of Autism and Developmental Disorders. 2002 October; 32(5): 479-93. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12463521&dopt=Abstract
·
A case of autism in a child with Apert's syndrome. Author(s): Morey-Canellas J, Sivagamasundari U, Barton H. Source: European Child & Adolescent Psychiatry. 2003 April; 12(2): 100-2. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12664274&dopt=Abstract
·
A clinicopathological study of autism. Author(s): Bailey A, Luthert P, Dean A, Harding B, Janota I, Montgomery M, Rutter M, Lantos P. Source: Brain; a Journal of Neurology. 1998 May; 121 ( Pt 5): 889-905. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9619192&dopt=Abstract
·
A comparison of WAIS-R profiles in adults with high-functioning autism or differing subtypes of learning disability. Author(s): Goldstein G, Beers SR, Siegel DJ, Minshew NJ. Source: Applied Neuropsychology. 2001; 8(3): 148-54. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11686649&dopt=Abstract
·
A pilot randomised control trial of a parent training intervention for pre-school children with autism. Preliminary findings and methodological challenges. Author(s): Drew A, Baird G, Baron-Cohen S, Cox A, Slonims V, Wheelwright S, Swettenham J, Berry B, Charman T. Source: European Child & Adolescent Psychiatry. 2002 December; 11(6): 266-72. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12541005&dopt=Abstract
·
A population-based study of measles, mumps, and rubella vaccination and autism. Author(s): Madsen KM, Hviid A, Vestergaard M, Schendel D, Wohlfahrt J, Thorsen P, Olsen J, Melbye M. Source: The New England Journal of Medicine. 2002 November 7; 347(19): 1477-82. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12421889&dopt=Abstract
Studies
73
·
A principal components analysis of the Autism Diagnostic Interview-Revised. Author(s): Tadevosyan-Leyfer O, Dowd M, Mankoski R, Winklosky B, Putnam S, McGrath L, Tager-Flusberg H, Folstein SE. Source: Journal of the American Academy of Child and Adolescent Psychiatry. 2003 July; 42(7): 864-72. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12819447&dopt=Abstract
·
A proposed primate animal model of autism. Author(s): Teitelbaum P. Source: European Child & Adolescent Psychiatry. 2003 January; 12(1): 48-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12601565&dopt=Abstract
·
Ability profiles in children with autism: influence of age and IQ. Author(s): Mayes SD, Calhoun SL. Source: Autism : the International Journal of Research and Practice. 2003 March; 7(1): 6580. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12638765&dopt=Abstract
·
Access to specialty medical care for children with mental retardation, autism, and other special health care needs. Author(s): Krauss MW, Gulley S, Sciegaj M, Wells N. Source: Mental Retardation. 2003 October; 41(5): 329-39. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12962535&dopt=Abstract
·
Adaptive skills and executive function in autism spectrum disorders. Author(s): Gilotty L, Kenworthy L, Sirian L, Black DO, Wagner AE. Source: Neuropsychology, Development, and Cognition. Section C, Child Neuropsychology : a Journal on Normal and Abnormal Development in Childhood and Adolescence. 2002 December; 8(4): 241-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12759821&dopt=Abstract
·
Amalgam, autism, and the beauty of Holland. Author(s): Gold SA. Source: J Calif Dent Assoc. 2002 June; 30(6): 405-6. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12519050&dopt=Abstract
·
Analysis of prevalence trends of autism spectrum disorder in Minnesota. Author(s): Gurney JG, Fritz MS, Ness KK, Sievers P, Newschaffer CJ, Shapiro EG. Source: Archives of Pediatrics & Adolescent Medicine. 2003 July; 157(7): 622-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12860781&dopt=Abstract
74 Autism
·
Analysis of transmission of novel polymorphisms in the somatostatin receptor 5 (SSTR5) gene in patients with autism. Author(s): Lauritsen MB, Nyegaard M, Betancur C, Colineaux C, Josiassen TL, Kruse TA, Leboyer M, Ewald H. Source: American Journal of Medical Genetics. 2003 August 15; 121B(1): 100-4. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12898583&dopt=Abstract
·
Asperger syndrome and high-functioning autism. Author(s): Gillberg C. Source: The British Journal of Psychiatry; the Journal of Mental Science. 1998 March; 172: 200-9. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9614468&dopt=Abstract
·
Assessing change in early intervention programs for children with autism. Author(s): Kasari C. Source: Journal of Autism and Developmental Disorders. 2002 October; 32(5): 447-61. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12463519&dopt=Abstract
·
Association between thimerosal-containing vaccine and autism. Author(s): Hviid A, Stellfeld M, Wohlfahrt J, Melbye M. Source: Jama : the Journal of the American Medical Association. 2003 October 1; 290(13): 1763-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=14519711&dopt=Abstract
·
Associative process as an indicator of interhemispheric interaction in healthy children and children with autism. Author(s): Nikolaenko NN. Source: Doklady Biological Sciences : Proceedings of the Academy of Sciences of the Ussr, Biological Sciences Sections / Translated from Russian. 2001 September-October; 380: 430-2. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12918395&dopt=Abstract
·
Autism and a deficit in broadening the spread of visual attention. Author(s): Mann TA, Walker P. Source: Journal of Child Psychology and Psychiatry, and Allied Disciplines. 2003 February; 44(2): 274-84. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12587863&dopt=Abstract
·
Autism and auditory brain stem responses. Author(s): Rosenhall U, Nordin V, Brantberg K, Gillberg C. Source: Ear and Hearing. 2003 June; 24(3): 206-14. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12799542&dopt=Abstract
Studies
75
·
Autism and autism risk in siblings of children with specific language impairment. Author(s): Tomblin JB, Hafeman LL, O'Brien M. Source: International Journal of Language & Communication Disorders / Royal College of Speech & Language Therapists. 2003 July-September; 38(3): 235-50. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12851077&dopt=Abstract
·
Autism and measles-mumps-rubella vaccination: controversy laid to rest? Author(s): DeStefano F, Chen RT. Source: Cns Drugs. 2001; 15(11): 831-7. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11700148&dopt=Abstract
·
Autism and mental retardation: the genetic relationship and contribution. Author(s): el-Hazmi MA. Source: East Mediterr Health J. 2001 May; 7(3): 536-43. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12690777&dopt=Abstract
·
Autism and Mobius sequence: an exploratory study of children in northeastern Brazil. Author(s): Bandim JM, Ventura LO, Miller MT, Almeida HC, Costa AE. Source: Arquivos De Neuro-Psiquiatria. 2003 June; 61(2A): 181-5. Epub 2003 June 09. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12806493&dopt=Abstract
·
Autism and visual fixation. Author(s): Kemner C, van Engeland H. Source: The American Journal of Psychiatry. 2003 July; 160(7): 1358-9; Author Reply 1359. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12832263&dopt=Abstract
·
Autism in Jamaica. Author(s): Pottinger AM. Source: The West Indian Medical Journal. 1998 March; 47(1): 10-4. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9619089&dopt=Abstract
·
Autism spectrum disorder is not as certain as implied. Author(s): Simpson D. Source: Bmj (Clinical Research Ed.). 2003 May 3; 326(7396): 986. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12727783&dopt=Abstract
·
Autism, inflammatory bowel disease, and MMR vaccine. Author(s): Tettenborn MA. Source: Lancet. 1998 May 2; 351(9112): 1357. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9643821&dopt=Abstract
76 Autism
·
Autism, inflammatory bowel disease, and MMR vaccine. Author(s): Bhatt R. Source: Lancet. 1998 May 2; 351(9112): 1357. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9643820&dopt=Abstract
·
Autism, inflammatory bowel disease, and MMR vaccine. Author(s): Walker-Smith JA. Source: Lancet. 1998 May 2; 351(9112): 1356-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9643819&dopt=Abstract
·
Autism, inflammatory bowel disease, and MMR vaccine. Author(s): Rouse A. Source: Lancet. 1998 May 2; 351(9112): 1356. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9643818&dopt=Abstract
·
Autism, inflammatory bowel disease, and MMR vaccine. Author(s): Richmond P, Goldblatt D. Source: Lancet. 1998 May 2; 351(9112): 1355-6; Author Reply 1356. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9643817&dopt=Abstract
·
Autism, inflammatory bowel disease, and MMR vaccine. Author(s): Sinclair L. Source: Lancet. 1998 May 2; 351(9112): 1355; Author Reply 1356. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9643816&dopt=Abstract
·
Autism, inflammatory bowel disease, and MMR vaccine. Author(s): Walker DR. Source: Lancet. 1998 May 2; 351(9112): 1355; Author Reply 1356. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9643815&dopt=Abstract
·
Autism, primary pragmatic difficulties, and specific language impairment: can we distinguish them using psycholinguistic markers? Author(s): Botting N, Conti-Ramsden G. Source: Developmental Medicine and Child Neurology. 2003 August; 45(8): 515-24. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12882530&dopt=Abstract
·
Autism, regression, and the broader autism phenotype. Author(s): Lainhart JE, Ozonoff S, Coon H, Krasny L, Dinh E, Nice J, McMahon W. Source: American Journal of Medical Genetics. 2002 December 1; 113(3): 231-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12439889&dopt=Abstract
Studies
77
·
Autism: an emerging public health problem. Author(s): Newschaffer CJ, Curran LK. Source: Public Health Reports (Washington, D.C. : 1974). 2003 September-October; 118(5): 393-9. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12941851&dopt=Abstract
·
Balancing interests in autism study. Author(s): Gross M. Source: Current Biology : Cb. 2001 August 21; 11(16): R630. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11525749&dopt=Abstract
·
Battling through autism confusion. Author(s): Gross M. Source: Current Biology : Cb. 2002 January 22; 12(2): R42. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11818072&dopt=Abstract
·
BC court wades into medical-necessity debate over autism treatment. Author(s): Kent H. Source: Cmaj : Canadian Medical Association Journal = Journal De L'association Medicale Canadienne. 2002 November 26; 167(11): 1278. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12451093&dopt=Abstract
·
BC families win suit over government payment for expensive autism therapy. Author(s): Kent H. Source: Cmaj : Canadian Medical Association Journal = Journal De L'association Medicale Canadienne. 2000 October 31; 163(9): 1181. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11079068&dopt=Abstract
·
Behavior analysis and intervention for adults with autism. Author(s): McClannahan LE, MacDuff GS, Krantz PJ. Source: Behavior Modification. 2002 January; 26(1): 9-26. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11799656&dopt=Abstract
·
Behavior problems of children with autism, parental self-efficacy, and mental health. Author(s): Hastings RP, Brown T. Source: Am J Ment Retard. 2002 May; 107(3): 222-32. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11966335&dopt=Abstract
78 Autism
·
Behavioral phenotypic variation in autism multiplex families: evidence for a continuous severity gradient. Author(s): Spiker D, Lotspeich LJ, Dimiceli S, Myers RM, Risch N. Source: American Journal of Medical Genetics. 2002 March 8; 114(2): 129-36. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11857572&dopt=Abstract
·
Behavioural problems, social competence and self-concept in siblings of children with autism. Author(s): Verte S, Roeyers H, Buysse A. Source: Child: Care, Health and Development. 2003 May; 29(3): 193-205. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12752610&dopt=Abstract
·
Benefit-cost analysis and autism services: a response to Jacobson and Mulick. Author(s): Marcus LM, Rubin JS, Rubin MA. Source: Journal of Autism and Developmental Disorders. 2000 December; 30(6): 595-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11261470&dopt=Abstract
·
Benefits and pitfalls in the merging of disciplines: the example of developmental psychopathology and the study of persons with autism. Author(s): Burack JA, Iarocci G, Bowler D, Mottron L. Source: Development and Psychopathology. 2002 Spring; 14(2): 225-37. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12030689&dopt=Abstract
·
Beyond expectations: autism, understanding embarrassment, and the relationship with theory of mind. Author(s): Hillier A, Allinson L. Source: Autism : the International Journal of Research and Practice. 2002 September; 6(3): 299-314. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12212920&dopt=Abstract
·
Big bucks for autism research. Author(s): Dove A. Source: Nature Medicine. 2002 November; 8(11): 1190. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12411928&dopt=Abstract
·
Birth order effects on nonverbal IQ scores in autism multiplex families. Author(s): Spiker D, Lotspeich LJ, Dimiceli S, Szatmari P, Myers RM, Risch N. Source: Journal of Autism and Developmental Disorders. 2001 October; 31(5): 449-60. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11794410&dopt=Abstract
Studies
79
·
Body mass index in male and female children with infantile autism. Author(s): Mouridsen SE, Rich B, Isager T. Source: Autism : the International Journal of Research and Practice. 2002 June; 6(2): 197205. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12083285&dopt=Abstract
·
Borna disease virus (BDV)-induced model of autism: application to vaccine safety test design. Author(s): Carbone KM, Rubin SA, Pletnikov M. Source: Molecular Psychiatry. 2002; 7 Suppl 2: S36-7. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12142944&dopt=Abstract
·
Borna disease virus infection of the neonatal rat: developmental brain injury model of autism spectrum disorders. Author(s): Pletnikov MV, Moran TH, Carbone KM. Source: Frontiers in Bioscience : a Journal and Virtual Library. 2002 March 1; 7: D593607. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11861216&dopt=Abstract
·
Brain anatomy in autism. Author(s): Minshew N. Source: Journal of Autism and Developmental Disorders. 2002 December; 32(6): 615-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12553598&dopt=Abstract
·
Brain perfusion in autism varies with age. Author(s): Wilcox J, Tsuang MT, Ledger E, Algeo J, Schnurr T. Source: Neuropsychobiology. 2002; 46(1): 13-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12207141&dopt=Abstract
·
Brain structural abnormalities in young children with autism spectrum disorder. Author(s): Sparks BF, Friedman SD, Shaw DW, Aylward EH, Echelard D, Artru AA, Maravilla KR, Giedd JN, Munson J, Dawson G, Dager SR. Source: Neurology. 2002 July 23; 59(2): 184-92. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12136055&dopt=Abstract
·
Brain volume in autism. Author(s): Hardan AY, Minshew NJ, Mallikarjuhn M, Keshavan MS. Source: Journal of Child Neurology. 2001 June; 16(6): 421-4. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11417608&dopt=Abstract
80 Autism
·
Bridging theory and practice: conceptual understanding of treatments for children with attention deficit hyperactivity disorder (ADHD), obsessive-compulsive disorder (OCD), autism, and depression. Author(s): Rapport MD. Source: Journal of Clinical Child Psychology. 2001 March; 30(1): 3-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11294075&dopt=Abstract
·
Brief report: A case of autism associated with del(2)(q32.1q32.2) or (q32.2q32.3). Author(s): Gallagher L, Becker K, Kearney G, Dunlop A, Stallings R, Green A, Fitzgerald M, Gill M. Source: Journal of Autism and Developmental Disorders. 2003 February; 33(1): 105-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12708586&dopt=Abstract
·
Brief report: A case of autism with interstitial deletion of chromosome 13. Author(s): Steele MM, Al-Adeimi M, Siu VM, Fan YS. Source: Journal of Autism and Developmental Disorders. 2001 April; 31(2): 231-4. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11450821&dopt=Abstract
·
Brief report: allergological evaluation of children with autism. Author(s): Renzoni E, Beltrami V, Sestini P, Pompella A, Menchetti G, Zappella M. Source: Journal of Autism and Developmental Disorders. 1995 June; 25(3): 327-33. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7559298&dopt=Abstract
·
Brief report: An assessment of stimulus generalization and contingency effects in functional communication training with two students with autism. Author(s): O'Neill RE, Sweetland-Baker M. Source: Journal of Autism and Developmental Disorders. 2001 April; 31(2): 235-40. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11450822&dopt=Abstract
·
Brief report: Behavioral adjustment of siblings of children with autism. Author(s): Hastings RP. Source: Journal of Autism and Developmental Disorders. 2003 February; 33(1): 99-104. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12708585&dopt=Abstract
·
Brief report: case reports on naltrexone use in children with autism: controlled observations regarding benefits and practical issues of medication management. Author(s): Williams PG, Allard A, Sears L, Dalrymple N, Bloom AS. Source: Journal of Autism and Developmental Disorders. 2001 February; 31(1): 103-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11439748&dopt=Abstract
Studies
81
·
Brief report: Children with autism as they grow up--description of adult inpatients with severe autism. Author(s): Stein D, Ring A, Shulman C, Meir D, Holan A, Weizman A, Barak Y. Source: Journal of Autism and Developmental Disorders. 2001 June; 31(3): 355-60. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11518489&dopt=Abstract
·
Brief report: imitation effects on children with autism. Author(s): Escalona A, Field T, Nadel J, Lundy B. Source: Journal of Autism and Developmental Disorders. 2002 April; 32(2): 141-4. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12058842&dopt=Abstract
·
Brief report: immune factors in autism: a critical review. Author(s): Krause I, He XS, Gershwin ME, Shoenfeld Y. Source: Journal of Autism and Developmental Disorders. 2002 August; 32(4): 337-45. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12199139&dopt=Abstract
·
Brief report: increasing communication skills for an elementary-aged student with autism using the Picture Exchange Communication System. Author(s): Kravits TR, Kamps DM, Kemmerer K, Potucek J. Source: Journal of Autism and Developmental Disorders. 2002 June; 32(3): 225-30. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12108624&dopt=Abstract
·
Brief report: macrographia in high-functioning adults with autism spectrum disorder. Author(s): Beversdorf DQ, Anderson JM, Manning SE, Anderson SL, Nordgren RE, Felopulos GJ, Bauman ML. Source: Journal of Autism and Developmental Disorders. 2001 February; 31(1): 97-101. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11439759&dopt=Abstract
·
Brief report: prevalence of autism spectrum conditions in children aged 5-11 years in Cambridgeshire, UK. Author(s): Fiona JS, Baron-Cohen S, Bolton P, Brayne C. Source: Autism : the International Journal of Research and Practice. 2002 September; 6(3): 231-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12212915&dopt=Abstract
·
Brief report: Recognition memory and stimulus-reward associations: indirect support for the role of ventromedial prefrontal dysfunction in autism. Author(s): Dawson G, Osterling J, Rinaldi J, Carver L, McPartland J. Source: Journal of Autism and Developmental Disorders. 2001 June; 31(3): 337-41. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11518486&dopt=Abstract
82 Autism
·
Brief report: reduction of inappropriate vocalizations for a child with autism using a self-management treatment program. Author(s): Mancina C, Tankersley M, Kamps D, Kravits T, Parrett J. Source: Journal of Autism and Developmental Disorders. 2000 December; 30(6): 599-606. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11261471&dopt=Abstract
·
Brief report: screening tool for autism in two-year-olds (STAT): development and preliminary data. Author(s): Stone WL, Coonrod EE, Ousley OY. Source: Journal of Autism and Developmental Disorders. 2000 December; 30(6): 607-12. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11261472&dopt=Abstract
·
Brief report: the impact of regression on language development in autism. Author(s): Brown J, Prelock PA. Source: Journal of Autism and Developmental Disorders. 1995 June; 25(3): 305-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7559295&dopt=Abstract
·
Brief report: thought disorder in Asperger syndrome: comparison with highfunctioning autism. Author(s): Ghaziuddin M, Leininger L, Tsai L. Source: Journal of Autism and Developmental Disorders. 1995 June; 25(3): 311-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7559296&dopt=Abstract
·
Brief report: vocabulary acquisition for children with autism: teacher or computer instruction. Author(s): Moore M, Calvert S. Source: Journal of Autism and Developmental Disorders. 2000 August; 30(4): 359-62. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11039862&dopt=Abstract
·
Can the checklist for autism in toddlers differentiate young children with autism from those with developmental delays? Author(s): Scambler D, Rogers SJ, Wehner EA. Source: Journal of the American Academy of Child and Adolescent Psychiatry. 2001 December; 40(12): 1457-63. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11765292&dopt=Abstract
·
Can the pathophysiology of autism be explained by the nature of the discovered urine peptides? Author(s): Reichelt KL, Knivsberg AM. Source: Nutritional Neuroscience. 2003 February; 6(1): 19-28. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12608733&dopt=Abstract
Studies
83
·
Caring for children and adolescents with autism who require challenging procedures. Author(s): Souders MC, Freeman KG, DePaul D, Levy SE. Source: Pediatric Nursing. 2002 November-December; 28(6): 555-62. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12593340&dopt=Abstract
·
Case of Myhre syndrome with autism and peculiar skin histological findings. Author(s): Titomanlio L, Marzano MG, Rossi E, D'Armiento M, De Brasi D, Vega GR, Andreucci MV, Orsini AV, Santoro L, Sebastio G. Source: American Journal of Medical Genetics. 2001 October 1; 103(2): 163-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11568925&dopt=Abstract
·
Case series: use of ziprasidone for maladaptive symptoms in youths with autism. Author(s): McDougle CJ, Kem DL, Posey DJ. Source: Journal of the American Academy of Child and Adolescent Psychiatry. 2002 August; 41(8): 921-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12164181&dopt=Abstract
·
Case-control family study of lesser variant traits in autism. Author(s): Wilcox JA, Tsuang MT, Schnurr T, Baida-Fragoso N. Source: Neuropsychobiology. 2003; 47(4): 171-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12824738&dopt=Abstract
·
Causes of death in autism. Author(s): Shavelle RM, Strauss DJ, Pickett J. Source: Journal of Autism and Developmental Disorders. 2001 December; 31(6): 569-76. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11814268&dopt=Abstract
·
Central coherence and cognitive shifting in relation to social improvement in highfunctioning young adults with autism. Author(s): Berger HJ, Aerts FH, van Spaendonck KP, Cools AR, Teunisse JP. Source: J Clin Exp Neuropsychol. 2003 June; 25(4): 502-11. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12911104&dopt=Abstract
·
Cerebral lobes in autism: early hyperplasia and abnormal age effects. Author(s): Carper RA, Moses P, Tigue ZD, Courchesne E. Source: Neuroimage. 2002 August; 16(4): 1038-51. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12202091&dopt=Abstract
·
Checklist for autism in toddlers. Author(s): Fitzgerald M. Source: Ir Med J. 2001 September; 94(8): 254. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11758633&dopt=Abstract
84 Autism
·
Child behaviour problems and partner mental health as correlates of stress in mothers and fathers of children with autism. Author(s): Hastings RP. Source: Journal of Intellectual Disability Research : Jidr. 2003 May-June; 47(Pt 4-5): 231-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12787155&dopt=Abstract
·
Childhood autism rating scale--Tokyo version for screening pervasive developmental disorders. Author(s): Tachimori H, Osada H, Kurita H. Source: Psychiatry and Clinical Neurosciences. 2003 February; 57(1): 113-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12519463&dopt=Abstract
·
Children with autism deserve evidence-based intervention. Author(s): Couper JJ, Sampson AJ. Source: The Medical Journal of Australia. 2003 May 5; 178(9): 424-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12720505&dopt=Abstract
·
Children with autism display more social behaviors after repeated imitation sessions. Author(s): Field T, Field T, Sanders C, Nadel J. Source: Autism : the International Journal of Research and Practice. 2001 September; 5(3): 317-23. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11708590&dopt=Abstract
·
Child'sTalk--for children with autism and pervasive developmental disorder. Author(s): Aldred C, Pollard C, Adams C. Source: International Journal of Language & Communication Disorders / Royal College of Speech & Language Therapists. 2001; 36 Suppl: 469-74. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11340834&dopt=Abstract
·
Cholinergic activity in autism: abnormalities in the cerebral cortex and basal forebrain. Author(s): Perry EK, Lee ML, Martin-Ruiz CM, Court JA, Volsen SG, Merrit J, Folly E, Iversen PE, Bauman ML, Perry RH, Wenk GL. Source: The American Journal of Psychiatry. 2001 July; 158(7): 1058-66. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11431227&dopt=Abstract
·
Clinical and macroscopic correlates of minicolumnar pathology in autism. Author(s): Casanova MF, Buxhoeveden DP, Brown C. Source: Journal of Child Neurology. 2002 September; 17(9): 692-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12503647&dopt=Abstract
Studies
85
·
Clinical and neurodevelopmental profile of young children with autism. Author(s): Singhi P, Malhi P. Source: Indian Pediatrics. 2001 April; 38(4): 384-90. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11313510&dopt=Abstract
·
Clinical and neurophysiological aspects of epilepsy in subjects with autism and mental retardation. Author(s): Elia M, Musumeci SA, Ferri R, Bergonzi P. Source: Am J Ment Retard. 1995 July; 100(1): 6-16. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7546638&dopt=Abstract
·
Clinical considerations in the diagnosis of autism spectrum disorders. Author(s): Baird G, Charman T, Santosh PJ. Source: Indian J Pediatr. 2001 May; 68(5): 439-49. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11407161&dopt=Abstract
·
Clinical practice guideline: screening and diagnosing autism. Author(s): Blackwell J. Source: Journal of the American Academy of Nurse Practitioners. 2001 December; 13(12): 534-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11836828&dopt=Abstract
·
Cognitive profiles and social-communicative functioning in children with autism spectrum disorder. Author(s): Joseph RM, Tager-Flusberg H, Lord C. Source: Journal of Child Psychology and Psychiatry, and Allied Disciplines. 2002 September; 43(6): 807-21. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12236615&dopt=Abstract
·
Comment: secretin for autism: unproven treatment or ineffective treatment? Author(s): Heisler MA, Guidry JR. Source: The Annals of Pharmacotherapy. 2002 July-August; 36(7-8): 1294; Author Reply 1295. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12086571&dopt=Abstract
·
Commentary: The Modified Checklist for Autism in Toddlers. Author(s): Charman T, Baron-Cohen I, Baird G, Cox A, Wheelwright S, Swettenham J, Drew A. Source: Journal of Autism and Developmental Disorders. 2001 April; 31(2): 145-8; Discussion 149-51. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11450813&dopt=Abstract
86 Autism
·
Communication intervention for children with autism: a review of treatment efficacy. Author(s): Goldstein H. Source: Journal of Autism and Developmental Disorders. 2002 October; 32(5): 373-96. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12463516&dopt=Abstract
·
Communicative abilities in autism: evidence for attentional deficits. Author(s): Bara BG, Bucciarelli M, Colle L. Source: Brain and Language. 2001 May; 77(2): 216-40. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11300705&dopt=Abstract
·
Comparison of Sensory Profile scores of young children with and without autism spectrum disorders. Author(s): Watling RL, Deitz J, White O. Source: Am J Occup Ther. 2001 July-August; 55(4): 416-23. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11723986&dopt=Abstract
·
Comparisons of discrete-trial and normalized behavioral language intervention for young children with autism. Author(s): Delprato DJ. Source: Journal of Autism and Developmental Disorders. 2001 June; 31(3): 315-25. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11518484&dopt=Abstract
·
Concurrent validity and classification accuracy of the Leiter and Leiter-R in lowfunctioning children with autism. Author(s): Tsatsanis KD, Dartnall N, Cicchetti D, Sparrow SS, Klin A, Volkmar FR. Source: Journal of Autism and Developmental Disorders. 2003 February; 33(1): 23-30. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12708577&dopt=Abstract
·
Congressional autism hearings continue: no evidence MMR vaccine causes disorder. Author(s): Vastag B. Source: Jama : the Journal of the American Medical Association. 2001 May 23-30; 285(20): 2567-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11368715&dopt=Abstract
·
Constipation with acquired megarectum in children with autism. Author(s): Afzal N, Murch S, Thirrupathy K, Berger L, Fagbemi A, Heuschkel R. Source: Pediatrics. 2003 October; 112(4): 939-42. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=14523189&dopt=Abstract
Studies
87
·
Construction of a physical map of an autism susceptibility region in 7q32.3-q33. Author(s): Beyer KS, Klauck SM, Wiemann S, Poustka A. Source: Gene. 2001 July 11; 272(1-2): 85-91. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11470513&dopt=Abstract
·
Contextualized behavioral support in early intervention for children with autism and their families. Author(s): Moes DR, Frea WD. Source: Journal of Autism and Developmental Disorders. 2002 December; 32(6): 519-33. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12553589&dopt=Abstract
·
Converging evidence for brain stem injury in autism. Author(s): Rodier PM. Source: Development and Psychopathology. 2002 Summer; 14(3): 537-57. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12349873&dopt=Abstract
·
Coping by redefinition: cognitive appraisals in mothers of children with autism and children without autism. Author(s): Tunali B, Power TG. Source: Journal of Autism and Developmental Disorders. 2002 February; 32(1): 25-34. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11916329&dopt=Abstract
·
Cortical sulcal maps in autism. Author(s): Levitt JG, Blanton RE, Smalley S, Thompson PM, Guthrie D, McCracken JT, Sadoun T, Heinichen L, Toga AW. Source: Cerebral Cortex (New York, N.Y. : 1991). 2003 July; 13(7): 728-35. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12816888&dopt=Abstract
·
Current investigations in autism brain tissue research. Author(s): Pickett J. Source: Journal of Autism and Developmental Disorders. 2001 December; 31(6): 521-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11814261&dopt=Abstract
·
Current topic: Screening and surveillance for autism and pervasive developmental disorders. Author(s): Baird G, Charman T, Cox A, Baron-Cohen S, Swettenham J, Wheelwright S, Drew A. Source: Archives of Disease in Childhood. 2001 June; 84(6): 468-75. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11369559&dopt=Abstract
88 Autism
·
Cyproheptadine in treatment of autism. Author(s): Gudarzi SS, Yasamy M, Akhondzadeh S. Source: European Psychiatry : the Journal of the Association of European Psychiatrists. 2002 July; 17(4): 230-1. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12231270&dopt=Abstract
·
De novo purine synthesis is increased in the fibroblasts of purine autism patients. Author(s): Page T, Coleman M. Source: Advances in Experimental Medicine and Biology. 1998; 431: 793-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9598172&dopt=Abstract
·
Decreasing disruptive behaviors of children with autism using social stories. Author(s): Scattone D, Wilczynski SM, Edwards RP, Rabian B. Source: Journal of Autism and Developmental Disorders. 2002 December; 32(6): 535-43. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12553590&dopt=Abstract
·
Deficits in the initiation of eye movements in the absence of a visual target in adolescents with high functioning autism. Author(s): Goldberg MC, Lasker AG, Zee DS, Garth E, Tien A, Landa RJ. Source: Neuropsychologia. 2002; 40(12): 2039-49. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12208001&dopt=Abstract
·
Defining and quantifying the social phenotype in autism. Author(s): Klin A, Jones W, Schultz R, Volkmar F, Cohen D. Source: The American Journal of Psychiatry. 2002 June; 159(6): 895-908. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12042174&dopt=Abstract
·
Defining the broader phenotype of autism: genetic, brain, and behavioral perspectives. Author(s): Dawson G, Webb S, Schellenberg GD, Dager S, Friedman S, Aylward E, Richards T. Source: Development and Psychopathology. 2002 Summer; 14(3): 581-611. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12349875&dopt=Abstract
·
Density and distribution of hippocampal neurotransmitter receptors in autism: an autoradiographic study. Author(s): Blatt GJ, Fitzgerald CM, Guptill JT, Booker AB, Kemper TL, Bauman ML. Source: Journal of Autism and Developmental Disorders. 2001 December; 31(6): 537-43. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11814263&dopt=Abstract
Studies
89
·
Depression in children with autism/pervasive developmental disorders: a casecontrol family history study. Author(s): Ghaziuddin M, Greden J. Source: Journal of Autism and Developmental Disorders. 1998 April; 28(2): 111-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9586773&dopt=Abstract
·
Depression in persons with autism: implications for research and clinical care. Author(s): Ghaziuddin M, Ghaziuddin N, Greden J. Source: Journal of Autism and Developmental Disorders. 2002 August; 32(4): 299-306. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12199134&dopt=Abstract
·
Descriptive epidemiology of autism in a California population: who is at risk? Author(s): Croen LA, Grether JK, Selvin S. Source: Journal of Autism and Developmental Disorders. 2002 June; 32(3): 217-24. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12108623&dopt=Abstract
·
Developing an information pack for the Asian carers of people with autism spectrum disorders. Author(s): Dobson S, Upadhyaya S, McNeil J, Venkateswaran S, Gilderdale D. Source: International Journal of Language & Communication Disorders / Royal College of Speech & Language Therapists. 2001; 36 Suppl: 216-21. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11340785&dopt=Abstract
·
Developing pretend play in children with autism: a case study. Author(s): Sherratt D. Source: Autism : the International Journal of Research and Practice. 2002 June; 6(2): 16979. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12083283&dopt=Abstract
·
Development and neural bases of face recognition in autism. Author(s): Carver LJ, Dawson G. Source: Molecular Psychiatry. 2002; 7 Suppl 2: S18-20. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12142937&dopt=Abstract
·
Development of the hippocampal formation from 2 to 42 years: MRI evidence of smaller area dentata in autism. Author(s): Saitoh O, Karns CM, Courchesne E. Source: Brain; a Journal of Neurology. 2001 July; 124(Pt 7): 1317-24. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11408327&dopt=Abstract
90 Autism
·
Development. New hints into the biological basis of autism. Author(s): Stokstad E. Source: Science. 2001 October 5; 294(5540): 34-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11588233&dopt=Abstract
·
Development. Scant evidence for an epidemic of autism. Author(s): Stokstad E. Source: Science. 2001 October 5; 294(5540): 35. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11588234&dopt=Abstract
·
Developmental depersonalization: the prefrontal cortex and self-functions in autism. Author(s): Ben Shalom D. Source: Consciousness and Cognition. 2000 September; 9(3): 457-60. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10993669&dopt=Abstract
·
Developmental disabilities: epilepsy, cerebral palsy, and autism. Author(s): Surabian SR. Source: J Calif Dent Assoc. 2001 June; 29(6): 424-32. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11484298&dopt=Abstract
·
Developmental profile and regression in a child with autism: a single case study. Author(s): Bernabei P, Camaioni L. Source: Autism : the International Journal of Research and Practice. 2001 September; 5(3): 287-97. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11708588&dopt=Abstract
·
Diagnosis of autism. Author(s): Baird G, Cass H, Slonims V. Source: Bmj (Clinical Research Ed.). 2003 August 30; 327(7413): 488-93. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12946972&dopt=Abstract
·
Diagnostic assessment of communicative and interactive behaviours in children with autism and receptive language disorder. Author(s): Noterdaeme M, Sitter S, Mildenberger K, Amorosa H. Source: European Child & Adolescent Psychiatry. 2000 December; 9(4): 295-300. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11202105&dopt=Abstract
·
Diagnostic conceptualization of autism among Indian psychiatrists, psychologists, and pediatricians. Author(s): Daley TC, Sigman MD. Source: Journal of Autism and Developmental Disorders. 2002 February; 32(1): 13-23. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11916328&dopt=Abstract
Studies
91
·
Diet in autism and associated disorders. Author(s): Garvey J. Source: J Fam Health Care. 2002; 12(2): 34-8. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12415751&dopt=Abstract
·
Differential effects of developmental cerebellar abnormality on cognitive and motor functions in the cerebellum: an fMRI study of autism. Author(s): Allen G, Courchesne E. Source: The American Journal of Psychiatry. 2003 February; 160(2): 262-73. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12562572&dopt=Abstract
·
Differentiation between autism and multiple complex developmental disorder in response to psychosocial stress. Author(s): Jansen LM, Gispen-de Wied CC, van der Gaag RJ, van Engeland H. Source: Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 2003 March; 28(3): 582-90. Epub 2002 August 06. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12629541&dopt=Abstract
·
Discovery of allelic variants of HOXA1 and HOXB1: genetic susceptibility to autism spectrum disorders. Author(s): Ingram JL, Stodgell CJ, Hyman SL, Figlewicz DA, Weitkamp LR, Rodier PM. Source: Teratology. 2000 December; 62(6): 393-405. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11091361&dopt=Abstract
·
Disease susceptibility genes for autism. Author(s): Bespalova IN, Buxbaum JD. Source: Annals of Medicine. 2003; 35(4): 274-81. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12846270&dopt=Abstract
·
Disentangling weak coherence and executive dysfunction: planning drawing in autism and attention-deficit/hyperactivity disorder. Author(s): Booth R, Charlton R, Hughes C, Happe F. Source: Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences. 2003 February 28; 358(1430): 387-92. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12639335&dopt=Abstract
·
Disordered visual processing and oscillatory brain activity in autism and Williams syndrome. Author(s): Grice SJ, Spratling MW, Karmiloff-Smith A, Halit H, Csibra G, de Haan M, Johnson MH. Source: Neuroreport. 2001 August 28; 12(12): 2697-700. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11522950&dopt=Abstract
92 Autism
·
Do autism spectrum disorders differ from each other and from non-spectrum disorders on emotion recognition tests? Author(s): Dyck MJ, Ferguson K, Shochet IM. Source: European Child & Adolescent Psychiatry. 2001 June; 10(2): 105-16. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11469282&dopt=Abstract
·
Do children with autism fail to process information in context? Author(s): Lopez B, Leekam SR. Source: Journal of Child Psychology and Psychiatry, and Allied Disciplines. 2003 February; 44(2): 285-300. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12587864&dopt=Abstract
·
Do children with autism learn to read more readily by computer assisted instruction or traditional book methods? A pilot study. Author(s): Williams C, Wright B, Callaghan G, Coughlan B. Source: Autism : the International Journal of Research and Practice. 2002 March; 6(1): 7191. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11918110&dopt=Abstract
·
Do children with autism who pass false belief tasks understand the mind as active interpreter? Author(s): Luckett T, Powell SD, Messer DJ, Thornton ME, Schulz J. Source: Journal of Autism and Developmental Disorders. 2002 April; 32(2): 127-40. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12058841&dopt=Abstract
·
Do vaccines cause autism? Author(s): Gorman C. Source: Time. 2002 November 18; 160(21): 150. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12455213&dopt=Abstract
·
Does measles-mumps-rubella (MMR) vaccination cause inflammatory bowel disease and autism? Author(s): Strauss B, Bigham M. Source: Can Commun Dis Rep. 2001 April 15; 27(8): 65-72. Review. English, French. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11338656&dopt=Abstract
·
Does the perception of moving eyes trigger reflexive visual orienting in autism? Author(s): Swettenham J, Condie S, Campbell R, Milne E, Coleman M. Source: Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences. 2003 February 28; 358(1430): 325-34. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12639330&dopt=Abstract
Studies
93
·
Double-blind placebo-controlled trial of secretin: effects on aberrant behavior in children with autism. Author(s): Carey T, Ratliff-Schaub K, Funk J, Weinle C, Myers M, Jenks J. Source: Journal of Autism and Developmental Disorders. 2002 June; 32(3): 161-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12108617&dopt=Abstract
·
Drawing ability in autism: a window into the imagination. Author(s): Craig J, Baron-Cohen S, Scott F. Source: The Israel Journal of Psychiatry and Related Sciences. 2001; 38(3-4): 242-53. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11725423&dopt=Abstract
·
Drawing insight from pictures: the development of concepts of false drawing and false belief in children with deafness, normal hearing, and autism. Author(s): Peterson CC. Source: Child Development. 2002 September-October; 73(5): 1442-59. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12361311&dopt=Abstract
·
Dual access to semantics in autism: is pictorial access superior to verbal access? Author(s): Kamio Y, Toichi M. Source: Journal of Child Psychology and Psychiatry, and Allied Disciplines. 2000 October; 41(7): 859-67. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11079428&dopt=Abstract
·
Early intervention system for preschool children with autism in the community: the DISCOVERY approach in Yokohama, Japan. Author(s): Honda H, Shimizu Y. Source: Autism : the International Journal of Research and Practice. 2002 September; 6(3): 239-57. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12212916&dopt=Abstract
·
Early recognition of 1-year-old infants with autism spectrum disorder versus mental retardation. Author(s): Osterling JA, Dawson G, Munson JA. Source: Development and Psychopathology. 2002 Spring; 14(2): 239-51. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12030690&dopt=Abstract
·
Eating habits of children with autism. Author(s): Williams PG, Dalrymple N, Neal J. Source: Pediatric Nursing. 2000 May-June; 26(3): 259-64. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12026389&dopt=Abstract
94 Autism
·
Echo and savant abilities versus central coherence in autism. Author(s): Loddo S. Source: Autism : the International Journal of Research and Practice. 2003 June; 7(2): 2267. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12846390&dopt=Abstract
·
EEG features and epilepsy in patients with autism. Author(s): Rossi PG, Parmeggiani A, Bach V, Santucci M, Visconti P. Source: Brain & Development. 1995 May-June; 17(3): 169-74. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7573755&dopt=Abstract
·
Effectiveness of a multimedia programme and therapist-instructed training for children with autism. Author(s): Wong SK, Tam SF. Source: International Journal of Rehabilitation Research. Internationale Zeitschrift Fur Rehabilitationsforschung. Revue Internationale De Recherches De Readaptation. 2001 December; 24(4): 269-78. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11775031&dopt=Abstract
·
Effects of age on brain volume and head circumference in autism. Author(s): Aylward EH, Minshew NJ, Field K, Sparks BF, Singh N. Source: Neurology. 2002 July 23; 59(2): 175-83. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12136053&dopt=Abstract
·
Effects of in-home training for culturally diverse fathers of children with autism. Author(s): Elder JH, Valcante G, Won D, Zylis R. Source: Issues in Mental Health Nursing. 2003 April-May; 24(3): 273-95. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12623686&dopt=Abstract
·
Effects of intravenous secretin on language and behavior of children with autism and gastrointestinal symptoms: a single-blinded, open-label pilot study. Author(s): Lightdale JR, Hayer C, Duer A, Lind-White C, Jenkins S, Siegel B, Elliott GR, Heyman MB. Source: Pediatrics. 2001 November; 108(5): E90. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11694674&dopt=Abstract
·
Efficacy of behavioral interventions for reducing problem behavior in persons with autism: a quantitative synthesis of single-subject research. Author(s): Campbell JM. Source: Research in Developmental Disabilities. 2003 March-April; 24(2): 120-38. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12623082&dopt=Abstract
Studies
95
·
Efficacy of porcine secretin in children with autism and pervasive developmental disorder. Author(s): Kern JK, Van Miller S, Evans PA, Trivedi MH. Source: Journal of Autism and Developmental Disorders. 2002 June; 32(3): 153-60. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12108616&dopt=Abstract
·
Efficacy of sensory and motor interventions for children with autism. Author(s): Baranek GT. Source: Journal of Autism and Developmental Disorders. 2002 October; 32(5): 397-422. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12463517&dopt=Abstract
·
Elevated plasma gamma-aminobutyric acid (GABA) levels in autistic youngsters: stimulus for a GABA hypothesis of autism. Author(s): Dhossche D, Applegate H, Abraham A, Maertens P, Bland L, Bencsath A, Martinez J. Source: Medical Science Monitor : International Medical Journal of Experimental and Clinical Research. 2002 August; 8(8): Pr1-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12165753&dopt=Abstract
·
Enhanced discrimination in autism. Author(s): Res Dev Disabil. 2002 Jan-Feb;23(1):81-104 Source: The Quarterly Journal of Experimental Psychology. A, Human Experimental Psychology. 2001 November; 54(4): 961-79. /entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=12071397
·
Enhanced pitch sensitivity in individuals with autism: a signal detection analysis. Author(s): Bonnel A, Mottron L, Peretz I, Trudel M, Gallun E, Bonnel AM. Source: Journal of Cognitive Neuroscience. 2003 February 15; 15(2): 226-35. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12676060&dopt=Abstract
·
Enhanced salience and emotion recognition in Autism: a PET study. Author(s): Hall GB, Szechtman H, Nahmias C. Source: The American Journal of Psychiatry. 2003 August; 160(8): 1439-41. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12900306&dopt=Abstract
·
Enterocolitis, autism and measles virus. Author(s): Wakefield AJ. Source: Molecular Psychiatry. 2002; 7 Suppl 2: S44-6. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12142948&dopt=Abstract
96 Autism
·
Enzyme-based therapy for autism spectrum disorders -- is it worth another look? Author(s): Brudnak MA, Rimland B, Kerry RE, Dailey M, Taylor R, Stayton B, Waickman F, Waickman M, Pangborn J, Buchholz I. Source: Medical Hypotheses. 2002 May; 58(5): 422-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12056881&dopt=Abstract
·
Epidemiological trends in rates of autism. Author(s): Fombonne E. Source: Molecular Psychiatry. 2002; 7 Suppl 2: S4-6. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12142931&dopt=Abstract
·
Epidemiology. Vaccine-autism link dealt blow. Author(s): Stokstad E. Source: Science. 2003 September 12; 301(5639): 1454-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12970526&dopt=Abstract
·
Epilepsy in autism. Author(s): Tuchman R, Rapin I. Source: Lancet. Neurology. 2002 October; 1(6): 352-8. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12849396&dopt=Abstract
·
Ethical aspects of research into the etiology of autism. Author(s): Chen DT, Miller FG, Rosenstein DL. Source: Mental Retardation and Developmental Disabilities Research Reviews. 2003; 9(1): 48-53. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12587138&dopt=Abstract
·
Evaluation of FOXP2 as an autism susceptibility gene. Author(s): Wassink TH, Piven J, Vieland VJ, Pietila J, Goedken RJ, Folstein SE, Sheffield VC. Source: American Journal of Medical Genetics. 2002 July 8; 114(5): 566-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12116195&dopt=Abstract
·
Evaluation of neuromotor deficits in children with autism and children with a specific speech and language disorder. Author(s): Noterdaeme M, Mildenberger K, Minow F, Amorosa H. Source: European Child & Adolescent Psychiatry. 2002 October; 11(5): 219-25. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12469239&dopt=Abstract
Studies
97
·
Evidence for a language quantitative trait locus on chromosome 7q in multiplex autism families. Author(s): Alarcon M, Cantor RM, Liu J, Gilliam TC, Geschwind DH; Autism Genetic Research Exchange Consortium. Source: American Journal of Human Genetics. 2002 January; 70(1): 60-71. Epub 2001 December 06. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11741194&dopt=Abstract
·
Evidence of brain overgrowth in the first year of life in autism. Author(s): Courchesne E, Carper R, Akshoomoff N. Source: Jama : the Journal of the American Medical Association. 2003 July 16; 290(3): 337-44. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12865374&dopt=Abstract
·
Evidence that eicosapentaenoic acid is effective in treating autism. Author(s): Johnson SM, Hollander E. Source: The Journal of Clinical Psychiatry. 2003 July; 64(7): 848-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12934990&dopt=Abstract
·
Executive functions and the natural habitat behaviors of children with autism. Author(s): Ruble LA, Scott MM. Source: Autism : the International Journal of Research and Practice. 2002 December; 6(4): 365-81. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12540128&dopt=Abstract
·
Exploratory subsetting of autism families based on savant skills improves evidence of genetic linkage to 15q11-q13. Author(s): Nurmi EL, Dowd M, Tadevosyan-Leyfer O, Haines JL, Folstein SE, Sutcliffe JS. Source: Journal of the American Academy of Child and Adolescent Psychiatry. 2003 July; 42(7): 856-63. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12819446&dopt=Abstract
·
Eye contact does not facilitate detection in children with autism. Author(s): Senju A, Yaguchi K, Tojo Y, Hasegawa T. Source: Cognition. 2003 August; 89(1): B43-51. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12893128&dopt=Abstract
·
Eye movements, visual attention, and autism: a saccadic reaction time study using the gap and overlap paradigm. Author(s): van der Geest JN, Kemner C, Camfferman G, Verbaten MN, van Engeland H. Source: Biological Psychiatry. 2001 October 15; 50(8): 614-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11690597&dopt=Abstract
98 Autism
·
Face processing occurs outside the fusiform 'face area' in autism: evidence from functional MRI. Author(s): Pierce K, Muller RA, Ambrose J, Allen G, Courchesne E. Source: Brain; a Journal of Neurology. 2001 October; 124(Pt 10): 2059-73. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11571222&dopt=Abstract
·
Facilitating factors and barriers to the implementation of intensive home-based behavioural intervention for young children with autism. Author(s): Johnson E, Hastings RP. Source: Child: Care, Health and Development. 2002 March; 28(2): 123-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11952647&dopt=Abstract
·
Familial clustering of autoimmune disorders and evaluation of medical risk factors in autism. Author(s): Comi AM, Zimmerman AW, Frye VH, Law PA, Peeden JN. Source: Journal of Child Neurology. 1999 June; 14(6): 388-94. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10385847&dopt=Abstract
·
Familiar face and voice matching and recognition in children with autism. Author(s): Boucher J, Lewis V, Collis G. Source: Journal of Child Psychology and Psychiatry, and Allied Disciplines. 1998 February; 39(2): 171-81. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9669230&dopt=Abstract
·
Family-based and population study of a functional promoter-region monoamine oxidase A polymorphism in autism: possible association with IQ. Author(s): Yirmiya N, Pilowsky T, Tidhar S, Nemanov L, Altmark L, Ebstein RP. Source: American Journal of Medical Genetics. 2002 April 8; 114(3): 284-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11920849&dopt=Abstract
·
Fetal valproate syndrome and autism: additional evidence of an association. Author(s): Williams G, King J, Cunningham M, Stephan M, Kerr B, Hersh JH. Source: Developmental Medicine and Child Neurology. 2001 March; 43(3): 202-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11263692&dopt=Abstract
·
Finding specific genes that cause autism: a combination of approaches will be needed to maximize power. Author(s): Folstein SE, Bisson E, Santangelo SL, Piven J. Source: Journal of Autism and Developmental Disorders. 1998 October; 28(5): 439-45. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9813779&dopt=Abstract
Studies
99
·
Fluoxetine in children with autism. Author(s): Peral M, Alcami M, Gilaberte I. Source: Journal of the American Academy of Child and Adolescent Psychiatry. 1999 December; 38(12): 1472-3. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10596244&dopt=Abstract
·
Fluoxetine in treatment of adolescent patients with autism: a longitudinal open trial. Author(s): Fatemi SH, Realmuto GM, Khan L, Thuras P. Source: Journal of Autism and Developmental Disorders. 1998 August; 28(4): 303-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9711486&dopt=Abstract
·
Following the child's lead: mothers' interactions with children with autism. Author(s): Watson LR. Source: Journal of Autism and Developmental Disorders. 1998 February; 28(1): 51-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9546302&dopt=Abstract
·
Follow-up of children with language delay and features of autism from preschool years to middle childhood. Author(s): Michelotti J, Charman T, Slonims V, Baird G. Source: Developmental Medicine and Child Neurology. 2002 December; 44(12): 812-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12455857&dopt=Abstract
·
Follow-up of two-year-olds referred for possible autism. Author(s): Lord C. Source: Journal of Child Psychology and Psychiatry, and Allied Disciplines. 1995 November; 36(8): 1365-82. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8988272&dopt=Abstract
·
Food allergy and infantile autism. Author(s): Lucarelli S, Frediani T, Zingoni AM, Ferruzzi F, Giardini O, Quintieri F, Barbato M, D'Eufemia P, Cardi E. Source: Panminerva Medica. 1995 September; 37(3): 137-41. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8869369&dopt=Abstract
·
FOXP2 is not a major susceptibility gene for autism or specific language impairment. Author(s): Newbury DF, Bonora E, Lamb JA, Fisher SE, Lai CS, Baird G, Jannoun L, Slonims V, Stott CM, Merricks MJ, Bolton PF, Bailey AJ, Monaco AP; International Molecular Genetic Study of Autism Consortium. Source: American Journal of Human Genetics. 2002 May; 70(5): 1318-27. Epub 2002 March 13. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11894222&dopt=Abstract
100 Autism
·
Fractionation of visual memory: agency detection and its impairment in autism. Author(s): Blair RJ, Frith U, Smith N, Abell F, Cipolotti L. Source: Neuropsychologia. 2002; 40(1): 108-18. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11595266&dopt=Abstract
·
Fragile-X syndrome, Down's syndrome and autism: awareness and knowledge amongst special educators. Author(s): York A, von Fraunhofer N, Turk J, Sedgwick P. Source: Journal of Intellectual Disability Research : Jidr. 1999 August; 43 ( Pt 4): 314-24. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10466870&dopt=Abstract
·
Fringe phenotypes in autism: a review of clinical, biochemical and cognitive studies. Author(s): Gousse V, Plumet MH, Chabane N, Mouren-Simeoni MC, Ferradian N, Leboyer M. Source: European Psychiatry : the Journal of the Association of European Psychiatrists. 2002 May; 17(3): 120-8. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12052572&dopt=Abstract
·
From categorization to classification: a comparison among individuals with autism, mental retardation, and normal development. Author(s): Shulman C, Yirmiya N, Greenbaum CW. Source: Journal of Abnormal Psychology. 1995 November; 104(4): 601-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8530762&dopt=Abstract
·
From impasse to insight in autism research: from behavioral symptoms to biological explanations. Author(s): Yeung-Courchesne R, Courchesne E. Source: Development and Psychopathology. 1997 Spring; 9(2): 389-419. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9201450&dopt=Abstract
·
Full inclusion and students with autism. Author(s): Mesibov GB, Shea V. Source: Journal of Autism and Developmental Disorders. 1996 June; 26(3): 337-46. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8792264&dopt=Abstract
·
Functional analysis of stereotypical ear covering in a child with autism. Author(s): Tang JC, Kennedy CH, Koppekin A, Caruso M. Source: J Appl Behav Anal. 2002 Spring; 35(1): 95-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11936553&dopt=Abstract
Studies 101
·
Functional communication training for the treatment of multiply determined challenging behavior in two boys with autism. Author(s): Sigafoos J, Meikle B. Source: Behavior Modification. 1996 January; 20(1): 60-84. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8561770&dopt=Abstract
·
Functional neuroimaging and childhood autism. Author(s): Boddaert N, Zilbovicius M. Source: Pediatric Radiology. 2002 January; 32(1): 1-7. Epub 2001 November 13. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11819054&dopt=Abstract
·
Further characterization of the autism susceptibility locus AUTS1 on chromosome 7q. Author(s): International Molecular Genetic Study of Autism Consortium (IMGSAC). Source: Human Molecular Genetics. 2001 April 15; 10(9): 973-82. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11392322&dopt=Abstract
·
Further evidence of intact working memory in autism. Author(s): Ozonoff S, Strayer DL. Source: Journal of Autism and Developmental Disorders. 2001 June; 31(3): 257-63. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11518480&dopt=Abstract
·
GABA-transaminase, the liver and infantile autism. Author(s): Cohen BI. Source: Medical Hypotheses. 2001 December; 57(6): 673-4. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11918424&dopt=Abstract
·
Gangliosides in cerebrospinal fluid in children with autism spectrum disorders. Author(s): Nordin V, Lekman A, Johansson M, Fredman P, Gillberg C. Source: Developmental Medicine and Child Neurology. 1998 September; 40(9): 587-94. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9766735&dopt=Abstract
·
Gangliosides in children with autism. Author(s): Lekman A, Skjeldal O, Sponheim E, Svennerholm L. Source: Acta Paediatrica (Oslo, Norway : 1992). 1995 July; 84(7): 787-90. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7549298&dopt=Abstract
102 Autism
·
Gastrointestinal microflora studies in late-onset autism. Author(s): Finegold SM, Molitoris D, Song Y, Liu C, Vaisanen ML, Bolte E, McTeague M, Sandler R, Wexler H, Marlowe EM, Collins MD, Lawson PA, Summanen P, Baysallar M, Tomzynski TJ, Read E, Johnson E, Rolfe R, Nasir P, Shah H, Haake DA, Manning P, Kaul A. Source: Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America. 2002 September 1; 35(Suppl 1): S6-S16. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12173102&dopt=Abstract
·
Gender and coping: the parents of children with high functioning autism. Author(s): Gray DE. Source: Social Science & Medicine (1982). 2003 February; 56(3): 631-42. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12570979&dopt=Abstract
·
Gender identity disorder in a girl with autism--a case report. Author(s): Landen M, Rasmussen P. Source: European Child & Adolescent Psychiatry. 1997 September; 6(3): 170-3. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9383652&dopt=Abstract
·
Generalized imitation and the mand: inducing first instances of speech in young children with autism. Author(s): Ross DE, Greer RD. Source: Research in Developmental Disabilities. 2003 January-February; 24(1): 58-74. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12553968&dopt=Abstract
·
Generating novel ideas: fluency performance in high-functioning and learning disabled individuals with autism. Author(s): Turner MA. Source: Journal of Child Psychology and Psychiatry, and Allied Disciplines. 1999 February; 40(2): 189-201. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10188701&dopt=Abstract
·
Generativity in the play of young people with autism. Author(s): Lewis V, Boucher J. Source: Journal of Autism and Developmental Disorders. 1995 April; 25(2): 105-21. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7559280&dopt=Abstract
·
Genes for Prader Willi syndrome/Angelman syndrome and fragile X syndrome are homologous, with genetic imprinting and unstable trinucleotide repeats causing mental retardation, autism and aggression. Author(s): Fischer KM. Source: Medical Hypotheses. 1996 October; 47(4): 289-98. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8910878&dopt=Abstract
Studies 103
·
Genes tPA, Fyn, and FAK in autism? Author(s): Waterhouse L. Source: Journal of Autism and Developmental Disorders. 1997 April; 27(2): 220-3. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9105973&dopt=Abstract
·
Genetic and immunologic considerations in autism. Author(s): Korvatska E, Van de Water J, Anders TF, Gershwin ME. Source: Neurobiology of Disease. 2002 March; 9(2): 107-25. Review. Erratum In: Neurobiol Dis 2002 June; 10(1): 69. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11895365&dopt=Abstract
·
Genetic clues to the biological basis of autism. Author(s): Turner M, Barnby G, Bailey A. Source: Molecular Medicine Today. 2000 June; 6(6): 238-44. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10840382&dopt=Abstract
·
Genetic counseling in autism and pervasive developmental disorders. Author(s): Simonoff E. Source: Journal of Autism and Developmental Disorders. 1998 October; 28(5): 447-56. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9813780&dopt=Abstract
·
Genetic influences in childhood-onset psychiatric disorders: autism and attentiondeficit/hyperactivity disorder. Author(s): Smalley SL. Source: American Journal of Human Genetics. 1997 June; 60(6): 1276-82. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9199546&dopt=Abstract
·
Genetic linkage of attention-deficit/hyperactivity disorder on chromosome 16p13, in a region implicated in autism. Author(s): Smalley SL, Kustanovich V, Minassian SL, Stone JL, Ogdie MN, McGough JJ, McCracken JT, MacPhie IL, Francks C, Fisher SE, Cantor RM, Monaco AP, Nelson SF. Source: American Journal of Human Genetics. 2002 October; 71(4): 959-63. Epub 2002 August 14. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12187510&dopt=Abstract
·
Genetic studies of autism: from the 1970s into the millennium. Author(s): Rutter M. Source: Journal of Abnormal Child Psychology. 2000 February; 28(1): 3-14. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10772346&dopt=Abstract
104 Autism
·
Genetics of autism. Author(s): Cook EH Jr. Source: Child Adolesc Psychiatr Clin N Am. 2001 April; 10(2): 333-50. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11351802&dopt=Abstract
·
Genetics of autism: complex aetiology for a heterogeneous disorder. Author(s): Folstein SE, Rosen-Sheidley B. Source: Nature Reviews. Genetics. 2001 December; 2(12): 943-55. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11733747&dopt=Abstract
·
Genetics of autism: overview and new directions. Author(s): Szatmari P, Jones MB, Zwaigenbaum L, MacLean JE. Source: Journal of Autism and Developmental Disorders. 1998 October; 28(5): 351-68. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9813773&dopt=Abstract
·
Genetics of childhood disorders: XLII. Autism, part 1: Diagnosis and assessment in autistic spectrum disorders. Author(s): Lord C, Volkmar F. Source: Journal of the American Academy of Child and Adolescent Psychiatry. 2002 September; 41(9): 1134-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12218436&dopt=Abstract
·
Genetics of childhood disorders: XLIII. Autism, part 2: neural foundations. Author(s): Schultz RT, Klin A. Source: Journal of the American Academy of Child and Adolescent Psychiatry. 2002 October; 41(10): 1259-62. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12364850&dopt=Abstract
·
Genetics of childhood disorders: XLIV. autism, part 3: psychopharmacology of autism. Author(s): McDougle CJ, Posey D. Source: Journal of the American Academy of Child and Adolescent Psychiatry. 2002 November; 41(11): 1380-3. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12410082&dopt=Abstract
·
Genetics of childhood disorders: XLV. Autism, part 4: serotonin in autism. Author(s): Anderson GM. Source: Journal of the American Academy of Child and Adolescent Psychiatry. 2002 December; 41(12): 1513-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12447040&dopt=Abstract
Studies 105
·
Genetics of childhood disorders: XLVI. Autism, part 5: genetics of autism. Author(s): Veenstra-Vanderweele J, Cook E Jr, Lombroso PJ. Source: Journal of the American Academy of Child and Adolescent Psychiatry. 2003 January; 42(1): 116-8. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12500084&dopt=Abstract
·
Genetics of childhood disorders: XLVII. Autism, part 6: duplication and inherited susceptibility of chromosome 15q11-q13 genes in autism. Author(s): Sutcliffe JS, Nurmi EL, Lombroso PJ. Source: Journal of the American Academy of Child and Adolescent Psychiatry. 2003 February; 42(2): 253-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12544187&dopt=Abstract
·
Genome-wide scan for autism susceptibility genes. Paris Autism Research International Sibpair Study. Author(s): Philippe A, Martinez M, Guilloud-Bataille M, Gillberg C, Rastam M, Sponheim E, Coleman M, Zappella M, Aschauer H, Van Maldergem L, Penet C, Feingold J, Brice A, Leboyer M, van Malldergerme L. Source: Human Molecular Genetics. 1999 May; 8(5): 805-12. Erratum In: Hum Mol Genet 1999 July; 8(7): 1353. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10196369&dopt=Abstract
·
Glucose metabolic correlates of continuous performance test performance in adults with a history of infantile autism, schizophrenics, and controls. Author(s): Siegel BV Jr, Nuechterlein KH, Abel L, Wu JC, Buchsbaum MS. Source: Schizophrenia Research. 1995 September; 17(1): 85-94. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8541254&dopt=Abstract
·
Gluten and casein free diets in autism: a study of the effects on food choice and nutrition. Author(s): Cornish E. Source: Journal of Human Nutrition and Dietetics : the Official Journal of the British Dietetic Association. 2002 August; 15(4): 261-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12153499&dopt=Abstract
·
Guidelines for evaluating intervention programs for children with autism. Author(s): Freeman BJ. Source: Journal of Autism and Developmental Disorders. 1997 December; 27(6): 641-51. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9455726&dopt=Abstract
106 Autism
·
Hand preference and hand skill in children with autism. Author(s): Cornish KM, McManus IC. Source: Journal of Autism and Developmental Disorders. 1996 December; 26(6): 597-609. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8986846&dopt=Abstract
·
Hand preference and motor functioning in children with autism. Author(s): Hauck JA, Dewey D. Source: Journal of Autism and Developmental Disorders. 2001 June; 31(3): 265-77. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11518481&dopt=Abstract
·
Harrdiness and social support as predictors of stress in mothers of typical children, children with autism, and children with mental retardation. Author(s): Weiss MJ. Source: Autism : the International Journal of Research and Practice. 2002 March; 6(1): 115-30. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11918107&dopt=Abstract
·
Head circumference in autism and other pervasive developmental disorders. Author(s): Woodhouse W, Bailey A, Rutter M, Bolton P, Baird G, Le Couteur A. Source: Journal of Child Psychology and Psychiatry, and Allied Disciplines. 1996 September; 37(6): 665-71. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8894947&dopt=Abstract
·
Head circumference in autism, Asperger syndrome, and ADHD: a comparative study. Author(s): Gillberg C, de Souza L. Source: Developmental Medicine and Child Neurology. 2002 May; 44(5): 296-300. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12033714&dopt=Abstract
·
Head circumference is an independent clinical finding associated with autism. Author(s): Miles JH, Hadden LL, Takahashi TN, Hillman RE. Source: American Journal of Medical Genetics. 2000 December 11; 95(4): 339-50. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11186888&dopt=Abstract
·
Head circumference measurements in children with autism. Author(s): Davidovitch M, Patterson B, Gartside P. Source: Journal of Child Neurology. 1996 September; 11(5): 389-93. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8877607&dopt=Abstract
·
Heat shock protein 90 antibodies in autism. Author(s): Evers M, Cunningham-Rundles C, Hollander E. Source: Molecular Psychiatry. 2002; 7 Suppl 2: S26-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12142940&dopt=Abstract
Studies 107
·
Hello and goodbye: a study of social engagement in autism. Author(s): Hobson RP, Lee A. Source: Journal of Autism and Developmental Disorders. 1998 April; 28(2): 117-27. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9586774&dopt=Abstract
·
Helping school nurses recognize student behaviors that may indicate PDD and other autism-related syndromes. Author(s): Dychkowski L. Source: School Nurse News. 2000 May; 17(3): 1-4, 8. Review. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11778246&dopt=Abstract
·
Hemoglobin and the brain: a piece of the autism puzzle? Author(s): Simon N. Source: Journal of Autism and Developmental Disorders. 1998 December; 28(6): 579-80. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9932245&dopt=Abstract
·
Heritable and nonheritable risk factors for autism spectrum disorders. Author(s): Newschaffer CJ, Fallin D, Lee NL. Source: Epidemiologic Reviews. 2002; 24(2): 137-53. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12762089&dopt=Abstract
·
Heterogeneity and the genetics of autism. Author(s): Szatmari P. Source: Journal of Psychiatry & Neuroscience : Jpn. 1999 March; 24(2): 159-65. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10212560&dopt=Abstract
·
Hey! It was just a joke! Understanding propositions and propositional attitudes by normally developing children and children with autism. Author(s): Baron-Cohen S. Source: The Israel Journal of Psychiatry and Related Sciences. 1997; 34(3): 174-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9334521&dopt=Abstract
·
High “intelligence,” low “IQ”? Speed of processing and measured IQ in children with autism. Author(s): Scheuffgen K, Happe F, Anderson M, Frith U. Source: Development and Psychopathology. 2000 Winter; 12(1): 83-90. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10774597&dopt=Abstract
·
High functioning autism and Childhood Disintegrative Disorder in half brothers. Author(s): Zwaigenbaum L, Szatmari P, Mahoney W, Bryson S, Bartolucci G, MacLean J. Source: Journal of Autism and Developmental Disorders. 2000 April; 30(2): 121-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10832776&dopt=Abstract
108 Autism
·
High motion coherence thresholds in children with autism. Author(s): Milne E, Swettenham J, Hansen P, Campbell R, Jeffries H, Plaisted K. Source: Journal of Child Psychology and Psychiatry, and Allied Disciplines. 2002 February; 43(2): 255-63. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11902604&dopt=Abstract
·
High phenotypic correlations among siblings with autism and pervasive developmental disorders. Author(s): Szatmari P, Jones MB, Holden J, Bryson S, Mahoney W, Tuff L, MacLean J, White B, Bartolucci G, Schutz C, Robinson P, Hoult L. Source: American Journal of Medical Genetics. 1996 July 26; 67(4): 354-60. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8837702&dopt=Abstract
·
Holistic and part-based face recognition in children with autism. Author(s): Joseph RM, Tanaka J. Source: Journal of Child Psychology and Psychiatry, and Allied Disciplines. 2003 May; 44(4): 529-42. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12751845&dopt=Abstract
·
Home-based behavioral treatment of young children with autism. Author(s): Sheinkopf SJ, Siegel B. Source: Journal of Autism and Developmental Disorders. 1998 February; 28(1): 15-23. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9546298&dopt=Abstract
·
How common are gastrointestinal disorders in children with autism? Author(s): Kuddo T, Nelson KB. Source: Current Opinion in Pediatrics. 2003 June; 15(3): 339-43. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12806268&dopt=Abstract
·
How commonly are known medical conditions associated with autism? Author(s): Barton M, Volkmar F. Source: Journal of Autism and Developmental Disorders. 1998 August; 28(4): 273-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9711483&dopt=Abstract
·
How well does early diagnosis of autism stand the test of time? Follow-up study of children assessed for autism at age 2 and development of an early diagnostic service. Author(s): Moore V, Goodson S. Source: Autism : the International Journal of Research and Practice. 2003 March; 7(1): 4763. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12638764&dopt=Abstract
Studies 109
·
Human beings, animals and inanimate objects: what do people with autism like? Author(s): Celani G. Source: Autism : the International Journal of Research and Practice. 2002 March; 6(1): 93102. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11918112&dopt=Abstract
·
Hydrogen proton magnetic resonance spectroscopy in autism: preliminary evidence of elevated choline/creatine ratio. Author(s): Sokol DK, Dunn DW, Edwards-Brown M, Feinberg J. Source: Journal of Child Neurology. 2002 April; 17(4): 245-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12088077&dopt=Abstract
·
Hyperserotoninemia and serotonin receptor antibodies in children with autism but not mental retardation. Author(s): Singh VK, Singh EA, Warren RP. Source: Biological Psychiatry. 1997 March 15; 41(6): 753-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9067002&dopt=Abstract
·
Hypothesis: is infantile autism a hypoglutamatergic disorder? Relevance of glutamate - serotonin interactions for pharmacotherapy. Author(s): Carlsson ML. Source: Journal of Neural Transmission (Vienna, Austria : 1996). 1998; 105(4-5): 525-35. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9720980&dopt=Abstract
·
Identification of indolyl-3-acryloylglycine in the urine of people with autism. Author(s): Anderson RJ, Bendell DJ, Garnett I, Groundwater PW, Lough WJ, Mills MJ, Savery D, Shattock PE. Source: The Journal of Pharmacy and Pharmacology. 2002 February; 54(2): 295-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11858215&dopt=Abstract
·
Identification of the human cortactin-binding protein-2 gene from the autism candidate region at 7q31. Author(s): Cheung J, Petek E, Nakabayashi K, Tsui LC, Vincent JB, Scherer SW. Source: Genomics. 2001 November; 78(1-2): 7-11. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11707066&dopt=Abstract
·
Identifying neurocognitive phenotypes in autism. Author(s): Tager-Flusberg H, Joseph RM. Source: Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences. 2003 February 28; 358(1430): 303-14. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12639328&dopt=Abstract
110 Autism
·
Impaired categorical perception of facial expressions in high-functioning adolescents with autism. Author(s): Teunisse JP, de Gelder B. Source: Neuropsychology, Development, and Cognition. Section C, Child Neuropsychology : a Journal on Normal and Abnormal Development in Childhood and Adolescence. 2001 March; 7(1): 1-14. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11815876&dopt=Abstract
·
In search of the hidden: an fMRI study with implications for the study of patients with autism and with acquired brain injury. Author(s): Manjaly ZM, Marshall JC, Stephan KE, Gurd JM, Zilles K, Fink GR. Source: Neuroimage. 2003 July; 19(3): 674-83. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12880798&dopt=Abstract
·
Including children with autism in general education classrooms. A review of effective strategies. Author(s): Harrower JK, Dunlap G. Source: Behavior Modification. 2001 October; 25(5): 762-84. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11573339&dopt=Abstract
·
Incorporating language phenotypes strengthens evidence of linkage to autism. Author(s): Collaborative Linkage Study of Autism. Source: American Journal of Medical Genetics. 2001 December 8; 105(8): 539-47. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11811141&dopt=Abstract
·
Increased rate of head growth during infancy in autism. Author(s): Lainhart JE. Source: Jama : the Journal of the American Medical Association. 2003 July 16; 290(3): 393-4. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12865381&dopt=Abstract
·
Increased rate of twins among affected sibling pairs with autism. Author(s): Betancur C, Leboyer M, Gillberg C. Source: American Journal of Human Genetics. 2002 May; 70(5): 1381-3. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11951183&dopt=Abstract
·
Increased serum albumin, gamma globulin, immunoglobulin IgG, and IgG2 and IgG4 in autism. Author(s): Croonenberghs J, Wauters A, Devreese K, Verkerk R, Scharpe S, Bosmans E, Egyed B, Deboutte D, Maes M. Source: Psychological Medicine. 2002 November; 32(8): 1457-63. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12455944&dopt=Abstract
Studies 111
·
Increasing social initiations in children with autism: effects of a tactile prompt. Author(s): Shabani DB, Katz RC, Wilder DA, Beauchamp K, Taylor CR, Fischer KJ. Source: J Appl Behav Anal. 2002 Spring; 35(1): 79-83. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11936550&dopt=Abstract
·
Inferential processing and story recall in children with communication problems: a comparison of specific language impairment, pragmatic language impairment and high-functioning autism. Author(s): Norbury CF, Bishop DV. Source: International Journal of Language & Communication Disorders / Royal College of Speech & Language Therapists. 2002 July-September; 37(3): 227-51. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12201976&dopt=Abstract
·
Inhibitory mechanisms in autism spectrum disorders: typical selective inhibition of location versus facilitated perceptual processing. Author(s): Brian JA, Tipper SP, Weaver B, Bryson SE. Source: Journal of Child Psychology and Psychiatry, and Allied Disciplines. 2003 May; 44(4): 552-60. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12751847&dopt=Abstract
·
Innate immunity associated with inflammatory responses and cytokine production against common dietary proteins in patients with autism spectrum disorder. Author(s): Jyonouchi H, Sun S, Itokazu N. Source: Neuropsychobiology. 2002; 46(2): 76-84. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12378124&dopt=Abstract
·
Intensive behavioral treatment at school for 4- to 7-year-old children with autism. A 1year comparison controlled study. Author(s): Eikeseth S, Smith T, Jahr E, Eldevik S. Source: Behavior Modification. 2002 January; 26(1): 49-68. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11799654&dopt=Abstract
·
Intensive behavioral treatment for a toddler at high risk for autism. Author(s): Green G, Brennan LC, Fein D. Source: Behavior Modification. 2002 January; 26(1): 69-102. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11799655&dopt=Abstract
112 Autism
·
Interaction patterns between children and their teachers when using a specific multimedia and communication strategy: observations from children with autism and mixed intellectual disabilities. Author(s): Tjus T, Heimann M, Nelson KE. Source: Autism : the International Journal of Research and Practice. 2001 June; 5(2): 17587. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11706865&dopt=Abstract
·
Interrelations among social-cognitive skills in young children with autism. Author(s): Carpenter M, Pennington BF, Rogers SJ. Source: Journal of Autism and Developmental Disorders. 2002 April; 32(2): 91-106. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12058847&dopt=Abstract
·
Interventions to facilitate social interaction for young children with autism: review of available research and recommendations for educational intervention and future research. Author(s): McConnell SR. Source: Journal of Autism and Developmental Disorders. 2002 October; 32(5): 351-72. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12463515&dopt=Abstract
·
Intestinal pathophysiology in autism. Author(s): White JF. Source: Experimental Biology and Medicine (Maywood, N.J.). 2003 June; 228(6): 639-49. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12773694&dopt=Abstract
·
Into life: Autism, Tourette's syndrome and the community of clinical research. Author(s): Cohen DJ. Source: The Israel Journal of Psychiatry and Related Sciences. 2001; 38(3-4): 226-34. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11725420&dopt=Abstract
·
Intuitive psychology and physics among children with autism and typically developing children. Author(s): Binnie L, Williams J. Source: Autism : the International Journal of Research and Practice. 2003 June; 7(2): 17393. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12846386&dopt=Abstract
Studies 113
·
Investigating individual differences in brain abnormalities in autism. Author(s): Salmond CH, de Haan M, Friston KJ, Gadian DG, Vargha-Khadem F. Source: Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences. 2003 February 28; 358(1430): 405-13. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12639337&dopt=Abstract
·
Investigation of a reinforcement-based toilet training procedure for children with autism. Author(s): Cicero FR, Pfadt A. Source: Research in Developmental Disabilities. 2002 September-October; 23(5): 319-31. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12401483&dopt=Abstract
·
Investigation of two variants in the DOPA decarboxylase gene in patients with autism. Author(s): Lauritsen MB, Borglum AD, Betancur C, Philippe A, Kruse TA, Leboyer M, Ewald H. Source: American Journal of Medical Genetics. 2002 May 8; 114(4): 466-70. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11992572&dopt=Abstract
·
Iron deficiency in autism and Asperger syndrome. Author(s): Latif A, Heinz P, Cook R. Source: Autism : the International Journal of Research and Practice. 2002 March; 6(1): 103-14. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11918106&dopt=Abstract
·
Is autism due to cerebral-cerebellum disconnection? Author(s): Skoyles JR. Source: Medical Hypotheses. 2002 April; 58(4): 332-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12027528&dopt=Abstract
·
Is exposure to alcohol during pregnancy a risk factor for autism? Author(s): Fombonne E. Source: Journal of Autism and Developmental Disorders. 2002 June; 32(3): 243. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12108626&dopt=Abstract
·
Is there an increase in the prevalence of autism spectrum disorders? Author(s): Prior M. Source: Journal of Paediatrics and Child Health. 2003 March; 39(2): 81-2. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12603792&dopt=Abstract
114 Autism
·
Islands of genius. Artistic brilliance and a dazzling memory can sometimes accompany autism and other developmental disorders. Author(s): Treffert DA, Wallace GL. Source: Scientific American. 2002 June; 286(6): 76-85. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12030094&dopt=Abstract
·
Joint attention and early social communication: implications for research on intervention with autism. Author(s): Mundy P, Crowson M. Source: Journal of Autism and Developmental Disorders. 1997 December; 27(6): 653-76. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9455727&dopt=Abstract
·
Joint attention and set-shifting in young children with autism. Author(s): Stahl L, Pry R. Source: Autism : the International Journal of Research and Practice. 2002 December; 6(4): 383-96. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12540129&dopt=Abstract
·
Joint attention in preverbal children: autism and developmental language disorder. Author(s): McArthur D, Adamson LB. Source: Journal of Autism and Developmental Disorders. 1996 October; 26(5): 481-96. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8906451&dopt=Abstract
·
Joint attention training for children with autism using behavior modification procedures. Author(s): Whalen C, Schreibman L. Source: Journal of Child Psychology and Psychiatry, and Allied Disciplines. 2003 March; 44(3): 456-68. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12635974&dopt=Abstract
·
Judgments of social appropriateness by children and adolescents with autism. Author(s): Loveland KA, Pearson DA, Tunali-Kotoski B, Ortegon J, Gibbs MC. Source: Journal of Autism and Developmental Disorders. 2001 August; 31(4): 367-76. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11569583&dopt=Abstract
·
Lack of association between HoxA1 and HoxB1 gene variants and autism in 110 multiplex families. Author(s): Li J, Tabor HK, Nguyen L, Gleason C, Lotspeich LJ, Spiker D, Risch N, Myers RM. Source: American Journal of Medical Genetics. 2002 January 8; 114(1): 24-30. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11840501&dopt=Abstract
Studies 115
·
Lack of association of the (AAAT)6 allele of the GXAlu tetranucleotide repeat in intron 27b of the NF1 gene with autism. Author(s): Plank SM, Copeland-Yates SA, Sossey-Alaoui K, Bell JM, Schroer RJ, Skinner C, Michaelis RC. Source: American Journal of Medical Genetics. 2001 July 8; 105(5): 404-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11449390&dopt=Abstract
·
Lack of benefit of a single dose of synthetic human secretin in the treatment of autism and pervasive developmental disorder. Author(s): Sandler AD, Sutton KA, DeWeese J, Girardi MA, Sheppard V, Bodfish JW. Source: The New England Journal of Medicine. 1999 December 9; 341(24): 1801-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10588965&dopt=Abstract
·
Lack of benefit of intravenous synthetic human secretin in the treatment of autism. Author(s): Molloy CA, Manning-Courtney P, Swayne S, Bean J, Brown JM, Murray DS, Kinsman AM, Brasington M, Ulrich CD 2nd. Source: Journal of Autism and Developmental Disorders. 2002 December; 32(6): 545-51. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12553591&dopt=Abstract
·
Lack of expansion of triplet repeats in the FMR1, FRAXE, and FRAXF loci in male multiplex families with autism and pervasive developmental disorders. Author(s): Holden JJ, Wing M, Chalifoux M, Julien-Inalsingh C, Schutz C, Robinson P, Szatmari P, White BN. Source: American Journal of Medical Genetics. 1996 August 9; 64(2): 399-403. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8844091&dopt=Abstract
·
Language and pragmatic functions in school-age children on the autism spectrum. Author(s): Ramberg C, Ehlers S, Nyden A, Johansson M, Gillberg C. Source: Eur J Disord Commun. 1996; 31(4): 387-413. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9059572&dopt=Abstract
·
Language disorders in children with autism. Author(s): Rapin I, Dunn M. Source: Semin Pediatr Neurol. 1997 June; 4(2): 86-92. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9195665&dopt=Abstract
·
Latent-class analysis of recurrence risks for complex phenotypes with selection and measurement error: a twin and family history study of autism. Author(s): Pickles A, Bolton P, Macdonald H, Bailey A, Le Couteur A, Sim CH, Rutter M. Source: American Journal of Human Genetics. 1995 September; 57(3): 717-26. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7668301&dopt=Abstract
116 Autism
·
Lateralization in individuals with high-functioning autism and Asperger's disorder: a frontostriatal model. Author(s): Rinehart NJ, Bradshaw JL, Brereton AV, Tonge BJ. Source: Journal of Autism and Developmental Disorders. 2002 August; 32(4): 321-331. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12199137&dopt=Abstract
·
Legitimacy of comparing fragile X with autism questioned. Author(s): Rapin I. Source: Journal of Autism and Developmental Disorders. 2002 February; 32(1): 60-1. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11916334&dopt=Abstract
·
Levels of cerebrospinal fluid nerve-growth factor differ in infantile autism and Rett syndrome. Author(s): Riikonen R, Vanhala R. Source: Developmental Medicine and Child Neurology. 1999 March; 41(3): 148-52. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10210246&dopt=Abstract
·
Limbic circuitry in patients with autism spectrum disorders studied with positron emission tomography and magnetic resonance imaging. Author(s): Haznedar MM, Buchsbaum MS, Wei TC, Hof PR, Cartwright C, Bienstock CA, Hollander E. Source: The American Journal of Psychiatry. 2000 December; 157(12): 1994-2001. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11097966&dopt=Abstract
·
Linguistic processing in high-functioning adults with autism or Asperger's syndrome. Is global coherence impaired? Author(s): Jolliffe T, Baron-Cohen S. Source: Psychological Medicine. 2000 September; 30(5): 1169-87. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12027052&dopt=Abstract
·
Linkage and association of the glutamate receptor 6 gene with autism. Author(s): Jamain S, Betancur C, Quach H, Philippe A, Fellous M, Giros B, Gillberg C, Leboyer M, Bourgeron T; Paris Autism Research International Sibpair (PARIS) Study. Source: Molecular Psychiatry. 2002; 7(3): 302-10. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11920157&dopt=Abstract
·
Linkage disequilibrium at the Angelman syndrome gene UBE3A in autism families. Author(s): Nurmi EL, Bradford Y, Chen Y, Hall J, Arnone B, Gardiner MB, Hutcheson HB, Gilbert JR, Pericak-Vance MA, Copeland-Yates SA, Michaelis RC, Wassink TH, Santangelo SL, Sheffield VC, Piven J, Folstein SE, Haines JL, Sutcliffe JS. Source: Genomics. 2001 September; 77(1-2): 105-13. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11543639&dopt=Abstract
Studies 117
·
Linking etiologies in humans and animal models: studies of autism. Author(s): Rodier PM, Ingram JL, Tisdale B, Croog VJ. Source: Reproductive Toxicology (Elmsford, N.Y.). 1997 March-June; 11(2-3): 417-22. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9100317&dopt=Abstract
·
Linking parental perceptions to interactions in young children with autism. Author(s): Kasari C, Sigman M. Source: Journal of Autism and Developmental Disorders. 1997 February; 27(1): 39-57. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9018581&dopt=Abstract
·
Linking theory of mind and central coherence bias in autism and in the general population. Author(s): Jarrold C, Butler DW, Cottington EM, Jimenez F. Source: Developmental Psychology. 2000 January; 36(1): 126-38. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10645750&dopt=Abstract
·
Links between social understanding and social behavior in verbally able children with autism. Author(s): Travis L, Sigman M, Ruskin E. Source: Journal of Autism and Developmental Disorders. 2001 April; 31(2): 119-30. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11450811&dopt=Abstract
·
Local and global processing of music in high-functioning persons with autism: beyond central coherence? Author(s): Mottron L, Peretz I, Menard E. Source: Journal of Child Psychology and Psychiatry, and Allied Disciplines. 2000 November; 41(8): 1057-65. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11099122&dopt=Abstract
·
Loneliness and friendship in high-functioning children with autism. Author(s): Bauminger N, Kasari C. Source: Child Development. 2000 March-April; 71(2): 447-56. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10834476&dopt=Abstract
·
Longitudinal changes in cognitive and adaptive behavior scores in children and adolescents with the fragile X mutation or autism. Author(s): Fisch GS, Simensen RJ, Schroer RJ. Source: Journal of Autism and Developmental Disorders. 2002 April; 32(2): 107-14. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12058838&dopt=Abstract
118 Autism
·
Long-term memory and levels-of-processing in autism. Author(s): Toichi M, Kamio Y. Source: Neuropsychologia. 2002; 40(7): 964-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11900748&dopt=Abstract
·
Long-term stability of individual differences in the emotional responsiveness of children with autism. Author(s): Dissanayake C, Sigman M, Kasari C. Source: Journal of Child Psychology and Psychiatry, and Allied Disciplines. 1996 May; 37(4): 461-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8735446&dopt=Abstract
·
Low levels of insulin-like growth factor-I in cerebrospinal fluid in children with autism. Author(s): Vanhala R, Turpeinen U, Riikonen R. Source: Developmental Medicine and Child Neurology. 2001 September; 43(9): 614-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11570630&dopt=Abstract
·
Low-dose naltrexone effects on plasma chemistries and clinical symptoms in autism: a double-blind, placebo-controlled study. Author(s): Bouvard MP, Leboyer M, Launay JM, Recasens C, Plumet MH, WallerPerotte D, Tabuteau F, Bondoux D, Dugas M, Lensing P, et al. Source: Psychiatry Research. 1995 October 16; 58(3): 191-201. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8570775&dopt=Abstract
·
Maternal neuronal antibodies associated with autism and a language disorder. Author(s): Dalton P, Deacon R, Blamire A, Pike M, McKinlay I, Stein J, Styles P, Vincent A. Source: Annals of Neurology. 2003 April; 53(4): 533-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12666123&dopt=Abstract
·
Measles, mumps and rubella vaccine, autism and inflammatory bowel disease: advising concerned parents. Author(s): Elliman DA, Bedford HE. Source: Paediatric Drugs. 2002; 4(10): 631-5. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12269839&dopt=Abstract
·
Measles, mumps, and rubella vaccination and autism. Author(s): Wakefield AJ. Source: The New England Journal of Medicine. 2003 March 6; 348(10): 951-4; Author Reply 951-4. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12622124&dopt=Abstract
Studies 119
·
Measles, mumps, and rubella vaccination and autism. Author(s): Noble KK, Miyasaka K. Source: The New England Journal of Medicine. 2003 March 6; 348(10): 951-4; Author Reply 951-4. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12622123&dopt=Abstract
·
Measles, mumps, and rubella vaccination and autism. Author(s): Mullins ME. Source: The New England Journal of Medicine. 2003 March 6; 348(10): 951-4; Author Reply 951-4. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12622122&dopt=Abstract
·
Measles, mumps, and rubella vaccination and autism. Author(s): Spitzer WO. Source: The New England Journal of Medicine. 2003 March 6; 348(10): 951-4; Author Reply 951-4. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12622119&dopt=Abstract
·
Measles-mumps-rubella vaccine and the development of autism. Author(s): Miller E. Source: Seminars in Pediatric Infectious Diseases. 2003 July; 14(3): 199-206. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12913832&dopt=Abstract
·
Measures in intervention research with young children who have autism. Author(s): Wolery M, Garfinkle AN. Source: Journal of Autism and Developmental Disorders. 2002 October; 32(5): 463-78. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12463520&dopt=Abstract
·
Measuring early language development in preschool children with autism spectrum disorder using the MacArthur Communicative Development Inventory (Infant Form). Author(s): Charman T, Drew A, Baird C, Baird G. Source: Journal of Child Language. 2003 February; 30(1): 213-36. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12718299&dopt=Abstract
·
Medical disorders among inpatients with autism in Denmark according to ICD-8: a nationwide register-based study. Author(s): Lauritsen MB, Mors O, Mortensen PB, Ewald H. Source: Journal of Autism and Developmental Disorders. 2002 April; 32(2): 115-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12058839&dopt=Abstract
120 Autism
·
Mitochondrial dysfunction in patients with hypotonia, epilepsy, autism, and developmental delay: HEADD syndrome. Author(s): Fillano JJ, Goldenthal MJ, Rhodes CH, Marin-Garcia J. Source: Journal of Child Neurology. 2002 June; 17(6): 435-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12174964&dopt=Abstract
·
MMR and autism: an overview of the debate to date. Author(s): Phelan AT. Source: British Journal of Nursing (Mark Allen Publishing). 2002 May 9-22; 11(9): 621-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12048476&dopt=Abstract
·
MMR and autism: moving from controversy toward consensus. Author(s): Coffin SE. Source: Expert Rev Vaccines. 2002 August; 1(2): 145-50. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12901553&dopt=Abstract
·
MMR vaccination and autism 1998. Medical practitioners need to give more than reassurance. Author(s): Selway. Source: Bmj (Clinical Research Ed.). 1998 June 13; 316(7147): 1824. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9652941&dopt=Abstract
·
MMR vaccination and autism 1998. There is no causal link between MMR vaccine and autism. Author(s): Roberts R. Source: Bmj (Clinical Research Ed.). 1998 June 13; 316(7147): 1824. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9624080&dopt=Abstract
·
MMR vaccination and autism 1998. Those giving MMR vaccine had no input into editorial. Author(s): Kiln MR. Source: Bmj (Clinical Research Ed.). 1998 June 13; 316(7147): 1824. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9652942&dopt=Abstract
·
MMR vaccination and autism: is there a link? Author(s): DeStefano F, Thompson WW. Source: Expert Opinion on Drug Safety. 2002 July; 1(2): 115-20. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12904145&dopt=Abstract
Studies 121
·
MMR vaccine and autism: a review of the evidence for a causal association. Author(s): DeStefano F. Source: Molecular Psychiatry. 2002; 7 Suppl 2: S51-2. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12142951&dopt=Abstract
·
Molecular genetic delineation of 2q37.3 deletion in autism and osteodystrophy: report of a case and of new markers for deletion screening by PCR. Author(s): Smith M, Escamilla JR, Filipek P, Bocian ME, Modahl C, Flodman P, Spence MA. Source: Cytogenetics and Cell Genetics. 2001; 94(1-2): 15-22. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11701947&dopt=Abstract
·
Molecular genetic delineation of a deletion of chromosome 13q12-->q13 in a patient with autism and auditory processing deficits. Author(s): Smith M, Woodroffe A, Smith R, Holguin S, Martinez J, Filipek PA, Modahl C, Moore B, Bocian ME, Mays L, Laulhere T, Flodman P, Spence MA. Source: Cytogenetic and Genome Research. 2002; 98(4): 233-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12826745&dopt=Abstract
·
Motion perception in autism: a “complex” issue. Author(s): Bertone A, Mottron L, Jelenic P, Faubert J. Source: Journal of Cognitive Neuroscience. 2003 February 15; 15(2): 218-25. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12676059&dopt=Abstract
·
Motor control and children with autism: deficit of anticipatory function? Author(s): Schmitz C, Martineau J, Barthelemy C, Assaiante C. Source: Neuroscience Letters. 2003 September 4; 348(1): 17-20. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12893415&dopt=Abstract
·
Motor performance and anatomic magnetic resonance imaging (MRI) of the basal ganglia in autism. Author(s): Hardan AY, Kilpatrick M, Keshavan MS, Minshew NJ. Source: Journal of Child Neurology. 2003 May; 18(5): 317-24. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12822815&dopt=Abstract
·
Multicomponent procedure to teach conditional discriminations to children with autism. Author(s): Perez-Gonzalez LA, Williams G. Source: Am J Ment Retard. 2002 July; 107(4): 293-301. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12069648&dopt=Abstract
122 Autism
·
Multiple doses of secretin in the treatment of autism: a controlled study. Author(s): Sponheim E, Oftedal G, Helverschou SB. Source: Acta Paediatrica (Oslo, Norway : 1992). 2002; 91(5): 540-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12113323&dopt=Abstract
·
Multisite, double-blind, placebo-controlled trial of porcine secretin in autism. Author(s): Owley T, McMahon W, Cook EH, Laulhere T, South M, Mays LZ, Shernoff ES, Lainhart J, Modahl CB, Corsello C, Ozonoff S, Risi S, Lord C, Leventhal BL, Filipek PA. Source: Journal of the American Academy of Child and Adolescent Psychiatry. 2001 November; 40(11): 1293-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11699803&dopt=Abstract
·
Mutation analysis of the coding sequence of the MECP2 gene in infantile autism. Author(s): Beyer KS, Blasi F, Bacchelli E, Klauck SM, Maestrini E, Poustka A; International Molecular Genetic Study of Autism Consortium (IMGSAC). Source: Human Genetics. 2002 October; 111(4-5): 305-9. Epub 2002 August 14. Erratum In: Hum Genet. 2003 April; 112(4): 436. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12384770&dopt=Abstract
·
Mutation screening and imprinting analysis of four candidate genes for autism in the 7q32 region. Author(s): Bonora E, Bacchelli E, Levy ER, Blasi F, Marlow A, Monaco AP, Maestrini E; International Molecular Genetic Study of Autism Consortium (IMGSAC). Source: Molecular Psychiatry. 2002; 7(3): 289-301. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11920156&dopt=Abstract
·
Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. Author(s): Jamain S, Quach H, Betancur C, Rastam M, Colineaux C, Gillberg IC, Soderstrom H, Giros B, Leboyer M, Gillberg C, Bourgeron T; Paris Autism Research International Sibpair Study. Source: Nature Genetics. 2003 May; 34(1): 27-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12669065&dopt=Abstract
·
Naltrexone and communication skills in young children with autism. Author(s): Feldman HM, Kolmen BK, Gonzaga AM. Source: Journal of the American Academy of Child and Adolescent Psychiatry. 1999 May; 38(5): 587-93. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10230191&dopt=Abstract
Studies 123
·
Naltrexone in children with autism. Author(s): Buitelaar JK, Willemsen-Swinkels S, Van Engeland H. Source: Journal of the American Academy of Child and Adolescent Psychiatry. 1998 August; 37(8): 800-2. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9695440&dopt=Abstract
·
Negative association between MMR and autism. Author(s): DeStefano F, Chen RT. Source: Lancet. 1999 June 12; 353(9169): 1987-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10376608&dopt=Abstract
·
Neither consenting nor protesting: an ethical analysis of a man with autism. Author(s): Diesfeld K. Source: Journal of Medical Ethics. 2000 August; 26(4): 277-81. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10951924&dopt=Abstract
·
Neocortical system abnormalities in autism: an fMRI study of spatial working memory. Author(s): Luna B, Minshew NJ, Garver KE, Lazar NA, Thulborn KR, Eddy WF, Sweeney JA. Source: Neurology. 2002 September 24; 59(6): 834-40. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12297562&dopt=Abstract
·
Neural correlates of face and object recognition in young children with autism spectrum disorder, developmental delay, and typical development. Author(s): Dawson G, Carver L, Meltzoff AN, Panagiotides H, McPartland J, Webb SJ. Source: Child Development. 2002 May-June; 73(3): 700-17. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12038546&dopt=Abstract
·
Neuroanatomic contributions to slowed orienting of attention in children with autism. Author(s): Harris NS, Courchesne E, Townsend J, Carper RA, Lord C. Source: Brain Research. Cognitive Brain Research. 1999 May; 8(1): 61-71. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10216274&dopt=Abstract
·
Neuroanatomical and neurocognitive differences in a pair of monozygous twins discordant for strictly defined autism. Author(s): Kates WR, Mostofsky SH, Zimmerman AW, Mazzocco MM, Landa R, Warsofsky IS, Kaufmann WE, Reiss AL. Source: Annals of Neurology. 1998 June; 43(6): 782-91. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9629848&dopt=Abstract
124 Autism
·
Neurocognitive function and joint attention ability in young children with autism spectrum disorder versus developmental delay. Author(s): Dawson G, Munson J, Estes A, Osterling J, McPartland J, Toth K, Carver L, Abbott R. Source: Child Development. 2002 March-April; 73(2): 345-58. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11949896&dopt=Abstract
·
Neurodevelopmental processes and psychological functioning in autism. Author(s): Gillberg C. Source: Development and Psychopathology. 1999 Summer; 11(3): 567-87. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10532625&dopt=Abstract
·
Neuro-epileptic determinants of autism spectrum disorders in tuberous sclerosis complex. Author(s): Bolton PF, Park RJ, Higgins JN, Griffiths PD, Pickles A. Source: Brain; a Journal of Neurology. 2002 June; 125(Pt 6): 1247-55. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12023313&dopt=Abstract
·
Neuroimaging in autism. Author(s): Deb S, Thompson B. Source: The British Journal of Psychiatry; the Journal of Mental Science. 1998 October; 173: 299-302. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9926032&dopt=Abstract
·
Neuropathology of infantile autism. Author(s): Kemper TL, Bauman ML. Source: Molecular Psychiatry. 2002; 7 Suppl 2: S12-3. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12142934&dopt=Abstract
·
Neuropathology of infantile autism. Author(s): Kemper TL, Bauman M. Source: Journal of Neuropathology and Experimental Neurology. 1998 July; 57(7): 64552. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9690668&dopt=Abstract
·
Neuropeptides and neurotrophins in neonatal blood of children with autism or mental retardation. Author(s): Nelson KB, Grether JK, Croen LA, Dambrosia JM, Dickens BF, Jelliffe LL, Hansen RL, Phillips TM. Source: Annals of Neurology. 2001 May; 49(5): 597-606. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11357950&dopt=Abstract
Studies 125
·
Neuropeptides and social behavior: animal models relevant to autism. Author(s): Young LJ, Pitkow LJ, Ferguson JN. Source: Molecular Psychiatry. 2002; 7 Suppl 2: S38-9. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12142945&dopt=Abstract
·
Neuropsychological correlates of early symptoms of autism. Author(s): Dawson G, Meltzoff AN, Osterling J, Rinaldi J. Source: Child Development. 1998 October; 69(5): 1276-85. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9839415&dopt=Abstract
·
New centers to focus on autism and other developmental disorders. Author(s): Wakefield J. Source: Environmental Health Perspectives. 2002 January; 110(1): A20-1. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11781177&dopt=Abstract
·
New research demolishes link between MMR vaccine and autism. Author(s): Bower H. Source: Bmj (Clinical Research Ed.). 1999 June 19; 318(7199): 1643. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10373156&dopt=Abstract
·
New research on autism and measles “proves nothing”. Author(s): Eaton L. Source: Bmj (Clinical Research Ed.). 2002 February 9; 324(7333): 315. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11834548&dopt=Abstract
·
New study fails to find link between MMR and autism. Author(s): Marshall H. Source: Trends in Immunology. 2001 April; 22(4): 185. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11274921&dopt=Abstract
·
Nicotinic receptor abnormalities in the cerebellar cortex in autism. Author(s): Lee M, Martin-Ruiz C, Graham A, Court J, Jaros E, Perry R, Iversen P, Bauman M, Perry E. Source: Brain; a Journal of Neurology. 2002 July; 125(Pt 7): 1483-95. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12076999&dopt=Abstract
·
NMR intensity of corpus callosum differs with age but not with diagnosis of autism. Author(s): Belmonte M, Egaas B, Townsend J, Courchesne E. Source: Neuroreport. 1995 June 19; 6(9): 1253-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7669980&dopt=Abstract
126 Autism
·
No association between HOXA1 and HOXB1 genes and autism spectrum disorders (ASD). Author(s): Talebizadeh Z, Bittel DC, Miles JH, Takahashi N, Wang CH, Kibiryeva N, Butler MG. Source: Journal of Medical Genetics. 2002 November; 39(11): E70. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12414832&dopt=Abstract
·
No evidence for a new variant of measles-mumps-rubella-induced autism. Author(s): Fombonne E, Chakrabarti S. Source: Pediatrics. 2001 October; 108(4): E58. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11581466&dopt=Abstract
·
No evidence for linkage of liability to autism to HOXA1 in a sample from the CPEA network. Author(s): Devlin B, Bennett P, Cook EH Jr, Dawson G, Gonen D, Grigorenko EL, McMahon W, Pauls D, Smith M, Spence MA, Schellenberg GD; CPEA Genetics Network. Collaborative Programs of Excellence in Austism. Source: American Journal of Medical Genetics. 2002 August 8; 114(6): 667-72. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12210285&dopt=Abstract
·
No evidence for measles, mumps, and rubella vaccine-associated inflammatory bowel disease or autism in a 14-year prospective study. Author(s): Peltola H, Patja A, Leinikki P, Valle M, Davidkin I, Paunio M. Source: Lancet. 1998 May 2; 351(9112): 1327-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9643797&dopt=Abstract
·
Non-significance of early speech delay in children with autism and normal intelligence and implications for DSM-IV Asperger's disorder. Author(s): Mayes SD, Calhoun SL. Source: Autism : the International Journal of Research and Practice. 2001 March; 5(1): 8194. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11708393&dopt=Abstract
·
Normal phospholipid-related signal transduction in autism. Author(s): Puri BK, Singh I. Source: Progress in Neuro-Psychopharmacology & Biological Psychiatry. 2002 December; 26(7-8): 1405-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12502030&dopt=Abstract
Studies 127
·
Obsessive compulsive behaviour in autism--towards an autistic-obsessive compulsive syndrome? Author(s): Gross-Isseroff R, Hermesh H, Weizman A. Source: World J Biol Psychiatry. 2001 October; 2(4): 193-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12587149&dopt=Abstract
·
Obsessive-compulsive behaviors in parents of multiplex autism families. Author(s): Hollander E, King A, Delaney K, Smith CJ, Silverman JM. Source: Psychiatry Research. 2003 January 25; 117(1): 11-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12581816&dopt=Abstract
·
Obstetric complications in autism: consequences or causes of the condition? Author(s): Bolton PF, Murphy M, Macdonald H, Whitlock B, Pickles A, Rutter M. Source: Journal of the American Academy of Child and Adolescent Psychiatry. 1997 February; 36(2): 272-81. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9031581&dopt=Abstract
·
Obstetric factors in Asperger syndrome: comparison with high-functioning autism. Author(s): Ghaziuddin M, Shakal J, Tsai L. Source: Journal of Intellectual Disability Research : Jidr. 1995 December; 39 ( Pt 6): 53843. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8746742&dopt=Abstract
·
Obstetrical suboptimality in children with autism: an Italian sample. Author(s): Zambrino CA, Balottin U, Bettaglio E, Gerardo A, Lanzi G. Source: Journal of Autism and Developmental Disorders. 1995 October; 25(5): 553-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8567599&dopt=Abstract
·
Oculomotor evidence for neocortical systems but not cerebellar dysfunction in autism. Author(s): Minshew NJ, Luna B, Sweeney JA. Source: Neurology. 1999 March 23; 52(5): 917-22. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10102406&dopt=Abstract
·
On cognitive variability in velocardiofacial syndrome: profound mental retardation and autism. Author(s): Kozma C. Source: American Journal of Medical Genetics. 1998 May 8; 81(3): 269-70. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9603617&dopt=Abstract
128 Autism
·
On developing self-concepts: a controlled study of children and adolescents with autism. Author(s): Lee A, Hobson RP. Source: Journal of Child Psychology and Psychiatry, and Allied Disciplines. 1998 November; 39(8): 1131-44. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9844983&dopt=Abstract
·
On the twin risk in autism. Author(s): Hallmayer J, Glasson EJ, Bower C, Petterson B, Croen L, Grether J, Risch N. Source: American Journal of Human Genetics. 2002 October; 71(4): 941-6. Epub 2002 September 12. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12297988&dopt=Abstract
·
Open-label risperidone treatment of 6 children and adolescents with autism. Author(s): Vercellino F, Zanotto E, Ravera G, Veneselli E. Source: Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 2001 August; 46(6): 559-60. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11526814&dopt=Abstract
·
Opioid peptides and dipeptidyl peptidase in autism. Author(s): Hunter LC, O'Hare A, Herron WJ, Fisher LA, Jones GE. Source: Developmental Medicine and Child Neurology. 2003 February; 45(2): 121-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12578238&dopt=Abstract
·
Opioid-immune interactions in autism: behavioural and immunological assessment during a double-blind treatment with naltrexone. Author(s): Scifo R, Cioni M, Nicolosi A, Batticane N, Tirolo C, Testa N, Quattropani MC, Morale MC, Gallo F, Marchetti B. Source: Ann Ist Super Sanita. 1996; 32(3): 351-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9028057&dopt=Abstract
·
Oral famotidine: a potential treatment for children with autism. Author(s): Linday LA. Source: Medical Hypotheses. 1997 May; 48(5): 381-6. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9185122&dopt=Abstract
·
Our grandson has autism. What do we do? Author(s): Harris SL. Source: Journal of Autism and Developmental Disorders. 2002 April; 32(2): 147. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12058844&dopt=Abstract
Studies 129
·
Outcome in high-functioning adults with autism with and without early language delays: implications for the differentiation between autism and Asperger syndrome. Author(s): Howlin P. Source: Journal of Autism and Developmental Disorders. 2003 February; 33(1): 3-13. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12708575&dopt=Abstract
·
Outcome research in Asperger syndrome and autism. Author(s): Tsatsanis KD. Source: Child Adolesc Psychiatr Clin N Am. 2003 January; 12(1): 47-63, Vi. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12512398&dopt=Abstract
·
Outcome survey of early intensive behavioral intervention for young children with autism in a community setting. Author(s): Boyd RD, Corley MJ. Source: Autism : the International Journal of Research and Practice. 2001 December; 5(4): 430-41. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11777258&dopt=Abstract
·
Overly literal interpretations of speech in autism: understanding that messages arise from minds. Author(s): Mitchell P, Saltmarsh R, Russell H. Source: Journal of Child Psychology and Psychiatry, and Allied Disciplines. 1997 September; 38(6): 685-91. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9315978&dopt=Abstract
·
Oxytocin, vasopressin, and autism: is there a connection? Author(s): Insel TR, O'Brien DJ, Leckman JF. Source: Biological Psychiatry. 1999 January 15; 45(2): 145-57. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9951561&dopt=Abstract
·
Parent and professional agreement on cognitive level of children with autism. Author(s): Geiger DM, Smith DT, Creaghead NA. Source: Journal of Autism and Developmental Disorders. 2002 August; 32(4): 307-12. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12199135&dopt=Abstract
·
Parent-mediated early intervention for young children with autism spectrum disorder. Author(s): Diggle T, McConachie HR, Randle VR. Source: Cochrane Database Syst Rev. 2003; (1): Cd003496. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12535477&dopt=Abstract
130 Autism
·
Past and future perspectives in autism epidemiology. Author(s): Yeargin-Allsopp M. Source: Molecular Psychiatry. 2002; 7 Suppl 2: S9-S11. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12142933&dopt=Abstract
·
Pathophysiological role of nitric oxide and adrenomedullin in autism. Author(s): Zoroglu SS, Yurekli M, Meram I, Sogut S, Tutkun H, Yetkin O, Sivasli E, Savas HA, Yanik M, Herken H, Akyol O. Source: Cell Biochemistry and Function. 2003 March; 21(1): 55-60. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12579522&dopt=Abstract
·
Pattern of semantic errors in autism: a brief research report. Author(s): Vogindroukas I, Papageorgiou V, Vostanis P. Source: Autism : the International Journal of Research and Practice. 2003 June; 7(2): 195203. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12846387&dopt=Abstract
·
Perinatal complications as predictors of infantile autism. Author(s): Wilkerson DS, Volpe AG, Dean RS, Titus JB. Source: The International Journal of Neuroscience. 2002 September; 112(9): 1085-98. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12487097&dopt=Abstract
·
Perinatal risk factors for infantile autism. Author(s): Hultman CM, Sparen P, Cnattingius S. Source: Epidemiology (Cambridge, Mass.). 2002 July; 13(4): 417-23. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12094096&dopt=Abstract
·
Pitch memory, labelling and disembedding in autism. Author(s): Heaton P. Source: Journal of Child Psychology and Psychiatry, and Allied Disciplines. 2003 May; 44(4): 543-51. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12751846&dopt=Abstract
·
Plasma amino acid levels in children with autism and their families. Author(s): Aldred S, Moore KM, Fitzgerald M, Waring RH. Source: Journal of Autism and Developmental Disorders. 2003 February; 33(1): 93-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12708584&dopt=Abstract
Studies 131
·
Plasma androgens in autism. Author(s): Tordjman S, Anderson GM, McBride PA, Hertzig ME, Snow ME, Hall LM, Ferrari P, Cohen DJ. Source: Journal of Autism and Developmental Disorders. 1995 June; 25(3): 295-304. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7559294&dopt=Abstract
·
Postmortem brain abnormalities of the glutamate neurotransmitter system in autism. Author(s): Purcell AE, Jeon OH, Zimmerman AW, Blue ME, Pevsner J. Source: Neurology. 2001 November 13; 57(9): 1618-28. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11706102&dopt=Abstract
·
Practice and serial reaction time of adolescents with autism. Author(s): Inui N, Suzuki K. Source: Percept Mot Skills. 1998 April; 86(2): 403-10. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9638741&dopt=Abstract
·
Predicting language outcome in infants with autism and pervasive developmental disorder. Author(s): Charman T, Baron-Cohen S, Swettenham J, Baird G, Drew A, Cox A. Source: International Journal of Language & Communication Disorders / Royal College of Speech & Language Therapists. 2003 July-September; 38(3): 265-85. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12851079&dopt=Abstract
·
Predictors of outcome among high functioning children with autism and Asperger syndrome. Author(s): Szatmari P, Bryson SE, Boyle MH, Streiner DL, Duku E. Source: Journal of Child Psychology and Psychiatry, and Allied Disciplines. 2003 May; 44(4): 520-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12751844&dopt=Abstract
·
Pregnancy and birth complications in autism and liability to the broader autism phenotype. Author(s): Zwaigenbaum L, Szatmari P, Jones MB, Bryson SE, MacLean JE, Mahoney WJ, Bartolucci G, Tuff L. Source: Journal of the American Academy of Child and Adolescent Psychiatry. 2002 May; 41(5): 572-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12014790&dopt=Abstract
132 Autism
·
Presence of large deletions in kindreds with autism. Author(s): Yu CE, Dawson G, Munson J, D'Souza I, Osterling J, Estes A, Leutenegger AL, Flodman P, Smith M, Raskind WH, Spence MA, McMahon W, Wijsman EM, Schellenberg GD. Source: American Journal of Human Genetics. 2002 July; 71(1): 100-15. Epub 2002 June 07. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12058345&dopt=Abstract
·
Prevalence and patterns of use of psychoactive medicines in individuals with autism in the Autism Society of North Carolina. Author(s): Langworthy-Lam KS, Aman MG, Van Bourgondien ME. Source: Journal of Child and Adolescent Psychopharmacology. 2002 Winter; 12(4): 31121. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12625991&dopt=Abstract
·
Prevalence of autism and parentally reported triggers in a north east London population. Author(s): Lingam R, Simmons A, Andrews N, Miller E, Stowe J, Taylor B. Source: Archives of Disease in Childhood. 2003 August; 88(8): 666-70. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12876158&dopt=Abstract
·
Prevalence of autism in a United States population: the Brick Township, New Jersey, investigation. Author(s): Bertrand J, Mars A, Boyle C, Bove F, Yeargin-Allsopp M, Decoufle P. Source: Pediatrics. 2001 November; 108(5): 1155-61. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11694696&dopt=Abstract
·
Prevalence of autism in a US metropolitan area. Author(s): Yeargin-Allsopp M, Rice C, Karapurkar T, Doernberg N, Boyle C, Murphy C. Source: Jama : the Journal of the American Medical Association. 2003 January 1; 289(1): 49-55. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12503976&dopt=Abstract
·
Prevalence of chronic gastrointestinal symptoms in children with autism and autistic spectrum disorders. Author(s): Molloy CA, Manning-Courtney P. Source: Autism : the International Journal of Research and Practice. 2003 June; 7(2): 16571. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12846385&dopt=Abstract
Studies 133
·
Priapism associated with trazodone in an adolescent with autism. Author(s): Kem DL, Posey DJ, McDougle CJ. Source: Journal of the American Academy of Child and Adolescent Psychiatry. 2002 July; 41(7): 758. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12108798&dopt=Abstract
·
Problem behavior interventions for young children with autism: a research synthesis. Author(s): Horner RH, Carr EG, Strain PS, Todd AW, Reed HK. Source: Journal of Autism and Developmental Disorders. 2002 October; 32(5): 423-46. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12463518&dopt=Abstract
·
Progress and outcomes for children with autism receiving parent-managed intensive interventions. Author(s): Bibby P, Eikeseth S, Martin NT, Mudford OC, Reeves D. Source: Research in Developmental Disabilities. 2002 January-February; 23(1): 81-104. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12071397&dopt=Abstract
·
Proinflammatory and regulatory cytokine production associated with innate and adaptive immune responses in children with autism spectrum disorders and developmental regression. Author(s): Jyonouchi H, Sun S, Le H. Source: Journal of Neuroimmunology. 2001 November 1; 120(1-2): 170-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11694332&dopt=Abstract
·
Prospective preliminary analysis of the development of autism and epilepsy in children with infantile spasms. Author(s): Askalan R, Mackay M, Brian J, Otsubo H, McDermott C, Bryson S, Boyd J, Snead C 3rd, Roberts W, Weiss S. Source: Journal of Child Neurology. 2003 March; 18(3): 165-70. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12731640&dopt=Abstract
·
Psychosocial functioning in a group of Swedish adults with Asperger syndrome or high-functioning autism. Author(s): Engstrom I, Ekstrom L, Emilsson B. Source: Autism : the International Journal of Research and Practice. 2003 March; 7(1): 99110. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12638767&dopt=Abstract
·
Purkinje cell size is reduced in cerebellum of patients with autism. Author(s): Fatemi SH, Halt AR, Realmuto G, Earle J, Kist DA, Thuras P, Merz A. Source: Cellular and Molecular Neurobiology. 2002 April; 22(2): 171-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12363198&dopt=Abstract
134 Autism
·
Purkinje cell vulnerability and autism: a possible etiological connection. Author(s): Kinnear Kern J. Source: Brain & Development. 2003 September; 25(6): 377-82. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12907269&dopt=Abstract
·
Pursuing the puzzle of autism. Author(s): Gross M. Source: Current Biology : Cb. 2002 October 15; 12(20): R679. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12401179&dopt=Abstract
·
QEEG assisted neuropsychological evaluation of autism. Author(s): Harrison DW, Demaree HA, Shenal BV, Everhart DE. Source: The International Journal of Neuroscience. 1998 February; 93(1-2): 133-40. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9604175&dopt=Abstract
·
Quantifying dimensions in autism: a factor-analytic study. Author(s): Szatmari P, Merette C, Bryson SE, Thivierge J, Roy MA, Cayer M, Maziade M. Source: Journal of the American Academy of Child and Adolescent Psychiatry. 2002 April; 41(4): 467-74. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11931604&dopt=Abstract
·
Quantifying the phenotype in autism spectrum disorders. Author(s): Lord C, Leventhal BL, Cook EH Jr. Source: American Journal of Medical Genetics. 2001 January 8; 105(1): 36-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11424991&dopt=Abstract
·
Quantitative magnetic resonance imaging in autism: the cerebellar vermis. Author(s): Filipek PA. Source: Current Opinion in Neurology. 1995 April; 8(2): 134-8. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7620587&dopt=Abstract
·
Race differences in the age at diagnosis among medicaid-eligible children with autism. Author(s): Mandell DS, Listerud J, Levy SE, Pinto-Martin JA. Source: Journal of the American Academy of Child and Adolescent Psychiatry. 2002 December; 41(12): 1447-53. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12447031&dopt=Abstract
·
Random number generation in autism. Author(s): Williams MA, Moss SA, Bradshaw JL, Rinehart NJ. Source: Journal of Autism and Developmental Disorders. 2002 February; 32(1): 43-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11916332&dopt=Abstract
Studies 135
·
Rapid eye movement sleep behavior disorder in children with autism. Author(s): Thirumalai SS, Shubin RA, Robinson R. Source: Journal of Child Neurology. 2002 March; 17(3): 173-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12026231&dopt=Abstract
·
Re: Secretin and autism: a two-part clinical investigation. Author(s): Clark CE. Source: Journal of Autism and Developmental Disorders. 2001 April; 31(2): 248-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11450825&dopt=Abstract
·
Reading the mind in the voice: a study with normal adults and adults with Asperger syndrome and high functioning autism. Author(s): Rutherford MD, Baron-Cohen S, Wheelwright S. Source: Journal of Autism and Developmental Disorders. 2002 June; 32(3): 189-94. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12108620&dopt=Abstract
·
Recall bias, MMR, and autism. Author(s): Andrews N, Miller E, Taylor B, Lingam R, Simmons A, Stowe J, Waight P. Source: Archives of Disease in Childhood. 2002 December; 87(6): 493-4. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12456546&dopt=Abstract
·
Reduced thalamic volume in high-functioning individuals with autism. Author(s): Tsatsanis KD, Rourke BP, Klin A, Volkmar FR, Cicchetti D, Schultz RT. Source: Biological Psychiatry. 2003 January 15; 53(2): 121-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12547467&dopt=Abstract
·
Reducing disruptive behavior of a group-home resident with autism and mental retardation. Author(s): Reese RM, Sherman JA, Sheldon JB. Source: Journal of Autism and Developmental Disorders. 1998 April; 28(2): 159-65. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9586778&dopt=Abstract
·
Reelin gene alleles and susceptibility to autism spectrum disorders. Author(s): Zhang H, Liu X, Zhang C, Mundo E, Macciardi F, Grayson DR, Guidotti AR, Holden JJ. Source: Molecular Psychiatry. 2002; 7(9): 1012-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12399956&dopt=Abstract
136 Autism
·
Reelin mutations in mouse and man: from reeler mouse to schizophrenia, mood disorders, autism and lissencephaly. Author(s): Fatemi SH. Source: Molecular Psychiatry. 2001 March; 6(2): 129-33. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11317213&dopt=Abstract
·
Regional brain chemical alterations in young children with autism spectrum disorder. Author(s): Friedman SD, Shaw DW, Artru AA, Richards TL, Gardner J, Dawson G, Posse S, Dager SR. Source: Neurology. 2003 January 14; 60(1): 100-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12525726&dopt=Abstract
·
Regional meta-analysis of published data supports linkage of autism with markers on chromosome 7. Author(s): Badner JA, Gershon ES. Source: Molecular Psychiatry. 2002; 7(1): 56-66. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11803446&dopt=Abstract
·
Relation of childhood gastrointestinal disorders to autism: nested case-control study using data from the UK General Practice Research Database. Author(s): Black C, Kaye JA, Jick H. Source: Bmj (Clinical Research Ed.). 2002 August 24; 325(7361): 419-21. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12193358&dopt=Abstract
·
Relation of the childhood autism rating scale-parent version to diagnosis, stress, and age. Author(s): Tobing LE, Glenwick DS. Source: Research in Developmental Disabilities. 2002 May-June; 23(3): 211-23. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12102589&dopt=Abstract
·
Repeated doses of porcine secretin in the treatment of autism: a randomized, placebocontrolled trial. Author(s): Roberts W, Weaver L, Brian J, Bryson S, Emelianova S, Griffiths AM, MacKinnon B, Yim C, Wolpin J, Koren G. Source: Pediatrics. 2001 May; 107(5): E71. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11331721&dopt=Abstract
·
Research in brief: what do medical students know about autism? Author(s): Shah K. Source: Autism : the International Journal of Research and Practice. 2001 June; 5(2): 12733. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11706861&dopt=Abstract
Studies 137
·
Research into early intervention for children with autism and related disorders: methodological and design issues. Report on a workshop funded by the Wellcome Trust, Institute of Child Health, London, UK, November 2001. Author(s): Charman T, Howlin P, Aldred C, Baird G, Degli Espinosa F, Diggle T, Kovshoff H, Law J, Le Couteur A, MacNiven J, Magiati I, Martin N, McConachie H, Peacock S, Pickles A, Randle V, Slonims V, Wolke D. Source: Autism : the International Journal of Research and Practice. 2003 June; 7(2): 21725. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12846389&dopt=Abstract
·
Research strategies in autism: a story with two sides. Author(s): Caviness VS. Source: Current Opinion in Neurology. 2001 April; 14(2): 141-3. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11262726&dopt=Abstract
·
Review article: the concept of entero-colonic encephalopathy, autism and opioid receptor ligands. Author(s): Wakefield AJ, Puleston JM, Montgomery SM, Anthony A, O'Leary JJ, Murch SH. Source: Alimentary Pharmacology & Therapeutics. 2002 April; 16(4): 663-74. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11929383&dopt=Abstract
·
Risperidone improves behavior in children with autism. Author(s): Caicedo C, Williams SH. Source: The Journal of Family Practice. 2002 November; 51(11): 915. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12485538&dopt=Abstract
·
Risperidone in children with autism and serious behavioral problems. Author(s): Munarriz R, Bennett L, Goldstein I. Source: The New England Journal of Medicine. 2002 December 5; 347(23): 1890-1; Author Reply 1890-1. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12472072&dopt=Abstract
·
Risperidone in children with autism and serious behavioral problems. Author(s): Valiquette G. Source: The New England Journal of Medicine. 2002 December 5; 347(23): 1890-1; Author Reply 1890-1. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12472071&dopt=Abstract
138 Autism
·
Risperidone in children with autism and serious behavioral problems. Author(s): Sandler L. Source: The New England Journal of Medicine. 2002 December 5; 347(23): 1890-1; Author Reply 1890-1. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12466518&dopt=Abstract
·
Risperidone in children with autism and serious behavioral problems. Author(s): McCracken JT, McGough J, Shah B, Cronin P, Hong D, Aman MG, Arnold LE, Lindsay R, Nash P, Hollway J, McDougle CJ, Posey D, Swiezy N, Kohn A, Scahill L, Martin A, Koenig K, Volkmar F, Carroll D, Lancor A, Tierney E, Ghuman J, Gonzalez NM, Grados M, Vitiello B, Ritz L, Davies M, Robinson J, McMahon D; Research Units on Pediatric Psychopharmacology Autism Network. Source: The New England Journal of Medicine. 2002 August 1; 347(5): 314-21. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12151468&dopt=Abstract
·
Risperidone treatment in children and adolescents with autism: short- and long-term safety and effectiveness. Author(s): Malone RP, Maislin G, Choudhury MS, Gifford C, Delaney MA. Source: Journal of the American Academy of Child and Adolescent Psychiatry. 2002 February; 41(2): 140-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11837403&dopt=Abstract
·
Risperidone: a potential treatment for autism. Author(s): Posey DJ, McDougle CJ. Source: Curr Opin Investig Drugs. 2002 August; 3(8): 1212-6. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12211417&dopt=Abstract
·
Role of altered brain serotonin mechanisms in autism. Author(s): Chugani DC. Source: Molecular Psychiatry. 2002; 7 Suppl 2: S16-7. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12142936&dopt=Abstract
·
Role of the serotonin transporter gene in the behavioral expression of autism. Author(s): Tordjman S, Gutknecht L, Carlier M, Spitz E, Antoine C, Slama F, Carsalade V, Cohen DJ, Ferrari P, Roubertoux PL, Anderson GM. Source: Molecular Psychiatry. 2001 July; 6(4): 434-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11443529&dopt=Abstract
Studies 139
·
Routine cytogenetic and FISH studies for 17p11/15q11 duplications and subtelomeric rearrangement studies in children with autism spectrum disorders. Author(s): Keller K, Williams C, Wharton P, Paulk M, Bent-Williams A, Gray B, Ward A, Stalker H, Wallace M, Carter R, Zori R. Source: American Journal of Medical Genetics. 2003 March 1; 117A(2): 105-11. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12567405&dopt=Abstract
·
Scottish expert group finds no link between MMR and autism. Author(s): Christie B. Source: Bmj (Clinical Research Ed.). 2002 May 11; 324(7346): 1118. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12008724&dopt=Abstract
·
Screening young children for autism and other social-communication disorders. Author(s): Blackwell PB. Source: J Ky Med Assoc. 2002 September; 100(9): 390-4. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12357915&dopt=Abstract
·
Screening young children for autism. Author(s): Tanguay PE. Source: J Ky Med Assoc. 2002 November; 100(11): 506. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12455459&dopt=Abstract
·
Screening young people for autism with the developmental behavior checklist. Author(s): Brereton AV, Tonge BJ, Mackinnon AJ, Einfeld SL. Source: Journal of the American Academy of Child and Adolescent Psychiatry. 2002 November; 41(11): 1369-75. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12410080&dopt=Abstract
·
Secretin and sleep in children with autism. Author(s): Honomichl RD, Goodlin-Jones BL, Burnham MM, Hansen RL, Anders TF. Source: Child Psychiatry and Human Development. 2002 Winter; 33(2): 107-23. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12462350&dopt=Abstract
·
Secretin for the treatment of autism. Author(s): McQueen JM, Heck AM. Source: The Annals of Pharmacotherapy. 2002 February; 36(2): 305-11. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11847953&dopt=Abstract
140 Autism
·
Sensitivity and specificity of the autism diagnostic inventory-telephone screening in Spanish. Author(s): Vrancic D, Nanclares V, Soares D, Kulesz A, Mordzinski C, Plebst C, Starkstein S. Source: Journal of Autism and Developmental Disorders. 2002 August; 32(4): 313-20. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12199136&dopt=Abstract
·
Serotonin transporter promoter variants in autism: functional effects and relationship to platelet hyperserotonemia. Author(s): Anderson GM, Gutknecht L, Cohen DJ, Brailly-Tabard S, Cohen JH, Ferrari P, Roubertoux PL, Tordjman S. Source: Molecular Psychiatry. 2002; 7(8): 831-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12232775&dopt=Abstract
·
Service evaluation of an autism diagnostic clinic for children. Author(s): Kerrell H. Source: Nurs Stand. 2001 June 6-12; 15(38): 33-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12205772&dopt=Abstract
·
Shape constancy in autism: the role of prior knowledge and perspective cues. Author(s): Ropar D, Mitchell P. Source: Journal of Child Psychology and Psychiatry, and Allied Disciplines. 2002 July; 43(5): 647-53. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12120860&dopt=Abstract
·
Sharing humour and laughter in autism and Down's syndrome. Author(s): Reddy V, Williams E, Vaughan A. Source: The British Journal of Psychology. 2002 May; 93(Pt 2): 219-42. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12031149&dopt=Abstract
·
Shifting attention and joint attention dissociation in Williams syndrome: implications for the cerebellum and social deficits in autism. Author(s): Lincoln A, Lai Z, Jones W. Source: Neurocase : Case Studies in Neuropsychology, Neuropsychiatry, and Behavioural Neurology. 2002; 8(3): 226-32. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12119319&dopt=Abstract
·
Small intestinal enteropathy with epithelial IgG and complement deposition in children with regressive autism. Author(s): Torrente F, Ashwood P, Day R, Machado N, Furlano RI, Anthony A, Davies SE, Wakefield AJ, Thomson MA, Walker-Smith JA, Murch SH. Source: Molecular Psychiatry. 2002; 7(4): 375-82, 334. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11986981&dopt=Abstract
Studies 141
·
Social and cardiac responses of young children with autism. Author(s): Sigman M, Dissanayake C, Corona R, Espinosa M. Source: Autism : the International Journal of Research and Practice. 2003 June; 7(2): 20516. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12846388&dopt=Abstract
·
Social interactions of children with autism in father-child and mother-child play sessions. Author(s): Elder JH, Valcante G, Groce S, Yarandi H, Carlton MS. Source: Pediatric Nursing. 2002 November-December; 28(6): 573-8, 581. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12593342&dopt=Abstract
·
Social interest and the development of cortical face specialization: what autism teaches us about face processing. Author(s): Grelotti DJ, Gauthier I, Schultz RT. Source: Developmental Psychobiology. 2002 April; 40(3): 213-25. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11891634&dopt=Abstract
·
Social skills interventions for the autism spectrum: essential ingredients and a model curriculum. Author(s): Krasny L, Williams BJ, Provencal S, Ozonoff S. Source: Child Adolesc Psychiatr Clin N Am. 2003 January; 12(1): 107-22. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12512401&dopt=Abstract
·
Social timing, clock genes and autism: a new hypothesis. Author(s): Wimpory D, Nicholas B, Nash S. Source: Journal of Intellectual Disability Research : Jidr. 2002 May; 46(Pt 4): 352-8. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12000587&dopt=Abstract
·
Social understanding in autism: eye gaze as a measure of core insights. Author(s): Ruffman T, Garnham W, Rideout P. Source: Journal of Child Psychology and Psychiatry, and Allied Disciplines. 2001 November; 42(8): 1083-94. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11806690&dopt=Abstract
·
Sodium channels SCN1A, SCN2A and SCN3A in familial autism. Author(s): Weiss LA, Escayg A, Kearney JA, Trudeau M, MacDonald BT, Mori M, Reichert J, Buxbaum JD, Meisler MH. Source: Molecular Psychiatry. 2003 February; 8(2): 186-94. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12610651&dopt=Abstract
142 Autism
·
Spatial reversal as a measure of executive functioning in children with autism. Author(s): Coldren JT, Halloran C. Source: The Journal of Genetic Psychology; Child Behavior, Animal Behavior, and Comparative Psychology. 2003 March; 164(1): 29-41. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12693742&dopt=Abstract
·
Specificity of cerebellar vermian abnormalities in autism: a quantitative magnetic resonance imaging study. Author(s): Kaufmann WE, Cooper KL, Mostofsky SH, Capone GT, Kates WR, Newschaffer CJ, Bukelis I, Stump MH, Jann AE, Lanham DC. Source: Journal of Child Neurology. 2003 July; 18(7): 463-70. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12940651&dopt=Abstract
·
Speech-sound-selective auditory impairment in children with autism: they can perceive but do not attend. Author(s): Ceponiene R, Lepisto T, Shestakova A, Vanhala R, Alku P, Naatanen R, Yaguchi K. Source: Proceedings of the National Academy of Sciences of the United States of America. 2003 April 29; 100(9): 5567-72. Epub 2003 Apr 17. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12702776&dopt=Abstract
·
Strategies for pharmacologic treatment of high functioning autism and Asperger syndrome. Author(s): Towbin KE. Source: Child Adolesc Psychiatr Clin N Am. 2003 January; 12(1): 23-45. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12512397&dopt=Abstract
·
Structural and functional magnetic resonance imaging of autism. Author(s): Cody H, Pelphrey K, Piven J. Source: International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience. 2002 June-August; 20(3-5): 42138. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12175882&dopt=Abstract
·
Supporting families of preschool children with autism: what parents want and what helps. Author(s): Whitaker P. Source: Autism : the International Journal of Research and Practice. 2002 December; 6(4): 411-26. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12540131&dopt=Abstract
Studies 143
·
Supratentorial tuber location and autism in tuberous sclerosis complex. Author(s): Walz NC, Byars AW, Egelhoff JC, Franz DN. Source: Journal of Child Neurology. 2002 November; 17(11): 830-2. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12585723&dopt=Abstract
·
Symptom domains in autism and related conditions: evidence for familiality. Author(s): Silverman JM, Smith CJ, Schmeidler J, Hollander E, Lawlor BA, Fitzgerald M, Buxbaum JD, Delaney K, Galvin P; Autism Genetic Research Exchange Consortium. Source: American Journal of Medical Genetics. 2002 January 8; 114(1): 64-73. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11840508&dopt=Abstract
·
Targeted treatments for symptom domains in child and adolescent autism. Author(s): Hollander E, Phillips AT, Yeh CC. Source: Lancet. 2003 August 30; 362(9385): 732-4. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12957098&dopt=Abstract
·
The autism “epidemic”: impressions from the perspective of immunization safety review. Author(s): McCormick MC. Source: Ambulatory Pediatrics : the Official Journal of the Ambulatory Pediatric Association. 2003 May-June; 3(3): 119-20. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12708887&dopt=Abstract
·
The causes of autism spectrum disorders. Author(s): Szatmari P. Source: Bmj (Clinical Research Ed.). 2003 January 25; 326(7382): 173-4. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12543815&dopt=Abstract
·
The communicative use of pointing in autism: developmental profile and factors related to change. Author(s): Camaioni L, Perucchini P, Muratori F, Parrini B, Cesari A. Source: European Psychiatry : the Journal of the Association of European Psychiatrists. 2003 February; 18(1): 6-12. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12648889&dopt=Abstract
·
The development and maintenance of friendship in high-functioning children with autism: maternal perceptions. Author(s): Bauminger N, Shulman C. Source: Autism : the International Journal of Research and Practice. 2003 March; 7(1): 8197. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12638766&dopt=Abstract
144 Autism
·
The effects of differential and lag reinforcement schedules on varied verbal responding by individuals with autism. Author(s): Lee R, McComas JJ, Jawor J. Source: J Appl Behav Anal. 2002 Winter; 35(4): 391-402. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12555910&dopt=Abstract
·
The ethics of autism: what's wrong with the dominant paradigms and how to fix them. Author(s): Beals KP. Source: Mental Retardation and Developmental Disabilities Research Reviews. 2003; 9(1): 32-9. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12587136&dopt=Abstract
·
The impact of the legal system on educational programming for young children with autism spectrum disorder. Author(s): Mandlawitz MR. Source: Journal of Autism and Developmental Disorders. 2002 October; 32(5): 495-508. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12463522&dopt=Abstract
·
The metabotropic glutamate receptor 8 gene at 7q31: partial duplication and possible association with autism. Author(s): Serajee FJ, Zhong H, Nabi R, Huq AH. Source: Journal of Medical Genetics. 2003 April; 40(4): E42. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12676915&dopt=Abstract
·
The neurobeachin gene is disrupted by a translocation in a patient with idiopathic autism. Author(s): Castermans D, Wilquet V, Parthoens E, Huysmans C, Steyaert J, Swinnen L, Fryns JP, Van de Ven W, Devriendt K. Source: Journal of Medical Genetics. 2003 May; 40(5): 352-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12746398&dopt=Abstract
·
The neurobiology of autism: new pieces of the puzzle. Author(s): Acosta MT, Pearl PL. Source: Curr Neurol Neurosci Rep. 2003 March; 3(2): 149-56. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12583844&dopt=Abstract
Studies 145
·
The Parent Interview for Autism-Clinical Version (PIA-CV): a measure of behavioral change for young children with autism. Author(s): Stone WL, Coonrod EE, Pozdol SL, Turner LM. Source: Autism : the International Journal of Research and Practice. 2003 March; 7(1): 930. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12638762&dopt=Abstract
·
The pathogenesis of autism: insights from congenital blindness. Author(s): Hobson RP, Bishop M. Source: Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences. 2003 February 28; 358(1430): 335-44. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12639331&dopt=Abstract
·
The prevalence of autism spectrum disorders. Recent evidence and future challenges. Author(s): Charman T. Source: European Child & Adolescent Psychiatry. 2002 December; 11(6): 249-56. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12541002&dopt=Abstract
·
The prevalence of autism. Author(s): Fombonne E. Source: Jama : the Journal of the American Medical Association. 2003 January 1; 289(1): 87-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12503982&dopt=Abstract
·
The reach-to-grasp movement in children with autism spectrum disorder. Author(s): Mari M, Castiello U, Marks D, Marraffa C, Prior M. Source: Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences. 2003 February 28; 358(1430): 393-403. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12639336&dopt=Abstract
·
The relation between general cognitive level and adaptive behavior domains in individuals with autism with and without co-morbid mental retardation. Author(s): Bolte S, Poustka F. Source: Child Psychiatry and Human Development. 2002 Winter; 33(2): 165-72. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12462353&dopt=Abstract
·
The role of cellular secretion in autism spectrum disorders: a unifying hypothesis. Author(s): Bolte ER. Source: Medical Hypotheses. 2003 January; 60(1): 119-22. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12450778&dopt=Abstract
146 Autism
·
The role of the fusiform face area in social cognition: implications for the pathobiology of autism. Author(s): Schultz RT, Grelotti DJ, Klin A, Kleinman J, Van der Gaag C, Marois R, Skudlarski P. Source: Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences. 2003 February 28; 358(1430): 415-27. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12639338&dopt=Abstract
·
The Son-Rise Program intervention for autism: an investigation into family experiences. Author(s): Williams KR, Wishart JG. Source: Journal of Intellectual Disability Research : Jidr. 2003 May-June; 47(Pt 4-5): 291-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12787161&dopt=Abstract
·
The systemizing quotient: an investigation of adults with Asperger syndrome or high-functioning autism, and normal sex differences. Author(s): Baron-Cohen S, Richler J, Bisarya D, Gurunathan N, Wheelwright S. Source: Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences. 2003 February 28; 358(1430): 361-74. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12639333&dopt=Abstract
·
Thimerosal and autism? Author(s): Nelson KB, Bauman ML. Source: Pediatrics. 2003 March; 111(3): 674-9. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12612255&dopt=Abstract
·
Thimerosal and the occurrence of autism: negative ecological evidence from Danish population-based data. Author(s): Madsen KM, Lauritsen MB, Pedersen CB, Thorsen P, Plesner AM, Andersen PH, Mortensen PB. Source: Pediatrics. 2003 September; 112(3 Pt 1): 604-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12949291&dopt=Abstract
·
Thought-bubbles help children with autism acquire an alternative to a theory of mind. Author(s): Wellman HM, Baron-Cohen S, Caswell R, Gomez JC, Swettenham J, Toye E, Lagattuta K. Source: Autism : the International Journal of Research and Practice. 2002 December; 6(4): 343-63. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12540127&dopt=Abstract
Studies 147
·
Tourette syndrome and prognosis in autism. Author(s): Kerbeshian J, Larry B. Source: European Child & Adolescent Psychiatry. 2003 April; 12(2): 103. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12747386&dopt=Abstract
·
Treatment of aggression in children and adolescents with autism and conduct disorder. Author(s): McDougle CJ, Stigler KA, Posey DJ. Source: The Journal of Clinical Psychiatry. 2003; 64 Suppl 4: 16-25. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12672261&dopt=Abstract
·
Treatment of late onset autism as a consequence of probable autommune processes related to chronic bacterial infection. Author(s): Matarazzo EB. Source: World J Biol Psychiatry. 2002 July; 3(3): 162-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12478882&dopt=Abstract
·
Treatment of sleep problems in a 5-year-old boy with autism using behavioural principles. Author(s): Weiskop S, Matthews J, Richdale A. Source: Autism : the International Journal of Research and Practice. 2001 June; 5(2): 20921. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11706867&dopt=Abstract
·
Uncertainties in aetiology and treatment of infantile autism--assumptions and evidence. Author(s): Kotsopoulos S. Source: Medicine, Health Care, and Philosophy. 2000; 3(2): 175-8. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11079346&dopt=Abstract
·
Understanding and listening to people with autism. Author(s): Aylott J. Source: British Journal of Nursing (Mark Allen Publishing). 2001 February 8-21; 10(3): 166-72. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12170661&dopt=Abstract
·
Understanding atypical emotions among children with autism. Author(s): Rieffe C, Meerum Terwogt M, Stockmann L. Source: Journal of Autism and Developmental Disorders. 2000 June; 30(3): 195-203. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11055456&dopt=Abstract
148 Autism
·
Understanding autism. Author(s): Cowley G. Source: Newsweek. 2000 July 31; 136(5): 46-54. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11009739&dopt=Abstract
·
Understanding autism: does anyone read new medical journals? Author(s): Gordon AG. Source: Journal of Psychiatry & Neuroscience : Jpn. 1999 September; 24(4): 352-3. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10516805&dopt=Abstract
·
Understanding autism--a work in progress. Author(s): Tanguay PE. Source: Journal of Psychiatry & Neuroscience : Jpn. 1999 March; 24(2): 95-6. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10212550&dopt=Abstract
·
Understanding children with autism: exploding the myths. Author(s): Aylott J. Source: British Journal of Nursing (Mark Allen Publishing). 2000 June 22-July 12; 9(12): 779-84. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11235299&dopt=Abstract
·
Understanding embarrassment among those with autism: breaking down the complex emotion of embarrassment among those with autism. Author(s): Hillier A, Allinson L. Source: Journal of Autism and Developmental Disorders. 2002 December; 32(6): 583-92. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12553594&dopt=Abstract
·
Understanding of others' intentions in children with autism. Author(s): Carpenter M, Pennington BF, Rogers SJ. Source: Journal of Autism and Developmental Disorders. 2001 December; 31(6): 589-99. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11814270&dopt=Abstract
·
Understanding the continuum of discrete-trial traditional behavioral to socialpragmatic developmental approaches in communication enhancement for young children with autism/PDD. Author(s): Prizant BM, Wetherby AM. Source: Seminars in Speech and Language. 1998; 19(4): 329-52; Quiz 353; 424. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9857391&dopt=Abstract
Studies 149
·
Urinary levels of neopterin and biopterin in autism. Author(s): Messahel S, Pheasant AE, Pall H, Ahmed-Choudhury J, Sungum-Paliwal RS, Vostanis P. Source: Neuroscience Letters. 1998 January 23; 241(1): 17-20. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9502205&dopt=Abstract
·
US expert group rejects link between MMR and autism. Author(s): Ashraf H. Source: Lancet. 2001 April 28; 357(9265): 1341. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11343745&dopt=Abstract
·
US report finds no link between MMR and autism. Author(s): Marwick C. Source: Bmj (Clinical Research Ed.). 2001 May 5; 322(7294): 1083. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11337432&dopt=Abstract
·
Use of a GABA-transaminase agonist for treatment of infantile autism. Author(s): Cohen BI. Source: Medical Hypotheses. 2002 July; 59(1): 115-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12160695&dopt=Abstract
·
Use of fluoxetine for obsessive-compulsive behavior in adults with autism. Author(s): Koshes RJ. Source: The American Journal of Psychiatry. 1997 April; 154(4): 578. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9090351&dopt=Abstract
·
Use of secretin in the treatment of childhood autism. Author(s): Kaminska B, Czaja M, Kozielska E, Mazur E, Korzon M. Source: Medical Science Monitor : International Medical Journal of Experimental and Clinical Research. 2002 January; 8(1): Ra22-6. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11782669&dopt=Abstract
·
Using objects of obsession as token reinforcers for children with autism. Author(s): Charlop-Christy MH, Haymes LK. Source: Journal of Autism and Developmental Disorders. 1998 June; 28(3): 189-98. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9656130&dopt=Abstract
·
Using obsessions as reinforcers with and without mild reductive procedures to decrease inappropriate behaviors of children with autism. Author(s): Charlop-Christy MH, Haymes LK. Source: Journal of Autism and Developmental Disorders. 1996 October; 26(5): 527-46. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8906454&dopt=Abstract
150 Autism
·
Using participant observation to study the meaning of occupations of young children with autism and other developmental disabilities. Author(s): Spitzer SL. Source: Am J Occup Ther. 2003 January-February; 57(1): 66-76. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12549892&dopt=Abstract
·
Using tests of false belief with children with autism: how valid and reliable are they? Author(s): Grant CM, Grayson A, Boucher J. Source: Autism : the International Journal of Research and Practice. 2001 June; 5(2): 13545. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11706862&dopt=Abstract
·
Using the picture exchange communication system (PECS) with children with autism: assessment of PECS acquisition, speech, social-communicative behavior, and problem behavior. Author(s): Charlop-Christy MH, Carpenter M, Le L, LeBlanc LA, Kellet K. Source: J Appl Behav Anal. 2002 Fall; 35(3): 213-31. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12365736&dopt=Abstract
·
Utility of the Gilliam Autism Rating Scale in research and clinical populations. Author(s): South M, Williams BJ, McMahon WM, Owley T, Filipek PA, Shernoff E, Corsello C, Lainhart JE, Landa R, Ozonoff S. Source: Journal of Autism and Developmental Disorders. 2002 December; 32(6): 593-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12553595&dopt=Abstract
·
Vaccines and autism. Author(s): DeStefano F. Source: The Pediatric Infectious Disease Journal. 2001 September; 20(9): 887-8. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11734770&dopt=Abstract
·
Vaccines, Crohn's disease and autism. Author(s): Afzal MA, Minor PD. Source: Molecular Psychiatry. 2002; 7 Suppl 2: S49-50. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12142950&dopt=Abstract
·
Validity of the Autism/Pervasive Developmental Disorder subscale of the Diagnostic Assessment for the Severely Handicapped-II. Author(s): Matson JL, Smiroldo BB, Hastings TL. Source: Journal of Autism and Developmental Disorders. 1998 February; 28(1): 77-81. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9546305&dopt=Abstract
Studies 151
·
Value of a clinical morphology examination in autism. Author(s): Miles JH, Hillman RE. Source: American Journal of Medical Genetics. 2000 April 10; 91(4): 245-53. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10766977&dopt=Abstract
·
Variable expression of mental retardation, autism, seizures, and dystonic hand movements in two families with an identical ARX gene mutation. Author(s): Turner G, Partington M, Kerr B, Mangelsdorf M, Gecz J. Source: American Journal of Medical Genetics. 2002 November 1; 112(4): 405-11. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12376946&dopt=Abstract
·
Variable expression of the autism broader phenotype: findings from extended pedigrees. Author(s): Pickles A, Starr E, Kazak S, Bolton P, Papanikolaou K, Bailey A, Goodman R, Rutter M. Source: Journal of Child Psychology and Psychiatry, and Allied Disciplines. 2000 May; 41(4): 491-502. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10836679&dopt=Abstract
·
Variables related to differences in standardized test outcomes for children with autism. Author(s): Koegel LK, Koegel RL, Smith A. Source: Journal of Autism and Developmental Disorders. 1997 June; 27(3): 233-43. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9229256&dopt=Abstract
·
Varieties of repetitive behavior in autism: comparisons to mental retardation. Author(s): Bodfish JW, Symons FJ, Parker DE, Lewis MH. Source: Journal of Autism and Developmental Disorders. 2000 June; 30(3): 237-43. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11055459&dopt=Abstract
·
Venlafaxine and increased aggression in a female with autism. Author(s): Marshall BL, Napolitano DA, McAdam DB, Dunleavy III JJ, Tessing JL, Varrell J. Source: Journal of the American Academy of Child and Adolescent Psychiatry. 2003 April; 42(4): 383-4. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12649624&dopt=Abstract
·
Venlafaxine in children, adolescents, and young adults with autism spectrum disorders: an open retrospective clinical report. Author(s): Hollander E, Kaplan A, Cartwright C, Reichman D. Source: Journal of Child Neurology. 2000 February; 15(2): 132-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10695900&dopt=Abstract
152 Autism
·
Verbal association for simple common words in high-functioning autism. Author(s): Toichi M, Kamio Y. Source: Journal of Autism and Developmental Disorders. 2001 October; 31(5): 483-90. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11794413&dopt=Abstract
·
Virtual reality for autism communication and education, with lessons for medical training simulators. Author(s): Max ML, Burke JC. Source: Studies in Health Technology and Informatics. 1997; 39: 46-53. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10184722&dopt=Abstract
·
Virtual reality for the treatment of autism. Author(s): Strickland D. Source: Studies in Health Technology and Informatics. 1997; 44: 81-6. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10184809&dopt=Abstract
·
Visual attention abnormalities in autism: delayed orienting to location. Author(s): Townsend J, Harris NS, Courchesne E. Source: Journal of the International Neuropsychological Society : Jins. 1996 November; 2(6): 541-50. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9375158&dopt=Abstract
·
Visual fixation patterns during viewing of naturalistic social situations as predictors of social competence in individuals with autism. Author(s): Klin A, Jones W, Schultz R, Volkmar F, Cohen D. Source: Archives of General Psychiatry. 2002 September; 59(9): 809-16. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12215080&dopt=Abstract
·
Visual pedagogy in dentistry for children with autism. Author(s): Backman B, Pilebro C. Source: Asdc J Dent Child. 1999 September-October; 66(5): 325-31, 294. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10631888&dopt=Abstract
·
Visual recognition of biological motion is impaired in children with autism. Author(s): Blake R, Turner LM, Smoski MJ, Pozdol SL, Stone WL. Source: Psychological Science : a Journal of the American Psychological Society / Aps. 2003 March; 14(2): 151-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12661677&dopt=Abstract
Studies 153
·
Visual scanning of faces in autism. Author(s): Pelphrey KA, Sasson NJ, Reznick JS, Paul G, Goldman BD, Piven J. Source: Journal of Autism and Developmental Disorders. 2002 August; 32(4): 249-61. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12199131&dopt=Abstract
·
Visual-spatial orienting in autism. Author(s): Wainwright JA, Bryson SE. Source: Journal of Autism and Developmental Disorders. 1996 August; 26(4): 423-38. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8863093&dopt=Abstract
·
Voice processing abilities in children with autism, children with specific language impairments, and young typically developing children. Author(s): Boucher J, Lewis V, Collis GM. Source: Journal of Child Psychology and Psychiatry, and Allied Disciplines. 2000 October; 41(7): 847-57. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11079427&dopt=Abstract
·
Volumetric MRI in autism: can high-tech craniometry provide neurobiological insights? Author(s): Mink JW, McKinstry RC. Source: Neurology. 2002 July 23; 59(2): 158-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12136049&dopt=Abstract
·
Wechsler IQ profiles in diagnosis of high-functioning autism. Author(s): Siegel DJ, Minshew NJ, Goldstein G. Source: Journal of Autism and Developmental Disorders. 1996 August; 26(4): 389-406. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8863091&dopt=Abstract
·
Weight gain in a controlled study of risperidone in children, adolescents and adults with mental retardation and autism. Author(s): Hellings JA, Zarcone JR, Crandall K, Wallace D, Schroeder SR. Source: Journal of Child and Adolescent Psychopharmacology. 2001 Fall; 11(3): 229-38. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11642473&dopt=Abstract
·
What are neuropeptides and neurotrophins and why are they important in autism? Author(s): Minshew N. Source: Journal of Autism and Developmental Disorders. 2001 October; 31(5): 517. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11794417&dopt=Abstract
154 Autism
·
What do executive factors contribute to the failure on false belief tasks by children with autism? Author(s): Russell J, Saltmarsh R, Hill E. Source: Journal of Child Psychology and Psychiatry, and Allied Disciplines. 1999 September; 40(6): 859-68. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10509881&dopt=Abstract
·
What is Childhood Disintegrative Disorder, how is it different from autism, and what is believed to be its cause? Author(s): Dawson G. Source: Journal of Autism and Developmental Disorders. 2000 April; 30(2): 177. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10832784&dopt=Abstract
·
What is melatonin? Is it a useful treatment for sleep problems in autism? Author(s): Lord C. Source: Journal of Autism and Developmental Disorders. 1998 August; 28(4): 345-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9711493&dopt=Abstract
·
What to measure in autism drug trials. Author(s): Roseman B, Schneider E, Crimmins D, Bostwick H, Visintainer P, Jaskow PA, Accardo P. Source: Journal of Autism and Developmental Disorders. 2001 June; 31(3): 361-2. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11518490&dopt=Abstract
·
Why is joint attention a pivotal skill in autism? Author(s): Charman T. Source: Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences. 2003 February 28; 358(1430): 315-24. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12639329&dopt=Abstract
·
Why no advice on autism. Author(s): Comm M. Source: Journal of Psychosocial Nursing and Mental Health Services. 1999 February; 37(2): 6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10023598&dopt=Abstract
·
Working memory in children with autism and with moderate learning difficulties. Author(s): Russell J, Jarrold C, Henry L. Source: Journal of Child Psychology and Psychiatry, and Allied Disciplines. 1996 September; 37(6): 673-86. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8894948&dopt=Abstract
Studies 155
·
X chromosome and infantile autism. Author(s): Petit E, Herault J, Raynaud M, Cherpi C, Perrot A, Barthelemy C, Lelord G, Muh JP. Source: Biological Psychiatry. 1996 September 15; 40(6): 457-64. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8879465&dopt=Abstract
·
Xeroderma pigmentosum group C splice mutation associated with autism and hypoglycinemia. Author(s): Khan SG, Levy HL, Legerski R, Quackenbush E, Reardon JT, Emmert S, Sancar A, Li L, Schneider TD, Cleaver JE, Kraemer KH. Source: The Journal of Investigative Dermatology. 1998 November; 111(5): 791-6. Erratum In: J Invest Dermatol 1999 March; 112(3): 402. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9804340&dopt=Abstract
·
Xp deletions associated with autism in three females. Author(s): Thomas NS, Sharp AJ, Browne CE, Skuse D, Hardie C, Dennis NR. Source: Human Genetics. 1999 January; 104(1): 43-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10071191&dopt=Abstract
·
Zebras in the living room: the changing faces of autism. Author(s): Accardo P, Bostwick H. Source: The Journal of Pediatrics. 1999 November; 135(5): 533-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10547235&dopt=Abstract
157
CHAPTER 2. NUTRITION AND AUTISM Overview In this chapter, we will show you how to find studies dedicated specifically to nutrition and autism.
Finding Nutrition Studies on Autism The National Institutes of Health’s Office of Dietary Supplements (ODS) offers a searchable bibliographic database called the IBIDS (International Bibliographic Information on Dietary Supplements; National Institutes of Health, Building 31, Room 1B29, 31 Center Drive, MSC 2086, Bethesda, Maryland 20892-2086, Tel: 301-435-2920, Fax: 301-480-1845, E-mail:
[email protected]). The IBIDS contains over 460,000 scientific citations and summaries about dietary supplements and nutrition as well as references to published international, scientific literature on dietary supplements such as vitamins, minerals, and botanicals.7 The IBIDS includes references and citations to both human and animal research studies. As a service of the ODS, access to the IBIDS database is available free of charge at the following Web address: http://ods.od.nih.gov/databases/ibids.html. After entering the search area, you have three choices: (1) IBIDS Consumer Database, (2) Full IBIDS Database, or (3) Peer Reviewed Citations Only. Now that you have selected a database, click on the “Advanced” tab. An advanced search allows you to retrieve up to 100 fully explained references in a comprehensive format. Type “autism” (or synonyms) into the search box, and click “Go.” To narrow the search, you can also select the “Title” field.
7
Adapted from http://ods.od.nih.gov. IBIDS is produced by the Office of Dietary Supplements (ODS) at the National Institutes of Health to assist the public, healthcare providers, educators, and researchers in locating credible, scientific information on dietary supplements. IBIDS was developed and will be maintained through an interagency partnership with the Food and Nutrition Information Center of the National Agricultural Library, U.S. Department of Agriculture.
158 Autism
The following information is typical of that found when using the “Full IBIDS Database” to search for “autism” (or a synonym): ·
A balanced approach towards healthy eating in autism. Author(s): Senior Community Dietitian, Community Health Services, NHS Trust, Southern Derbyshire, Wilderslowe, 121 Osmaston Road, Derby DE1 2GA (United Kingdom) Source: Cornish, E. Journal-of-Human-Nutrition-and-Dietetics (United Kingdom). (1998). volume 11(6) page 501-509. children mankind vitamins nutritional status body measurements nutrients trace elements mineral nutrients feeding habits nervous system diseases diet ascorbic acid iron vitamin d nicotinamide riboflavin pyridoxine calcium zinc Summary: enfant genre humain vitamine etat nutritionnel mensuration corporelle substance nutritive oligoelement substance nutritive minerale comportement alimentaire trouble du systeme nerveux regime alimentaire acide ascorbique fer vitamine d nicotinamide riboflavine pyridoxine calcium zinc
Additional physician-oriented references include: ·
A 15-year follow-up of a boy with pyridoxine (vitamin B6)-dependent seizures with autism, breath holding, and severe mental retardation. Author(s): Department of Pediatrics, School of Medicine and Health Sciences, University of North Dakota, Grand Forks, USA.
[email protected] Source: Burd, L Stenehjem, A Franceschini, L A Kerbeshian, J J-Child-Neurol. 2000 November; 15(11): 763-5 0883-0738
·
A case report of naltrexone treatment of self-injury and social withdrawal in autism. Author(s): Brown University Program in Medicine, Emma Pendleton Bradley Hospital, East Providence, Rhode Island 02915. Source: Walters, A S Barrett, R P Feinstein, C Mercurio, A Hole, W T J-Autism-DevDisord. 1990 June; 20(2): 169-76 0162-3257
·
A controlled trial with ORG 2766, an ACTH-(4-9) analog, in 50 relatively able children with autism. Author(s): Department of Child and Adolescent Psychiatry, University of Utrecht, Netherlands. Source: Buitelaar, J K Dekker, M E van Ree, J M van Engeland, H EurNeuropsychopharmacol. 1996 March; 6(1): 13-9 0924-977X
·
A double-blind, placebo-controlled crossover study investigating the effect of porcine secretin in children with autism. Author(s): Department of Pediatrics, Divisions of Pediatric Neurology, University of Minnesota, Minneapolis, MN, USA. Source: Corbett, B Khan, K Czapansky Beilman, D Brady, N Dropik, P Goldman, D Z Delaney, K Sharp, H Mueller, I Shapiro, E Ziegler, R Clin-Pediatr-(Phila). 2001 June; 40(6): 327-31 0009-9228
·
A novel biochemical model linking dysfunctions in brain melatonin, proopiomelanocortin peptides, and serotonin in autism. Author(s): Brain Research Center, Children's National Medical Center, Washington, D.C. 20010. Source: Chamberlain, R S Herman, B H Biol-Psychiatry. 1990 November 1; 28(9): 773-93 0006-3223
Nutrition 159
·
A randomized, double-blind, placebo-controlled trial of single-dose intravenous secretin as treatment for children with autism. Author(s): Division of Developmental Pediatrics, The Marcus Institute at Emory University, Atlanta, Georgia, USA. Source: Coniglio, S J Lewis, J D Lang, C Burns, T G Subhani Siddique, R Weintraub, A Schub, H Holden, E W J-Pediatr. 2001 May; 138(5): 649-55 0022-3476
·
Amisulpride versus bromocriptine in infantile autism: a controlled crossover comparative study of two drugs with opposite effects on dopaminergic function. Author(s): University of Rouen, Department of Psychiatry. Source: Dollfus, S Petit, M Menard, J F Lesieur, P J-Autism-Dev-Disord. 1992 March; 22(1): 47-60 0162-3257
·
An assessment of food acceptance in children with autism or pervasive developmental disorder-not otherwise specified. Author(s): The New England Center for Children, Southboro, MA 01772-2108, USA.
[email protected] Source: Ahearn, W H Castine, T Nault, K Green, G J-Autism-Dev-Disord. 2001 October; 31(5): 505-11 0162-3257
·
An enzyme/brain-barrier theory of psychiatric pathogenesis: unifying observations on phenylketonuria, autism, schizophrenia and postpartum psychosis. Author(s): Department of General Practice, University of Oslo, Blindern, Norway. Source: Seim, A R Reichelt, K L Med-Hypotheses. 1995 November; 45(5): 498-502 03069877
·
An open trial of divalproex sodium in autism spectrum disorders. Author(s): Department of Psychiatry and Seaver Autism Research Center, Mt. Sinai School of Medicine, New York, NY 10029-6574, USA.
[email protected] Source: Hollander, E Dolgoff Kaspar, R Cartwright, C Rawitt, R Novotny, S J-ClinPsychiatry. 2001 July; 62(7): 530-4 0160-6689
·
Anterior insular cortex: linking intestinal pathology and brain function in autismspectrum subgroups. Author(s): Institute for Molecular Introspections, Estes Park, Colorado 80517, USA.
[email protected] Source: Binstock, T Med-Hypotheses. 2001 December; 57(6): 714-7 0306-9877
·
Antibodies to neuron-specific antigens in children with autism: possible crossreaction with encephalitogenic proteins from milk, Chlamydia pneumoniae and Streptococcus group A. Author(s): Section of Neuroimmunology, Immunosciences Laboratory, Inc., 8693 Wilshire Boulevard, Suite 200, Beverly Hills, CA 90211, USA.
[email protected] Source: Vojdani, A Campbell, A W Anyanwu, E Kashanian, A Bock, K Vojdani, E JNeuroimmunol. 2002 August; 129(1-2): 168-77 0165-5728
·
Application of genomeceuticals to the molecular and immunological aspects of autism. Author(s): MAK Wood Inc., Thiensville, Wisconsin 53024, USA.
[email protected] Source: Brudnak, M A Med-Hypotheses. 2001 August; 57(2): 186-91 0306-9877
·
Auditory integration training and facilitated communication for autism. American Academy of Pediatrics. Committee on Children with Disabilities. Source: Anonymous Pediatrics. 1998 August; 102(2 Pt 1): 431-3 0031-4005
160 Autism
·
Autism in tuberous sclerosis complex is related to both cortical and subcortical dysfunction. Author(s): Department of Pediatrics, Children's Hospital of Michigan, Wayne State University, Detroit 48201, USA. Source: Asano, E Chugani, D C Muzik, O Behen, M Janisse, J Rothermel, R Mangner, T J Chakraborty, P K Chugani, H T Neurology. 2001 October 9; 57(7): 1269-77 0028-3878
·
Autism, an extreme challenge to integrative medicine. Part 2: medical management. Source: Kidd, P M Altern-Med-Revolume 2002 December; 7(6): 472-99 1089-5159
·
Brain opioids and autism: an updated analysis of possible linkages. Source: Sahley, T L Panksepp, J J-Autism-Dev-Disord. 1987 June; 17(2): 201-16 0162-3257
·
Can the pathophysiology of autism be explained by the nature of the discovered urine peptides? Author(s): Institute of Pediatric Research, Univ of Oslo, Rikshospitalet, N-0027, Oslo, Norway.
[email protected] Source: Reichelt, K L Knivsberg, A M Nutr-Neurosci. 2003 February; 6(1): 19-28 1028415X
·
Clinical effects of naltrexone on autistic behavior. Author(s): Sonoma Developmental Center, Eldridge, CA 95431. Source: Zingarelli, G Ellman, G Hom, A Wymore, M Heidorn, S Chicz DeMet, A Am-JMent-Retard. 1992 July; 97(1): 57-63 0895-8017
·
Combined vitamin B6-magnesium treatment in autism spectrum disorder. Author(s): UCF Center for Autism & Related Disabilities, 12001 Science Dr, Suite 145, Orlando, Florida 32826, USA.
[email protected] Source: Nye, C Brice, A Cochrane-Database-Syst-Revolume 2002; (4): CD003497 1469493X
·
Comments on “Secretin and autism: a two-part clinical investigation” by M.G. Chez et al. Source: Rimland, B J-Autism-Dev-Disord. 2000 April; 30(2): 95; discussion 97-8 01623257
·
Controversies in the treatment of autistic children: vitamin and drug therapy. Author(s): Institute for Child Behavior Research, San Diego, CA 92116. Source: Rimland, B J-Child-Neurol. 1988; 3 SupplS68-72 0883-0738
·
Deficits in social behavior in autism and their modification by a synthetic adrenocorticotrophic hormone (4-9) analog. Author(s): Department of Child and Adolescent Psychiatry, Utrecht University Hospital, The Netherlands. Source: Buitelaar, J K van Engeland, H de Kogel, C H de Vries, H van Hooff, J A van Ree, J M Experientia. 1992 April 15; 48(4): 391-4 0014-4754
·
Diet in autism and associated disorders. Author(s): Royal Free Hospital, London. Source: Garvey, J J-Fam-Health-Care. 2002; 12(2): 34-8 1474-9114
·
Double-blind placebo-controlled trial of secretin: effects on aberrant behavior in children with autism. Author(s): Department of Pediatrics, Medical College of Ohio, Toledo 43608, USA.
[email protected] Source: Carey, T Ratliff Schaub, K Funk, J Weinle, C Myers, M Jenks, J J-Autism-DevDisord. 2002 June; 32(3): 161-7 0162-3257
Nutrition 161
·
Effectiveness of N,N-dimethylglycine in autism and pervasive developmental disorder. Author(s): Department of Human Development, University of Texas at Dallas, USA.
[email protected] Source: Kern, J K Miller, V S Cauller, P L Kendall, P R Mehta, P J Dodd, M J-ChildNeurol. 2001 March; 16(3): 169-73 0883-0738
·
Effects of intravenous secretin on language and behavior of children with autism and gastrointestinal symptoms: a single-blinded, open-label pilot study. Author(s): Combined Program in Pediatric Gastroenterology and Nutrition, Harvard Medical School, Boston, Massachusetts, USA. Source: Lightdale, J R Hayer, C Duer, A Lind White, C Jenkins, S Siegel, B Elliott, G R Heyman, M B Pediatrics. 2001 November; 108(5): E90 1098-4275
·
Efficacy of porcine secretin in children with autism and pervasive developmental disorder. Author(s): Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas 75390-9101, USA.
[email protected] Source: Kern, J K Van Miller, S Evans, P A Trivedi, M H J-Autism-Dev-Disord. 2002 June; 32(3): 153-60 0162-3257
·
Enzyme-based therapy for autism spectrum disorders -- is it worth another look? Author(s): Autism Research Institute, San Diego, CA, USA. Source: Brudnak, M A Rimland, B Kerry, R E Dailey, M Taylor, R Stayton, B Waickman, F Waickman, M Pangborn, J Buchholz, I Med-Hypotheses. 2002 May; 58(5): 422-8 03069877
·
Fetal valproate syndrome and autism: additional evidence of an association. Author(s): University of Louisville Child Evaluation Center, KY 20402-3828, USA. Source: Williams, G King, J Cunningham, M Stephan, M Kerr, B Hersh, J H Dev-MedChild-Neurol. 2001 March; 43(3): 202-6 0012-1622
·
Gastrointestinal microflora studies in late-onset autism. Author(s): Infectious Diseases Section, Veterans Affairs Medical Center, West Los Angeles, CA, USA.
[email protected] Source: Finegold, Sydney M Molitoris, Denise Song, Yuli Liu, Chengxu Vaisanen, Marja Liisa Bolte, Ellen McTeague, Maureen Sandler, Richard Wexler, Hannah Marlowe, Elizabeth M Collins, Matthew D Lawson, Paul A Summanen, Paula Baysallar, Mehmet Tomzynski, Thomas J Read, Erik Johnson, Eric Rolfe, Rial Nasir, Palwasha Shah, Haroun Haake, David A Manning, Patricia Kaul, Ajay Clin-Infect-Dis. 2002 September 1; 35(Suppl 1): S6-S16 1537-6591
·
Gluten and casein free diets in autism: a study of the effects on food choice and nutrition. Author(s): Community Nutrition Service, South Derbyshire Community Health NHS Trust, Dar es Salaam, Tanzania. Source: Cornish, E J-Hum-Nutr-Diet. 2002 August; 15(4): 261-9 0952-3871
·
Homeopathic Secretin in autism: a clinical pilot study. Author(s): Barton House, Beaminster, Dorset, UK. Source: Robinson, T W Br-Homeopath-J. 2001 April; 90(2): 86-91 0007-0785
·
Identification of indolyl-3-acryloylglycine in the urine of people with autism. Author(s): Institute of Pharmacy, Chemistry and Biomedical Sciences, University of Sunderland, UK.
[email protected]
162 Autism
Source: Anderson, Rosaleen J Bendell, David J Garnett, Ian Groundwater, Paul W Lough, W John Mills, Malcolm J Savery, Dawn Shattock, Paul E G J-Pharm-Pharmacol. 2002 February; 54(2): 295-8 0022-3573 ·
Increased monoamine concentration in the brain and blood of fetal thalidomide- and valproic acid-exposed rat: putative animal models for autism. Author(s): Neurobiology Laboratory, Institute of Basic Medical Sciences, University of Tsukuba, Ibaraki, Japan. Source: Narita, N Kato, M Tazoe, M Miyazaki, K Narita, M Okado, N Pediatr-Res. 2002 October; 52(4): 576-9 0031-3998
·
Innate immunity associated with inflammatory responses and cytokine production against common dietary proteins in patients with autism spectrum disorder. Author(s): Department of Pediatrics, University of Minnesota, Minneapolis, Minn, USA. Source: Jyonouchi, H Sun, S Itokazu, N Neuropsychobiology. 2002; 46(2): 76-84 0302282X
·
Inositol treatment of autism. Author(s): Abarbanel Mental Health Center, Bat Yam, Israel. Source: Levine, J Aviram, A Holan, A Ring, A Barak, Y Belmaker, R H J-Neural-Transm. 1997; 104(2-3): 307-10
·
Intelligence patterns among children with high-functioning autism, phenylketonuria, and childhood head injury. Author(s): Department of Psychology, Hospital for Sick Children, Toronto, Canada. Source: Dennis, M Lockyer, L Lazenby, A L Donnelly, R E Wilkinson, M Schoonheyt, W J-Autism-Dev-Disord. 1999 February; 29(1): 5-17 0162-3257
·
Is autism a G-alpha protein defect reversible with natural vitamin A? Author(s): Pediatric and Adolescent Ability Center, Richmond, VA 23226, USA. Source: Megson, M N Med-Hypotheses. 2000 June; 54(6): 979-83 0306-9877
·
Is there a basis for novel pharmacotherapy of autism? Author(s): Temple University School of Pharmacy, Philadelphia, PA 19140, USA. Source: Hunsinger, D M Nguyen, T Zebraski, S E Raffa, R B Life-Sci. 2000 August 25; 67(14): 1667-82 0024-3205
·
Lack of benefit of a single dose of synthetic human secretin in the treatment of autism and pervasive developmental disorder. Author(s): Olson Huff Center for Child Development, Thoms Rehabilitation Hospital, Asheville, NC 28803, USA.
[email protected] Source: Sandler, A D Sutton, K A DeWeese, J Girardi, M A Sheppard, V Bodfish, J W NEngl-J-Med. 1999 December 9; 341(24): 1801-6 0028-4793
·
Lithium carbonate in the treatment of two patients with infantile autism and atypical bipolar symptomatology. Author(s): Department of Neuroscience, University of North Dakota School of Medicine, Grand Forks. Source: Kerbeshian, J Burd, L Fisher, W J-Clin-Psychopharmacol. 1987 December; 7(6): 401-5 0271-0749
·
Lithium responsive manic-like symptoms in two individuals with autism and mental retardation. Source: Steingard, R Biederman, J J-Am-Acad-Child-Adolesc-Psychiatry. 1987 November; 26(6): 932-5 0890-8567
·
Metabolic approaches to the treatment of autism spectrum disorders. Author(s): Department of Neurosciences, University of California, San Diego, USA.
Nutrition 163
Source: Page, T J-Autism-Dev-Disord. 2000 October; 30(5): 463-9 0162-3257 ·
Micronutrient accumulation and depletion in schizophrenia, epilepsy, autism and Parkinson's disease? Author(s): Moses Lake, Washington 98837, USA. Source: Johnson, S Med-Hypotheses. 2001 May; 56(5): 641-5 0306-9877
·
Multisite, double-blind, placebo-controlled trial of porcine secretin in autism. Author(s): Department of Psychiatry, University of Chicago, IL 60637, USA.
[email protected] Source: Owley, T McMahon, W Cook, E H Laulhere, T South, M Mays, L Z Shernoff, E S Lainhart, J Modahl, C B Corsello, C Ozonoff, S Risi, S Lord, C Leventhal, B L Filipek, P A J-Am-Acad-Child-Adolesc-Psychiatry. 2001 November; 40(11): 1293-9 0890-8567
·
Naltrexone and communication skills in young children with autism. Author(s): Department of Pediatrics, University of Pittsburgh School of Medicine, Children's Hospital of Pittsburgh, PA 15213, USA. Source: Feldman, H M Kolmen, B K Gonzaga, A M J-Am-Acad-Child-AdolescPsychiatry. 1999 May; 38(5): 587-93 0890-8567
·
Naltrexone in infantile autism. Source: Campbell, M Adams, P Small, A M Tesch, L M Curren, E L PsychopharmacolBull. 1988; 24(1): 135-9 0048-5764
·
Nutritional treatments currently under investigation in autism. Source: Coleman, M. Clin-Nutr. St. Louis, Mo. : C.V. Mosby Company. Sept/October 1989. volume 8 (5) page 210-212. 0733-2327
·
Opioid-immune interactions in autism: behavioural and immunological assessment during a double-blind treatment with naltrexone. Author(s): Servizio di Psichiatria, Istituto OASI per lo Studio del Ritardo Mentale e l'Involuzione Cerebrale, Troina (Enna), Italy. Source: Scifo, R Cioni, M Nicolosi, A Batticane, N Tirolo, C Testa, N Quattropani, M C Morale, M C Gallo, F Marchetti, B Ann-Ist-Super-Sanita. 1996; 32(3): 351-9 0021-2571
·
Pharmacotherapeutic management of autism. Author(s): Department of Psychiatry, Indaiana University School of Medicine, USA.
[email protected]. Source: Posey, D J McDougle, C J Expert-Opin-Pharmacother. 2001 April; 2(4): 587-600 1465-6566
·
Placebo effects in autism: lessons from secretin. Author(s): Olson Huff Center for Child Development, Thoms Rehabilitation Hospital, Asheville, North Carolina, USA.
[email protected] Source: Sandler, A D Bodfish, J W J-Dev-Behav-Pediatr. 2000 October; 21(5): 347-50 0196206X
·
Plasma and urinary levels of biopterin, neopterin, and related pterins and plasma levels of folate in infantile autism. Author(s): Department of Nutrition Sciences, University of Alabama, Birmingham 35294. Source: Eto, I Bandy, M D Butterworth, C E J-Autism-Dev-Disord. 1992 June; 22(2): 295308 0162-3257
·
Plasma excitatory amino acids in autism. Author(s): Servicio de Medicina Genetica Perinatal, Hospital Chiquinquira, Maracaibo, Venezuela.
164 Autism
Source: Moreno Fuenmayor, H Borjas, L Arrieta, A Valera, V Socorro Candanoza, L Invest-Clin. 1996 June; 37(2): 113-28 0535-5133 ·
Plasma fatty acid levels in autistic children. Author(s): Laboratoire de Nutrition et Securite Alimentaire, INRA, domaine de Vilvert, 78352 Jouy-en-Josas cedex, France.
[email protected] Source: Vancassel, S Durand, G Barthelemy, C Lejeune, B Martineau, J Guilloteau, D Andres, C Chalon, S Prostaglandins-Leukot-Essent-Fatty-Acids. 2001 July; 65(1): 1-7 0952-3278
·
Prenatal exposure of rats to valproic acid reproduces the cerebellar anomalies associated with autism. Author(s): Department of Obstetrics and Gynecology, University of Rochester School of Medicine and Dentistry, 14642, Rochester, NY, USA. Source: Ingram, J L Peckham, S M Tisdale, B Rodier, P M Neurotoxicol-Teratol. 2000 May-June; 22(3): 319-24 0892-0362
·
Prognosis in autism: do specialist treatments affect long-term outcome? Author(s): Department of Psychology, St. George's Hospital Medical School, Tooting, London, United Kingdom. Source: Howlin, P Eur-Child-Adolesc-Psychiatry. 1997 June; 6(2): 55-72 1018-8827
·
Prognostic significance of depression occurrence in infantile autism. Author(s): Servizio Neuropsichiatria Infantile Universita degli Studi-Catania. Source: Scifo, R Calandra, C Parrinello, M A Marchetti, B Minerva-Pediatr. 1996 November; 48(11): 495-8 0026-4946
·
Proinflammatory and regulatory cytokine production associated with innate and adaptive immune responses in children with autism spectrum disorders and developmental regression. Author(s): Department of Pediatrics, University of Minnesota, MMC 610 FUMC, 420 Delaware Street SE, Minneapolis, MN 55455, USA.
[email protected] Source: Jyonouchi, H Sun, S Le, H J-Neuroimmunol. 2001 November 1; 120(1-2): 170-9 0165-5728
·
Psychopharmacology in autism. Author(s): Child and Adolescent Psychiatric Hospital, University of Michigan Medical School, Ann Arbor 48109-0390, USA. Source: Tsai, L Y Psychosom-Med. 1999 Sep-October; 61(5): 651-65 0033-3174
·
Regional brain chemical alterations in young children with autism spectrum disorder. Author(s): Department of Radiology, University of Washington School of Medicine, Seattle 98105-6099, USA. Source: Friedman, S D Shaw, D W Artru, A A Richards, T L Gardner, J Dawson, G Posse, S Dager, S R Neurology. 2003 January 14; 60(1): 100-7 1526-632X
·
Secretin and autism: a two-part clinical investigation. Author(s): Pediatric Neurology, Lake Forest Hospital, Illinois 60045, USA.
[email protected] Source: Chez, M G Buchanan, C P Bagan, B T Hammer, M S McCarthy, K S Ovrutskaya, I Nowinski, C V Cohen, Z S J-Autism-Dev-Disord. 2000 April; 30(2): 87-94 0162-3257
·
Secretin and sleep in children with autism. Author(s): University of California, Davis 95616, USA. Source: Honomichl, R D Goodlin Jones, B L Burnham, M M Hansen, R L Anders, T F Child-Psychiatry-Hum-Devolume 2002 Winter; 33(2): 107-23 0009-398X
Nutrition 165
·
Secretin for the treatment of autism. Author(s): Ambulatory Services, University Hospital, Health Alliance, Cincinnati, OH, USA.
[email protected] Source: McQueen, Joanna M Heck, Amy M Ann-Pharmacother. 2002 February; 36(2): 305-11 1060-0280
·
Sexual behaviors in autism: problems of definition and management. Author(s): Division of Child and Adolescent Psychiatry, University of Minnesota, Minneapolis 55455, USA.
[email protected] Source: Realmuto, G M Ruble, L A J-Autism-Dev-Disord. 1999 April; 29(2): 121-7 01623257
·
Sudden infant death syndrome and secretin treatment for autism. Author(s): Upstate Medical University, State University of New York, Syracuse 13202, USA. Source: Blatt, S D Meguid, V Church, C C Curr-Opin-Pediatr. 2000 April; 12(2): 179-83 1040-8703
·
Sulphur metabolism in autism. Source: Waring, R.H. Klovrza, L.V. J-nutr-environ-med. Abingdon, U.K. : Carfax Publishing Company. March 2000. volume10 (1) page 25-32. 1359-0847
·
The use of adrenocorticotrophic hormone (4-9) analog ORG 2766 in autistic children: effects on the organization of behavior. Author(s): Department of Child and Adolescent Psychiatry, Utrecht University Hospital, The Netherlands. Source: Buitelaar, J K van Engeland, H de Kogel, K H de Vries, H van Hooff, J A van Ree, J M Biol-Psychiatry. 1992 June 1; 31(11): 1119-29 0006-3223
·
Transdermal secretin for autism - a case report. Author(s): Coordinator of Oncology, Bastyr University, Kenmore, WA, USA.
[email protected] Source: Lamson, D W Plaza, S M Altern-Med-Revolume 2001 June; 6(3): 311-3 1089-5159
·
Treatment of autism spectrum children with thiamine tetrahydrofurfuryl disulfide: a pilot study. Author(s): Preventive Medicine Group, 24700 Center Ridge Road, Westlake, OH 44145, USA.
[email protected] Source: Lonsdale, D Shamberger, R J Audhya, T Neuroendocrinol-Lett. 2002 August; 23(4): 303-8 0172-780X
·
Use of secretin in the treatment of childhood autism. Author(s): Department and Clinic of Pediatrics, Gastroenterology and Pediatric Oncology, Medical University, Gdansk, Poland. Source: Kaminska, Barbara Czaja, Mariusz Kozielska, Ewa Mazur, Elzbieta Korzon, Maria Med-Sci-Monit. 2002 January; 8(1): RA22-6 1234-1010
·
Weight gain in a controlled study of risperidone in children, adolescents and adults with mental retardation and autism. Author(s): Department of Psychiatry and Behavioral Sciences, University of Kansas Medical Center, Kansas City 66160, USA.
[email protected] Source: Hellings, J A Zarcone, J R Crandall, K Wallace, D Schroeder, S R J-ChildAdolesc-Psychopharmacol. 2001 Fall; 11(3): 229-38 1044-5463
·
What is melatonin? Is it a useful treatment for sleep problems in autism? Source: Lord, C J-Autism-Dev-Disord. 1998 August; 28(4): 345-6 0162-3257
166 Autism
·
Xeroderma pigmentosum group C splice mutation associated with autism and hypoglycinemia. Author(s): Laboratory of Molecular Carcinogenesis, National Cancer Institute, Bethesda, Maryland 20892, USA. Source: Khan, S G Levy, H L Legerski, R Quackenbush, E Reardon, J T Emmert, S Sancar, A Li, L Schneider, T D Cleaver, J E Kraemer, K H J-Invest-Dermatol. 1998 November; 111(5): 791-6 0022-202X
Federal Resources on Nutrition In addition to the IBIDS, the United States Department of Health and Human Services (HHS) and the United States Department of Agriculture (USDA) provide many sources of information on general nutrition and health. Recommended resources include: ·
healthfinder®, HHS’s gateway to health information, including diet and nutrition: http://www.healthfinder.gov/scripts/SearchContext.asp?topic=238&page=0
·
The United States Department of Agriculture’s Web site dedicated to nutrition information: www.nutrition.gov
·
The Food and Drug Administration’s Web site for federal food safety information: www.foodsafety.gov
·
The National Action Plan on Overweight and Obesity sponsored by the United States Surgeon General: http://www.surgeongeneral.gov/topics/obesity/
·
The Center for Food Safety and Applied Nutrition has an Internet site sponsored by the Food and Drug Administration and the Department of Health and Human Services: http://vm.cfsan.fda.gov/
·
Center for Nutrition Policy and Promotion sponsored by the United States Department of Agriculture: http://www.usda.gov/cnpp/
·
Food and Nutrition Information Center, National Agricultural Library sponsored by the United States Department of Agriculture: http://www.nal.usda.gov/fnic/
·
Food and Nutrition Service sponsored by the United States Department of Agriculture: http://www.fns.usda.gov/fns/
Additional Web Resources A number of additional Web sites offer encyclopedic information covering food and nutrition. The following is a representative sample: ·
AOL: http://search.aol.com/cat.adp?id=174&layer=&from=subcats
·
Family Village: http://www.familyvillage.wisc.edu/med_nutrition.html
·
Google: http://directory.google.com/Top/Health/Nutrition/
·
Healthnotes: http://www.healthnotes.com/
·
Open Directory Project: http://dmoz.org/Health/Nutrition/
·
Yahoo.com: http://dir.yahoo.com/Health/Nutrition/
Nutrition 167
·
WebMDÒHealth: http://my.webmd.com/nutrition
·
WholeHealthMD.com: http://www.wholehealthmd.com/reflib/0,1529,00.html
The following is a specific Web list relating to autism; please note that any particular subject below may indicate either a therapeutic use, or a contraindication (potential danger), and does not reflect an official recommendation: ·
Vitamins Vitamin B6 Source: Healthnotes, Inc.; www.healthnotes.com Vitamin B6 Source: Prima Communications, Inc.www.personalhealthzone.com Vitamin C Source: Healthnotes, Inc.; www.healthnotes.com
·
Minerals Magnesium Source: Healthnotes, Inc.; www.healthnotes.com Magnesium Source: Prima Communications, Inc.www.personalhealthzone.com
169
CHAPTER 3. ALTERNATIVE MEDICINE AND AUTISM Overview In this chapter, we will begin by introducing you to official information sources on complementary and alternative medicine (CAM) relating to autism. At the conclusion of this chapter, we will provide additional sources.
National Center for Complementary and Alternative Medicine The National Center for Complementary and Alternative Medicine (NCCAM) of the National Institutes of Health (http://nccam.nih.gov/) has created a link to the National Library of Medicine’s databases to facilitate research for articles that specifically relate to autism and complementary medicine. To search the database, go to the following Web site: http://www.nlm.nih.gov/nccam/camonpubmed.html. Select “CAM on PubMed.” Enter “autism” (or synonyms) into the search box. Click “Go.” The following references provide information on particular aspects of complementary and alternative medicine that are related to autism: ·
A medical model of autism: etiology, pathology and treatment. Author(s): Ritvo ER, Freeman BJ. Source: Pediatric Annals. 1984 April; 13(4): 298-305. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=6610163&dopt=Abstract
·
Alcohol, deafness, epilepsy, and autism. Author(s): Gordon AG. Source: Alcoholism, Clinical and Experimental Research. 1993 August; 17(4): 926-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8214437&dopt=Abstract
·
An animal model of autism: behavioural studies in the GS guinea-pig. Author(s): Caston J, Yon E, Mellier D, Godfrey HP, Delhaye-bouchaud N, Mariani J.
170 Autism
Source: The European Journal of Neuroscience. 1998 August; 10(8): 2677-84. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9767397&dopt=Abstract ·
An approach to the nutritional management of autism. Author(s): Kidd PM. Source: Alternative Therapies in Health and Medicine. 2003 September-October; 9(5): 2231; Quiz 32, 126. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=14526708&dopt=Abstract
·
An electrophysiologic indication of auditory processing defects in autism. Author(s): Novick B, Vaughan HG Jr, Kurtzberg D, Simson R. Source: Psychiatry Research. 1980 September; 3(1): 107-14. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=6934552&dopt=Abstract
·
An electrophysiologic indication of defective information storage in childhood autism. Author(s): Novick B, Kurtzberg D, Vaughn HG Jr. Source: Psychiatry Research. 1979 July; 1(1): 101-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=298335&dopt=Abstract
·
Are children with autism superior at folk physics? Author(s): Baron-Cohen S. Source: New Dir Child Dev. 1997 Spring; (75): 45-54. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9306745&dopt=Abstract
·
Auditory associative cortex dysfunction in children with autism: evidence from late auditory evoked potentials (N1 wave-T complex). Author(s): Bruneau N, Roux S, Adrien JL, Barthelemy C. Source: Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology. 1999 November; 110(11): 1927-34. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10576489&dopt=Abstract
·
Auditory brainstem responses in autism: brainstem dysfunction or peripheral hearing loss? Author(s): Klin A. Source: Journal of Autism and Developmental Disorders. 1993 March; 23(1): 15-35. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8463195&dopt=Abstract
·
Auditory integration training for children with autism: no behavioral benefits detected. Author(s): Mudford OC, Cross BA, Breen S, Cullen C, Reeves D, Gould J, Douglas J.
Alternative Medicine 171
Source: Am J Ment Retard. 2000 March; 105(2): 118-29. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10755175&dopt=Abstract ·
Auditory processing abilities in non-retarded adolescents and young adults with developmental receptive language disorder and autism. Author(s): Lincoln AJ, Dickstein P, Courchesne E, Elmasian R, Tallal P. Source: Brain and Language. 1992 November; 43(4): 613-22. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=1483193&dopt=Abstract
·
Autism AKA communication disorder. Author(s): Greenspan SI. Source: Journal of the American Academy of Child and Adolescent Psychiatry. 1993 January; 32(1): 221-2. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7679094&dopt=Abstract
·
Autism and the immune system. Author(s): van Gent T, Heijnen CJ, Treffers PD. Source: Journal of Child Psychology and Psychiatry, and Allied Disciplines. 1997 March; 38(3): 337-49. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9232480&dopt=Abstract
·
Autism and visual agnosia in a child with right occipital lobectomy. Author(s): Jambaque I, Mottron L, Ponsot G, Chiron C. Source: Journal of Neurology, Neurosurgery, and Psychiatry. 1998 October; 65(4): 55560. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9771784&dopt=Abstract
·
Autism as a neurodevelopmental disorder affecting communication and learning in early childhood: prenatal origins, post-natal course and effective educational support. Author(s): Trevarthen C. Source: Prostaglandins, Leukotrienes, and Essential Fatty Acids. 2000 July-August; 63(12): 41-6. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10970712&dopt=Abstract
·
Autism from the inside. Author(s): White BB, White MS. Source: Medical Hypotheses. 1987 November; 24(3): 223-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=3696026&dopt=Abstract
·
Autism in young children: an update. Author(s): Mays RM, Gillon JE.
172 Autism
Source: Journal of Pediatric Health Care : Official Publication of National Association of Pediatric Nurse Associates & Practitioners. 1993 January-February; 7(1): 17-23. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8421239&dopt=Abstract ·
Autism revisited. Author(s): Schechter MD, Shurley JT, Toussieng PW, Maier WJ. Source: J Okla State Med Assoc. 1970 July; 63(7): 297-300. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=5515622&dopt=Abstract
·
Autism, an extreme challenge to integrative medicine. Part 2: medical management. Author(s): Kidd PM. Source: Alternative Medicine Review : a Journal of Clinical Therapeutic. 2002 December; 7(6): 472-99. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12495373&dopt=Abstract
·
Autism, an extreme challenge to integrative medicine. Part: 1: The knowledge base. Author(s): Kidd PM. Source: Alternative Medicine Review : a Journal of Clinical Therapeutic. 2002 August; 7(4): 292-316. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12197782&dopt=Abstract
·
Autism: a medical primer. Author(s): Prater CD, Zylstra RG. Source: American Family Physician. 2002 November 1; 66(9): 1667-74. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12449265&dopt=Abstract
·
Autism: time for a national approach to early assessment and management. Author(s): Sampson AJ, Hale LG. Source: The Medical Journal of Australia. 1997 April 21; 166(8): 443; Author Reply 443, 446. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9140353&dopt=Abstract
·
Autism--the quest continues: reflections on the Novartis symposium on autism, June 2002. Author(s): Frith U. Source: Neuroreport. 2002 October 7; 13(14): 1703-5. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12395107&dopt=Abstract
·
Behavioral and magnetic resonance spectroscopic studies in the rat hyperserotonemic model of autism. Author(s): Kahne D, Tudorica A, Borella A, Shapiro L, Johnstone F, Huang W, WhitakerAzmitia PM.
Alternative Medicine 173
Source: Physiology & Behavior. 2002 March; 75(3): 403-10. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11897268&dopt=Abstract ·
Behavioural techniques to reduce self-injurious behaviour in children with autism. Author(s): Howlin P. Source: Acta Paedopsychiatr. 1993; 56(2): 75-84. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8135115&dopt=Abstract
·
Brief report: a pilot study of auditory integration training in autism. Author(s): Rimland B, Edelson SM. Source: Journal of Autism and Developmental Disorders. 1995 February; 25(1): 61-70. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7608035&dopt=Abstract
·
Brief report: alternative approaches to the development of effective treatments for autism. Author(s): Rimland B, Baker SM. Source: Journal of Autism and Developmental Disorders. 1996 April; 26(2): 237-41. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8744492&dopt=Abstract
·
Brief report: improvements in the behavior of children with autism following massage therapy. Author(s): Escalona A, Field T, Singer-Strunck R, Cullen C, Hartshorn K. Source: Journal of Autism and Developmental Disorders. 2001 October; 31(5): 513-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11794416&dopt=Abstract
·
Brief report: musical interaction therapy for children with autism: an evaluative case study with two-year follow-up. Author(s): Wimpory D, Chadwick P, Nash S. Source: Journal of Autism and Developmental Disorders. 1995 October; 25(5): 541-52. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8567598&dopt=Abstract
·
Combined vitamin B6-magnesium treatment in autism spectrum disorder. Author(s): Nye C, Brice A. Source: Cochrane Database Syst Rev. 2002; (4): Cd003497. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12519599&dopt=Abstract
·
Developing a diagnostic and intervention package for 2- to 3-year-olds with autism: outcomes of the frameworks for communication approach. Author(s): Chandler S, Christie P, Newson E, Prevezer W.
174 Autism
Source: Autism : the International Journal of Research and Practice. 2002 March; 6(1): 4769. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11918109&dopt=Abstract ·
Domain specificity in conceptual development: neuropsychological evidence from autism. Author(s): Leslie AM, Thaiss L. Source: Cognition. 1992 June; 43(3): 225-51. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=1643814&dopt=Abstract
·
Early environmental stress and infantile autism. Author(s): Harper J, Williams S. Source: The Medical Journal of Australia. 1974 March 9; 1(10): 341-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=4825826&dopt=Abstract
·
Early infantile autism and receptor processes. Author(s): Schopler E. Source: Archives of General Psychiatry. 1965 October; 13(4): 327-35. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=5318111&dopt=Abstract
·
Early infantile autism: diagnosis, etiology, and treatment. Author(s): Ward AJ. Source: Psychological Bulletin. 1970 May; 73(5): 350-62. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=4097056&dopt=Abstract
·
Early intensive behavioral intervention for children with autism: parental therapeutic self-efficacy. Author(s): Hastings RP, Symes MD. Source: Research in Developmental Disabilities. 2002 September-October; 23(5): 332-41. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12401484&dopt=Abstract
·
Effects of sociodramatic play training on children with autism. Author(s): Thorp DM, Stahmer AC, Schreibman L. Source: Journal of Autism and Developmental Disorders. 1995 June; 25(3): 265-82. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7559292&dopt=Abstract
·
Effects of synthetic speech output and orthographic feedback on spelling in a student with autism: a preliminary study. Author(s): Schlosser RW, Blischak DM, Belfiore PJ, Bartley C, Barnett N. Source: Journal of Autism and Developmental Disorders. 1998 August; 28(4): 309-19. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9711487&dopt=Abstract
Alternative Medicine 175
·
Efficacy of vitamin B6 and magnesium in the treatment of autism: a methodology review and summary of outcomes. Author(s): Pfeiffer SI, Norton J, Nelson L, Shott S. Source: Journal of Autism and Developmental Disorders. 1995 October; 25(5): 481-93. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8567594&dopt=Abstract
·
Event-related potentials in cross-modal divided attention in autism. Author(s): Ciesielski KT, Knight JE, Prince RJ, Harris RJ, Handmaker SD. Source: Neuropsychologia. 1995 February; 33(2): 225-46. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7746366&dopt=Abstract
·
High dose vitamin B6 and magnesium in treating autism: response to study by Findling et al. Author(s): Rimland B. Source: Journal of Autism and Developmental Disorders. 1998 December; 28(6): 581-2. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9932247&dopt=Abstract
·
Homeopathic Secretin in autism: a clinical pilot study. Author(s): Robinson TW. Source: Br Homeopath J. 2001 April; 90(2): 86-91. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11341462&dopt=Abstract
·
Hypersensitivity to acoustic change in children with autism: electrophysiological evidence of left frontal cortex dysfunctioning. Author(s): Gomot M, Giard MH, Adrien JL, Barthelemy C, Bruneau N. Source: Psychophysiology. 2002 September; 39(5): 577-84. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12236323&dopt=Abstract
·
I, you, me, and autism: an experimental study. Author(s): Lee A, Hobson RP, Chiat S. Source: Journal of Autism and Developmental Disorders. 1994 April; 24(2): 155-76. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8040159&dopt=Abstract
·
Increasing complex social behaviors in children with autism: effects of peerimplemented pivotal response training. Author(s): Pierce K, Schreibman L. Source: J Appl Behav Anal. 1995 Fall; 28(3): 285-95. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7592145&dopt=Abstract
·
Is asperger syndrome/high-functioning autism necessarily a disability? Author(s): Baron-Cohen S.
176 Autism
Source: Development and Psychopathology. 2000 Summer; 12(3): 489-500. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11014749&dopt=Abstract ·
'Kiss, cuddle, squeeze': the experiences and meaning of touch among parents of children with autism attending a Touch Therapy Programme. Author(s): Cullen L, Barlow J. Source: Journal of Child Health Care : for Professionals Working with Children in the Hospital and Community. 2002 September; 6(3): 171-81. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12224834&dopt=Abstract
·
Memory deficits in early infantile autism: some similarities to the amnesic syndrome. Author(s): Boucher J, Warrington EK. Source: The British Journal of Psychology. 1976 February; 67(1): 73-87. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=1268453&dopt=Abstract
·
Multiple peer use of pivotal response training to increase social behaviors of classmates with autism: results from trained and untrained peers. Author(s): Pierce K, Schreibman L. Source: J Appl Behav Anal. 1997 Spring; 30(1): 157-60. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9103991&dopt=Abstract
·
Musically adapted social stories to modify behaviors in students with autism: four case studies. Author(s): Brownell MD. Source: J Music Ther. 2002 Summer; 39(2): 117-44. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12213082&dopt=Abstract
·
Normal P50 gating in children with autism. Author(s): Kemner C, Oranje B, Verbaten MN, van Engeland H. Source: The Journal of Clinical Psychiatry. 2002 March; 63(3): 214-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11926720&dopt=Abstract
·
'Obsessions' in children with autism or Asperger syndrome. Content analysis in terms of core domains of cognition. Author(s): Baron-Cohen S, Wheelwright S. Source: The British Journal of Psychiatry; the Journal of Mental Science. 1999 November; 175: 484-90. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10789283&dopt=Abstract
·
Ontogenic development of EEG-asymmetry in early infantile autism. Author(s): Ogawa T, Sugiyama A, Ishiwa S, Suzuki M, Ishihara T, Sato K.
Alternative Medicine 177
Source: Brain & Development. 1982; 4(6): 439-49. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7168481&dopt=Abstract ·
Participation of children with autism and nondisabled peers in a cooperatively structured community art program. Author(s): Schleien SJ, Mustonen T, Rynders JE. Source: Journal of Autism and Developmental Disorders. 1995 August; 25(4): 397-413. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7592251&dopt=Abstract
·
Perceptual inconstancy in early infantile autism. The syndrome of early infant autism and its variants including certain cases of childhood schizophrenia. Author(s): Ornitz EM, Ritvo ER. Source: Archives of General Psychiatry. 1968 January; 18(1): 76-98. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=4169269&dopt=Abstract
·
Possible effects of tetrahydrobiopterin treatment in six children with autism--clinical and positron emission tomography data: a pilot study. Author(s): Fernell E, Watanabe Y, Adolfsson I, Tani Y, Bergstrom M, Hartvig P, Lilja A, von Knorring AL, Gillberg C, Langstrom B. Source: Developmental Medicine and Child Neurology. 1997 May; 39(5): 313-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9236697&dopt=Abstract
·
Psychopharmacology in autism. Author(s): Tsai LY. Source: Psychosomatic Medicine. 1999 September-October; 61(5): 651-65. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10511014&dopt=Abstract
·
Quantified multidimensional assessment of autism and other pervasive developmental disorders. Application for bioclinical research. Author(s): Hameury L, Roux S, Barthelemy C, Adrien JL, Desombre H, Sauvage D, Garreau B, Lelord G. Source: European Child & Adolescent Psychiatry. 1995 April; 4(2): 123-35. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7796250&dopt=Abstract
·
Reapproaching Mahler: new perspectives on normal autism, symbiosis, splitting and libidinal object constancy from cognitive developmental theory. Author(s): Gergely G. Source: J Am Psychoanal Assoc. 2000; 48(4): 1197-228. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11212188&dopt=Abstract
·
Role taking and social competence in autism and mental retardation. Author(s): Oswald DP, Ollendick TH.
178 Autism
Source: Journal of Autism and Developmental Disorders. 1989 March; 19(1): 119-27. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=2708295&dopt=Abstract ·
Saccharomyces boulardii: potential adjunctive treatment for children with autism and diarrhea. Author(s): Linday LA. Source: Journal of Child Neurology. 2001 May; 16(5): 387. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11392529&dopt=Abstract
·
Semantic fields in low-functioning autism. Author(s): Boser K, Higgins S, Fetherston A, Preissler MA, Gordon B. Source: Journal of Autism and Developmental Disorders. 2002 December; 32(6): 563-82. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12553593&dopt=Abstract
·
Sleep disorder in children with autism. Author(s): Taira M, Takase M, Sasaki H. Source: Psychiatry and Clinical Neurosciences. 1998 April; 52(2): 182-3. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9628139&dopt=Abstract
·
Social-cognitive abilities in children with lesser variants of autism: skill deficits or failure to apply skills? Author(s): Serra M, Minderaa RB, van Geert PL, Jackson AE. Source: European Child & Adolescent Psychiatry. 1999 December; 8(4): 301-11. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10654124&dopt=Abstract
·
Startle modulation studies in autism. Author(s): Ornitz EM, Lane SJ, Sugiyama T, de Traversay J. Source: Journal of Autism and Developmental Disorders. 1993 December; 23(4): 619-37. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8106303&dopt=Abstract
·
Teaching children with autism to initiate to peers: effects of a script-fading procedure. Author(s): Krantz PJ, McClannahan LE. Source: J Appl Behav Anal. 1993 Spring; 26(1): 121-32. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8473251&dopt=Abstract
·
The biological significance of gaze aversion with particular reference to the syndrome of infantile autism. Author(s): Hutt C, Ounsted C. Source: Behavioral Science. 1966 September; 11(5): 346-56. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=5970485&dopt=Abstract
Alternative Medicine 179
·
The effects of progressive relaxation training on the disruptive behavior of a boy with autism. Author(s): Mullins JL, Christian L. Source: Research in Developmental Disabilities. 2001 November-December; 22(6): 44962. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11768670&dopt=Abstract
·
The enactive mind, or from actions to cognition: lessons from autism. Author(s): Klin A, Jones W, Schultz R, Volkmar F. Source: Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences. 2003 February 28; 358(1430): 345-60. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12639332&dopt=Abstract
·
The link between autism and skills such as engineering, maths, physics and computing: a reply to Jarrold and Routh. Author(s): Wheelwright S, Baron-Cohen S. Source: Autism : the International Journal of Research and Practice. 2001 June; 5(2): 2237. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11706868&dopt=Abstract
·
The long-term effects of auditory training on children with autism. Author(s): Bettison S. Source: Journal of Autism and Developmental Disorders. 1996 June; 26(3): 361-74. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8792266&dopt=Abstract
·
The NAS EarlyBird Programme: autism-specific early intervention for parents. Author(s): Shields J. Source: Prof Care Mother Child. 2000; 10(2): 53-4. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11040767&dopt=Abstract
·
The neuropathology of the autism spectrum disorders: what have we learned? Author(s): Bauman ML, Kemper TL. Source: Novartis Found Symp. 2003; 251: 112-22; Discussion 122-8, 281-97. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=14521190&dopt=Abstract
·
The path to care in autism: is it better now? Author(s): Smith B, Chung MC, Vostanis P. Source: Journal of Autism and Developmental Disorders. 1994 October; 24(5): 551-63. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7814305&dopt=Abstract
·
The pathophysiology and treatment of autism. Author(s): Posey DJ, McDougle CJ.
180 Autism
Source: Current Psychiatry Reports. 2001 April; 3(2): 101-8. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11276404&dopt=Abstract ·
Theory of mind abilities in individuals with autism, Down syndrome, and mental retardation of unknown etiology: the role of age and intelligence. Author(s): Yirmiya N, Solomonica-Levi D, Shulman C, Pilowsky T. Source: Journal of Child Psychology and Psychiatry, and Allied Disciplines. 1996 November; 37(8): 1003-14. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9119934&dopt=Abstract
·
Toward a theory of early infantile autism. Author(s): Moore DJ, Shiek DA. Source: Psychological Review. 1971 September; 78(5): 451-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=5165835&dopt=Abstract
·
Transdermal secretin for autism - a case report. Author(s): Lamson DW, Plaza SM. Source: Alternative Medicine Review : a Journal of Clinical Therapeutic. 2001 June; 6(3): 311-3. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11410075&dopt=Abstract
·
Understanding autism: insights from mind and brain. Author(s): Hill EL, Frith U. Source: Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences. 2003 February 28; 358(1430): 281-9. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12639326&dopt=Abstract
·
Unimodal and crossmodal reactivity in autism: presence of auditory evoked responses and effect of the repetition of auditory stimuli. Author(s): Martineau J, Roux S, Garreau B, Adrien JL, Lelord G. Source: Biological Psychiatry. 1992 June 15; 31(12): 1190-203. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=1391280&dopt=Abstract
Additional Web Resources A number of additional Web sites offer encyclopedic information covering CAM and related topics. The following is a representative sample: ·
Alternative Medicine Foundation, Inc.: http://www.herbmed.org/
·
AOL: http://search.aol.com/cat.adp?id=169&layer=&from=subcats
·
Chinese Medicine: http://www.newcenturynutrition.com/
·
drkoop.comÒ: http://www.drkoop.com/InteractiveMedicine/IndexC.html
Alternative Medicine 181
·
Family Village: http://www.familyvillage.wisc.edu/med_altn.htm
·
Google: http://directory.google.com/Top/Health/Alternative/
·
Healthnotes: http://www.healthnotes.com/
·
MedWebPlus: http://medwebplus.com/subject/Alternative_and_Complementary_Medicine
·
Open Directory Project: http://dmoz.org/Health/Alternative/
·
HealthGate: http://www.tnp.com/
·
WebMDÒHealth: http://my.webmd.com/drugs_and_herbs
·
WholeHealthMD.com: http://www.wholehealthmd.com/reflib/0,1529,00.html
·
Yahoo.com: http://dir.yahoo.com/Health/Alternative_Medicine/
The following is a specific Web list relating to autism; please note that any particular subject below may indicate either a therapeutic use, or a contraindication (potential danger), and does not reflect an official recommendation: ·
General Overview Autism Source: Healthnotes, Inc.; www.healthnotes.com Rubella Source: Integrative Medicine Communications; www.drkoop.com
·
Alternative Therapy Autism Alternative names: infantile autism Source: The Canoe version of A Dictionary of Alternative-Medicine Methods, by Priorities for Health editor Jack Raso, M.S., R.D. Hyperlink: http://www.canoe.ca/AltmedDictionary/a.html Facilitated Communication Alternative names: FC Facilitated Communication therapy facilitated communication training [FCT] Source: The Canoe version of A Dictionary of Alternative-Medicine Methods, by Priorities for Health editor Jack Raso, M.S., R.D. Hyperlink: http://www.canoe.ca/AltmedDictionary/f.html Massage Source: Integrative Medicine Communications; www.drkoop.com Massage Therapy Source: WholeHealthMD.com, LLC.; www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,716,00.html
182 Autism
Music Therapy Source: WholeHealthMD.com, LLC.; www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,719,00.html ·
Herbs and Supplements Melatonin Source: Integrative Medicine Communications; www.drkoop.com
General References A good place to find general background information on CAM is the National Library of Medicine. It has prepared within the MEDLINEplus system an information topic page dedicated to complementary and alternative medicine. To access this page, go to the MEDLINEplus site at http://www.nlm.nih.gov/medlineplus/alternativemedicine.html. This Web site provides a general overview of various topics and can lead to a number of general sources.
183
CHAPTER 4. DISSERTATIONS ON AUTISM Overview In this chapter, we will give you a bibliography on recent dissertations relating to autism. We will also provide you with information on how to use the Internet to stay current on dissertations. IMPORTANT NOTE: When following the search strategy described below, you may discover non-medical dissertations that use the generic term “autism” (or a synonym) in their titles. To accurately reflect the results that you might find while conducting research on autism, we have not necessarily excluded non-medical dissertations in this bibliography.
Dissertations on Autism ProQuest Digital Dissertations, the largest archive of academic dissertations available, is located at the following Web address: http://wwwlib.umi.com/dissertations. From this archive, we have compiled the following list covering dissertations devoted to autism. You will see that the information provided includes the dissertation’s title, its author, and the institution with which the author is associated. The following covers recent dissertations found when using this search procedure: ·
A Biopsychosocial Treatment Model for Older Autistic Children and Their Families by Snider Anderson, Joanna Lyn; Psyd from Spalding University, 2002, 118 pages http://wwwlib.umi.com/dissertations/fullcit/3065641
·
A Comparative Study of the Conversational Skills of Fragile-x, Autistic, and Down Syndrome Individuals by Ferrier, Linda J., Phd from Boston University, 1987, 225 pages http://wwwlib.umi.com/dissertations/fullcit/8715419
·
A Comparison of Individuals with Asperger Syndrome and Autism on Neuropsychological Measures Sensitive to the Ability to Shift Attention by Hanson, Ellen M.; Phd from Alliant International University, San Diego, 2002, 96 pages http://wwwlib.umi.com/dissertations/fullcit/3077368
·
A Comparison of One-to-one and Group Teaching Instructional Methods across Classrooms Serving Students with Autism and Other Developmental Disabilities by Walker, Dale, Phd from University of Kansas, 1988, 94 pages http://wwwlib.umi.com/dissertations/fullcit/8918424
184 Autism
·
A Comparison of One-to-one and Small Group Instruction for Young Children with Autism: Focus on Effective Teaching and Behavior Management by Bertsch, Kathy Marie; Phd from Western Michigan University, 2002, 113 pages http://wwwlib.umi.com/dissertations/fullcit/3077372
·
A Comparison of Prompt Delivery Procedures for Increasing Spontaneous Speech among Children with Autism by Harrower, Joshua Keith; Phd from University of California, Santa Barbara, 1999, 114 pages http://wwwlib.umi.com/dissertations/fullcit/9956155
·
A Comparison of Simultaneous and Most-to-least Prompting Procedures in Teaching Receptive Identification of Pictures to Toddlers with Autism by Boulware, Gusty-lee; Phd from University of Washington, 2001, 114 pages http://wwwlib.umi.com/dissertations/fullcit/3013933
·
A Comparison of Spoken Language Abilities in Children with Aphasia, Autism, Learning Disabilities, and Normal Language Abilities by Mcdonough, Dayle Davis, Phd from University of New Orleans, 1986, 162 pages http://wwwlib.umi.com/dissertations/fullcit/8625151
·
A Comparison of Teacher and Parental Expectations for Children with Autism by Ivey, Julie Kathryn; Phd from Oklahoma State University, 2001, 119 pages http://wwwlib.umi.com/dissertations/fullcit/3057279
·
A Comparison of the Attitudes of Parents Whose Children Are Diagnosed with Autism and of Parents Whose Children Are Diagnosed with Mental Retardation by Yeager, Mark Horren, Phd from The University of Southern Mississippi, 1998, 86 pages http://wwwlib.umi.com/dissertations/fullcit/9916049
·
A Comparison of the Spontaneous Utterances of Students with Autism across Two Educational Settings by Peterson, Mary E., Edd from Western Michigan University, 1996, 163 pages http://wwwlib.umi.com/dissertations/fullcit/9639811
·
A Descriptive Study of Parental Reports and Perceptions of Psychotropic Medication Prevalence, Patterns of Use, and Quality of Services in Autism Spectrum Disorders by Schall, Carol Marie; Phd from Virginia Commonwealth University, 2003, 251 pages http://wwwlib.umi.com/dissertations/fullcit/3080578
·
A Developmental Analysis of Joint Attention and Requesting Skills in Young Children with Autism by Paparella, Tanya; Phd from University of California, Los Angeles, 2000, 112 pages http://wwwlib.umi.com/dissertations/fullcit/9961641
·
A Follow-up Study of Autistic and Autistic-like Children by Mccallon, Denise, Phd from University of North Texas, 1988, 137 pages http://wwwlib.umi.com/dissertations/fullcit/8900360
·
A Functional Analysis of the Echolalic Behavior of Three Children with Autism in a Residential School Setting by Townsend, Bessie Juanita Kelsay; Phd from Mississippi State University, 2000, 87 pages http://wwwlib.umi.com/dissertations/fullcit/9970351
·
A Play-based Treatment Model for Improving the Social Play Development of Children with Autism Spectrum Disorder by Jelveh, Mojgan; Phd from University of California, Berkeley, 2002, 118 pages http://wwwlib.umi.com/dissertations/fullcit/3082243
Dissertations 185
·
A Review of the Texas Education Agency's Impartial Hearing Officers' Decisions in Autistic Cases from 1983 to 1994 and Their Relevance to Public School Administrators by Bossey, Consuelo Pauline, Edd from East Texas State University, 1994, 143 pages http://wwwlib.umi.com/dissertations/fullcit/9510957
·
A Socio-legal Study Within the Area of Autism. the Use of Law in an Environment of Knowledge Rivalry by Pfannenstill, Annika Susanne; Phd from Lunds Universitet (sweden), 2002, 214 pages http://wwwlib.umi.com/dissertations/fullcit/f1010273
·
A Study of Employers' Perceptions of the Most Essential Social and Behavior Skills Necessary for Individuals with Autism to Maintain Employment by Polignano, Maria L.; Edd from Seton Hall University, College of Education and Human Services, 1999, 136 pages http://wwwlib.umi.com/dissertations/fullcit/9956021
·
A Study of Moral Reasoning in Adults with Autism (reasoning) by Keel, Jill Hinton, Phd from The University of North Carolina at Chapel Hill, 1993, 70 pages http://wwwlib.umi.com/dissertations/fullcit/9415339
·
A Validation Study of a Jordanian Version of the Autism Behavior Checklist (abc) of the Autism Screening Instrument for Educational Planning (asiep) by Smadi, Jamil Mahmoud, Phd from Michigan State University, 1985, 89 pages http://wwwlib.umi.com/dissertations/fullcit/8520561
·
A Validity Analysis of Selected Instruments Used to Assess Autism by Teal, Madalyn Brand, Phd from Texas Woman's University, 1981, 106 pages http://wwwlib.umi.com/dissertations/fullcit/8201720
·
Accessibility of In-home Family Training Information for Autism: an Examination of Educational Preparation for Independent Living in Texas by Tepper, Bonita, Phd from Texas Woman's University, 1998, 99 pages http://wwwlib.umi.com/dissertations/fullcit/9916250
·
Acquisition, Maintenance, and Generalization of a Categorization Strategy by Children with Autism (learning Strategies) by Bock, Marjorie A., Edd from University of Kansas, 1990, 163 pages http://wwwlib.umi.com/dissertations/fullcit/9119049
·
Adaptive Behavior of Children with Infantile Autism Compared to Children with Down's Syndrome and Children with Schizophrenia (developmental Disability, Childhood Disorders) by Wood, Jesse David, Phd from Texas A&m University, 1984, 200 pages http://wwwlib.umi.com/dissertations/fullcit/8417790
·
Adults with Autism and Their Constructed Identities: a Qualitative Study (facilitated Communication) by Duncan, Janet Mary, Phd from Syracuse University, 1994, 193 pages http://wwwlib.umi.com/dissertations/fullcit/9522520
·
Adults with Autism Speak Out: Perceptions of Their Life Experiences by Hurlbutt, Karen S.; Phd from The University of North Dakota, 2000, 115 pages http://wwwlib.umi.com/dissertations/fullcit/9986531
·
Aerobic Exercise Related to Functional Aerobic Capacity, Repetitive/interfering Behavior, and Platelet Serotonin Concentration of Individuals with Autism by Schmidt, Gordon James, Phd from Indiana University, 1989, 221 pages http://wwwlib.umi.com/dissertations/fullcit/9020695
186 Autism
·
Affect Discrimination in Autism: Using a Learning Task to Assess Discrimination Strategies by Hogan, Kerry L.; Phd from Vanderbilt University, 2002, 154 pages http://wwwlib.umi.com/dissertations/fullcit/3058703
·
Affective Perspective-taking Skills in More Able Individuals with Autism by Negrishoultz, Nanette Alanna, Phd from The University of Wisconsin - Madison, 1987, 221 pages http://wwwlib.umi.com/dissertations/fullcit/8720822
·
An Analysis of Source Memory in Children with Pervasive Developmental Disorders by O'shea, Angela Garcia; Phd from The University of Connecticut, 2003, 68 pages http://wwwlib.umi.com/dissertations/fullcit/3089756
·
An Analysis of the Validity of the Definition of Autism by the National Society for Autistic Children by Bauer, Anne Marie, Edd from Southern Illinois University at Edwardsville, 1983, 347 pages http://wwwlib.umi.com/dissertations/fullcit/8311395
·
An Applied Behavior Analysis After-school Program to Treat Autistic Children and Educate Their Parents by De La Osa, Dagmary; Psyd from Carlos Albizu University, 2002, 153 pages http://wwwlib.umi.com/dissertations/fullcit/3077970
·
An Empirical and Social Validation of Response Covariation in the Reduction of Aberrant Behavior in an Autistic Boy (stereotypic, Auditory Feedback, Autism, Symptom Substitution, Collateral Effects) by Gunter, Philip Lee, Phd from Vanderbilt University, 1984, 80 pages http://wwwlib.umi.com/dissertations/fullcit/8522471
·
An Examination of Adaptive Functioning in Children and Adolescents with High Functioning Autism and Asperger's Syndrome by Kopp Smily, Julie Meredith; Phd from The George Washington University, 2003, 52 pages http://wwwlib.umi.com/dissertations/fullcit/3075192
·
An Exploration of Alternative Treatment Use in Young Children with Autistic Spectrum Disorders by Erba, Heather Whiteford; Phd from The University of North Carolina at Chapel Hill, 2000, 171 pages http://wwwlib.umi.com/dissertations/fullcit/9993303
·
An Innovative Approach for Children with Autism Spectrum Disorders: a Preliminary Outcome Evaluation by Shade-monuteaux, Dena Michelle; Phd from Tufts University, 2003, 70 pages http://wwwlib.umi.com/dissertations/fullcit/3074510
·
An Investigation of Paraprofessional Training to Facilitate the Inclusion of Young Children with Severe Multiple Disabilities and Autism in Community Preschools (mainstreaming) by Wickham, Donna Ruth, Phd from University of Kansas, 1993, 227 pages http://wwwlib.umi.com/dissertations/fullcit/9425972
·
An Investigation of the Effectiveness of Touchmath on Elementary Students with Autism by Barry, David Kurt; Phd from The Claremont Graduate University, 2001, 166 pages http://wwwlib.umi.com/dissertations/fullcit/9998941
·
An Observational Study of the Interactions of a Child with Learning and Communication Difficulties Associated with Autism and a Nonhandicapped Child
Dissertations 187
When Interacting with Family Members by Murphy, Molly Elizabeth, Phd from The University of Wisconsin - Madison, 1989, 349 pages http://wwwlib.umi.com/dissertations/fullcit/8923807 ·
An Observational Study of the Interactions of Autistic Children and Their Families in the Natural Home Environment by Anderson, Jacki Lynn, Phd from The University of Wisconsin - Madison, 1982, 196 pages http://wwwlib.umi.com/dissertations/fullcit/8225629
·
Analysis of Critical Skills Used by Educators of Students with Autism by Bunsen, Teresa Dawn, Phd from University of North Texas, 1989, 134 pages http://wwwlib.umi.com/dissertations/fullcit/9005314
·
Analysis of Social Referencing Skills in Children with Autism by Brim, Devorah; Phd from City University of New York, 2002, 74 pages http://wwwlib.umi.com/dissertations/fullcit/3063808
·
Analyzing the Effects of Self Recording on Teacher Use of Incidental Teaching Procedures to Teach Language to Children with Autism by Vener, Susan Melissa; Phd from City University of New York, 2002, 124 pages http://wwwlib.umi.com/dissertations/fullcit/3037451
·
Anxiety in Individuals with Autism Spectrum Disorders: the Role of Social Skill Deficits by Bellini, Scott Curtis; Phd from Indiana University, 2002, 158 pages http://wwwlib.umi.com/dissertations/fullcit/3075930
·
Are Social Stories Effective in Modifying Behavior in Children with Autism? by Romano, Jeanne; Psyd from Fairleigh Dickinson University, 2002, 70 pages http://wwwlib.umi.com/dissertations/fullcit/3044313
·
Are There Identifiable Factors in Autism Which Can Predict Outcome and Are Outcomes Changing? (developmental Disabilities, Handicapped, Teaching) by Sullivan, Ruth Christ, Phd from Ohio University, 1984, 133 pages http://wwwlib.umi.com/dissertations/fullcit/8504156
·
Assessment of Cognitive Abilities in High-functioning Children with Autistic Disorder: a Comparison of the Wisc-iii and the Leiter-r by Hanzel, Elise Phelps; Phd from Alliant International University, San Diego, 2003, 159 pages http://wwwlib.umi.com/dissertations/fullcit/3083449
·
Assessment of Discrimination Skills in Individuals with Autism: Validity of the Assessment of Basic Learning Abilities (abla) by Condillac, Rosemary Antoinette; Phd from University of Toronto (canada), 2002, 195 pages http://wwwlib.umi.com/dissertations/fullcit/NQ74662
·
Attachment and Social Relatedness in Autism by Vanmeter, Lori Ann, Phd from The University of Connecticut, 1995, 74 pages http://wwwlib.umi.com/dissertations/fullcit/9539530
·
Attachment Behaviors in Children with Autism by Spencer, Amelia Gunn, Phd from The University of North Carolina at Chapel Hill, 1993, 98 pages http://wwwlib.umi.com/dissertations/fullcit/9324104
·
Attitudes toward and Applications of Facilitated Communication in Greater Chicago (illinois, Autism) by Kopnick, Nancy Magnus, Phd from University of Illinois at Chicago, Health Sciences Center, 1995, 237 pages http://wwwlib.umi.com/dissertations/fullcit/9544346
188 Autism
·
Auditory Brainstem Evoked Response: Comparative Analysis of Autistic, Mentally Retarded, Normal Children and Normal Toddlers by Arick, Joel Robert, Phd from University of Oregon, 1981, 84 pages http://wwwlib.umi